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ABSTRACT 
The Roma (Gypsies) are a European people composed of a mosaic of culturally 
heterogeneous populations. Linguistic analyses point to their origins in the Indian 
subcontinent. Cultural diversity in extant Romani populations suggests that they are 
descended from a mixture of Indian populations. Previous population genetic studies of 
the Roma have supported this claim by demonstrating the genetic heterogeneity of 
Romani populations. More recently, medical genetic research has detected identical 
founder mutations in separated Romani populations, which provides evidence of their 
relatedness. In this thesis, the genetic· heritage of the Roma and its significance for 
genetic disease and research is investigated. Male and female lineages were analysed in 
eight traditionally endogamous Romani populations. Asian specific Y chromosome 
haplogroup VI-68 and mitochondrial DNA (mtDNA) haplogroup M were detected in all 
populations and accounted for 39% and 25% of all lineages respectively. Diversity 
within haplogroups was assessed by genotyping Y chromosome short tandem repeats (Y 
STRs) and sequencing the mtDNA hypervariable segment 1 (HVSl). Lineages within 
haplogroups VI-68 and M were found to be closely related suggesting that Romani 
populations are predominantly descended from a single Indian ethnic population. The 
differing historical legacies of Romani populations and adherence to endogamous 
practices have resulted in genetic substructure and limited diversity within populations. 
Thus, the Roma are shown to comprise a conglomerate of related admixed population 
isolates. The unique genetic heritage of the Roma provides a powerful tool for the 
positional cloning of monogenic disease genes. This is demonstrated through the 
reduction of the critical chromosomal region for a novel genetic disorder, hereditary 
motor and sensory neuropathy type Lorn (HMSNL). In the initial report, the HMSNL 
disease locus was defined as a 3cM region on chromosome 8q24. In this study, refined 
genetic mapping utilising historical and parental recombinations observed in Romani 
individuals from different populations reduced the HMSNL critical interval to 202kb. 
Sequence analysis of two genes contained within this genomic interval found all affected 
individuals to be homozygous for a C--tT mutation in codon 148 of N-myc downstream 
regulated gene 1 (NDRGJ), resulting in a truncating Rl48X mutation. Investigation of 
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the population distribution of the R148X disease allele shows that it occurs in six of 
eight separated Romani populations. Another founder mutation, C283Y in the y-
sarcoglycan gene (SGCG), which causes limb girdle muscular dystrophy type 2C 
· (:tGMD2C), was found in two of eight Romani populations. Profound founder effects 
are apparent within Romani populations with a carrier frequency of 19.5% determined 
for the R148X mutation in the Lorn population, and 6.25% for the C283Y allele in the 
Turgovzi population. High carrier frequencies for autosomal recessive diseases can be 
expected to pose a significant health risk for these communities. Thus, community-wide 
carrier testing represents a potential means of addressing this health problem. A pilot 
community based carrier-testing program was implemented in a Romani community of 
northeastern Bulgaria and relevant attitudes assessed by means of a questionnaire. 
Community-based carrier screening was demonstrated to be an appropriate approach to 
improving health amongst the Roma. 
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INTRODUCTION 
Human populations that are genetically isolated by geography or culture provide 
a unique resource for identifying the genetic basis of Mendelian disorders. In these 
populations, there is typically a reduction in the diversity of factors underlying inherited 
disease. In addition, monogenic traits that are otherwise rare or absent in other 
populations often occur at increased frequencies. This combination of factors permits 
approaches to the discovery of disease genes in population isolates that are inapplicable 
in heterogeneous populations. Determination of these gene defects generally leads to 
diagnostic and predictive testing tools .and rational approaches to disease management. 
In addition, the identification of malfunctioning genes provides an entry point from 
which gene function and cellular processes can be investigated. Therefore, knowledge 
gained from studies of rare genetic diseases in minority populations extends beyond the 
scope of the specific disorder. 
During the last ten to fifteen years, studies of Mendelian disorders in population 
isolates have been successful in identifying a large number of novel disease genes. 
Frequently, the success of these studies ·has required the construction of hypotheses 
informed by knowledge of population history and social structure. The investigation of 
polymorphic genetic markers provides a means of correlating history and social 
phenomena with the genetic composition and structure of populations. Knowledge 
gained from such investigations has been essential to the design of studies that seek to 
determine the aetiology of genetic disorders within the population. At-the same time, 
studies of heritable markers within a population can serve to illuminate its history, which 
otherwise may remain ill defined in the absence of historical or archaeological records. 
Through the characterisation of genetic variation, the origins, histories and social 
practices of a population can be inferred. Using molecular genetic tools, it is now 
possible to examine questions of varying depths in time, and to compare the possibly 
contrasting histories of males and females within a population. 
Scriver (1992) has distinguished two causative factors resulting in the 
manifestation of genetic disease. The ultimate cause is the biological component, 
namely the disease gene. The more proximate causes are dependent on the 
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circumstances of an individual s life. At a population level, the proximate causes of a 
particular genetic disorder include demographic circumstances and cultural practices. 
Hence, the investigation of genetic disease within populations requires the combined 
study of biological and social phenomena. My personal interests lie in biochemistry and 
molecular genetics, and in anthropology and archaeology. The study of genetic 
variation and disease in human populations represents a field in which these seemingly 
disparate disciplines can be integrated. Whilst I am fascinated by the physical 
phenomena that constitute life at the cellular level, my particular passion is discovering 
the rich diversity within human populations and in their histories, their cultures, and 
their legacies. Thus, in this doctoral thesis I have attempted to conduct a study that 
encompasses my diverse interests through the examination of the proximate and ultimate 
causes of genetic disease. 
From a variety of perspectives, the Roma of Europe are a complex and 
fascinating study population. On the basis of linguistics and social anthropology, 
Romani populations are believed to have originated in the Indian subcontinent and 
historical records point to their arrival in Europe at least 800 years ago (Fraser, 1992). 
The legacy of the Roma in Europe has been one of marginalisation and persecution 
which, combined with a strong internal social cohesion manifest in the practice of 
endogamy, has resulted in the maintenance of group identities distinct from those of 
other European populations. Today, the extant Romani populations of Europe represent 
an amalgam of geographically and socially separated groups. These groups are 
culturally diverse, with complex intergroup affinities that often exclude n~ighbouring 
I 
communities while transcending national boundaries. The historical relatedness of these 
many groups has hitherto remained unclear. 
Previous genetic studies of the Roma have demonstrated that the social and 
cultural diversity of specific sub-populations is reflected in their genetic composition. 
Numerous studies of the Roma have sought evidence of biological affinities with Indian 
populations. However, the heterogeneity of Romani populations and the methodologies 
employed in these studies have effectively precluded the formation of rigorous 
conclusions regarding the population origin of the Roma. Many studies purport to show 
that Romani groups are genetically distinct from other European populations, and 
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comparisons between different Romani populations suggest that many are only distantly 
related. This conclusion is not supported by the presence of identical founder mutations 
in geographically (Abicht et al., 1999; Lasa et al., 1998; Piccolo et al., 1996; Todorova, 
Ashikov, Beltcheva, Toumev, & Kremensky, 1999) and socially (Kalaydjieva et al., 
1996) separated Romani populations, which provides evidence of their genetic 
relatedness. Thus, the precise nature of the genetic relationships between Romani 
populations remains unclear. 
Illumination of the genetic structure of the Roma can be expected to be of benefit 
to research into genetic disorders in these populations. Novel genetic disorders 
identified in the Roma have all shown evidence of homogeneous aetiologies 
(Angelicheva et al., 1999; Kalaydjieva et al., 1996; Rogers et al., 2000). However, the 
appropriate strategies for refining genomic regions and elucidating the causative gene 
defects in the Roma have been unknown. Although identical disease-causing mutations 
have been identified in different Romani populations, their distribution has not been 
systematically examined. Knowledge of the distribution of deleterious alleles in the 
Roma should provide a useful resource for disease diagnosis and predictive testing. 
Populations in which specific disease alleles occur at high frequencies lend themselves 
to targeted carrier testing. This has never been undertaken in Romani populations and 
thus the appropriate approach, and the salient social and psychologjcal factors that 
would impact on predictive testing, are yet to be determined. 
In this thesis, I have explored the hypothesis that separated Romani populations 
comprise a mosaic of related genetic isolates. Through the use of molecular genetic 
tools, the origin and nature of the genetic heritage of the Roma has been examined. The 
populations included in the study are culturally and geographically diverse allowing an 
examination of the relationship between social and genetic structure. I hypothesise that 
knowledge of the genetic structure of the Roma is a useful tool for application to the 
positional cloning of disease genes. Furthermore, this structure is predicted to impact on 
the distribution and frequency of disease alleles, and therefore is an important 
consideration in approaches to predictive testing and health. To investigate the central 
hypothesis of the thesis and associated issues, I have considered specific aspects of 
genetic variation and disease in the Roma. These are represented by four inter-related 
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studies that collectively form a complementary approach to the study of proximate and 
ultimate causes of genetic disease in the Roma. In the body of the dissertation, these 
studies are presented in the following format: 
In section I, the genetic composition, structure and diversity of the Roma is 
assessed through the characterisation of maternal and paternal lineages. This allows 
insights into sex-specific histories and social practices. Comparison of these lineages 
with other worldwide populations provides a means of disentangling population origins. 
Within the Roma, the examination of lineages in different populations affords insights 
into their relatedness, and their differing historical legacies. Analysis of lineages within 
Romani populations examines the implication of the cultural practice of endogamy on 
intrapopulation genetic diversity. 
In section II, the relevance of genetic structure in the Roma to the investigation 
of genetic disease is examined. This is achieved through the refined genetic mapping 
and positional cloning of the gene defect underlying a novel autosomal recessive genetic 
disorder, hereditary motor and sensory neuropathy type Lorn (HMSNL). HMSNL was 
first identified by Kalaydjieva et al., (1996) with a conserved disease haplotype spanning 
3cM on chromosome 8q24 pointing to an identical founder mutation in three socially 
separated Romani populations. In that study, limited haplotype diversity within a large 
kindred was useful for mapping the disease gene. However, the refinement of a disease 
locus requires variation in disease chromosomes that has resulted from recombination. 
Thus, the most appropriate approach to identifying the disease gene was not immediately 
apparent. In this study, I examine the relevance of population history and structure to 
refined genetic mapping and positional cloning in the Roma. 
Section III comprises an investigation of the history and distribution of disease 
alleles in different Romani populations. Haplotype analysis provides a means of tracing 
the evolution and history of a mutation within populations. This approach allows 
additional insights into population history, thus complementing the use of paternal and 
maternal lineages described in section I. Furthermore, the history and diversification of 
disease haplotypes is an important consideration for disease gene mapping and 
positional cloning. This history is also related to the distribution of disease alleles. 
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Systematic examination of disease alleles in different Romani populations is useful for 
diagnostic purposes and the design of carrier testing programs. 
In section IV, a pilot genetic carrier screening study for a private mutation 
causing limb girdle muscular dystrophy type 2C (LGMD2C) is described and assessed. 
Genetic determinants are usually traced within families; however, a high disease allele 
frequency within an isolated Romani population has been shown to result in an entire 
population being at increased risk for a rare genetic disorder (Plasilova et al., 1999). In 
such cases, it is possible that carrier testing should not be limited to family members of 
index cases, but provided to entire communities. Effectiveness of carrier testing within a 
community is largely dependent on the prevailing cultural and psychological attitudes 
within the community. To investigate these attitudes, I have analysed the results of a 
questionnaire administered to the Romani community participating in the pilot carrier 
testing study. 
The four sections of the thesis provide a comprehensive approach to the study of 
genetic variation and disease in the Roma and are presented in a natural order that allows 
the knowledge gained in each study to be applied to the following section(s). It should 
be noted that the sections have not been presented in the strict order in which the studies 
were performed and where possible, I have attempted to avoid repetition of data and 
ideas from each section. At this point it is also worth mentioning the use of terminology 
within the thesis. The term Gypsy has derogatory connotations that merit its 
discontinuance. Therefore, I have used the term Roma as the noun describing the 
population of study. The adjective used to describe the population is Romani. To avoid 
confusion, I refer to the language spoken by these people as Romany. 
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CHAPTER I 
REVIEW OF LITERATURE ON THE ROMA 
1.1 History Of The Roma 
1.1.1 Introduction 
The Roma are a people found throughout Europe and former European colonies. 
The total size of the Romani population is difficult to determine, but estimates range 
from 4 to 10 million within Europe (Fraser, 1992; Liegeois, 1994) and possibly 12-15 
million worldwide (Liegeois, 1994). The Roma comprise numerous socially and 
culturally distinct groups. These groups may live in close geographical proximity but 
speak different dialects and languages, practice different traditional trades, conform to 
different religions, adhere to different cultural customs and have vastly different 
historical legacies. At the same time, many Romani populations have retained cultural 
characteristics that are common to disparate groups. Salient commonalties include the 
Romany language in its many dialects, the preservation of the "Group", and cultural 
features such as strict hygiene laws and a belief in spiritual power and fate (Rishi, 1976). 
For much of their history in Europe, the Roma have been the target of state-sanctioned 
discriminatory policies and faced persecution from neighbouring peoples. Therefore, 
whether by choice or of necessity, the Roma have lead a largely peripatetic existence 
(Fraser, 1992). The adoption of specialised trades required by the macro-society 
enabled the Roma to fill economic niches. Today, the Roma have generally adopted 
sedentary lifestyles and abandoned their traditional trades. Nevertheless, significant 
migrations still occur in present times, typically as a result of social upheavals in the 
macro-society. Recent examples of events precipitating major migrations of Romani 
people include the political changes in Eastern Europe in the early 1990s and the 1999 
war in Kosovo. 
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The origins of the Roma have been a disputed academic and social question 
virtually since their appearance in Europe. The Roma have no historical records and it is 
generally believed that they are unaware of their origins. According to Fraser (1992) 
three scholars are credited with more or less simultaneously identifying Romany as 
having Indo-Aryan roots; Vali (1753-4), Rudiger (1782) and Bryant (1785). However, 
the use of linguistics to study the Roma did not enter the realm of serious scholarship 
until 1870 when the gypsiologist, Paspati, stated that "thekey to the history of the Roma 
should be sought in the study of the Romany language" (Fraser, 1992). Thus, for the 
past 150 years and largely on the basis of linguistic evidence, the Roma have been 
considered as being of Indian origin. Some researchers have disputed this claim, for 
example Okely (1983), who contends that the British Roma are displaced serfs from the 
agricultural revolution. The issue is not unimportant since, according to the Romani 
scholar Ian Hancock (1991), the claims of European origins of the Roma imply that the 
historical and current practices of discrimination against them are based on social, rather 
than racist grounds. 
Discriminatory practices against the Roma have been common throughout their 
history in Europe. At one time or another, in many of the countries of Europe it has 
been illegal to be a "Gypsy" and such a crime was punishable by death. Policies and 
practices of forcible expulsion, internment, sedenterisation, assimilation and 
extermination have ensured that the Gypsies have been oppressed for the majority of 
their history in Europe. This has been punctuated by particularly heinous atrocities, such 
as the 500 years of enslavement in the Danubian principalities of Wallachia and 
Moldavia and the annihilation of the Roma during the Third Reich. Genetic studies 
played a notorious role in the Holocaust (referred to by the Roma as the Pojaramos, the 
Great Devouring) through the "scientific" classification of people of "Gypsy blood" 
bound for the death camps (Muller-Hill, 1998). 
1.1.2 On the Origins and Exodus of the Roma 
Original historical records, which describe the Roma, generally refer to them as 
being of Egyptian ancestry. However, scholars have discounted these records as 
perpetuating a historical misnomer. It is possible that this arose because one of the first 
7 
places in Europe where the Roma resided was known as Little Egypt in Greek Albania 
(Fraser, 1992). However, it is also likely that the foreign immigrants were simply 
deemed to be Egyptians due to their physical appearance. This incorrectly ascribed 
Egyptian origin is believed to provide an explanation for the etymology of the Greek 
word, Astinagoi, the English word, Gypsy, and related appellations in other languages 
(eg. Tsigani, Gitano). 
In the absence of a written history, evidence for an Indian origin of the Roma has 
been sought in a variety of social and cultural domains. Several scholars have claimed 
that the cultural practices of the Roma provide the most irrefutable evidence of Indian 
origins. Hancock (1999a) states that [i]t is in the area of spiritual and physical well-
being that the Indian origin of the Romani people is most clearly seen . Marushiakova 
and Popov (1997) have claimed that the Gypsy group [provides] the most convincing 
evidence of the Indian origins of the Roma. Other shared social and cultural practices 
with Indian populations are found in marriage customs, female warrior goddess worship 
(Shaktism), hygiene laws and, according to one author, a love of buffalo milk (Rishi, 
1976). Similarly, parallels between musical styles used by populations in India to those 
of the Romain Europe suggest at least cultural if not ethnic affmities (Gatliff, 1993). 
Linguistic analyses have thus far provided the most robust and informative 
evidence regarding the Indian origin of the Roma. The similarities between Romany 
and Sanskrit were first noted over 200 years ago. Since then, linguistic analyses have 
been used to reconstruct the time and route of migration from India and to refine the 
origin of the Roma within Indian populations. Whilst Romany holds many similarities 
to Sanskrit, it also has similarities to more modern Indic and Dardic languages, 
indicating that Romany dates from post-Sanskrit times (Fraser, 1992). Hancock (2001a) 
has asserted that the distribution of genders in the Romany language points to a 
departure from India after 1000AD. However, others have concluded that the proto-
Roma had moved out of India into Persian territories before 300 BC (Kaufman, 1984). 
Support for claims of an early Indian exit is weak and, although the time of departure 
from India remains unresolved, there is general agreement that it occurred around 1,000 
years ago. 
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No historical records from India have ever been shown to describe the Roma and 
their emigration from India. Therefore, the reasons that the Roma left India, and with 
which populations in India they are most closely related, are the subjects of much 
speculation. One commonly retold scenario, which has entered popular folklore, 
contends that the Roma are descended from 10,000 musicians that were given as a gift to 
Bahram Gur, the ruler of Persia, in 439 AD (Fraser, 1992). Today, people known as the 
Luri, who speak an Indian-based language, live throughout the Middle East and are 
believed to be descendants of those Sindhian musicians (Hancock, 1999a). Whilst this 
has been proposed as an explanation for the origins of the Roma, others claim that the 
Luri are of no relation to the European Roma (Hancock, 1999a). 
Within India, possible ethnic affiliations have been suggested to a nomadic 
people, the Dom, who are a caste of musicians (Fraser, 1992). However, this assertion 
appears to be based only on the superficial similarity between the word Dom and Rom. 
Moreover, Fraser (1992) himself states that too often the assumption has been 
made that any reference to a migrant group pursuing a Gypsy-like occupation can for 
that reason be equated with them . 
Another hypothesis asserts that the Roma are derived from a high caste warrior 
group. Hancock ( 1999b) has rejuvenated this hypothesis, now over a century old, which 
claims that the Roma are descendants of an Indian military force comprised of a 
conglomerate of non-Aryan people. This military group was called the Rajputs, but also 
contained individuals from the Lohars, Gujjars, Tands, and Siddhis (Hancock, 1999b). 
In addition, Hancock (1999b) proposes the inclusion of East Africans immigrants in the 
military force. The aim of the assembled force was to fight off the incursion of the 
Islamic forces of Mahmud of Ghazi. This campaign was eventually unsuccessful and 
the Rajputs were forced to exit India via the Hindu Kush. As they moved further from 
India, class distinctions became less clear and the traditional jatis, the sub-caste 
groupings, all but disappeared. Thus, the Roma reached Europe as a socially cohesive 
group of people of relatively diverse ethnic origins. 
As evidence for this claim ofheterogeneous population origins, Hancock (2000) 
has argued that the Romany language is a koine, a product of the mixing of linguistic 
subsystems, which emerged outside of India. Though a military origin of the Roma is 
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not widely accepted, there is general consensus that the proto-Roma were ethnically 
diverse. Indeed, it has been asserted that [m]ost scientists think that Gypsies belonged 
to the lowest social layer in their homeland and did not constitute a separate ethnic 
group (Marushiakova & Popov, 1997). Claims of heterogeneous origins of the Roma 
present the possibility that a number of independent migrations by Indian populations 
may have occurred. However, this theory has not been widely promoted amongst 
Romani scholars. 
Linguistic analysis has been applied to reconstruct the migration route followed 
by the Roma from India to Europe. Hancock (1999a) has summarised a possible route 
out of India on the basis of acquired linguistic features found in present-day Romany 
(figure 1-1). This reconstruction relies on the assumption that no major changes in 
linguistic territories have occurred. According to work performed by Hancock and 
others, the migrants passed through the Hindu Kush, along the southern shoreline of the 
Caspian Sea and through Persian linguistic territory. Fraser (1992) suggests a prolonged 
stay in Persia based on the presence of a significant number of Persian loanwords in 
Romany. Conversely, the absence of any Afghani contribution to the language provides 
evidence of this region having been avoided (Lee, 1998). This is compatible with claims 
that the Roma were a military force as Afghani territory was home to the Islamic 
invaders. The migrants continued through the southern Caucasus spending a 
considerable amount of time in Armenia, as evidenced by the significant number of 
Armenian loanwords in Romany (Fraser, 1992). The invasion of Armenia by the Seljuk 
Turks possibly provided the impetus to move into the Asian regions of the Byzantine 
Empire (Marushiakova & Popov, 1997) and further still into Europe (Fraser, 1992; 
Marushiakova & Popov, 1997). A large Medieval Greek contribution points to the 
likelihood that considerable time was spent within the Byzantine Empire before the 
Roma dispersed throughout Europe (Fraser, 1992; Hancock, 1999a). 
Competing claims that Gypsies are a behaviourally defined segment of the 
European population have been alluded to since the early 1500s (Hancock, 2001 b). The 
anthropologist Judith Okely (1983), has asserted that the Roma represent displaced serfs 
from the agricultural revolution. The contention of this theory is that peasant workers 
who were unable to adapt to the upheaval of the agricultural revolution assumed a 
10 
nomadic existence. The hypothesis of indigenous European ancestry of the Roma has 
found support amongst linguists (Wexler, 1997) and· other scholars (Sandland, 1996) 
who are critical of the evidence of Indian origins. Okely (1983) claims that the Indian 
origins have been used to provide the Roma with a mythical charter and are spawned by 
the exoticisation of the Roma by non-Romani researchers. The implicit premise of this 
theory is that the Roma stem from an indigenous European social class rather than a 
non-European ethnic group. It is possible that this theory is symptomatic of the 
complexity of European itinerant groups. Several other populations are found in 
Europe, besides the Roma, who lead a nomadic existence. These include groups such as 
the Travellers in Ireland, the Tartars in Scandinavia, the woowagenbewoners in 
Holland, and the quinquis of Spain (Fraser, 1992). Contacts between the Roma and 
some of these groups are evident from the existence of Romani loanwords in their 
vocabulary. However, whether such groups are genetically related to the Roma is not 
known. Therefore, a theory of European origins of the Roma may be a result of 
incorrect extrapolations from findings in other itinerant groups, since much of Okely s 
work is based in the United Kingdom where there may be Gypsies who are not related 
to the Roma. 
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Figure 1-1 Migration Route of the Roma. The migration route of the Roma from India to Europe has been reconstructed on the 
basis of linguistic analysis. 
in Romany. 
Extended stays in Persia (Iran) and Armenia are supported by significant representation of these languages 
1.1.3 Early Historical Records of the Romain Europe 
The earliest possible reference to the Roma in Europe comes from monastic 
records in Constantinople in 1068 AD (Fraser, 1992). However, this is not consistent 
with the suggestion that the Roma fled Armenia following the invasion by the Seljuk 
Turks in 1071 AD (Fraser, 1992; Marushiakova & Popov, 1997). The next historical 
reference that clearly refers to the Roma in the Byzantine capital dates to the 1 th 
century (Fraser, 1992). Reconstructions from historical records suggest the Roma 
proceeded into Thrace and Greece and then further into the Balkans. Church records 
point to the settlement of the Roma tln:oughoutthe Balkans in the 13th and 14th century 
with possible earlier incursions (Marushiakova & Popov, 1997) .. In Serbia, the earliest 
historical records of the Roma date to 1348 AD and 1362 AD (Fraser, 1992). In 1378 
AD, the Bulgarian Tsar is recorded as giving some villages, partly inhabited by 
sedentary Roma, to the Rila monastery (Fraser, 1992). The Roma are first described in 
the Danubian principalities ofWallachia and Moldavia in 1385 AD (Fraser, 1994). The 
first tax registry taking the Roma into account in Rumelia (the Balkan provinces of the 
Ottoman Empire) dates from 1475 (Marushiakova & Popov, 1997). 
Based on historical records, the penetration of the Roma into Western Europe 
appears to have begun during the 15th century. The Roma are first described in German 
records in 1407 AD (Hancock, 1991) and in France in 1419 AD (Fraser, 1992). The first 
document providing evidence of the Romain Spain is dated 1425 AD, when King Juan 
II of Aragon provided a pass for travelling Roma (Fraser, 1992). Thus, by the mid-
fifteenth century, historical records indicate the presence of Roma throughout Western 
Europe. It is apparent that this movement was followed by more widespread migrations 
into Europe, as the Roma are first mentioned in England and Poland-Lithuania in the 
early 1500s (Patrin, 1999). Historical records from this early period of residence in 
Western Europe invariably describe the Romani populations as comprising 30-400 
people lead by a Duke or King and presenting letters of Imperial (or even Papal) 
safe conduct, which introduced them as penitents wandering the world to expiate their 
sins (Fraser, 1992). Fraser (1992) has described this period as a sort ofreconnaissance 
conducted by numerous bands with a seeming unity of action and close connection with 
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each other . The historical descriptions of small groups are of particular relevance for 
genetic studies, as this population segmentation provided the template from which 
current population structure was forged. 
Early historical descriptions in Europe do not record the Roma as being Indian 
migrants. Where their origins are recorded they are usually described as being Egyptian. 
However, India was certainly not an unknown entity to Europe at that time. Indeed, the 
1492 voyage of Columbus set out with the express aim of finding a passage to India. 
Contact between India and the Phoenicians dates to as early as 925 BC (Rawlinson, 
1975). The earliest contact between India and Greece occurred about 510 BC and 
Indians formed part of the Persian tp.ilitary force that invaded Greece in 480 BC 
(Rawlinson, 1975). In 305 BC, the marriage between a member oflndian royalty and a 
Greek princess cemented a political alliance (Rawlinson, 1975). Thus, contact between 
Europe and India would have existed for well over a thousand years before the proposed 
arrival of the Roma in Europe. It is perplexing that Indian immigrants were not 
recognised as such, despite the social and cultural evidence. 
1.1.4 History of Roma in Europe: 1500AD to Present 
A historical overview of the last 500 years of the Roma in Europe would be 
extensive and is beyond the purpose of this thesis. However, several historical events 
can be expected to have profoundly impacted on the genetic composition of the Roma 
and are outlined below. 
The present day distribution of the Roma can be considered as the product of 
four major migrations (figure 1-2). The first was the arrival of the Romain the Balkans 
during the lih and 13th centuries. Roma who have remained there ever since are 
referred to as the Balkan Roma. This was followed by the migration of Roma into 
Western Europe, during the 15th and 16th centuries. The third major migration followed 
the emancipation of the Roma from slavery in Wallachia and Moldavia in the mid-
nineteenth century (Marushiakova & Popov, 1997). During this migration, Roma 
moved south into the Balkans and west into Europe in a process that resembled the 
initial westward migration of the Roma some 400 years earlier (Fraser, 1992). The 
populations that have migrated from the Danubian principalities are known as the Vlach 
14 
Roma. A fourth major migration has occurred in response to the political upheaval in 
Eastern Europe during the early 1990s and continues to this day. During this period, 
Roma have again moved into Western Europe and beyond to North America and 
Australia. These four migrations provide a historical framework in which the gross 
demography of the Roma can be framed. However, they should be understood as 
amplifications of a continual process of population redistribution through migration. 
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Figure 1-2 Major migrations of the Roma within Europe. These migrations have shaped the main population groupings of the 
Roma into Balkan, West European and Vlach Roma. 
From at least as early as the 151h century penetrations into Western Europe, the 
Romani population has been undergoing a process of population fission. Some Romani 
groups sedenterised soon after their arrival in Europe and others settled at different 
stages thereafter. Many Romani groups, however, have led a nomadic existence for the 
majority of their time in Europe. The adoption of a mobile existence and the practice of 
specialised trades, such as metal-working or horse-trading, allowed them to coexist with 
the often hostile macro-society. This mode of existence, in which population size was 
kept small and mobile, is possibly a result of the persecution that the Roma faced 
throughout much of Europe beyond the Ottoman Empire. Indeed, their very [s]urvival 
rested upon separating into small groups and living unobtrusively on the edges of the 
gadzikano (i.e. non-Roma) society (Hancock, 1991). The period spanning 1550 to the 
late 1700s marked a distinct hardening in attitudes toward the Roma and the introduction 
of laws that would have resulted in their extermination if they had been successfully 
implemented (Fraser, 1992). During this time the Roma were variably interned, 
expelled, forced into servitude, forcibly assimilated or killed for the crime of being a 
Roma. It is an interesting historical footnote that in this period one of the policies 
adopted by both Spain and Portugal was the shipping of many of their resident Roma to 
their nascent colonies in South America and, in an ironic practice, to the Portuguese 
colony of Goa in Western India (Fraser, 1992). 
In contrast to the maltreatment of the Roma in Western Europe during this time, 
Roma within much of the Ottoman Empire were left relatively unmolested (Fraser, 
1992). The Ottomans remained largely uninvolved i11. the affairs of their subject states. 
Whilst this meant that there was no legislature discriminating against Roma in much of 
the Balkans, slavery in the vassal states of Wallachia and Moldavia continued unabated 
(Crowe, 1991 ). Romani slaves in these two principalities fell into three categories; 
slaves of the Crown, slaves of the monasteries and slaves of the estate owners (Fraser, 
1992). The slaves of the Crown comprised numerous groups including the Ursara 
(bear-trainers), the Lingurara (wood-workers), the Aurara/Rudara (gold miners), and 
the Laiesi who had no fixed occupation and were able to roam the principalities (Fraser, 
1992). Many of the contemporary divisions of Vlach Romani groups are derived from 
the names given to them during this period (Crowe, 1991). It is difficult to know how 
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many Roma were enslaved during this period, but one estimate from the 19th century 
reported 200,000 slaves in Wallachia and Moldavia (Fraser, 1992). 
The oppression and marginalisation of the Roma reached its zenith in Europe 
during the Second World War when the Nazis selectively murdered people of Romani 
ethnicity in Germany and the occupied territories. This genocide, called the Pojaramos 
(the Great Devouring) by the Roma, was undertaken with the aid of "scientific" 
investigations headed by anthropologist Dr Robert Ritter of the "Research Centre for 
Racial Hygiene and Population Biology", who constructed detailed pedigrees 
demonstrating Romani heritage (MUller-Hill, 1998). In 1940 a report by Ritter stated 
that "[t]he Gypsy question can be considered solved when the main body of asocial and 
good-for-nothing Gypsy individuals of mixed blood is collected together in large labour 
camps and kept working there, and when further breeding of this population of mixed 
blood is stopped once and for all" (Muller-Hill, 1998, author's italics). This policy of 
population annihilation was pursued by the Third Reich, which forcibly sterilised Roma 
and sent them to their deaths in the concentration camps. The determination of one-
eighth Romani ancestry (i.e. a single great-grandparent) was sufficient to condemn an 
individual to the death camps (Heuss, 1997). However, Ritter argued for the 
preservation of "pure Gypsies" for further studies (MUller-Hill, 1998). It is not known 
how many Roma were murdered during this time. Estimates range from 250,000-
500,000 individuals (Fraser, 1992), to claims that up to two-thirds of the Romani 
population in Europe was killed (Patrin, 1999). 
1.1.5 Historical Demography of the European Roma 
Historical data on the number of Roma are scant and generally obscured by a 
lack of specificity. However, records exist that provide rough indications of the 
numbers ofRoma in different regions. The 1522-1523 tax registry in Rumelia reported 
10,294 Christian and Muslim Romani households, which equates to an approximate total 
population of 66,000 Roma in the Balkans (Marushiakova & Popov, 1997). In 1695 
there were 45,000 tax-paying Romani males in the Ottoman Empire, which extended 
from Mesopotamia to the Balkans (Fraser, 1992). This would be equivalent to a 
population totalling 225,000 individuals in the Ottoman Empire, assuming an average 
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family size of three children. A 1780-1783 census in Hungarian territories (which 
included Croatia and Slovenia, but not Transylvania) placed the total number ofRoma at 
30,241-43,609 (Fraser, 1992). In 1785, there were 12,000 Roma in Spain with two-
thirds of these resident in Andalusia (Fraser, 1992). A scholar in 1783 estimated that 
there were 700,000-800,000 Roma in Europe (Fraser, 1992). Thus, the current Romani 
population in Europe, totalling 7-8 million would represent a 10-fold increase over 
roughly 200 years. Extrapolating this rate of growth to earlier years, one would arrive at 
population sizes of 70,000-80,000 in 1583, 7,000-8,000 in 1383 and 700-800 in 1183, 
around the time of their arrival in Europe. The simplifying assumption of a continual 
rate of population growth is no doubt incorrect; however, alongside recorded population 
sizes it suggests that the Romani founding population in Europe was small in number. 
1.2 Anthropology of the Roma 
1.2.1 Anthropological Classifications of Extant Romani Populations 
The populations subsumed under the ethnonym Roma are multiple and varied. 
Furthermore, numerous populations exist within Europe that are typically described as 
Gypsies but are distinguished from the Roma. In many cases, the historical and 
cultural bases of these ethnological distinctions are unclear. Therefore, attempts to 
classify populations and to identify relationships between them are obscured by semantic 
uncertainties. The anthropologists Marushiakova and Popov (1997) have described the 
Roma as a disperse transboundary minority ethnic community which represent a 
constellation of groups . Classifications of these groups are based on criteria such as 
language and dialect, religion, traditional trade, self-appellation, rules of endogamy and 
lifestyle (i.e. nomadic or sedentary). Many of these criteria correlate with historical 
migrations and the subsequent different histories of the populations. Some broadly 
classificatory regional names are used: the Sinti of Germany, the manouches of France, 
the Cafe of Spain, the Ciganos of Portugal and the gitans of southern France. However, 
in general, nationality is a poor criterion for classifications (Fraser, 1992). 
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Language is a major parameter used to classify Romani populations. On the 
basis of language it has been proposed that Romany can be classed into four 
metadialects. These include the Balkan dialects, the Vlach dialects of Rumanian 
influence, the Carpathian dialects of Hungarian and Serbian influences, and the Nordic 
dialects of mostly German influence (Tcherenkov & Laederich, unpublished 
manuscript). This classification by metadialect is compatible with population divisions 
dictated by major migrations. Religion, whilst generally considered an inaccurate 
parameter for defining Romani groups, is used to distinguish the Xoroxane Roma, who 
are Muslims, from Christian Roma. 
Such classifications are necessarily generalising and, to a large degree, the 
historical relationships between populations subsumed under the groupings are unclear. 
It is apparent that the Roma have not existed as a monolithic population for over 500 
years. In 1775-1776, a Hungarian scholar pointed out that although all Gypsies have 
many features in common, there was no longer a homogeneous Gypsy nation or 
collective culture (Fraser, 1992). This heterogeneity is apparent within individual 
European countries. In the former Yugoslavia at least twenty groups were identified 
(Fraser, 1992), and it is normal to come across three or more groups in one town 
(Boretzky, 1995). The meticulous chronicler of Bulgarian Romani groups, Gilliat-
Smith1, reported at least 19 distinct tribes in the north-east of Bulgaria around the time 
of the First World War ("Petulengro", 1915-1916), and current estimates suggest as 
many as 50 groups in Bulgaria (Marushiakova & Popov, 1997). 
1.2.2 Salient Social and Cultural Features of Romani Populations 
Numerous social and cultural features of the Roma distinguish them from other 
European peoples. Several of these traditional practices can be predicted to impact on 
the genetics of the population, particularly their marriage patterns and customs. A 
typical feature of Romani groups is the strict adherence to endogamic marriages 
(Marushiakova & Popov, 1997). For Romani groups, the maintenance of the Group is 
of primary importance and its purity is preserved through admission to the group only 
1 After spending a large proportion of his life studying the Roma, the British ethnographer, Gilliat-Smith 
adopted the Romany name, Petulengro. 
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through birth (Marushiakova & Popov, 1997). Thus, the selection of marriage partners 
from within the group ensures the preservation of a cohesive identity. This practice 
restricts marriages between members of different Romani groups and between Roma and 
non-Roma. It is generally asserted that first cousin marriages are forbidden in Romani 
culture (Rishi, 1976). However, consanguineous unions are common amongst many 
Indian populations (Bittles, Mason, Greene, & Rao, 1991). The stringent practice of 
endogamy can be expected to entail the marriage of close relatives, and studies that have 
examined marriage types within a Slovak Romani population report high coefficients of 
inbreeding (Fenik, Gen9ik, & Genyikova, 1982; Fenl.k, Sivakova, & Sieglova, 1987). 
Whether this reflects a preference for close kin marriage or a restricted choice of 
marriage partners is unclear. 
In traditional groups, marriage contracts are often arranged and bride prices are 
paid in a similar manner to Indian practices (Marushiakova & Popov, 1997). Marriages 
generally occur at a very early age: between 13-16 years for females and between 15-21 
years for males (Marushiakova & Popov, 1997). After the marriage it is customary for 
the couple to live with the family of the husband (Marushiakova & Popov, 1997). 
Belonging to large families is highly regarded, as is the bearing of a large number of 
children. 
1.2.3 The Roma in Bulgaria 
In Bulgaria, the Roma are known as the Tsigani, which is derived from the 
Greek, Astinagoi. Their initial arrival can be inferred as occurring SOQletime in the 13th 
or 14th century (Marushiakova & Popov, 1997). The first Ottoman tax register 
mentioning the Romain Bulgarian lands was in 1475 and information including religion, 
occupation and areas occupied by the Roma has been recorded ever since 
(Marushiakova & Popov, 1997). Early records tell of Christian Roma in the Ottoman 
Empire, which indicates their presence prior to the Ottomans (Marushiakova & Popov, 
1997). Tax registers record that many Roma were employed as town blacksmiths or 
musicians, however, over time more Roma became sedenterised and abandoned their 
traditional trades for new employment and for farming. Whilst the Roma were not 
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officially slaves in Bulgaria, in many cases they led a life of servitude (Marushiakova & 
Popov, 1997). 
In Bulgaria, the 1522-1523 tax registry reported a total of 5,700 Roma and the 
1881-1885 census data report 62,324 Roma (Marushiakova & Popov, 1997). Data from 
subsequent censuses report 99,004 Roma in 1905, 122,296 in 1910, 134,844 in 1926, 
170,011 in 1946 and 197,805 in 1956 (Marushiakova & Popov, 1997). This suggests a 
two-fold increase in population over 50 years. The current Romani population of 
Bulgaria, believed to be 700,000-800,000 (Liegeois, 1994), would represent a four-fold 
increase in the following 50 years. However, a review of censuses from a three-year 
period between 1989-1992 reveals serious discrepancies in results due to the differing 
and sometimes arbitrary criteria used to define a person as a Roma (Marushiakova & 
Popov, 1997). 
The demography and composition of the Bulgarian Romani population has been 
shaped to a large extent by the major migrations of Romani groups previously described. 
However, owing to the close geographical proximity to Rumania, there were migrations 
of Vlach Roma into Bulgaria prior to the end of slavery. These groups are generally 
characterised as speaking old-Vlach dialects (Marushiakova & Popov, 1997). 
1.2.3.1 Social anthropology of the Bulgarian Roma 
The Bulgarian Romani population was the subject of extensive ethnographic and 
linguistic investigations at the turn of this century by the British-born researcher B. J. 
Gilliat-Smith (Petulengro). Having spent four years in the Bulgarian city of Varna, 
Gilliat-Smith classified "Gypsy tribes inhabiting the Balkan Peninsula" based on "(1) the 
district, (2) the religion, (3) the mode of life- whether sedentary of nomadic, [and] (4) 
the occupation or trade" (Petulengro, 1915-1916). Using this taxonomic system, Gilliat-
Smith (1915-1916) identified 19 individual groups in Northeast Bulgaria. 
These fundamental criteria for classifying Romani groups have been used more 
recently by Marushiakova and Popov (1997). They have expanded the criteria to create 
a more comprehensive taxonomy that includes the preferred self-appellations of the 
group, the time of arrival in Bulgaria and endogamy rules as important differentiating 
characteristics. The authors have devised a classificatory system that delineates three 
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main Romani metagroups widely dispersed throughout Bulgaria. A metagroup 
combines several groups with infringed boundaries (Marushiakova & Popov, 1997) 
and is the overarching population structure. Groups within a metagroup are generally 
mutually endogamous, however, rules of endogamy within a metagroup can collapse 
when subjected to external forces (Marushiakova & Popov, 1997). The three Romani 
metagroups found in Bulgaria are: 
1. Jerlii 
The Jerlii are descendants of the first Roma to settle in Bulgaria. They are the 
most numerous and diverse metagroup in Bulgaria. The majority of the Jerlii 
abandoned a nomadic existence during the time of the Ottoman Empire. Linguistically, 
this group is characterised as speaking Turkish or Romany dialects; which are classed as 
Balkan or non-Vlach dialects. The Jerlii are subdivided into two main groups - the 
Dassikane Roma who are Christians and the Xoroxane Roma who are Muslims. These 
are still broad definitions and contain numerous well-preserved traditional groups, which 
practice strict endogamy and are clearly delineated. The Jerlii are scattered evenly 
throughout Bulgaria, with the bulk of the Xoroxane population in the northeast of 
Bulgaria. 
2. Kalderash 
The Kalderash (Kaldarasi) are the descendants of groups who left Wallachia, 
Moldavia and Transylvania during the Great Kalderara Invasion of the· second half of 
the nineteenth century following their emancipation. They are subdivided into the 
Lovari and Kelderari. The Kalderash speak their own Vlach dialects, which are also 
known as Stratum III of the Balkan dialects. They are largely Orthodox Christians. 
They were nomadic until 1958 when they were forcibly settled by the Bulgarian 
government. Their adherence to traditional practices often leads them to assert that they 
are Gypsy Gypsies. The Kalderash have adopted an extended endogamy that 
comprises the entire meta group and which extends beyond the borders of Bulgaria. The 
Kalderash avoid co-residence with other Roma and do not form distinct 
neighbourhoods. They generally exist in small groups of 10 to 15 families, dispersed 
among the surrounding population. 
3. Rudari/Ludari 
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The Rudari (or Ludari) represent the third major Romani group in Bulgaria. 
They also refer to themselves as Wallachians or Wailachs as they were enslaved in 
Wallachia and Moldavia. This group entered Bulgaria after the end of slavery in the 191h 
century. They speak an ancient form of Rumanian and adhere to Eastern Orthodox 
Christianity. This metagroup is further sub-divided into the Lingurari (spoon-makers) 
and Ursari (bear-trainers). The Lingurari prefer to live in villages by rivers or in the 
mountain foothills. These geographically differentiated groups are known as the Intreni 
and Monteni respectively. The Ursari are spread widely throughout Bulgaria. 
A modified schematic outline of Marushiakova and Popov s stratification of 
Bulgarian Roma groups is presented in figure 1-3. Contact between members of these 
three metagroups is virtually non-existent and they have little to do with each other s 
affairs. Marriages between individuals from the different metagroups are discouraged 
and extremely rare. Within the three broadly defined metagroups there is a myriad of 
well-preserved subgroups. The classifications are based on practiced trades (both 
former and current), region of residence and kinship ties. Strict endogamy is observed 
within many of these groups; however, a complex system of regulations dictates 
permissible marital partners who may originate from outside the immediate group. In 
some groups it is more acceptable for non-Roma to marry into the population than Roma 
from other groups. It has been asserted that Romani communities are even more 
exclusive than other ethnic communities (Marushiakova & Popov, 1997). In Bulgarian 
Romani populations, adherence to strict endogamy appears to have been practiced for a 
long time, and thus can be expected to have impacted on the genetic structure and 
diversity within these populations. 
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Dassikane 
Rom a 
Xoroxane 
Rom a 
Kalderash 
Kinship and Regional sub-divisions and sub-groups 
Figure 1-3 Anthropological classification of the Roma in Bulgaria (adapted from 
Marushiakova and Popov, 1997). The three metagroups (Jerlii, Kalderash and Rudari) 
are mutually endogamous. Complex social rules dictate marriage patterns within the 
metagroups. 
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1.3 Population Genetics of the. Roma 
1.3.1 Population Genetic Studies of the Roma 
The investigation of polymorphic heritable markers in Romani populations has 
be(fn undertaken for over eighty years. Researchers have examined Roma throughout 
Europe, although the majority of studies have examined Romani populations from 
Eastern Europe. A survey of relevant publications yields ·at least 30 independent studies 
of the genetics of Romani populations. Typically, investigators have used classical 
polymorphisms: blood group systems, enzyme polymorphisms and the human leukocyte 
antigen (HLA) system. The questions that these studies have endeavoured to answer 
invariably fall into three broad categories: the biological relationship between 
neighbouring Romani and non-Romani population, the relatedness of geographically 
separated Romani populations and the ethnic origins of the Roma. The issues explored 
are not only of interest to population biologists, but also to scholars of Romani history, 
anthropology and culture, and the Roma themselves. Indeed, many general texts and 
discussions on the Roma cite the evidence provided by genetic studies to support their 
own arguments (Rishi, 1976). Even amongst those authors who have eloquently 
criticised many aspects of genetic studies of Roma (Kohn, 1996), the overall conclusions 
have not been questioned. Thus, the assertions that the Roma are genetically distinct 
from other European populations and that genetic studies provide scientific proof of · 
their Indian ethnicity have come to be widely accepted. 
The vast majority of population studies on the Roma have employed the 
polymorphic blood group systems (serogenetic markers). Of these studies, the greatest 
body of comparable data has been collected on phenotypic variation in the ABO, Rhesus 
(Rh), MN and haptoglobin systems (table 1-1). Generally, the frequency distributions of 
phenotypic variants in each of these systems have been compared with other populations 
and conclusions drawn on the basis of observed differences and similarities. Using this 
piece-meal approach, many studies of Romany populations are characterised by 
confounding and seemingly contradictory results from the different systems. The cause 
of these discrepant results remains unclear. A possible explanation is the effect of 
genetic drift acting in small populations, which can significantly skew the distributions 
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of polymorphic traits. Moreover, drift will act independently on the different 
polymorphic systems, affecting the variant frequencies 0f different systems in markedly 
different ways. Different genetic heritages and different sources of admixture could also 
yield the observed diversity. It is likely that study designs that fail to address population 
history or social structure have incorrectly defined Romani populations. This would be 
expected to further confound findings and interpretations from these studies. Thus, an 
examination of previous population genetic studies requires careful consideration of 
study design and the methodologies employed. Nonetheless, examination of data 
generated from these studies provides some insights into Romani populations. 
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Table 1-1 
Phenotyp_ic freq_uencies of.E.ol)!_mop_hic variants in Romani p_op_ulations as rep_orted in relevant literature 
Author Population Sample ABO blood group Rhesus MN blood group Haptoglobin 
size bloodgrou 
AI Az AB B 0 Rh+ Rh- MM MN NN 1-1 2-1 2-2 
Rex-Kiss et al. 1973 Hungarian 507-600 30.8 3.5 10.7 28.0 27.0 89.1 10.9 31.0 49.8 19.2 5.8 29.2 64.6 
Bartsocas et al. 1979 Greek 200 29.0 11.5 32.0 27.5 91 9 47.5 40.5 12.0 
Harper et al. 1977 Welsh 84 35.7 7.1 0 14.3 42.8 95.7 4.3 22.9 47.1 30.0 3.9 39.5 56.6 
Bemasovsky et al. 1975 Slovakia 2935 32.9 2.4 9.3 25.2 30.2 89.5 10.5 27.2 51.6 21.2 
Sivakova et al. 1994 SE Slovakia (SGPl) 50 34 2 20 26 18 88 12 56 28 16 14 22 64 
SE Slovakia (SGP2) 51 41 2 16 21.6 20 94 6 31.4 47 24.6 
Bemavosky et al. 1994 W allachians in 119 20 4 0.8 6.7 68 80.7 19.3 44.5 51.4 5 10.1 40.3 49.6 
Slovakia 
Beckman and Takman 1965 Sweden 116 59.48 3.45 6.03 31.03 95.7 4.3 20.0 55.7 24.4 0 23.5 76.5 
Clarke 1973 Britian 109 33.03 14.68 4.58 8.26 39.45 85.3 14.7 49.5 41.3 9.2 15.5 52.4 32.0 
Avcin 1969 Slovenia 350 49.42 5.99 10.28 34.28 85.1 14.9 19.1 46.9 34.0 
Galikova 1969 Slovakia (east) 180 1.1 21.2 77.9 
Galikova 1969 Slovakia (west) 180 2.2 32.2 65.6 
Cazal et al. 1951" France 113 23.0 2.70 14.1 38.1 22.1 85 15 36.0 46.5 17.4 
Ely 1961"' France (north) 47 21.0 6.0 19.0 53.0 97.6 2.4 
Ely 1966"' France (south) 41 41.0 10.0 27.0 22.0 87.8 12.2 
Nicoli and Sermet 1965"' France (south) 92 40.0 7.6 9.7 42.0 87.6 12.4 
Schmidt 1930" Yugoslavia (pop 1) 299 23.0 7.7 24.4 45.0 
Yugoslavia (pop 2) 126 40.0 7.1 19.8 33.0 
V erzar and W erszecky 1921 "' Hungary 385 21.0 5.7 39 34.2 
Libman 1930"' Uzbekistan 104 42.3 9.6 28.8 19.2 
Hesch 1930"' Romania 102 27.4 8.8 37.2 26.5 
"'Values calculated from data in Harper et a!., 1977 
N 
00 
1.3.1.1 A critique of sampling methodologies used in population genetic 
studies of Roma 
Poor sampling techniques have adversely affected the majority of genetic studies 
of Romani populations. The fundamental flaw of many of these studies is the 
application of inappropriate classificatory criteria to the study population, most notably 
nationality. In cases where researchers have defined the population, they have relied 
either on folk-taxonomic classifications of Romani populations (eg Clarke, 1973 
classifies British Roma into Romanies, Posh-rats, Didakis and Travellers according to 
the amount of "Romany blood" in the individual) or crude regional classifications ( eg. 
Bernasovsky, Suchy, Bernasovska, & Vargova, (1976) studied ''East Slovak Gypsies"). 
In some cases, where anthropological distinctions between Romani groups have been 
made it has been under the notion that the degree of social assimilation with the macro-
society (eg. Galikova, Vilimova, Fen!k, & Mayerova, [1969] define assimilated, semi-
assimilated and unassimilated Romani groups) and choice of residency (Rex-Kiss, 
Szabo, Szabo, & Hartmann, 1973) is of biological relevance. Notions of racial purity in 
the selection of individuals for investigation have been even more disturbing. 
Researchers have been insistent that they have sampled only "genuine Gypsies" 
(Beckman & Takman, 1965) or individuals of Romani lineage (Clarke, 1973; Harper, 
Williams, & Sunderland, 1977) although the criteria used for these distinctions are 
unclear. These inaccurate and inappropriate classifications used by population 
geneticists stand in marked contrast to the great complexity of Romani population 
structure as demonstrated by historians, linguists and anthropologists. 
Authors have generally omitted details of the circumstances under which 
biological samples were obtained. However, two papers state that samples were obtained 
from Romani males in jail (Rex-Kiss et al., 1973; Sivakova, 1983). The use of prisoners 
as research subjects introduces a sampling bias to the study, whilst implying the 
prejudiced notion that a jail would be the logical place to obtain samples from Roma. 
Furthermore, it is unclear whether these studies had been undertaken with the informed 
consent of subjects. 
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1.3.1.2 Genetic evidence for the relatedness of Roma with other European 
populations 
A number of studies have aimed at comparing the genetic composition of 
Romani populations with that of indigenous European populations. Generally, these 
comparisons have involved an examination of each independent polymorphic system for 
differences and similarities observed between populations. Typically, autochthonous 
European populations are characterised by a relatively low frequency of the B blood 
group (Mourant, Kopec, & Domaniewska-Sobczak, 1976). Thus, the ABO blood group 
system has been the primary means of comparing the Roma with other European 
populations. The conclusions offered by these results have not always been clear. 
Moreover, when other polymorphic systems are examined they often suggest 
contradictory conclusions. 
In the Welsh Roma, the frequency of the B blood type is similar to that found in 
the non-Romani Welsh population (Harper et al., 1977). However, the two populations 
have different phenotypic distributions of the Rh, MN and haptoglobin systems (Harper 
et al., 1977). Alternatively, in a large Slovak Roma sample, the MN system shows no 
significant differences between the Romani and non-Romani populations, whereas 
statistically significant differences are seen using the ABO and Rh system (Bemasovsky 
et al., 1976). Similar discordance in the results using different polymorphic systems has 
been observed in the Hungarian Roma (Rex-Kiss et al., 1973) and a study of Slovak 
Roma (Sivakova, Sieglova, Lubyova, & Novakova, 1994). In the Greek Romani 
population, a very high frequency of B blood type was observed which differs 
significantly from the autochthonous population (Bartsocas et al., 1979). Differences 
between the two populations were also observed using the Rh and MN systems, however 
the distribution of phenotypes using the Kell and Duffy system was identical in the 
Romani and non-Romani populations (Bartsocas et al., 1979). Similarly, a high 
frequency of the B blood type distinguishes another sample ofHungarian Roma from the 
autochthonous population (Tauszik et al., 1985). Differences between the two 
populations are observed in the Rh and MN systems but not in the P and Kidd systems 
(Tauszik et al., 1985). Whereas these studies have found a much higher frequency of the 
B blood group than that found in the local population, a study of Slovenian Roma 
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determined that the B blood type frequency was some 4-8% less than in the non-Romani 
Slovenians (A vein, 1969). Significant differences between these two populations were 
also apparent using the MN and Rh systems (A vein, 1969). 
Using the HLA system, Gyodi et al., (1981) found that the most frequent 
haplotypes in the Roma occur at low frequency in Hungarians and conversely the most 
frequent haplotype in Hungarians is absent in Roma. A study of Spanish Roma by de 
Pablo et al., (1992) based on HLA data showed genetic distances between the Roma and 
autochthonous European populations were large compared to those observed between 
autochthonous populations. Genetic distance and principal component analyses of blood 
group data from various ethnic groups in Hungary demonstrated the genetic separateness 
of Hungarian Roma from all other populations in the country (Guglielmino & Beres, 
1996). 
Thus, it is clear that throughout Europe, Romani populations are consistently 
found to be genetically distinct from populations alongside whom they have resided for 
many hundreds of years. This indicates that the Roma are genetically isolated from 
other European populations. Whether this is due to social isolation and genetic drift or 
to different ethnic origins is unknown. 
1.3.1.3 Relationships between the Romani populations of Europe as revealed 
by population genetic studies 
Given the large degree of socio-cultural heterogeneity exhibited by the European 
Roma, it is reasonable to expect significant differences at a biological level. Indeed, a 
comparison of the data collected from geographically separated groups points to 
significant biological heterogeneity (table 1-1). Attempts to identify genetic affinities 
between different Romani populations have generally used the methodological approach 
by which Romani populations were compared to autochthonous populations; that is, a 
comparison of similarities and differences observed in the marker frequencies of 
different systems in different populations. As such, these studies have encountered the 
same problems in terms of lack of consistency using different systems. 
The majority of authors have utilised the ABO blood group system as a means of 
inferring genetic affinities between Romani groups from different countries, usually 
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emphasising the frequency of the B blood type. The frequency of this phenotypic 
variant can be seen to range from 6-38% (table 1-1). The somewhat arbitrary division 
between Roma groups that exhibit a B blood type frequency in the range of 20-40% and 
those groups in which the B blood type frequency is markedly lower (5-15%) has 
prompted one author to surmise that the Roma comprise two different populations 
(Clarke, 1973). Harper et al., (1977) determined a frequency of the B blood type of 10% 
in Welsh Roma, a result comparable to that found in French (Nicoli and Sermet, 1965), 
Swedish (Beckman & Takman, 1965), British (Clarke, 1973) and Yugoslavian (A vein, 
1969) Roma populations. A later study of Wallachian Roma in Slovakia, relatively 
recent immigrants from Rumania, reported a B blood type frequency of 6. 7% 
(Bernasovsky, Halko, Biros, Sivakova, & Jurickova, 1994). Thus, populations with a 
low frequency of blood group B have been observed throughout Europe and do not 
conform to any geographic structuring. A comparison of the frequency distributions of 
other polymorphic systems in these populations do not support the relationships implied 
by the ABO system. 
In contrast, a number of Romani populations are characterised by elevated B 
blood group frequencies. The Greek Roma studied by Bartsocas et al. (1979), have a B 
phenotype frequency of 32%, one of the highest values of any Romani population in 
Europe. However, the frequency of theM phenotype in the same population is most 
similar to that of the British Roma, who are characterised by a very low B type 
frequency. A similarly high B blood group frequency was found in Hungarian Roma 
(Rex-Kiss et al., 1973), who also have a comparable Rh distribution to the Greek Roma; 
however, the two populations differ dramatically in the distribution of MN variants. The 
large study of East Slovak Roma by Bemasovsky et al., (1976) found that phenotypic 
frequencies at the ABO, Rh and MN loci all corresponded closely with those found in 
Hungarian Roma by Rex-Kiss et al., (1973). These two populations provide the only 
example of complete concordance in results from different systems. 
A limited number of studies have examined genetic markers in more than one 
Romani population within the same country. Galikova et al., (1969) investigated the 
frequency distributions of haptoglobin types in Romani populations from East and West 
Slovakia and found significant differences between the two. Sivakova et al., (1994) 
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investigated two different populations of Roma from southeast Slovakia and found that 
the two populations were genetically differentiable. The study of Wallachian Romain 
Slovakia reported different phenotypic frequencies across all systems compared to those 
found in other Slovak Roma (Bernasovsky et al., 1994). Gyodi et al., (1981) used the 
HLA system to investigate two Romani groups in Hungary and found significant 
differences between them. These data were compared to HLA data from Spanish Roma 
in a later study by de Pablo et al., (1992). Genetic distances between the two Romani 
populations were greater than the distances between the Roma and all other European 
populations examined (de Pablo et al., 1992). 
Mastana & Papiha, (1992) attempted to synthesise published data of blood group 
polymorphisms in Romani populations. They concluded, on the basis of genetic 
distance and principal component analyses, that significant heterogeneity exists in the 
European Roma and argued for a significant differentiation between Eastern European 
and Western European Roma (Mastana & Papiha, 1992). A reanalysis of data from 
classical markers by Kalaydjieva, Gresham, & Calafell, (2001) illustrates the large 
genetic distances between Romani populations. However, no clinal structuring is 
apparent. Thus, the vast variation in polymorphic systems observed in Romani 
populations throughout Europe indicates that they are best described as a conglomerate 
of genetic isolates. Attempts to identify genetic affinities between geographically 
separated groups by comparing the distribution of polymorphic traits have been 
inconclusive due to the approaches taken and the limited resolving power of the 
polymorphic systems used. 
1.3.1.4 Relationships between Romani and Indian populations as revealed 
by genetic studies 
V erzar & Weszeczky, ( 1921) were the first to point out that the high frequency 
of the B blood group in the Roma resembled the elevated frequency of the B blood 
group found in populations of the Indian subcontinent. A number of studies following 
this work have confirmed that a high frequency of the B blood group is characteristic of 
the majority of Romani populations ( 13 out of the 19 populations listed in table 1-1 have 
a B blood group frequency> 15%). Mourant, Kopec, & Domaniewska-Sobczak, (1976) 
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in an attempt to summarise previous findings, declared that the mean A and B gene 
frequencies of nearly 5,000 European Gypsies are each approximately 22 per cent, 
figures which are closely comparable to those of West Pakistan . Thus, the observation 
of a high B blood group frequency has been the primary basis for the assertion that 
genetic data confirm the Indian origins of the Roma. This conclusion has been 
supported by findings of a high M frequency in the MN system, low Rh (d) frequencies 
in the Rhesus system, and elevated Hp 1 frequencies in the haptoglobin system, all of 
which are characteristic of northern Indian populations (Mourant, Kopec, & 
Domaniewska-Sobczak, 1976) 
However, the summary of blood group frequencies in Romani populations points 
to striking genetic heterogeneity (table 1-1). The extremes of between-population 
phenotypic variation in B blood group frequencies are evident in the very low values 
seen in the Wallachian Roma population in Slovakia (Bemasovsky et al., 1994) and the 
Swedish Roma (Beckman & Takman, 1965). This is in direct contrast to those reported 
in French (Cazal, Graafland, & Mathieu, 1951) and Hungarian (Verzar & Weszeczky, 
1921) Roma where values close to 40% have been ,observed for the B blood group 
frequency. Analyses of the MN system further illustrate the heterogeneity of Romani 
populations across Europe. Frequencies of the M phenotype have been found to be as 
low as 19% (A vein, 1969) and as high as 56% (Sivakova et al., 1994). Similar variation 
between populations in the frequency of the Rhesus blood group phenotypes is evident, 
with Rh (d) frequencies ranging from 2% (Ely, 1961) to 19% (Bemasovsky et al., 1994) 
in Romani populations across Europe. The frequency of haptoglobin polymorphisms in 
Roma populations across Europe also exhibit significant variability, with the frequency 
of the Hp1 phenotype ranging from 15.5% in British Roma (Clarke, 1973) to its 
complete absence in Swedish Roma (Beckman & Takman, 1965). 
A comparison of data from multiple polymorphic loci within Romani and Indian 
subcontinental populations illustrates a lack of consistency in the conclusions offered by 
the evidence. Within the Welsh Roma, the low frequencies ofthe Band M blood groups 
suggest no genetic affinities with Indian populations, and contrast with the Rh (d) and 
Hp1 frequencies, which are of Indian magnitude (Harper et al., 1977). Investigations of 
British Roma provide no indication of Indian origins on the basis of ABO and 
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haptoglobin frequencies, however the high level of the M phenotype is of Indian 
magnitude (Clarke, 1973). In a study of the Swedish· Roma, the frequency of the B 
blood group was found to be well below Indian values, whereas Rh and haptoglobin 
distributions were reported as being compatible with Indian origins (Beckman & 
Takman, 1965). Rex-Kiss et al., (1973) reported that the distribution of variants of the 
different blood group systems in Hungarian Roma was almost identical to those found in 
Pakistani populations, with the exception of the MN system. Bartsocas et al., (1979) 
claimed that frequencies in the blood group systems demonstrated similarities with the 
inhabitants of the Punjab and Western Pakistan, especially with regards to the ABO, Rh 
and Duffy blood groups. Sivakova (1983) examined the distributions ofred blood cell 
acid phosphatase (ACP), phosphoglucomutase (PGM1) and adenylate kinase (AK) iso-
enzymes in samples from Slovak Roma. Phenotypic distributions in the ACP and 
PGM1 systems were compatible with data from North Indian populations, however the 
results from the AK system appeared to contradict the conclusion of a North Indian 
ethnogenesis. Others have claimed evidence for Indian origins of the Roma based on a 
single locus. Galikova et al. (1969) investigated the haptoglobin polymorphism 
distribution among Slovak Roma and concluded its distribution supported an Indian 
origin. Tauszik, Forrai, & Hollan, (1987) investigated the percentage of tasters of 
phenylthiocarbamide among Hungarian Roma and reported the high proportion of 
tasters provided further confirmation of Indian origins. An investigation of 
immunoglobulin allotypes in a Hungarian Roma population claimed that Indian and 
Pakistani populations were the only ones to contain all variants found in the Roma, 
thereby supporting claims oflndian origins (van Loghem, Tauszik, Hollan, & Nijenhuis, 
1985). 
Thus, claims that the frequency distributions of genetic polymorphisms provide 
evidence supporting Indian origins of the Roma are not credible when the entire body of 
data is considered. The genetic heterogeneity observed amongst populations and 
polymorphic systems within populations prevent any general conclusions. When genetic 
distances between Romani populations and Indian populations have been calculated on 
the basis of blood group polymorphisms, the analysis has been conducted without the 
inclusion of European populations (Mastana & Papiha, 1992), thus preventing a 
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comparison of the relative relatedness of Roma to Europeans with that of Roma to 
Indians. When data from the HLA system have been used to calculate genetic distances, 
distances between Indians and some autochthonous European populations are less than, 
or similar to, those between Indian and Romani populations (de Pablo et al., 1992). A 
population tree constructed from mtDNA, places Romani populations distant to all other 
populations, including Europeans and Indians (Kalaydjieva et al., 2001). Therefore, a 
survey of the relevant literature illustrates that the genetic evidence for the Indian origins 
of the Roma is weak. 
1.3.2 Mendelian Genetic Disorders in the Roma 
A number of mendelian disorders have been identified in the Roma. Of these, 
three are novel disorders and thus far appear to occur uniquely in the Roma. In addition, 
a number of known rare genetic disorders have been identified. In many cases, a single 
mutation has been identified as the predominant cause of the disorder. This suggests 
that founder effects have inflated the frequency of these disease alleles. In addition to 
these disorders, disease-causing mutations found in other populations have been 
identified in the Roma. The small number of studies into genetic disorders in different 
Romani populations offers some insights into the distribution of the apparently private 
mutations. 
The three novel disorders found in the Roma have been initially described in 
Romani populations in Bulgaria. Hereditary motor and sensory neuropathy type Lorn 
(HMSNL) was the first novel genetic disorder identified in the Roma. Kalaydjieva et 
al., (1996) reported the mapping of the disease locus to 8q24. The homogeneity of 
disease haplotypes ied the authors to propose a putative founder mutation present in 
three socially separated Romani populations. Subsequently, a second novel disorder, the 
congenital cataracts and facial dysmorphism neuropathy syndrome (CCFDN) was 
reported (Angelicheva et al., 1999). The gene for CCFDN was mapped to 18qter and a 
conserved common disease haplotype indicated a founder mutation (Angelicheva et al., 
1999). Recently, a third disorder, termed hereditary motor and sensory neuropathy type 
Russe (HMSNR), has been identified (Rogers et al., 2000). Haplotype analysis suggests 
a founder mutation that maps to 10q23 (Rogers et al., 2000). HMSNR, which is 
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phenotypically similar to HMSML but with a unique genetic aetiology, was found to 
segregate within some HMSNL families (Rogers et al., 2000). 
Founder mutations have also been identified as causing genetic disorders 
originally identified in other populations. A C283Y mutation in the y-sarcoglycan gene 
(SGCG) was reported as the cause of limb girdle muscular dystrophy type 2C 
(LGMD2C) in seven unrelated Spanish, French and Italian Romani families (Piccolo et 
al., 1996). Closely related disease haplotypes confirmed that this was a single founder 
mutation (Piccolo et al., 1996). The C283Y mutation was subsequently reported in 
Portuguese Roma (Lasa et a.I., 1998). This mutation has also been found in Bulgarian 
Romani LGMD2C patients (Toumev et al., 1998), and carriers identified in a sample of 
Romani neonates from Northeast Bulgaria (Todorova, Ashikov, Beltcheva, Toumev, & 
Kremensky, 1999). It is likely that this is the identical founder mutation, although 
haplotype analysis is required to prove this. Galactosemia in the Bulgarian Roma has 
been found to result from a P28T founder mutation in the galactokinase gene (GKJ) 
(Kalaydjieva et al., 1999). Subsequent to this study, the mutation has been identified in 
Spanish and Hungarian Roma (Hunter, 2000). A 1267delG founder mutation in the 
acetylcholine receptor s subunit gene (AChRs) has been identified as the cause of 
congenital myasthenia in Roma from Hungary, Serbia and Macedonia (Abicht et al., 
1999). In addition, a founder E387K mutation in the cytochrome P4501B1 (CYPJBJ) 
has been identified as the cause of congenital glaucoma in Slovakian Roma (Plasilova et 
al., 1999). Private mu~ations have also been identified as causing Type 3 von 
Willebrand disease (Casana et al., 2000), autosomal dominant polycystic kidney disease 
(Forrai et al., 1989; Veldhuisen et al., 1997) and Glanzmann thrombasthenia (Schegel et 
al., 1994). Disease-causing mutations identified in the Roma that are found in other 
populations include mutations causing phenylketonuria (Desviat, Perez, & Ugarte, 1997; 
Kalanin et al., 1994; Kalaydjieva et al., 1992) and medium-chain acyl coA 
dehydrogenase (MCAD) deficiency (Kremensky et al., 1998; Martinez et al., 1998). 
A limited number of studies have examined the population frequency of founder 
mutations. These studies indicate that some private mutations occur at gene frequencies 
in the range of0.01-0.025 in the Roma (Kalaydjieva et al., 1999; Plasilova et al., 1999; 
Todorova et al., 1999). These values correspond with carrier frequencies ranging from 
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2-5%. Preliminary evidence exists that some Romani populations may be at increased 
risk for particular disorders, as illustrated by a Slovakian Romani group in which the 
carrier frequency of the CYPJBJ E387K allele is 11% (Plasilova et al., 1999). In this 
population the high carrier frequency was reported to result in cases of pseudodominant 
inheritance of congenital glaucoma. 
1.3.3 Summary of Genetic Studies of Roma 
Investigations of polymorphic genetic markers and disease genes point to the 
unique genetic heritage of the Roma. Characterisation of Romani populations using 
polymorphic markers has demonstrated that these populations are genetically distinct 
from other European populations. The identification of private disease-causing founder 
mutations supports this conclusion. However, the failure to identify these mutations in 
other European populations cannot be equated with their absence in these populations. 
Therefore, the historical basis of the unique genetic composition of the Roma is unclear. 
Clearly, the occurrence of identical founder mutations in different Romani populations 
provides presumptive evidence for common origins or admixture. However, population 
genetic studies have shed little light on the genetic relatedness of populations. Small 
populations with possibly long and restrictive bottleneck effects and limited gene flow 
may rapidly diverge from each other, thereby obscuring evidence of common origins. It 
is apparent that the use of genetic markers with increased resolution, and study designs 
that account for social history and structure of the Roma are required in order to gain 
insights into the genetic origins and structure of the Roma. 
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CHAPTER2 
REVIEW OF LITERATURE ON MOLECULAR GENETIC STUDIES 
OF POPULATIONS AND DISEASE 
2.1 On the Application of Molecular Genetics to the Study of Human 
Populations 
2.1.1 Introduction 
Investigations of biological variation in human populations have enjoyed 
renewed interest with the .advent of molecular genetics and the ability to identify genetic 
variation at the genotypic level. This field of investigation, termed population genetics, 
attempts to combine mendelism, darwinism and biometry to determine how the gene 
could explain the creation, maintenance and distribution of phenotypes in populations 
(Chakravarti, 2001). As well as providing new insights into population history, the 
characterisation of human populations has emerged as an essential component of many 
genetic investigations. Furthermore, the growing concept of an anthropology of genetic 
disease (Weiss, 1998) has broad applications to many aspects of genetics, from 
methodological approaches of gene identification to rational approaches for disease 
diagnosis and treatment. 
The first study of genetic variation in human populations - examining ABO 
blood group frequencies - was published in 1919 (Stoneking, 2001). These protein 
polymorphisms and others provided the first means of investigating molecular genetic 
variation. However, these genetic variants are phenotypic variants and thus possibly 
subject to selective pressures. The identification of variation in DNA sequence has 
provided researchers with an abundance of new polymorphic loci for population genetic 
studies (Cavalli-Sforza, 1998). DNA polymorphisms are numerous and include 
variation of single nucleotides, insertions and deletions (indels), mini- and micro-
satellite DNA and a multitude of complex repetitive sequences. Variation is found 
39 
throughout the human genome on the autosomes, sex chromosomes and mitochondrial 
DNA. Of these, the Y chromosome and mtDNA have become most widely used in 
population genetic studies, as they are uniparentally inherited and exist in the haploid 
state thereby escaping the potentially scrambling effects of recombination. 
2.1.2 On the Use of Mitochondrial DNA for the Study of Human Populations 
The mitochondria are cytosolic organelles responsible for cellular respiration in 
almost all eukaryotes (Voet & Voet, 1995). Many hundreds or thousands of 
mitochondria are contained within each cell. Each mitochondrion contains multiple 
copies of a small and unique genome co!lsisting of 16,569 base pairs of highly conserved 
and economically organised DNA sequence (Anderson et al., 1981). The sequence of 
the human mitochondrial genome encodes 13 proteins involved in oxidative 
phosphorylation. In addition, two ribosomal RNAs (rRNAs) and 22 transfer RNAs 
(tRNAs) are encoded in the genome. The mitochondrion-specific tRNAs facilitate the 
use of a unique genetic code in mitochondrial translation (Voet & Voet, 1995). 
Mitochondria are transmitted alongside the other cytosolic components from the mother 
to the oocyte. Thus, mitochondrial DNA follows a strictly maternal inheritance. 
The mitochondrial genome exhibits a number of unique features that make it 
useful for population genetic studies and related disciplines (e.g. forensic science). 
These features include its maternal inheritance, an apparent lack of recombination and a 
relatively high degree of mutability. The haploid maternal inheritance of mtDNA means 
that it is particularly sensitive to reductions and expansions in population size (Parsons 
et al., 1997). Furthermore, the high mutation rate and apparent lack of selection result in 
the rapid differentiation of maternal lineages between populations (Parsons et al., 1997). 
The mitochondrial genome has long been considered not to undergo homologous 
recombination. Thus, variation in the genome arises exclusively from DNA mutation. 
An increased rate of mutation has been observed in the displacement loop (D-loop), an 
1,122bp region between the tRNAPRo and tRNAPHE genes in which no genes are encoded 
(Anderson et al., 1981 ), relative to that observed in the coding regions of the genome. 
The difference in mutational rates in different regions of the genome provides varying 
degrees of temporal resolution for population genetic studies. 
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Although some studies have sequenced the entire mitochondrial genome to 
examine genetic variation (Finnila, Lehtonen, & Majamaa, 2001; Horai, Hayasaka, 
Kondo, Tsugane, & Takahata, 1995), two approaches that are less labour-intensive are 
generally utilised to estimate the total mitochondrial DNA variation. In the coding 
portion of the genome, variation is typically characterised using restriction fragment 
length polymorphism (RFLP) analysis. Within the D-loop, the Hypervariable Segments 
1 and 2 (HVS1 and HVS2 respectively) are characterised using direct sequencing. 
Using these approaches to characterise genomic variation, a standard nomenclature and 
phylogenetic relationship for mtDNA types have been developed. Superhaplogroups 
and haplogroups are broad classes of mtDNA types defined on the basis of variation in 
the coding region. The assignment of mitochondrial genomes to defined haplogroups is 
generally performed using diagnostic RFLP analysis. In addition, characteristic 
sequence variants in the HVS 1 have been found to be associated with specific 
haplogroups (Macaulay et al., 1999; Richards et al., 2000; Richards, Macaulay, Bandelt, 
& Sykes, 1998; Simoni, Calafell, Pettener, Bertranpetit, & Barbujani, 2000a). However, 
use of this association as a means of inferring haplogroups is contentious (see the debate 
between Torroni et al., (2000) and Simoni, Calafell, Pettener, Bertranpetit, & Barbujani, 
(2000b ]). Within each haplogroup, sequence variation in the HVS 1 and HVS2 provides 
additional degrees of resolution. 
Mitochondrial DNA analysis has been used to address questions ranging in time-
scale from evolutionary to recent population history, and to assess current population 
structure and variation. Since the initial study on mtDNA variation in continental 
populations (Cann, Stoneking, & Wilson, 1987), research has consistently shown greater 
mtDNA variation in Mrican populations than other worldwide populations (eg. Vigilant 
et al., 1991; Chen, Torroni, Excoffier, Santachiara-Benerecetti, & Wallace, 1995). This 
has provided support for a common African origin of Homo sapiens sapiens some 
150,000 years ago (Stoneking, 2001). Mitochondrial analysis has been used to address 
other major prehistoric demographic events such as the Neolithic expansion in Europe 
(Bertran petit, Calafell, Comas, Perez-Lezaun, & Mateu, 1998; Comas et al., 1997; 
Richards et al., 1996; Sykes, Corte-Real, & Richards, 1998) and the peopling of the 
Americas (Ward, 1998). 
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The structure of populations and relationships between linguistically and/or 
historically related populations have been investigated using mtDNA analysis. Mateu et 
al., (1997) used mtDNA analysis to compare the peopling oftwo islands off the coast of 
Africa, and showed that the impact of different population histories was reflected in the 
mtDNA of present-day inhabitants. A study of mtDNA in Australian Aborigines (van 
Holst Pellekaan, Frommer, Sved, & Boettcher, 1998) showed that there was population 
substructuring at the tribal level, whereas a study of two Indian popuiations (Mountain et 
al., 1995) found that the cultural identification of individuals was inconsistent with 
genetic grouping. In a study of mtDNA sequences of Bulgarians and Turks, it was 
found that the physical boundary b~tween Europe and Asia corresponded with 
significant differences between ;European and West Asian maternal lineages (Calafell, 
Underhill, Tolun, Angelicheva, & Kalaydjieva, 1996). Similarly, investigation of 
mtDNA in the Saami, an indigenous nomadic people of northern Scandinavia, 
demonstrated that this population is genetically distinct from the rest of Europe 
(Delghandi, Utsi, & Krauss, 1998). 
With the proliferation in studies of mtDNA lineages, particularly in European 
populations, researchers have begun to synthesise the existing data (Macaulay et al., 
1999; Richards et al., 1998). Investigations of other global populations are rapidly 
clarifying the continental origins of different mitochondrial types (Quintana-Murci et al., 
1999; Richards et al., 2000). The emerging picture is that some specific mtDNAs are 
restricted to regional populations. These data serve as a reference from which the 
ethnogenesis ofpopulations, such as those ofCentral Asia (Comas et al., 1998), Iceland 
(Helgason, Sigurethardottir, Gulcher, Ward, & Stefansson, 2000), Brazil (Alves-Silva et 
al., 2000) and Colombia (Mesa et al., 2000) might be reconstructed. 
Although mtDNA analysis has been widely applied to the study of human 
populations, some of the unique features that make it appropriate for this purpose have 
been questioned. Namely, it is possible that a strictly maternal inheritance may not be 
the case in humans, given that paternal inheritance of mtDNA has been observed in 
other species, including mussels (Zouros, Freeman, Ball, & Pogson, 1992) and fungi 
(Yang & Griffiths, 1993 ). Furthermore, paternal leakage has been observed in 
Drosophila melanogastor (Kondo, Matsuura, & Chigusa, 1992) and mice (Gyllensten, 
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Wharton, Josefsson, & Wilson, 1991). Recently, the commonly accepted lack of 
recombination in the mitochondrial genome has been questioned on the basis of a 
negative correlation between linkage and distance (Awadalla, Eyre-Walker, & Smith, 
1999; Eyre-Walker, 2000). However, alternative mechanisms have been proposed that 
might explain this finding, including nonindependent mutation mechanisms and parallel 
sequencing protocols that may introduce systematic errors causing some covariation 
with distance (Hey, 2000), errors in the data (Kivisild & Villems, 2000) and 
inappropriate methodological approaches (Jorde & Ba~shad, 2000; Kumar, Hedrick, 
Dowling, & Stoneking, 2000; Parsons & Irwin, 2000). Moreover, another study has 
:.. failed to replicate the findings of the initial report (Elson et al., 2001). 
The application of mtDNA analysis to the study of populations is based on the 
premise that variation is due to an accumulation of selectively neutral mutations. 
However, the mechanisms and forces acting on this process in mitochondria remain 
unresolved. It has been shown that mutational rates within the D-loop vary between 
nucleotide sites (Excoffier & Yang, 1999; Meyer, Weiss, & von Haeseler, 1999). 
Hypervariable sites have been shown to be mutational hotspots, although the reason for 
this hypervariabilty remains unknown (Stoneking, 2000). Some evidence suggests that 
the mutability of specific sites is dependent on the sequence context (Howell & Smejkal, 
2000; Malyarchuk & Derenko, 1999). 
Estimations of mutational rates vary depending on the method by which they 
have been determined. The largest discrepancy in rates occurs between results obtained 
using phylogenetic studies and those obtained via pedigree studies. In the non-coding 
region, Parsons et al., (1997) obtained an empirically observed mutation rate of 
2.5/site/million years (Myr), some twenty times greater than with values inferred from 
phylogenetic studies (Horai et al., 1995). A larger pedigree study provided a result 
intermediate to these two values [0.32/site/Myr] (Sigurgardottir, Helgason, Gulcher, 
Stefansson, & Donnelly, 2000). The discrepancy between rates determined from 
pedigree and evolutionary studies is a consistent finding that suggests the rate and 
pattern of mutations observed between generations differ from those observed over 
longer periods of time (Parsons et al., 1997). A possible reason is the presence of 
multiple copies of the genome within each mitochondrion, each of which can potentially 
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differ at nucleotide sites. This phenomenon, referred to as heteroplasmy, varies between 
individuals and has been shown to vary with tissue type and with age (Calloway, 
Reynolds, Herrin, & Anderson, 2000). It is reasonable to assume that, given the many 
billions of copies of mtDNA in an individual, everyone is heteroplasmic to some degree 
(Tully et al., 2000). Detecting heteroplasmy requires techniques that are sufficiently 
sensitive to detect alternative nucleotides occurring at low frequency. Using fluorescent 
sequencing techniques one report claimed the ability to detect heteroplasmic mutations 
occurring at a frequency of 20% (Cavelier, Jazin, Jalonen, & Gyllensten, 2000) whilst a 
group using denaturing gradient-gel electrophoresis assay estimated the detection of 
heteroplasmic variants occurring at levels of 5% and greater (Tully et al., 2000). The 
latter study suggested that approximately 14% of the population is heteroplasmic within 
this detection level (Tully et al., 2000). Therefore, an important consideration for 
population geneticists is that mutations must segregate within a larger mtDNA pool at 
the organellar, cellular, intergenerational and developmental levels before they can be 
detected as substitutions (Parsons et al., 1997). The forces acting on the segregation of 
mitochondrial types during oogenesis are debatable, with conflicting evidence reported 
for preferential transmission of mutant genomes (Chinnery et al., 2000), or random 
genetic drift being the principal determinant (Brown, Samuels, Michael, Turnbull, & 
Chinnery, 2001). 
2.1.3 The Use ofY Chromosome Analyses to Study Human Populations 
The Y chromosome exhibits exclusive male inheritance, making it analogous to 
mtDNA in its uni-parental mode of transmission. The haploid state of the Y 
chromosome means that it escapes recombination, with the exception of a small region 
known as the pseudoautosomal region [PAR] (Jobling & Tyler-Smith, 1995). The entire 
60-megabase chromosome can therefore be considered as a single locus. The exclusive 
father-to-son transmission ofthe Y chromosome provides a means of investigating male-
specific histories in human populations. The history of males in a population is likely to 
differ from female history and will reflect cultural practices governing mating patterns, 
migrations, wars and colonisation (Jobling & Tyler-Smith, 1995). Following the initial 
reports ofY chromosome polymorphisms (Casanova et al., 1985; Lucotte & Ngo, 1985) 
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the number of known polymorphic variants has rapidly increased to over 400 (de Knijff, 
2000; Underhill et al., 2000; Underhill et al., 2001). Y chromosome polymorphisms 
currently being exploited for population genetic studies fall into three classes: unique 
mutation events (UMEs), microsatellite and minisatellite loci. 
Loci that have undergone a mutation once on a single Y chromosome provide a 
means of differentiating deep-rooted male lineages. UMEs that have been identified on 
theY chromosome include ALU polymorphisms (Hammer, 1994; Spurdle, Hammer, & 
Jenkins, 1994), single nucleotide polymorphisms [SNPs] (Underhill et al., 1997; 
Underhill et al., 2000), and long interspersed nucleotide elements [LINES] (Santos et al., 
2000). Amongst these polymorphisms, ~NPs are by far the most numerous, with recent 
publications bringing the number of Y chromosome SNPs to over 200 (Underhill et al., 
2000; Underhill et al., 2001). The singularity of these mutational events allows the 
construction of a most parsimonious gene tree, thus simplifying the reconstruction of the 
evolutionary history of the chromosome. Distinct Y chromosomes that are defined 
solely on the basis of UMEs are designated haplogroups (de Knijff, 2000). The 
antiquity of Y chromosomes defined by UMEs makes haplogroup analysis appropriate 
for addressing questions regarding evolutionary events (Hammer & Horai, 1995; 
Underhill et al., 2000) and the peopling and relatedness of regional populations (Semino 
et al., 2000; Suet al., 1999; Underhill, Jin, Zemans, Oefner, & Cavalli-Sforza, 1996; 
Zerjal et al., 1997). 
In contrast to SNPs, Y chromosome microsatellites or short tandem repeats (Y 
STRs) demonstrate moderate mutability (Jobling & Tyler-Smith, 1995). Microsatellite 
DNA generally consists of di-, tri-, tetra- and penta-nucleotide repeat sequence motifs. 
Y chromosomes that are defined using microsatellites are denoted haplotypes (de 
Knijff, 2000). The number ofmicrosatellite loci in use on theY chromosome is small, 
with the initial 14 loci (de Knijff et al., 1997; Kayser et al., 1997) augmented with an 
additional 6 loci (White, Tatum, Deaven, & Longmire, 1999). Mutations at these simple 
repeats loci are thought to occur due to DNA polymerase slippage during DNA 
replication, resulting in the sequence increasing or decreasing by one or two repeat units 
(Goldstein & Pollock, 1997). Two pedigree-based studies of Y STRs have reported 
mutational rates of 3.2 X 10-3 mutations/generation (Kayser et al., 1997) and 21% X 10-3 
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mutations/generation (Heyer, Puymirat, Dieltjes, Bakker, & de Knijff, 1997). An 
expanded study of almost 5,000 observed meioses reported an average mutational rate 
over 15 Y STR loci of 2.8 x 10-3 mutations/generation (Kayser et al., 2000), closely 
matching the results from studies of autosomal STRs (Weber & Wong, 1993). In 
contrast to these findings, mutation rates inferred from evolutionary data are an order of 
magnitude smaller (Forster et al., 2000). Furthermore, significant variation in mutation 
rates at different Y STR loci has been proposed by some authors (Carvalho-Silva, 
Santos, Hutz, Salzano, & Pena, 1999; Thomas et al., 2000; Thomas et al., 1998) and 
empirical observations show locus-specific variation ranging from 0-8.58 x 10-3 
mutations/generation (Kayser et al., 2000). The directionality ofmicrosatellite mutation 
has been shown to be dependent on allele size (Ellegren, 2000; Xu, Peng, & Fang, 2000) 
and this directional bias has been observed in Y STRs (Kayser et al., 2000), indicating 
the need for this variable to be included in analyses of Y STRs. Analysis of the different 
loci also has shown that many microsatellites are compound repeats (de Knijff et al., 
1997; Kayser et al., 1997; Kayser et al., 2000), and since not all mutations are 
necessarily observed using the original methods, protocols have been adjusted 
accordingly (Forster et al., 1998; Forster et al., 2000; Rolf, Meyer, Brinkmann, & de 
Knijff, 1998). 
Given the rapid rate of diversification of Y STR haplotypes through the 
processes of mutation and genetic drift, it is possible to draw conclusions about male 
history and social behaviour on the basis of the relationships between different 
haplotypes found in populations. Conclusions based on Y STR haplotypes are further 
justified by the observation that identical microsatellite haplotypes are seldom 
independently generated along different lineages (Malaspina et al., 1998). Thus, the 
observation that a single haplotype is frequent in both Ashkenazi and Sephardic priests 
suggests a common origin of the religious leaders from these two historically separated 
populations (Thomas et al., 1998). In the Finns, the identification oftwo predominant Y 
chromosome haplotypes, separated by more than ten mutational steps, provides evidence 
for the dual origins of the male population (Kittles et al., 1998). Meanwhile, within 
India, a study has demonstrated that the majority of Y haplotypes occur uniquely in 
ethnic groups (Bhattacharyya et al., 1999). 
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Minisatellite DNA are tandem arrays of short repeats (6-12bp). A single 
minisatellite has been identified on the Y chromosome, termed MSY1 (Jobling, 
Bouzekri, & Taylor, 1998). The MSY1 locus has been shown to have a complex 
structure that is, however, amenable to high-throughput analysis (Bouzekri, Taylor, 
Hammer, & Jobling, 1998; Jobling, Bouzekri & Taylor., 1998). Although the 
mutational mechanism of minisatellites is poorly understood they are known to be 
rapidly mutating systems with mutation rates estimated for the MSY1 locus from 0.02-
0.11 mutations/generation (Bouzekri et al., 1998; de Knijff, 2000; Jobling, Bouzekri & 
Taylor, 1998). The high mutability ofMSYl provides an additional degree of resolution 
for the Y chromosome. This is particularly useful for paternity test cases (Jobling, 
Bouzekri & Taylor., 1998), but should also be useful for looking at short-term 
population history. 
All three mutable systems on the Y chromosome can be applied to investigations 
of human history, ranging from evolutionary questions-to migrations, genetic affiliations 
between linguistic groups, and the history of population admixture and ethnogenesis. As 
the mutational rates of the three systems differ by orders of magnitude, the applicability 
of each system is dependent on the research questions. Clearly, the creation of 
completely characterised lineages using combinations of, or all three mutable systems, 
provides the most comprehensive means of investigating male history. 
Y chromosomes that are characterised using UEPs and microsatellites, termed 
"lineages" by de Knijff, (2000), have been found to be restricted to single populations. 
Thus, Y chromosome lineages in more than one population suggest common origins or 
male-mediated gene flow. Based on this premise, examination of the genetic 
composition of a population that is the product of admixture can disentangle the origins 
of the paternal lineages. Thus, the study of an older population, such as the Lemba from 
southern Africa, demonstrated possible Semitic admixture (Thomas et al., 2000), and 
investigation of the composition of the Icelandic population suggests 20-25% Gaelic 
male founders with the remainder of Norse ancestry (Helgason, Sigurethardottir, 
Nicholson et al., 2000). This same approach has been applied to the characterisation of 
populations resulting from recent colonial history. In both a "white" Brazilian 
(Carvalho-Silva, Santos, Rocha, & Pena, 2001) and Colombian "settler" (Carvajal-
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Carmona eta!., 2000) population, the vast majority ofY chromosomes have been shown 
to be of European ancestry, with minimal but discernible African and Amerindian male 
contributions. 
The use of a male-specific system for investigating genetic diversity and 
composition complements the study of mtDNA variation that pertains exclusively to 
females. A number of studies have utilised the two systems in concert, to reveal 
significantly different male and female genetic histories within the same population. An 
investigation of the two genetic systems in Ethiopians revealed that one quarter of the Y 
chromosomes in the population had a possible Caucasoid origin, whereas only 10% of 
the mtDNA were Caucasoid, indicating that Caucasoid gene flow was primarily through 
males (Passarino et al., 1998). Similarly, a comparative study of Indian castes suggested 
that mtDNA distances reflected social rank and were the result of female gene flow 
between castes, while a lack of male gene flow resulted in no correlation between social 
rank andY chromosome distances (Bamshad et al., 1998). In the aforementioned Latin 
American populations, which are composed of mainly European patrilineages, 90% of 
the Colombian matrilineages were shown to be of Amerindian origin (Carvajal-Carmona 
et a!., 2000; Mesa et a!., 2000) whilst at least 60% of the Brazilian matrilineages were 
African or Amerindian (Alves-Silva et a!., 2000). More general conclusions have also 
been made on the basis of complementary studies, such as the assertion that world-wide 
female migration rates have been eight times higher throughout history than those of 
males (Seielstad, Minch, & Cavalli-Sforza, 1998). 
Although theY chromosome is a potent tool for investigating population history, 
there are a number of unresolved issues regarding its application. Y chromosomes have 
a smaller effective population size than autosomal chromosomes which accounts for 
reduced diversity observed at polymorphic loci. This smaller effective population size 
results in genetic drift having a more dramatic effect on Y chromosomal variation than 
on autosomes (Perez-Lezaun et al., 1997). This may potentially make it a more sensitive 
index of population history however, conversely, such sensitivity may provide results 
that are not representative ofthe entire population's history (de Knijff, 2000). Within a 
population, assortative mating may result in genetic profiles that do not accurately 
represent population history. A further consideration is the possible lack of neutrality of 
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the Y chromosome. The Y chromosome contains a number of genes which have 
homologues on the X chromosome, whilst others are involved in testes development and 
function (Lahn & Page, 1997). Jobling et al., (1998) demonstrated an instance of 
selection acting on a particular Y chromosome haplotype associated with infertile males. 
Additional evidence for selection acting on the Y chromosome has been reviewed 
(Jobling & Tyler-Smith, 2000) and, whilst inconclusive, it suggests that such a 
possibility should not be discounted. If an advantageous mutation was to occur on a Y 
chromosome at some point in a population's history, such a chromosome (and its neutral 
variants) could rapidly increase in frequency. This type of "selective sweep" has been 
discounted on a global scale due to the concordance in autosomal and Y chromosomal 
FsT values (Bertranpetit, 2000; Perez-Lezaun et al., 1997); however, these findings do 
not preclude the occurrence of localised selective advantages. Whilst these unresolved 
issues await developments in the field, a more pressing problem should be addressed. 
That is in the nomenclature of Y chromosomes. Currently, with each new report on the 
Y chromosome, there is a new study-specific nomenclature offered. This makes 
interpretations and comparisons of data sets from publications very difficult. To 
facilitate unimpeded comparisons of Y chromosome data, it is essential that 
terminologies and methodologies are standardised. 
2.1.4 The Application of Disease Allele Haplotype Analyses to the Study of 
Populations 
Each mutation at a disease locus originates on a chromosome, with its 
polymorphic characteristics giving rise to a distinct marker haplotype footprint (Guo & 
Xiong, 1997). Perturbations in this "footprint" can then occur through marker mutation 
and recombination. Through the examination of variation generated at associated 
neutral sites, one can attempt to reconstruct the history of the mutation in the population. 
Dating of a disease-causing mutation can aid in the understanding of the origin, 
evolution, and dispersion of the disease (Guo & Xiong, 1997). This can provide insights 
into population history and structure. This undertaking is based on the premise that the 
number of different haplotypes that have evolved from the ancestral chromosome is 
proportional to the time since the mutation occurred (Morral et al., 1994). 
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By convention, the most common haplotype associated with the disease-causing 
mutation is designated the ancestral haplotype. The· oldest disease haplotype in the 
population is expected to have given rise to the highest degree of variation (Morral et al., 
1994). A model must be employed that explains the variation generated at the different 
polymorphic loci and determines the amount of time required for the observed variation 
to occur. Estimations of the rate at which changes accumulate pose the greatest 
difficulty to researchers. Recombination is one means by which haplotype variation is 
produced. The rate of recombination is roughly correlated with the physical distance 
between genetic elements (Terwilliger & Ott, 1994). However, large deviations from 
this general correlation and inaccuracies in published genetic maps, such as errors in 
estimates of genetic distance between markers and in the physical order of those 
markers, greatly affect calculations. Variation also occurs at loci through marker 
mutation. Attempts have been made to empirically determine mutation rates at 
autosomal microsatellite loci (Brinkmann, Klintschar, Neuhuber, Huhne, & Rolf, 1998; 
Weber & Wong, 1993). However, there appears to be a large degree of variation in 
mutation rates at different loci. Therefore, average mutation rates, which are generally 
used in calculations, may be vastly different to those at specific loci. In the development 
of methods and algorithms for determining the age of mutations, various studies have 
accounted for either recombination or mutation, whilst disregarding the other variable. 
A minority of studies have attempted to include both phenomena ih their calculations. 
Morral et al., (1994) used three intragenic markers in the cystic fibrosis gene, 
cystic fibrosis transmembrane conductance regulator (CFTR), to date the ~F508 
mutation in European populations. Intragenic markers were used to justify discounting 
recombination and calculation of the age of the mutation was based solely on 
microsatellite mutation. However, this simplifying assumption is not entirely valid as 
there is no reason to suppose that intragenic recombination cannot occur. By 
constructing a most parsimonious tree, relating all haplotypes to the ancestral haplotype, 
the mean number of mutations to the root haplotype was used to calculate the age of the 
mutation (Bertranpetit & Calafell, 1996). The limitations of this method are exemplified 
by the fact that the authors concluded a possible age range of the mutational event 
between 52,000- 173,000 years before present. 
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Attempts to date mutations by considering only recombination have similarly 
been limited by uncertainty regarding recombination rates. Studies on the history of a 
founder mutation causing Infantile Onset Spinocerebellar Ataxia (IOSCA) in the Finnish 
population (Varilo et al., 1996), and Idiopathic Torsion Dystonia (lTD) in the Ashkenazi 
Jewish population (Risch et al., 1995), used linkage disequilibrium to date disease-
causing mutations. In these cases, linkage disequilibrium could still be observed over 
large genetic distances, which indicated a relatively recent mutational event in these 
founder populations. Risch et al., (1995) argue that the degree oflinkage disequilibrium 
represents an estimate of the proportion of disease chromosomes bearing the original 
associated marker allele, and that dif~erences in this value across marker loci should 
primarily result from the effects of recombination. Using this logic, calculation of the 
number of generations required to generate the observed diversity becomes a function of 
linkage disequilibrium and genetic distance. 
Stephens et al., (1998) developed an algorithm which incorporates variation at 
marker loci due to recombination and mutation. In dating the origin of the CCR5-L\32 
allele conferring resistance to AIDS, they estimated a rate of change at microsatellite 
loci that accounted for both means of generating new alleles at the loci investigated. 
Reconstruction of the most parsimonious phylogenetic history and the present haplotype 
frequencies was used to calculate the time required to produce the extant distribution of 
haplotypes (Stephens et al., 1998). This methods assumes that the proportion of 
haplotypes that show no change from the ancestral haplotype can be used to estimate the 
age of origin of the allele. This approach has the benefit of providing estimates that are 
independent of gene tree topology. 
The efforts to date mutations have necessarily been based on simplifying 
assumptions that are likely to have a detrimental effect on the result. The ability to 
determine accurately the age of the mutational event requires improved understanding of 
the biological mechanisms of microsatellite mutation and recombination and their rates 
of occurrence. In addition, factors such as population size, mating patterns, genetic drift 
and carrier selection can be expected to profoundly affect gene frequencies and thereby 
further confound this endeavour. Population modelling that examined these factors 
would provide important information about the fate of disease alleles and their haplotype 
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backgrounds. Nonetheless, the dates that are determined using current methods can 
serve to provide a timeframe that allows some insight into the population being studied. 
It would seem that the incorporation of additional resources, such as genealogies and 
known historical events, would provide a useful resource for complementing this 
undertaking. Furthermore, the integration of this analysis with information on variation 
elsewhere in the genome would provide a broader approach to studying the history of 
disease genes and the populations in which they occur. 
2.1.5 Summary of Molecular Genetic Tools for Studying Populations 
Genetic studies provide a unique. insight into the origins, history and structure of 
human populations. These studies can serve to support conclusions from historical and 
socioanthropological data. However, as the field of population molecular genetics 
develops, it is becoming increasingly possible to address questions for which evidence 
from other sources is virtually absent. The analysis of mtDNA andY chromosomes 
affords a complementary approach to the study of human populations. They tell sex-
specific histories of populations, which often differ. Though there are numerous 
uncertainties with regard to the biology of these two genetic elements, their haploid state 
simplifies interpretations. Analysis of the evolution of a disease haplotype within a 
population provides an additional means of investigating population history, which is 
not sex-specific. Using these three approaches in parallel, bearing in mind the 
limitations of each, allows independent and complementary means of addressing 
questions about the genetic structure and history of a population. 
2.2 The Identification of Disease Genes and the Role of Population Structure 
Determination of the ultimate cause of an inherited disease entails the 
identification of the mutation at the genome level. The enormity of this task is evident 
when one considers the 3 billion nucleotides of the human genome, of which only 1-2% 
encode functional genes (Lander et al., 2001). Furthermore, as the majority of genes are 
not yet characterised, this task often entails not only the identification of a gene defect 
but of the gene itself. The identification of disease genes has numerous implications for 
medicine. These include the development of DNA diagnostics and the detection of 
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disease carriers facilitating presymptomatic or prenatal counselling, and the possible 
development of gene therapies (Collins, 1992). In addition, the identification of disease 
genes is an important step in unravelling the aetiology of a genetic disorder. The 
determination of the primary gene defect directs the next stage of research, in which the 
protein malfunction may be studied. Although the majority of single gene disorders are 
extremely rare, the new understanding of cellular physiology should aid in 
understanding and treating more common disorders. 
2.2.1 General Approaches to Identifying Disease Genes 
Up until the early 1990s, the majority of disease genes were identified using 
functional cloning (Collins, 1992). This approach entails the prior determination of the 
protein defect. Knowledge of the protein that is defective in the disorder means that the 
amino acid sequence can be used to probe and identify the DNA sequence. Therefore, 
functional cloning of disease genes is limited to disorders whose biochemical basis is 
known (Collins, 1992). Furthermore, purification of the protein and determination of the 
peptide sequence is a necessity. This method is of limited applicability for the majority 
of genetic disorders, as functional knowledge is scant or non-existent for all but a few 
diseases. 
To overcome this problem, the strategy that has superseded functional cloning is 
known as positional cloning. This approach to gene identification entails mapping the 
gene defect to a chromosomal location without any prior knowledge of the gene 
function. The gene is mapped based on a genetic model and a known mode of 
inheritance. Polymorphic marker loci are used to analyse the DNA of affected 
individuals in relation to unaffected family members or a sample from a control 
population. A statistically significant relationship between the disease and known 
polymorphic loci enables the chromosomal localisation of the disease gene locus and 
eventual determination of the genetic defect. Investigations into the function of the 
disease gene are only commenced subsequent to its identification. This method of 
identifying disease genes has commonly been referred to as reverse genetics but it has 
been claimed that it is in fact genetics in purest form, unadulterated by any influences 
of biochemistry, cell biology or physiology (Collins, 1992). 
53 
In reality, many disease gene identification projects do not adopt a strict 
positional cloning approach. Mapping efforts will often localise the disease gene to a 
large chromosomal region, which may contain many hundreds of genes and transcripts. 
In an effort to overcome the daunting task of analysing every gene in the region, 
reasonable functional candidates, as determined from knowledge of expression patterns 
and homology to genes of known function, are selected and preferentially investigated. 
2.2.2 Gene Mapping Strategies and the Role of Population Structure 
The identification of a disease gene using the positional cloning approach entails 
an initial stage of mapping the locus to a. chromosomal segment. If one is using pedigree 
data, gene mapping is performed using linkage analysis (Ott & Hoh, 2000). This is the 
process whereby the unknown gene defect is found to be statistically associated with 
known loci. The localisation of disease loci using this method is entirely dependent on 
the biological phenomenon of recombination (Ott, 1991 ). Statistical analysis of the 
transmission of allel~s within a pedigree and their association with a particular 
phenotype produces a lod score, which quantifies the likelihood that the locus is 
associated with the inheritance of the phenotype (Morton, 1955; Botstein, White, 
Skolnick, & Davis, 1980). A statistically significant relationship provides evidence that 
the polymorphic locus is physically linked to the disease-causing locus. As lod scores 
are additive, it is possible to use numerous unrelated families to reach the canonical 
threshold value of 3 (this log value indicates a locus is 1,000 times more likely to be 
linked to the disease gene than not linked). 
A number of alternative methods to classical linkage analysis have been 
employed for mapping disease genes. These methods offer the benefit of having high 
statistical power without requiring large sample sizes. In addition, some of the methods 
do not necessarily require extended multigenerational pedigrees and can use single 
affected individuals. At the same time, a number of essential criteria, such as a low 
disease gene frequency and a young age of the mutation, limit their application. The 
methods are commonly employed as a means of rapidly localising the disease-gene 
locus to a gross chromosomal region, and are followed by saturation of the candidate 
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~ regions with polymorphic markers and the employment of additional methods to confirm 
and refine the locus. 
Lander and Botstein (1987) proposed a method termed homozygosity mapping to 
map disease genes in the offspring of consanguineous unions. The method is based on 
::._the expectation that one-sixteenth of the genome will be homozygous by descent (HBD) 
in the offspring of first cousin matings. The homozygous regions are expected to be 
randomly distributed between different offspring of these matings, except at a common 
disease locus (Lander & Botstein, 1987). The method is particularly useful as it requires 
only singletons from consanguineous marriages rather than families with multiple 
-- affected individuals (Kruglyak, Daly, & Lander, 1995). Consanguineous unions which 
,- are more distant than first cousin yield more information about linkage but this is 
countered by the decreased region of homozygosity (Lander & Botstein, 1987). 
Samples from different populations can be used, as exemplified by the use of 
homozygosity mapping to identify the ataxia-oculomotor apraxia locus m 
consanguineous families from Japan and Portugal (Ceu Moreira et al., 2001). However, 
heterogeneous genetic aetiologies of similar phenotypes are more likely in disparate 
populations. Within population isolates, unexpected allelic heterogeneity and unrelated 
homozygous segments can impede this approach (Miano et al., 2000). 
A similar approach to the identification of candidate disease-gene regions is 
referred to as segment sharing (Houwen et al., 1994). This method is appropriate for 
recently founded populations in which the disease allele can be either be demonstrated 
or inferred as originating from a common ancestor. In the initial study by Houwen et al., 
(1994), the authors performed a genome scan using just 250 markers in an extended 
pedigree of 10 individuals, four of whom were affected. An essentially empirical 
approach was taken in constructing haplotypes using two adjacent markers spaced about 
1 OcM apart and searching for shared genomic segments between affected individuals. If 
a sufficient number of meioses have occurred, the disease locus can be expected to 
segregate with those segments shared only by affected individuals. This approach can 
use a very small sample of patients and unaffected relatives that would not produce a 
significant result in traditional linkage. 
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In population isolates one can reasonably expect increased allelic homogeneity 
of disorders, due to founder effect. A founder mutation is observed as an identical 
mutation that occurs on closely related haplotypes. Following the initial mutational 
event, the original haplotype begins to decay through the process of recombination (Guo 
_ & Xiong, 1997). The extent of the decay varies greatly depending on the number of 
meioses since the mutation - which is in tum dependent on the age of the mutation, 
demographic expansions and drift - and on the physical characteristics of the 
chromosomal segment. In both homozygosity mapping and segment sharing, an 
essential assumption is that the deleterious allele is rare and that the mutation is not too 
old. Both of these factors translate to th~ requirement that sufficiently few meioses have 
occurred, so that the haplotype is preserved over detectable regions. In homozygosity 
mapping, underestimating the frequency of a disease-allele will lead to overestimation of 
the lod score (Kruglyak et al., 1995). Similarly, mutations that have occurred in the 
distant past, and therefore have undergone numerous meioses, will have a greatly 
reduced region of homozygosity. In populations that were founded and expanded in the 
distant past, one can expect that identical by descent (IBD) segments associated with a 
disease locus will be less than 1 eM, whereas in more recently founded populations IBD 
regions should be 5-20cM (Houwen et al., 1994). The impact ofthese parameters on the 
mapping approach that is adopted highlights the importance of understanding the history 
and structure of the population from which the study subjects are selected. 
An alternative approach to the search for IBD chromosomal segments in affected 
individuals, is to assess linkage disequilibrium within a population in a genome-wide 
scan. This is based on the hypothesis that a particular disorder in a population is due to 
founder effect and that identical by state (IBS) alleles are in fact IBD. This approach, 
commonly referred to as linkage disequilibrium mapping or an association study, looks 
for significant non-random association between a specific allele at a polymorphic locus 
and the occurrence of the disease. Linkage disequilibrium mapping differs from 
classical linkage in that it attempts to gain information from parental and historical 
recombinations rather than just from those observed in existing families (Peltonen, 
2000). In undertaking such a gene mapping strategy two assumptions are made; namely, 
that all affected individuals have a common ancestor and therefore there is strong 
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linkage disequilibrium with markers close to the disease locus, and that the mutation is 
young enough for linkage disequilibrium to be detected with a reasonable marker 
- density (Visapaa et al., 1998). This approach to gene mapping facilitates the novel 
method of pooling the DNA of affected and unaffected individuals. Linkage 
~disequilibrium at polymorphic loci can be observed in the different intensities of peaks 
or bands in an electrophoretic gel (Sheffield, Nishimura, & Stone, 1995). Although the 
approach would require careful DNA quantification, it was successfully used in the 
mapping of Hirschsprung s disease to chromosome 13q22 in an extensive Mennonite 
kindred (Puffenberger et al., 1994), and an axonal form of CMT in a large Tunisian 
- family (Barhoumi et al., 2001). 
Genome-wide scans are useful for localising a disease locus to a broadly defined 
chromosomal region; however, determination of the disease gene within these regions 
_ can be a laborious and time-consuming undertaking. In population isolates, although 
linkage disequilibrium can be identified over large genetic intervals, identical haplotypes 
_ in affected persons from different families are found only across highly restricted DNA 
regions (Peltonen, 2000). Therefore, fine scale genetic mapping can be used to narrow 
the region of investigation to one that is amenable to physical characterisation. This is 
largely an empirical exercise, which entails constructing dense marker haplotypes of the 
region in affected individuals. Both historical and parental recombinations can be 
observed, and used to refine the region to one of complete homozygosity. This has 
proved extremely useful in reducing the region of interest to an interval measured in 
kilobases (Peltonen, 2000). The application of the method is valid only in populations 
fulfilling certain criteria; namely, that the majority of disease alleles descend from a 
single ancestral mutation that now has a relatively high frequency, and that the disease 
allele has had sufficient time to undergo recombinations in the population, thus reducing 
the region of strongest linkage disequilibrium (Hastbacka et al., 1992; Lehesjoki et al., 
1993). These criteria are almost exactly opposite to those required to initially map a 
gene in a genome scan using linkage disequilibrium. Thus, younger populations are 
useful for identifying linkage disequilibrium over large distances, whereas older 
populations are more amenable to refining the region (Jorde, Watkins, Kere, Nyman, & 
Eriksson, 2000). 
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It is apparent that well characterised population isolates can provide an efficient 
means of localising a disease gene locus and narrowing the chromosomal region of 
~ interest. However, a major limitation to the use of population isolates for identifying 
~ 
~ genetic defects occurs in the final stage of gene identification. Once the conserved 
.. 
:-- haplotype has been narrowed to the smallest possible region using all available meioses, 
; all genes within the region are candidate disease genes. In analysing the sequence of 
-
f ··these genes, distinguishing disease causing mutations from non-disease causing 
OL 
' mutations can be problematic. This is because any base substitution found within the 
~ candidate genes can be argued to be unique polymorphism occurring in an isolated 
f founder population (Bonn -Tamir et aL, 1997). Furthermore, in the absence of allelic 
~· heterogeneity, the search for a single disease causing mutation can be painstaking. This 
- is highlighted by the search for the diastrophic dysplasia gene which was initially 
- mapped in 1990 (Hastbacka, Kaitila, Sistonen, & de la Chapelle, 1990) and successfully 
identified in 1994 (Hastbacka et al., 1994) based on mutations in non-Finnish 
'"' _individuals. However, the Finnish founder mutation, a splice donor site mutation, was 
- not reported until nine years after the initial report (Hastbacka et al., 1999). 
- 2.2.3 Construction of Integrated Physical and Genetic maps 
An essential component of a positional cloning project is the construction of a 
comprehensive physical map of the chromosomal region. This is usually undertaken in 
parallel with refined genetic mapping and provides the correct marker order, which is 
essential for mapping recombination breakpoints. In addition, physical mapping 
involves the identification of known genes and transcripts that map to the chromosomal 
segment. This clarifies the genomic content of the region and serves to identify the 
positional candidate genes. 
The first step in physical mapping is the construction of a map of contiguous 
genomic clones (i.e. a contig) covering the region. This is performed by screening 
genomic libraries such as yeast artificial chromosomes (YACs), bacterial artificial 
chromosomes (BACs) and Pl artificial chromosomes (PACs). The library is initially 
probed with polymorphic markers, which define the critical region. Each clone is then 
used as a probe to identify successive overlapping clones in a process known as 
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chromosome walking (Voet & Voet, 1995). This piecemeal process can be pursued in 
both directions until complete coverage of the critical region is obtained. 
Clonal coverage of the genomic region of interest allows the mapping of 
sequence tagged sites (STSs) to the region. These can include anonymous STSs 
(genomic fragments of no known function), ESTs (expressed sequence tags, which are 
derived from mRNAs), polymorphic markers and genes. The relative order of these 
STSs can often be determined by comparative mapping in the genomic clones or using 
radiation hybrid mapping. Genomic clones can also be used to identify novel genes in 
the region using techniques such as exon trapping, eDNA selection (Hastbacka et al., 
1994), zoo blots and northern blots (Collins, 1992). 
More recently, large scale sequencing and the advances of the human genome 
project (Collins et al., 1998; Lander et al., 2001) have enabled the analysis of the 
complete genome sequence in the region of interest. This serves to provide integrated 
maps which are much more comprehensive and reliable (Collins, 2000) and has resulted 
__ in a shift away from laboratory-based physical mapping to the primacy of computer 
databases and exon prediction programs, commonly referred to as cloning in silico. 
2.2.4 Well Characterised Population Isolates: Population structure and examples of 
mapped genes 
Exploitation of the increased genetic homogeneity of mendelian disorders in 
population isolates has proved fruitful in yielding disease genes. In many cases, a 
predominant disease haplotype is observed which accounts for the majority of disease 
alleles in the population and is found to bear a single mutation. However, it should be 
noted that minor haplotypes are found in these populations and allelic homogeneity is 
rarely complete. In many of the molecular genetic studies performed in these 
populations, historical and genealogical records have been of great benefit. In addition, 
the application of population genetic techniques has enhanced the understanding of the 
populations and thereby the search for disease genes. A brief summary of three of the 
best characterised genetic isolates follows. 
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2.2.4.1 The Ashkenazi Jews 
The Jews have a history that extends well beyond 3,000 years (Blaney, 2000). 
_ Apart from Biblical sources, the initial size of the Jewish population is unknown. They 
are a population of Middle Eastern origins who have been dispersed throughout the 
-~orld. The demographic history of the Jews is one of numerous expansions and 
contractions over the past 2,000-3,000 years. Amongst the most notable is the division 
of the Jews into the Sephardim and Ashkenazim. Today, the Ashkenazim mainly inhabit 
Europe and North America whilst the Sephardim are resident in the Middle East and 
North Africa. In many of these countries, Jews have maintained endogamous practices 
and admixture with the surrounding society has been uncommon (Rosenberg et al., 
=:: 2001). 
Population genetic studies of the Jews have served to illuminate the structure and 
- history of these dispersed subpopulations. Studies of the Y chromosome in Jewish 
_ populations support a common origin of Ashkenazi and Sephardic males (Santachiara 
=- Benerecetti et al., 1993). Analysis ofthe Y chromosomes of priests in both populations 
indicated their descent from a common ancestor possibly 3,000 years before present 
(Thomas et al., 1998). Later studies examined Jewish populations dispersed throughout 
North Africa, the Middle East and Europe using Y chromosome loci (Hammer et al., 
2000) and Libya, Ethiopia and Yemen using autosomal loci (Rosenberg et al., 2001), 
and clearly demonstrated their common origins and isolation from neighbouring 
communities. Genetic research into an idiopathic torsional dystonia (lTD) founder 
mutation prompted the suggestion that the current Ashkenazi Jewish populations 
descend from one thousand or fewer individuals as recently as 500 years ago (Risch et 
al., 1995). 
As a result of long-term cultural isolation, the Jews have a unique spectrum of 
genetic disorders (Goodman, 1978). Many of these disorders have been extensively 
studied and the genetic basis for a number has been elucidated (Motulsky, 1995). In 
many cases, gene-mapping strategies have been employed that make use of the 
population structuring. For example, linkage disequilibrium mapping was used to 
localise the idiopathic torsional dystonia gene [DYTl] (Risch et al., 1995). Where 
founder effects have been demonstrated, invariably a high gene frequency has been 
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observed. This corresponds to high carrier frequencies such as 1/29 for Tay-Sachs 
disease, 1140 for Canavan disease, 1117 for Gaucher disease, and 11100 for Bloom 
syndrome (summarised in Gilbert, 1998). The cause of these inflated gene frequencies 
in the Ashkenazi Jewish population has been the source of continued debate with some 
-researchers arguing the action of natural selection (Zlotogora, 1994; 1998; Zlotogora, 
Zeigler, & Bach, 1988), recent genetic drift (Risch et al., 1995) or high gene frequencies 
in the original population (Goldstein et al., 1999). 
2.2.4.2 The Finnish Population 
The present-day Finnish population is believed to be derived from a migration of 
Uralic speakers some 4,000 years ago (Peltonen, Jalanko, & Varilo, 1999). This was 
followed by a major population expansion 2,000 to 2,500 year ago which coincided with 
increased migration from Baltic and Germanic regions (de la Chapelle, 1993). Early 
settlement in Finland was mainly centred in the south of the country, with the north not 
occupied until the 16th century (Peltonen et al.., 1999). Hence, areas settled during this 
later period represent a subset of the general Finnish population (de la Chapelle, 1993), 
and/or the entrance of new migrants (Kittles et al., 1999; Kittles et al., 1998). This 
population is sometimes referred to as the New Finnish population. The size of the 
Finnish population has expanded rapidly from around 250,000 individuals in the 
beginning of the 18th century to the present number of5.1 million (Peltonen et al., 1999). 
Molecular genetic studies of the population history of the Finns suggest a 
population bottleneck some 2,000 years ago (Kittles et al., 1999). This is reflected in the 
relatively limited genetic diversity observed in the Finns, a result of the small founding 
population and minimal admixture. Further analysis of the Y chromosome has provided 
evidence that there were two predominant founding populations (Kittles et al., 1999; 
Kittles et al., 1998). In addition, the Finnish population has undergone numerous minor 
contractions and expansions, which represent multiple minor bottlenecks. 
The occurrence of unique genetic disorders in the Finnish population was first 
noted by doctors in the 1960s and termed the Finnish disease heritage (Norio, 
Nevanlinna, & Perheentupa, 1973). Many of the causative disease alleles occur at high 
frequencies. Molecular genetic studies of these disorders have proved remarkably 
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successful in positioning and identifying the disease genes. This is largely due to the 
genetic homogeneity of many of the disorders. Initial localisation of the genes has 
utilised traditional linkage methods, as well as searches for shared genomic segments 
and linkage disequilibrium mapping (Peltonen, Palotie, & Lange, 2000). The fact that 
for all the cloned Finnish disease genes one major mutation has accounted for t70% of 
disease chromosomes (Peltonen et al., 1999), has meant that fine structure genetic 
mapping has been powerful in narrowing the genomic region and eventually identifying 
the disease gene. There are numerous examples of the successful identification of 
disease genes in the Finnish disease heritage in which the two stage approach has been 
applied. Peltonen et al., (1999) lists 32 disease loci that have been identified and 15 in 
which the mutated gene has been identified. For example, the locus for the disorder 
presenile frontal lobe dementia with bone cysts (PLO-SL) was mapped to a 9cM region 
that was then reduced to 150kb through refined mapping (Pekkarinen, Hovatta et al., 
1998; Pekkarinen, Kestila et al., 1998). Similarly, the progressive myoclonus epilepsy 
(EPMl) locus was mapped to a 7cM region and reduced to 176kb through refined 
mapping (Lehesjoki et al., 1993; Lehesjoki et al., 1991). 
In Finland, regional clustering of disorders and mutations has been noted (de 1a 
Chapelle, 1993). This reflects substructuring in the Finnish population with differing 
histories of the disorders and mutations in each subpopulation. Indeed, in the haplotype 
analysis of the diastrophic dysplasia gene, the major disease haplotype was found to be 
distributed evenly across Finland whilst the minor haplotypes showed east and west 
geographic clustering (Hastbacka et al., 1992). Regional clustering of HLA haplotypes 
has also been observed in the Finnish population (Siren, Sareneva, Lokki, & Koskimies, 
1996). Population substructure provides a useful resource, as gene mapping is 
facilitated in the younger population and refinement of the regions is aided by the 
increased diversity in the Old Finnish population (Jorde et al., 2000). 
2.2.4.3 The French Canadians 
French colonisation ofCanadabegan in the early 1 ih century and continued until 
the capture of Quebec by the British in 1759, at which point it virtually ceased altogether 
(Scriver, 1992). During this time it is estimated that only 8,000-10,000 people 
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permanently established themselves in the colony (Charbonneau et al., 1987). Limited 
subsequent migration and emigration means that the current 5 million Francophones in 
Quebec are mainly descended from these colonists. During the almost 400 year history 
of the French population in Canada a number of migrations into different regional areas, 
such as Charlevoix, along the Saguenay River and the Lac-Saint-Jean area (often 
referred to as the CSLSJ populations) have occurred (Labuda et al., 1996). Thus, the 
French Canadians represent a much more recently founded population isolate than the 
Jews or Finns, with internal migrations representing subsequent population bottlenecks. 
Molecular genetic studies (Heyer, Tremblay, & Desjardins, 1997), and genealogical and 
demographic studies (Heyer & Tremblay, 1995), have shown that a small number of 
founders have contributed to the majority of the present day gene pool. 
In Quebec, a number of known genetic disorders occur at increased frequencies 
(Scriver & Fujiwara, 1992), and a number of previously unknown disorders have been 
identified in this population (Labuda et al., 1996). Many of these genetic disorders have 
carrier frequencies in the range 1.5-5% including spastic ataxia, 1/21; polyneuropathy, 
1/25; histidinemia, 1/32 and pyruvate kinase deficiency, 1/64 (summarised in Labuda et 
al., 1996). Theoretical studies have shown that these frequencies can be explained by 
their introduction by a single founder (Heyer, 1999). In many cases, genetic 
homogeneity and founder effect have facilitated the application of linkage 
disequilibrium mapping to localise and refine disease loci. An example is the autosomal 
recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) locus, which was initially 
localised using a small number of polymorphic loci examined for excess of 
homozygosity under the assumption of a founder mutation (Bouchard et al., 1998). An 
apparent increase in homozygosity at one locus on chromosome 13 focused attention to 
this region, and linkage analysis was used to map the gene to an 11.1 eM segment on 
chromosome 13qll which was refined to 5.5cM on the basis of a recombination 
(Bouchard et al., 1998). Haplotype analysis refined this to a 1.6cM region and location 
score analysis predicted that the disease locus was 0.42cM distal from one of the 
polymorphic loci (Richter et al., 1999). It is interesting to note that the authors were not 
able to further refine the region using haplotype analysis. Linkage disequilibrium 
around the ARSACS locus was shown to be much greater than around the DTD locus in 
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the Finns, an older founder population (Engert et al., 2000). The fact that the candidate 
region could only be reduced to 1.6cM highlights the possible pitfalls of a founder 
population that is too young to allow further refinement of the disease locus. 
2.3 Diseases Under Investigation 
Two autosomal recessive disorders were investigated in this thesis. A summary 
of the literature on clinical and genetic aspects of the disorders is provided below. 
2.3.1 Hereditary Motor and Sensory Neuropathy- Type Lorn (HMSNL) 
Hereditary motor and sensory n~uropathy type - Lorn (HMSNL) is an autosomal 
recessive disorder that was first identified in Roma resident in Bulgaria (Kalaydjieva et 
al., 1996). It is named after the Bulgarian town in which affected individuals were 
initially identified. However, in addition to the Lorn population, the disorder was also 
identified in the Monteni and Kalderash (Kalaydjieva et al., 1996). Since the initial 
report of the disorder several more affected Romani individuals have been identified in 
different European countries including Italy (Merlini et al., 1998), Spain (Colomer et al., 
2000), Slovenia (Butinar et al., 1999), France and Rumania. Furthermore, the clinical 
and neuropathological characterisation of this novel disorder has been refined. 
2.3.1.1 Clinical Features ofHMSNL 
HMSNL is an inherited disorder affecting the peripheral nervous system (OMIM 
#601455). HMSNL is classified as an autosomal recessive form of Charcot-Marie-
Tooth disease type 1 (CMT4D2). This heterogeneous class of disorders comprises 
demyelinating neuropathies, as opposed to axonal neuropathies which are classified as 
CMT23 (Scherer, 1999) and spinal CMT (Timmerman, Nelis, de Jonge, Martin, & van 
Broeckhoven, 1998). Clinical features common to CMTl include distal muscle 
weakness, diminished tendon reflexes, and often foot deformities such as pes cavus 
(Timmerman et al., 1998). 
2 The nomenclature currently in use distinguishes recessive forms of CMTl by denoting them as CMT4. 
However, it has been argued that this confusing classification should be abandoned (Thomas, 
2000). 
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HMSNL is a severe form of CMT1. Onset typically occurs during the first 
decade oflife and it initially manifests as difficulty in walking (Kalaydjieva et al., 1998). 
Skeletal deformities frequently occur in patients and all sensory modalities are impaired 
(Kalaydjieva et al., 1998). Electrophysiological studies have revealed greatly reduced 
nerve conduction velocities (Kalaydjieva et al., 1998). A distinguishing feature of 
HMSNL is its association with sensorineural deafness (Butinar et al., 1999; Kalaydjieva 
et al., 1996; Kalaydjieva et al., 1998). 
2.3.1.2 Neuropathology ofHMSNL 
The histopathological hallmarks of CMTl include extensive de- and 
remyelination, resulting in hypertrophic changes and onion bulb formations observed in 
peripheral nerve biopsies (Timmerman et al., 1998). Sural nerve biopsies of HMSNL 
patients have shown a dramatic reduction in myelinated nerve fibres and fibre density 
(Kalaydjieva et al., 1998) and the myelin is uncompacted (King et al., 1999). The 
occurrence of poorly developed atypical onion bulb formations has been reported from a 
number of studies of HMSNL patients (Baethmann, Gohlich-Ratmann, Schroder, 
Kalaydjieva, & Voit, 1998; Ka1aydjieva et al., 1998; Merlini et al., 1998). In addition, 
severe and early axonal loss is a pathological feature of HMSNL (Baethmann et al., 
1998). A distinguishing feature of HMSNL is the intra-axonal accumulation of 
irregularly arranged curvilinear profiles, which has previously been observed in cultured 
cells under experimental vitamin E deficiency (Baethmann et al., 1998; King et al., 
1999). 
2.3.1.3 Genetic aetiology of HMSNL 
HMSNL was initially reported as occurring in three Romani populations in 
Bulgaria (Kalaydjieva et al., 1996). The disorder has an autosomal recessive pattern of 
inheritance. The authors mapped the gene using a two-stage strategy. Initially, three 
affected individuals connected by an average of 9.5 meioses in an extended pedigree 
were examined in a genome scan for segment sharing. Two shared segments were 
3 Current nomenclature specifies dominant forms of axonal neuropathies· as CMT2 and recessive forms as 
CMT3. 
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identified on chromosome 8. The investigation was then expanded to include all 
individuals in the pedigrees and the gene was mapped distal to these segments using 2-
point and multi-point lod scores. The highest lod score of7.7 was obtained for marker 
D8S378 at a recombination fraction of e = 0. Saturation of the region with known 
polymorphic markers identified a core disease haplotype spanning approximately 3cM 
with evidence of three possible recombinations. All patients were homozygous for a 
two-marker haplotype that spanned 1.6cM. Then observed allelic homogeneity led the 
authors to hypothesise that HMSNL in the Roma is caused by a single ancestral founder 
mutation that occurred more than 800 years ago. 
Myelinopathies consist of a spectrum of clinical disorders, which in addition to 
CMT1, include hereditary neuropathy with li~bility to pressure palsy (HNPP), Dejerine-
Sottas syndrome (DSS), and congenital hypomyelinating neuropathy (Lupski, 2000). 
Thus far, molecular genetic studies have revealed a number of defects in different genes 
causing these disorders. CMT1A, CMT1B and CMTX are caused by mutations in 
peripheral myelin protein 22kd (PMP22), myelin protein zero (MPZ), and connexin 32 
( CX32) respectively (Suter & Snipes, 1995). In all cases, the mutations have occurred in 
the heterozygous state and exhibit a dominant or sex-linked form of inheritance. 
Recessive inheritance ofCMTl is rare but it is believed to be clinically more severe than 
dominant forms. A number of autosomal recessive loci for CMT 1 have been identified 
using gene mapping approaches in population isolates. These include a locus on 8q 13-
q22.1 identified in Tunisian families (Ben Othmane et al., 1993), a locus on 5q23.33 in 
an Algerian kindred (LeGuem et al., 1996) and a locus on llq23 in a large Italian 
kindred (Bolino et al., 1996). Prior to the end of 1999, no genes had been identified that 
cause recessive CMT1 leaving the molecular basis of this heterogeneous class of 
disorders unknown. The report by Bolino et al., (2000) of mutations in myotubularin-
related protein-2 causing CMT4B represented the identification of the first gene causing 
autosomal recessive CMTl. 
2.3.2 Limb Girdle Muscular Dystrophy Type 2C (LGMD2C) 
Autosomal recessive muscular dystrophies resembling X-linked Duchenne 
muscular dystrophy form a wide spectrum of clinical severities. To date, at least seven 
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types of autosomal recessive limb girdle muscular dystrophies (LGMD) have been 
identified with the probability of further examples (0:£-vHM, 2001). The underlying 
genetic aetiology of many of these disorders has been elucidated and found to involve 
defects in different components of the dystro-sarcoglycan complex, which spans the 
sarcolemma to provide a link between the subsarcolemmal cytoskeleton and the 
extracellular matrix component, laminin (OMIM, 2001). Limb Girdle Muscular 
Dystrophy type 2C (OMIM *253700) is caused by mutations in the y-sarcoglycan gene 
(SGCG) and is one of the most severe autosomal recessive sarcoglycanopathies. 
2.3.2.1 Clinical Features of LGMD2C 
Onset of the disorder typically occurs by 5 years of age, with most patients 
wheelchair-bound by 12 years of age. Wasting primarily affects the striated muscles of 
the limb girdle and truncal muscles (OMIM, 2001). Life expectancy is greatly reduced 
and patients rarely live to be more than 25 years of age. Investigation of clinical severity 
in LGMD2C has shown that there is considerable phenotypic variation in individuals 
with the same mutation (McNally et al., 1996). Merlini et al., (2000) have studied the 
phenotype of patients homozygous for the C283Y mutation and determined that 49% 
were severely affected and 51% had a more moderate phenotype. 
2.3.2.2 Neuropathology of LGMD2C 
Gamma sarcoglycan is an essential subunit of the dystroglycan complex (DGC). 
It is a transmembrane protein with a postulated structural function in the linking of 
dystrophin and laminin across the muscle cell membrane (Vainzof et al., 1996). 
Absence of the y-sarcoglycan subunit, either due to primary mutations in the gene or to 
mutations in other subunits of the DGC, invariably results in a severe phenotype 
(Vainzof et al., 1996). It has been noted that y-sarcoglycan deficiency is sufficient to 
cause the dystrophic process independently of dystrophin, which is normal in LGMD2C 
(Hack et al., 1998). Furthermore, the deficiency of dystrophin in Duchenne Muscular 
Dsytrophy causes a secondary deficiency of y-sarcoglycan, leading some to suggest that 
Duchenne Muscular Dystrophy and LGMD2C share a common pathogenesis related to 
the deficiency of gamma sarcoglycan (Li, Dickson, & Spiro, 1998). 
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2.3.2.3 Genetic Aetiology of LGMD2C 
Cosegregation of chromosome 13 markers with one form of Severe Childhood 
Autosomal Recessive Muscular Dystrophy (SCARMD)4 was first reported in a Tunisian 
kindred by Ben Othmane et al., (1995). Soon afterwards, Noguchi et al., (1995) reported 
the cloning of a novel gene encoding a 35 kDa Dystrophin-associated protein, termed 'Y 
sarcoglycan (SGCG). The paper demonstrated that mutations in the SGCG result in 
LGMD2C and a founder mutation in this gene was responsible for the SCARMD in the 
Tunisian patients. In 1996, Picccolo et al., reported a C283Y mutation in SGCG of 
LGMD2C affected individuals of Romani ethnicity. Closely related disease haplotypes 
suggested a common founder mutation at least 1,200 years old. Following these initiaal 
studies, numerous mutations in SGCG causing LGMD2C have been reported (OMIM, 
2001). 
2.4 Community Genetics 
Community genetics is a field that marries predictive testing for inherited 
disorders with public health. The establishment in 1998 of a dedicated academic 
journal, Community Genetics, which addresses developments in this field, is testament to 
its growing importance. The editor of Community Genetics, Leo P. ten Kate (1998), has 
defined community genetics as encompassing all activities to enable the identification 
of people in a community with increased genetic risks who want to acquire this 
knowledge in order to make informed decisions. In the same inaugural issue of the 
journal, Modell and Kuliev (1998) define community genetics as embracing all 
approaches for the early identification and prevention of genetic risk that can be applied 
to whole populations . As with all public health programs, the ultimate aim of 
community genetics is to improve the health of the population. This is achieved through 
the central roles of genetic epidemiology, education, audit, development of infrastructure 
and collaboration with support associations (Modell & Kuliev, 1998). The fundamental 
4 Prior to identification of the genes that encode proteins in the dystroglycan complex a number of 
disorders with similar phenotype were referred to collectively as severe childhood autosomal 
recessive muscular dystrophies (SCARMDs). Identification of the causative genes has facilitated 
refmed classification of the disorders on the basis of phenotype and genotype. 
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distinction between community genetics and clinical genetics is in the approach. 
- Whereas clinical genetics entails waiting for people to request a consultation, 
community genetics is the process of approaching members of the community who may 
be at risk but have not yet been identified or helped (ten Kate, 1998). 
2.4.1 Carrier Screening 
Carrier screening is the identification of healthy individuals who possess a single 
copy of a deleterious disease allele that may lead to an inherited disease in their 
offspring. With the development of molecular genetic techniques, it is now possible to 
directly and definitively ascertain an ~ndividual s status with regard to a particular 
disease-causing mutation. Thus, carrier testing can be offered to help individuals make 
more informed reproductive decisions (Wilfond & Fost, 1990). 
The British Medical Association ( 1998) has stated that the following criteria 
should be met in order to justify a genetic screening program: 
• The problem must be important, that is it must affect a high proportion of the 
population or it must be sufficiently severe. 
• A suitable screening test should be available in terms of reliability, sensitivity 
and predictive value. 
• It must provide useful information for the management and reproductive 
decisions. 
• The benefits must outweigh the risks. 
• Adequate provision must be made for information, counselling and privacy. 
Genetic screening programs are often targeted at all members of a community or 
population. However, alternatives to a general population-based screening program 
have been offered by a number of researchers. Wald (1991) and Wald, George, Wald, & 
Mackenzie (1993) proposed treating the reproductive couple as the screening unit and 
categorising them as at risk or no risk, thereby avoiding potential psychological strains 
caused by knowledge of an individuals carrier status. However, this approach denies 
the right of the individual to genetic knowledge. Super, Schwarz, & Malone (1992) 
proposed a cascade testing method in which screening is focused on the relatives of 
index cases. Other authors have stated that the identification of a carrier or affected 
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family member provides the impetus for screening the extended family (Kolodny, 1992). 
In communities that are deemed to be at high risk for particular disorders, such an 
approach may unfairly discriminate against unrelated at-risk individuals. 
In undertaking a carrier testing program, Brock (1994, 1995) identified four 
_ potential targets; neonates, high school children, young adults, and pregnant women. A 
number of programs have detected carriers in neonates. This information is, however, of 
little use until the person reaches reproductive age, and this does not allow informed 
consent of the individual. Scriver et al., (1984) have demonstrated the success of 
heterozygote screening in high school students. However, there is general consensus 
that young adults represent the most logical target groups (Brock, 1994). In a statement 
from the American Society of Human Genetics (ASHG/ACMG, 1995) it was stated that 
[i]f the medical or psychosocial benefits of a genetic test will not accrue until 
adulthood, as in the case of carrier status or adult-onset diseases, genetic testing 
generally should be deferred. However, this assertion may not be cross-culturally 
applicable. Obviously, carrier-testing should precede conception, thus the appropriate 
age for genetic testing should account for marriage practices within a community. 
Regardless of the approach taken, there appears to be a large variation in success 
in terms of uptake, depending on the immediacy of the service offered. Watson, Mayall, 
Lamb, Chapple, & Williamson, (1992) found that when an offer of screening was made 
opportunistically by members of the research team, 66-87% agreed to the test, but when 
offered by written invitation, only 10% submitted to the test. Similarly, Bekker et al., 
(1993) found that the most important variable determining participation rates in 
screening programs was the personal approach by a professional and the offer of 
immediate testing. 
A measurement of the validity and reliability of the actual test will aid in 
justifying its use. Holtzman, (1989) outlines three parameters by which a genetic test for 
disease should be judged. These parameters can be adapted for application to genetic 
screening for carriers as follows: 
• Sensitivity: What proportion of carriers for the disorder will be detected? 
• Specificity: What proportion of people who are not carriers will have normal 
(negative) results? 
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• Predictive value: What proportion of positive tests are true positives in the 
population? 
It is essential that the limitations of genetic testing be adequately addressed and 
conveyed to an individual. Tests have been introduced into health care prematurely, for 
-~example, the rapid introduction of cystic fibrosis testing prior to confirmation of its 
suitability (Holtzman, Murphy, Watson, & Barr, 1997). Currently, even for many 
monogenic traits, the detection rate of genetic mutations is only 60-90% (van Ommen, 
Bakker, & den Dunnen, 1999). Therefore, careful consideration of the criteria outlined 
by Holtzman, (1989) is essential prior to the implementation of carrier testing programs. 
2.4.2 Genetic Counselling 
Genetic counselling has been described as the provision of genetic education 
coupled with psychosocial counselling (Bowles Biesecker & Marteau, 1999). They 
define the goals of genetic counselling as: 
• Facilitation of autonomous and informed decision making. 
• Engendering an appreciation of the inheritance of the genetic condition. 
• The integration of genetic information into a useful framework. 
• Improvement of the emotional well-being of those affected or their family 
members. 
There are two fundamental concepts that must be conveyed to an individual who 
has undergone carrier testing. The least subjective concept is that of risk in terms of the 
likelihood of giving birth to a child with the disease. For a simple autosomal recessive 
disorder, this risk for an individual carrier is simply a product of the chance of 
transmitting the disease allele to an offspring and the frequency of the disease allele in 
the population. If a reproductive couple is tested and both parents are found to be 
carriers of an autosomal recessive disorder, the risk of producing a child with the disease 
is one in four, based on the principle of mendelian inheritance. 
The concept of risk is distinct from the subjective notion ofburden. Burden can 
be considered as morbidity and the possibility of early mortality, together with the 
physical, emotional, and financial load for parents (Leonard, Chase, & Childs, 1972). A 
determination of burden therefore results from a consideration of many factors and can 
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be heavily influenced by socioeconomic status and culture. However, it is burden more 
than risk that has a large role in decisions about future childbearing (Leonard et al., 
1972). 
Once knowledge of carrier status is gained, there are a number of options 
available to the individual or couple. These are largely determined by the stage at which 
the relevant information is obtained and the autonomous decisions of those identified to 
be at risk. The possible outcomes or actions include: 
• Selecting a partner who is not a carrier for that disorder. 
• Remaining childless. 
• Fertility treatment to avoid the disorder, such as oocyte or sperm donation, or 
preimplantation diagnosis. 
• Prenatal diagnosis and termination or continuation of pregnancy. 
• leaving the outcome to fate . 
(BMA, 1998, p 1 06) 
It has long been held that the fundamental ethos of genetic counselling is that of 
non-directive counselling. This stems from the concept of an individuals right to make 
reproductive decisions unencumbered by the opinions of the health practitioner. There 
has been continued widespread support amongst genetic counsellors and medical 
geneticists for a policy ofnon-directiveness (Wertz & Fletcher, 1988). However, the 
value and practicality of this approach have been questioned (Clarke, 1991 ). A study 
that explicitly quantified directiveness in the clinical setting found that all consultations 
were characterised by some degree of directiveness (Michie, Bron, Bobrow, & Marteau, 
1997). This finding has been welcomed by some who claim that nondirective genetic 
counselling is an impossibility and the focus on nondirectiveness diverts attention from 
other important goals of genetic counselling (Bernhardt, 1997). Moreover, others assert 
that there exists no evidence in the literature that the nondirective approach benefits the 
individual (Wolff & Jung, 1995). 
2.4.3 Genetic Screening in Population Isolates 
The relative importance of genetic disorders as a health concern is a function of 
the overall health situation of the individual, family or population. Clearly, in many 
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countries health problems exist that are of far greater concern than genetic disorders. 
The importance of genetic disorders tends to be recognised when infant mortality falls 
below about 40/1,000 (Modell & Kuliev, 1998). Therefore, it can be expected that as 
general health improves in a population, genetic disorders will become an increasing 
health concern. 
In a population isolate, the frequency of particular genetic diseases is often high 
and a small number of disease causing mutations is to be expected (Chiba-Falek et al., 
1998). The reduction in allelic heterogeneity in such populations translates into 
increased sensitivity for carrier testing. Thus, population screening programs have 
proved successful in populations su'?h as the Ashkenazi Jews in which a greater 
proportion of carriers can be successfully identified (Kaplan, 1998). However, 
population-based carrier screening has a history of both spectacular successes and 
failures. By 1992, nearly one million young adults had been tested for Tay-Sachs 
disease (Kaback et al., 1993). This had resulted in the detection of 36,000 heterozygotes 
and 1,056 couples deemed to be at risk. A total of 2,516 pregnancies had been 
monitored and of the 469 affected foetuses identified, 451 had been aborted (Kaback et 
al., 1993). As a result of this program, the incidence of children born with Tay-Sachs 
disease has diminished markedly. In contrast, the screening of African-Americans for 
carriers of s~ckle-cell anaemia has demonstrated how genetic screening should not be 
performed. During the 1970s, seventeen U.S. states passed laws on sickle cell 
screening. In seven of these states screening was mandatory and, in five, marriage 
licenses and school attendance was denied to those who chose not to be tested 
(Holtzman, 1989). The draconian measures employed by the states resulted in the 
eventual abandonment of carrier testing for sickle-cell anaemia. 
Carrier testing raises a myriad of issues that must be approached sensitively and 
thoughtfully. Many of these issues, such as informed consent, non-directive counselling, 
and post-test alternatives are common to all testing programs. However, carrier testing 
in small identifiable populations presents novel issues many of which have only recently 
begun to be addressed in the literature. Paramount among these issues is that of group 
identity and fears of collective stigmatisation. It is likely that a group s own sense of 
self-worth and solidarity may be undermined by the finding that they have a greater 
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genetic propensity for certain inherited diseases (Juengst, 1998). Indeed, Jews in the 
U.S.A. have expressed concern at the numerous genetic studies that have focused on 
their population (Foster, Bemsten, & Carter, 1998). Such concern is warranted, given 
the history of the popular and political misappropriation of genetic studies to support 
_ racist agendas (Kohn, 1996). This leagcy dictates that community genetics programs 
should be implemented in consultation with community members, and in accordance 
with their desires and concerns. 
2.5 Summary of the Literature Review and Research Aims of this PhD 
Thesis 
Increasingly genetics, the science of heredity, is focusing on populations as the 
unit of study. This represents the fusion of medical genetics· and evolutionary 
population genetics. The convergence of these fields has yielded advances that would 
not have occurred if they had remained mutually isolated. Thus far, the most fruitful 
studies have been of population isolates - those populations in which social or 
geographic constraints restrict the gene pool. The study of genetic structure, diversity 
and variation has provided insights into the origins and histories of these populations. 
The incorporation of these findings with knowledge from the humanities informs 
hypotheses regarding the genetic basis of disease for both the clinician and the 
researcher. Knowledge of prevalent mutations within a population provides a rational 
starting point for molecular diagnoses and predictive testing. Meanwhile, the 
assumption that occurrence of a disease within a population is due to the population-
wide segregation of a disease allele derived from a common ancestor dictates the 
appropriate strategy for gene identification. 
Genetic studies of the Roma indicate that they have some of the characteristics of 
a population isolate. Mendelian disorders have been shown to be the result of private 
founder mutations. The homogeneity and frequency of disease alleles are consistent 
with founder effects in genetically restricted populations. Related disease genes 
identified in different populations point to genetic affinities between some Romani 
groups. However, the studies of non-disease loci provide contradictory and confounding 
evidence. A review of the genetic evidence suggests that the Roma comprise a 
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genetically heterogeneous conglomerate of populations, and their relatedness and origins 
remain unclear. 
The purpose of this thesis is to address some of the unresolved questions 
regarding the genetic architecture of the Roma- its composition, the relatedness of 
populations and diversity within each population. Four broad aims have been developed 
to address unresolved questions of the genetics of the Roma. Specific questions 
developed within each aim are stated at the commencement of the four sections, which 
are focused on one of the following objectives: 
• To study the genetic composition and structure of Romani populations 
through the investigation of neutral genetic variation. 
• To apply knowledge of the unique structure of the Romani population to 
refined genetic mapping and positional cloning of the HMSNL gene. 
• To investigate the distribution and history of two founder mutations, causing 
LGMD2C and HMSNL, in Romani populations. 
• To assess a pilot genetic screening program for a founder mutation causing 
LGMD2C in a high-risk Romani community. 
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Section I 
A POPULATION GENETIC STUDY OF THE ROMA 
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CHAPTER3 
SUBJECTS AND METHODS 
3.1 Introduction and Study Design 
3.1.1 Summary of Previous Findings 
Genetic investigations of the Roma have been undertaken for over eighty years. 
The initial study by Verzar & Weszeczky (1921) and the majority of subsequent studies 
have focused on the origins of the Roma and the relatedness of Romani populations. 
Many of these studies have been impoverished by flaws in study design, inaccurate 
definition of populations, and inappropriate sampling approaches and methodologies. 
This is primarily due to a disregard of the social history of the Roma in attempting to 
interpret genetic data. 
Preliminary evidence for genetic relationships between some of these 
populations is suggested by shared disease mutations (Kalaydjieva et al., 1996; Piccolo 
et al., 1996; Abicht et al., 1999). These private mutations, found in diverse Romani 
populations, suggest either common origins or gene flow. Evidence for genetic 
relatedness of three socially separated Romani populations resident in Bulgaria, in which 
HMSNL occurs, is provided by a common predominant paternal lineage and shared 
maternal lineages (Kalaydjieva et al., 2001). However, genetic relationships between a 
wide range of Romani groups have not been investigated using uniparentally inherited 
markers. 
Social anthropological studies invariably describe strict endogamous marriage 
practices in the Roma (Marushiakova & Popov, 1997). Virtually every genetic study of 
Romani populations indicates that the population differs from autochthonous 
populations and from other Romani populations. This is possibly due to the rapid 
divergence of allele frequencies in genetically restricted populations. Limited male-
specific diversity has been noted in three Vlach Romani populations by Kalaydjieva et 
al., (2001), and in a forensic study of Hungarian Roma (Fiiredi, Woller, Padar, & 
Angyal, 1999). Founder mutations also provide possible evidence of limited genetic 
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diversity. However, knowledge of the relationship between social practices and genetic 
diversity in the Roma is poorly understood. 
:: 3.1.2 Research Questions 
This study aims to address three broad issues pertaining to the population history 
- and structure of the Roma. A number of questions are posed within these aims: 
, 1. To investigate the origins of the Roma and their relationship to other populations. 
A. What does the composition of the Romani gene pool indicate about the parental 
population(s) from which the present day Roma are derived? 
B . How are the Roma relate~ to other worldwide populations, including 
autochthonous Asian, European and African populations? 
C. Are the Roma descended from an ethnically diverse or homogeneous people? 
2. To investigate the relatedness of Romani populations. 
A. Do socially and geographically separated Romani populations share common 
biological origins? 
B. How are geographically and socially separated Romani populations related to 
each other? 
C. Can population histories be inferred from the genetic data? 
3. To investigate the biological impact of social practices. 
A. What impact has the practice of endogamy had on the genetic diversity? 
B. Can the impact of social history be observed in the genetic composition of the 
populations? 
C. Are sex-specific histories discernible from the genetic data? 
3.1.3 Design ofthe Study 
Data were generated for five Romani populations for the first time in this study. 
These are the Turgovzi, Feredjelli, Intreni, Spanish and Lithuanian Roma. Data from 
three Romani populations investigated by Kalaydjieva et al., (2001) were included in 
data analyses: the Lorn, Monteni and Kalderash. The populations studied are 
geographically dispersed throughout Bulgaria and Europe (figure 3-1). Romani 
populations sampled in Bulgaria provide a representation of the three metagroups 
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outlined by Marushiakova & Popov, (1997); namely, the Jerlii, Kalderash and Rudari. 
The Spanish and Lithuanian Roma provide examples of Western and Northern European 
Romani groups. Thus, the eight populations studied provided representation of the three 
major migrations that have occurred within Europe - migration into the Balkans, the 
migration into Western and Northern Europe (henceforth referred to as the West 
European migration), and the migration from Moldavia and Wallachia. Table 3-1 
provides a summary of demographic, anthropological and historical information for the 
Romani populations investigated in this study. 
The investigation of variation in the female-specific mtDNA and male-specific 
Y -chromosome provide a complementary approach to the study of these populations. 
Both systems were examined using two classes of polymorphic loci with differing rates 
of mutation, which allows different degrees of temporal resolution. Characterisation of 
Y chromosomal variation was performed by genotyping unique event polymorphisms 
(UEPs) and microsatellite DNA/short tandem repeats (STRs). Analysis ofmtDNA was 
performed using RFLP analysis and direct sequencing of the HVS 1. Both maternal and 
paternal lineages were examined in the same male subjects. Statistical analyses were 
used to quantify genetic composition and to assess interpopulation and intrapopulation 
structure. 
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Figure 3-1. Geographic locations of the Romani populations included in the population genetic study 
----------------~ 
Table 3-1 p 
Cultural and historical summary o[populations included in population genetic study 
Population Country of Major migrational Meta-group Religion Language Estimated size Lifestyle and social practices 
residence grouping 
Turgovzi Bulgaria Balkan Jelii Muslim Turkish 5,000 Settled 
Romany Regional endogamy 
(Balkan dialect) 
Feredjelli Bulgaria Balkan Jerlii Muslim Turkish 3,000 Settled 
Group endogamy 
S:ganish Spain West European Cal Roman Cal 800,000 Settled 
Roma Catholic Regional endogamy 
Lithuanian Lithuania West European Russian Roman Baltic Romany 10,000 Ex-nomads 
Roma Catholic Strict group endogamy 
Intreni Bulgaria Vlach Rudari Eastern Rumanian NA Ex-nomads (1920s) 
Orthodox Endogamous within metagroup 
Christian 
Monteni'~' Bulgaria Vlach Rudari Eastern Rumanian NA Ex-nomads (1920s) 
Orthodox Endogamous within metagroup 
Christian 
Lorn'~' Bulgaria Vlach Rudari Baptist Romany 7,000 Ex-nomads (1890s) 
(Old Vlach) Regional endogamy 
Kalderash'~' Bulgaria Vlach Kalderash Eastern Romany 40,000-80,000 Ex-nomads (1950-1960s) 
Orthodox (New Vlach) Strict inter-group endogamy 
Christian (complex trans-national 
interclan rules 
'~'Populations studied by Kalaydjieva et al., (2001) 
00 
-
3.1.4 Sample Collection 
Biological samples from Romani populations resident in Bulgaria, Spain, and 
-Lithuania were obtained by various senior researchers (table 3-2). Blood samples were 
obtained from individuals with informed oral consent, and all studies were performed in 
accordance with the ethical guidelines stipulated by Edith Cowan University. DNA 
samples of twenty Lithuanian Romani males and one hundred sex-anonymous Spanish 
Roma were provided by collaborating researchers. 
Table 3-2 
Information on population sampling programs 
Population Place of residence Sampling 
Turgovzi 
Feredjelli 
Intreni 
Monteni"' 
Lorn"' 
Kalderash"' 
Spanish 
Roma 
Lithuanian Roma 
Total 
Omurtag, Bulgaria 
Omurtag, Bulgaria 
Liaskovetz, Tantra 
Valley, Bulgaria 
Balkan Mountains, 
Bulgaria 
Lorn, Bulgaria 
Various locations, 
Bulgaria 
Madrid, Spain 
Vilnius, Lithuania 
performed by 
Drs Kalaydjieva, 
Angelicheva and 
Tournev 
Drs Kalaydjieva, 
Angelicheva and 
Tournev 
Drs Kalaydjieva, 
Angelicheva and 
Tournev 
Drs Kalaydjieva, 
Angelicheva and 
Tournev 
Drs Kalaydjieva, 
Angelicheva 
Drs Kalaydjieva, 
Angelicheva and 
Tournev 
Dr de Pablo 
Dr Kucinskas 
"'Population studied by Kalaydjieva et al., (2001). 
Number of 
unrelated males 
investigated 
36 
21 
18 
42 
19 
15 
35 
20 
206 
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3.2 Preparation and Quantification of DNA Samples 
3.2.1 Isolation of DNA Samples 
Most blood samples from the Turgovzi, Feredjelli and Intreni individuals were 
collected on FTA™ Genecards (Invitrogen™ Life Technologies). This system is 
designed to lyse the blood cells and permanently bind DNA upon contact with the paper 
matrix. Purification ofFTA™ Genecards removes all proteins, carbohydrates, lipids and 
organic matter whilst leaving the DNA immobilised on the paper. The washing protocol 
recommended by the manufacturers was followed with minor amendments that were 
found to enhance the purity of the end product. 
A small disc of approximately 4mm diameter was excised from each FTA™ 
Genecard using a punch. The disc was placed in a 2501J.L EppendorfrM tube and 2001J.L 
of FTA™ Purification Reagent (Invitrogen™ Life Technologies) was added. At this 
point, incubation of the sample at 4°C for twelve hours greatly expedited the cleaning 
process through a reduction in total labour time and with no apparent detriment to the 
end-product. Following the initial incubation, the FTA™ Purification Reagent was 
removed and the disc was subjected to two additiomi.l washes using 2001J.l of FTA™ 
Purification Reagent with incubation for five minutes at ·room temperature on each 
occasion. During each wash, the mixture was briefly vortexed at t = 0 minutes, t = 2.5 
minutes and t = 5 minutes. After a total of three washes with the FT A ™ Purification 
Reagent, the sample was rinsed twice with Tris-EDTA solution. The sample was then 
dried at room temperature for one hour. 
Samples collected on 3MM Whatman filter paper (Whatman) required 
conventional DNA extraction using a salting out protocol. A 1cm2 blood spot was cut 
from the filter paper and placed in a 1. 5mL-EppendorfrM tube along with 2501J.L of 0. 1% 
Triton X-100 and l51J.L of 10mg/mL proteinase K. The mixture was vortexed for one 
minute and incubated at 50DC for 30 minutes. This step was repeated once and 25J.1.L of 
1 Ox SET buffer was added. A 1: 1 chloroform/phenol extraction was performed using 
2501J.L of chloroform and 2501J.L of phenol. The contents of the tube were mixed by 
inversion and then centrifuged at 13000rpm for 10 minutes. The supernatant was 
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removed to a fresh 250~-LL EppendorfTM tube and 1/10 the volume of 3M sodium acetate 
(pH 4.9) added. To precipitate the DNA, an equal volume of 100% isopropanol was 
added and the mixture was left overnight at -20DC. The next day, the mixture was 
centrifuged at 13000rpm for 30 minutes. The resulting pellet was washed once with ice 
_ cold 70% ethanol and centrifuged for 15 minutes at 13000rpm. All liquid was removed 
and the pellet was air dried for 1 hour. The dried pellet was then resuspended in 50~-LL 
ofdHzO. 
3.2.2 Quantification of DNA Samples 
Liquid DNA samples were quantified using a Beckman DU 640 UV 
spectrophotometer (Beckman Coulter Inc.). A 1:50 dilution of the DNA specimen in 
water was prepared and the absorbance determined at wavelengths of 260nm (Az60nm) 
and 280nm (A280nm). The spectrophotometer was blanked using dH20. Absorbance by 
nucleic acids is read at 260nm and by proteins at 280nm. A ratio of 1.8±0.2: 1 of A260nm: 
_ A280nm was indicative of suitable product purity for enzymatic manipulation of DNA. 
DNA concentration was determined using Beer's law, A26onm = b·!ll·c where c is the 
DNA concentration, b is the path length of the light and IE! is the molar absorbance 
coefficient. Working solutions of 1 Ong/!JL were prepared from stock DNA 
DNA samples immobilised on FT A Genecards™ cannot be quantified. 
3.2.3 Sex Determination of Anonymous DNA Samples 
Samples of unrelated Spanish Roma were sex-anonymous. Therefore, sex 
identification was performed using the amelogenin locus PCR assay. The amelogenin 
gene is present in the pseudoautosomal region (PAR) of the X and Y chromosomes; 
however, a small deletion in the former allows determination of sex-chromosome 
genotype. 
The amelogenin locus was amplified as described by Nakahori, Hamano, Iwaya 
& Nakagome (1991) using the primers AMXY-F (5'CTG-ATG-GTT-GGC-CTC-AAG-
CCT-GTG-3') and AMXY-R (5'TAA-AGA-GAT-TCA-TTA-ACT-TGA-CTG-3'). 
PCR reagents were l11L of lOx PCR buffer (Qiagen), 0.4~-LL of 15mM Mg2+ (final 
concentration of 6mM), 0.4~-LL of SmM dNTPs, O.l!JL of each primer (at S11M 
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concentration), 0.1~-tL ofTaq polymerase (ie. 0.1U) [Qiagen], 6.6~-tL of dH20 and 1~-tL 
of 1 Ong/f..LL DNA Touchdown PCR was performed as follows: initial denaturation of 10 
minutes at 94P C; 20 cycles of 1 minute at 94e C, 2 minutes at 6SC' C (d-O. Sill C /cycle), 
2 minutes at 72b C; 15 cycles of 1 minute at 94° C, 2 minutes at 55° C, 2 minutes at 
72° C; final extension period of 10 minutes at 72° C; cooling to 4° C. PCR products 
were then loaded on to a 2% agarose containing 2.31-tL of 100% ethidium bromide and 
electrophoresed in 1x TAE at 90V for 30 minutes. 
XX genotypes yield a single PCR fragment of 190bp. XY genotypes produce the 
190bp fragment and a fragment of 320bp. DNA fragments were visualised using a 
Mighty BrightTM UV transilluminator (Hoeffer Scientific Instruments) and photographed 
using the Kodak® DC120 Electrophoresis Documentation and Analysis System™ 
(Eastman Kodak Company), which includes the Kodak® DC Zoom™ Digital Camera 
and 1D Image Analysis Software™. 
3.3 Analysis of Y Chromosome Variation 
3.3.1 Introduction 
Y -chromosomes were genotyped in unrelated males at 31 UEP loci and 8 
microsatellite loci. All loci are situated on the non-recombining portion of the Y-
chromosome. 
3.3.2 Y Chrom.osome Unique Event Polymorphism (UEP) Genotyping 
Y chromosome UEPs were genotyped by Dr Peter Underhill at the Department 
of Genetics, Stanford University. UEPs were genotyped using a combination of 
denaturing high-pressure liquid chromatography (DHPLC) and direct sequencing. Raw 
data were forwarded to myself for analysis. The UEP loci genotyped were M1, M145, 
M40, M96, M174, M33, M75, M2, M35, MIS, MSS, M9, M45, M89, M172, M170, 
M173,M67,M124,M52,M69,M82,M92,M17,M12,M73,M201,PN2,M168,M216 
and M217. These loci are SNPs, except M1, which is an Alu insertion (Spurdle, 
Hammer, & Jenkins, 1994) and PN2 and M82, which are 2-bp deletions. Information on 
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UEP loci, including primer sequences, PCR protocols and allelic is in Underhill et al., 
(2000) and Underhill et al., (2001). 
· 3.3.3 Y Chromosome Microsatellite Genotyping 
Seven Y chromosome microsatellite loci were characterised using methodologies 
outlined in Kayser et al., ( 1997). Y -chromosome microsatellite loci included the 
tetranucleotide repeat loci DYS19, DYS390, DYS391, DY393, DYS389I and 
DYS389II; and the trinucleotide repeat locus DYS392. Six primer pairs amplify these 
~ loci as the DYS389 forward primer anneals twice yielding two polymorphic PCR 
r 
~ products. Information regarding PCR .primer sequences and amplification conditions, 
,. standardised nomenclature, consensus sequence of the loci and PCR fragment size and 
repeat number correlations are available from the website 
- http://ruly70.medfac.leidenuniv.nl/~fldo/(.) Allelic ladders for microsatellite loci 
(excluding DYS389AB and CD) were provided by Dr P de Knijff of the Forensic 
Laboratory for DNA Research, Department of Human Genetics, Leiden University. 
PCR primers were commercially prepared (Geneworks Pty Ltd), with a 
fluorescent label chemically attached to one primer of each pair. Markers DYS393, 
DYS390 and DYS391 were labelled with 4, 7, 2, 7-tetrachloro-6-carboxyfluorescein 
(TET) which appears as green when using Filter set Bon the ABI 373A DNA Analyser. 
Primers for DYS389 were labelled with 6-carboxyfluorescein (F AM) which appears as 
blue using Filter set B on the ABI 373A DNA Analyser. DYS19 and DYS392 were 
labelled with 4, 7, 2, 4, 5, 7 -hexachloro-6-carboxyfluorescein (HEX) which appears as 
yellow using Filter set B on the ABI 373A DNA Analyser. 
3.3.3.1 PCR protocols for Y chromosome microsatellites 
For the seven microsatellite loci, two optimised PCR mixtures and four 
temperature cycling protocols were found to provide the best results. PCR mixtures 
were a total of 1 OJ.l.L and their composition varied only in the final MgCh concentration. 
PCR mixtures for markers DYS390, DYS391, DYS392, DYS393 and DYS19 contained 
lJ.l.L of lOx PCR buffer (Qiagen), lJ.l.L of a mixture containing 2.5mM of each dNTP 
(Australian Biotech Inc.), 0.4J.l.L of 25J.l.M forward and reverse primers, 0.1 U of Taq 
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: DNA Polymerase (Quiagen), 0.8JlL of25mM MgCh (Qiagen), 3.3j.LL of dH20 and 3J!L 
- of IOng/J!L sample DNA The PCR mixture for DYS389 was near-identical, except it 
:orequired 0.6JlL of 25mM MgCh and 3.5JlL of dH20. The four optimised thermocycling 
0 programs for the GeneAmp PCR System 9600 (Applied Biosystems) are outlined in 
::...table 3-3 
3-3 
··. Optimised PCR cycling conditions for Y chromosome microsatellite loci 
Cycle Stage DYS389 DYS-19,391,392 & 393 DYS390 
Denaturation 5min@94 C Smin@94°'=C 5min@94o·c 
·· Amplification 14 cycles: 16 cycles: 10 cycles: 
' 20s@94• C 20s@94~ C 30s@94°'C 
30s@63• C(6.- ·lmin@63°!C(6.- 30s@6~ C(6.-
0.5• C/cycle) 0.51':C/cycle) 0.5' C/cycle) 
:: 30s@72• C lmin@n•,c 30s@72° C 
20 cycles: 25 cycles: 25 cycles: 
20s@94• C 20s@94• C 20s@94~· C 
30s@56' c 45s@5:• .. c 30s@556 C 
30s@72• C lmin@72' C 30s@72• C 
- Final Extension 5min@72":C Srnin@72!' C 5min@72" C 
Cooling 4°:C 4' C 4" C 
-3.3.4 Sample Preparation for the 373A DNA Analyser 
PCR products from DYS393 were diluted 1:100 with dH20. This prevented 
signal peaks from being too large on the 373A ABI DNA Analyser (Applied 
Biosystems). Samples for the ABI 373A DNA Analyser were prepared in a 250JlL 
Eppendorftube with 2.5JlL of PCR product mixed with 2.5JlL of formamide, O.SJlL of 
loading buffer and 0.6 JlL ofN, N, N', N'-tetramethyl-6-carboxyrhodiamine (TAMRA)-
labelled internal size standard (Applied Biosystems). Multiplexing of samples was also 
performed. The optimal results were obtained when PCR products labelled with the 
same fluorescent tag were run in the same lane, that is PCR products from the loci 
DYS390, DYS391 and DYS393; and DYS19 and DYS392 were combined. When 
multiplexing samples, the total volume ofPCR product remained 2.5JlL and comprised 
equal volumes of each sample. Samples were vortexed and centrifuged to collect all 
liquid. They were placed on a hot plate at 94 fl C for 4 minutes to denature PCR 
products and stored on ice prior to being loaded on the gel. 
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3.3.5 Size Separation of DNA Fragments Using the 373A DNA Analyser 
Polyacrylamide gels were prepared using 50mL of 6% acrylamide!bisacrylamide 
at a ratio of 19:1. Po1ymerisation of the acrylamide was catalysed by the addition of 
350~L of 10% ammomum persulphate and 35~ L of N,N,N ,N-
tetramethylethylenediamine (TEMED). Gels were formed between 36cm gel plates 
using 0.4mm spacers, and a 50 lane square tooth well former was inserted. The gel was 
left to set for a period of at least two hours. It was then loaded into the machine and pre-
run for 5 minutes using lx TBE as the running buffer. 
The 373A DNA Analyser (Applied Biosystems) run parameters were set as filter 
set B, a PMT of645, a voltage of 1200V, laser power of 40V, a current of 800 milliamps 
and 10 scans per minute. Approximately 1.5~L of denatured sample was loaded into 
each well, and samples were electrophoresed for 8 hours. Sample lanes were tracked 
manually on the gel image and extracted using the GENESCAN™ program (Applied 
Biosystems). The TAMRA-500 size standard (Applied Biosystems) was defined 
according to the values provided by the manufacturer and manually verified for each 
lane. The data were exported to the GENOTYPER™ program (Applied Biosystems), 
which assigns allele sizes to peaks based on the internal size standard. Peaks were 
manually checked to ensure data quality, and split or ambiguous peaks were rejected. 
Allelic ladders were run on each gel to account for any gel-specific variation. This 
ensured that the correct repeat number for each microsatellite was determined. 
3.4 Analysis of Mitochondrial DNA 
3.4.1 Introduction 
DNA variation in the coding region and hyper-variable sequence 1 (HVS 1) of 
the noncoding D-loop of the mitochondrial genome was assessed using RFLP analysis 
and direct sequencing respectively. 
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3.4.2 RFLP Genotyping 
l DNA samples were analysed for diagnostic coding region RFLPs by Dr 
luuiseppe Passarino of the Department of Genetics, Stanford University. Standard 
.. 
.... 
t restriction endonuclease digests were performed according to protocols of Passarino et 
t::.::.. . 
~al., (1996) and Richards, Macaulay, Bandelt, & Sykes, (1998). Raw data from 
~-
[ genotyping results were forwarded to myself. 
~--
-
~- 3.4.3 Analysis of the mtDNA HVSl 
... 
~ 
3.4.3.1 PCR amplification of the HVS 1 
The HVS 1 of the mitochondrial DNA D-loop was amplified using composite 
primers, which consist of phage M13 and human mtDNA-specific sequences. The 
segment of the mitochondrial genome spanning nucleotide positions 15,997 to 16,400 
was amplified using a "hot start" PCR technique. This was found to be essential to 
ensure a high quality PCR product amenable to sequencing. PCR was performed in a 
total volume of SOJ.!L. An initial mixture was made containing 3 J.!L of 1 Ox PCR buffer 
(Qiagen), 3J.1L of25mM MgCh, 0.5J.1L of 5mM dNTPs, 0.5J.!L of lOJ.!M forward primer 
37 .• 5J.1L of dH20 and 3J.1L of lOng/J.!L genomic DNA sample. This mixture was heated 
at 94 ° C in a thermocycler for 5 minutes to ensure complete denaturation of the target 
DNA After this period, the remaining reagents consisting of 2J.1L of lOx PCR buffer, 
O.SJ.!L ofthe reverse primer and 0.25J.1L ofTaq polymerase (Qiagen) were added to the 
reaction. Thermocycling proceeded with 30 cycles of 94" C for 45 seconds, 66° C for 
60 seconds and 72c C for 60 seconds. This was followed by a final extension time of 10 
minutes at 72° C and subsequent cooling to 4 C. 
3.4.3.2 Confirmation and Cleanup of HVSl PCR Product 
A sample of 5J.1L of PCR product was electrophoresed on an ethidium bromide 
stained 2% agarose gel for 30 minutes at 80 volts. A product of 460bp indicated a 
positive result. The PCR products were purified by gel filtration chromatography using 
QIAquick PCR Purification Kit (Qiagen) following the manufacturer's protocol. 
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3.4.3.3 Sequencing Reaction for HVSl 
Direct cycle sequencing of PCR products was performed using the M13 Ready 
Reaction Dye Primer" kit (Applied Biosystems). Thermocycling conditions entailed 
25 cycles of 94°C for 5 seconds, 60.:'C for 5 seconds and 72c-c for 60 seconds. PCR 
~products were sequenced in both directions using the M13 -21 and reverse primers in 
- order to confirm sequence variants. 
Sequencing products were precipitated at -20°C for 1 hour with the addition of 
45JlL of 100% ethanol and 2JlL of 4.9M NaOH. This mixture was centrifuged at 13,000 
rpm for 30 minutes. The pelleted sequencing products were dried at room temperature 
and resuspended in a 5: 1 formamide to loading buffer mixture. Samples were then 
denatured at 94"C for 5 minutes and placed on ice until loaded on to the 373A DNA 
Analyser (Applied Biosystems). 
3.4.3.4 Sequence Determination Using 373A DNA Analyser 
Sequencing gels were formed from freshly prepared 4% polyacrylamide mixes as 
follows: 30g of urea were dissolved in 22mL of dH20 to which was added 6mL of 40% 
19:1 acrylamide/bisacrylamide solution. The mixture was deionised using lg of 
deionising resin beads and filtered and degassed under vacuum. To the filtrate was 
added 6mL of filtered 1 Ox TBE and additional dH20 to a total volume of 60mL. 
Polymerisation was catalysed with 300JlL of 10% ammonium persulphate and 30JlL of 
TEMED and the solution was poured between 48cm well-to-read glass plates separated 
by 4mm spacers. The gel was allowed to set for 2 hours at room temperature. Wells 
were formed using a plastic shark tooth comb. The gel was loaded into the 3 73A DNA 
Analyser and pre-run for 5 minutes. 
A denatured sample of 1.5JlL was loaded into each well. Filter set A was used 
with a PMT of 640, a voltage of 1200V, a laser power of 40W and a run time of 12 
hours. Gel images were captured using Sequence Analyser (Applied Biosystems). 
Sample lanes were manually tacked and exported to Sequence Navigator (Applied 
Biosystems) for analysis. 
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3.5 Statistical Analyses 
3.5.1 Processing ofY chromosome Data 
PCR fragment sizes were entered into a Microsoft Excel spreadsheet and 
manually converted to repeat numbers based on the sequenced allelic ladders. 
Amplification of DYS389 and subsequent gel electrophoresis results in two easily 
distinguishable products, denoted DYS389I and DYS389II. The sequence structure of 
this locus is well-characterised and contains 2 repetitive segments, denoted DYS389AB 
and DYS389CD, each of which is composed of two different types of repeat units, 
interrupted with an invariant segment (Rolf, Meyer, Brinkmann, & de Knijff, 1998). For 
analytic purposes, authors have either rejected one of the fragments (Bhattacharyya et 
al., 1999; Bosch et al., 1999), analysed all four fragments separately using a nested PCR 
protocol (Forster et al., 2000), subtracted the smaller fragment from the larger (Hurles et 
al., 1999) or used raw PCR fragment sizes (Black, 1999). For the purposes of this study, 
- the DYS389II fragment was considered as being composed of repeat blocks ABCD 
(referred to as m, n, p and q by Forster et al., 2000). The PCR fragment DYS389I 
includes blocks C and D and is thus referred to as DYS389CD. Subtracting DYS389I 
from DYS389II leaves blocks A and Band is therefore referred to as DYS389AB. This 
approach ensures that the two loci are treated independently and variation is neither 
missed nor counted twice. 
3.5.2 Processing of Mitochondrial DNA Data 
Raw sequence data were analysed using Sequence Navigator (Applied 
Biosystems ). Sequences were edited manually by examination of the electropherogram 
and consensus sequences were determined from forward and reverse sequences. In 
order to compare results with previous studies, a 360bp segment from positions 16,024-
16,383 (Anderson et al., 1981) was analysed. Edited sequences were exported as 
ASCII2 text files for analysis using computer programs. 
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~· 3.5.3 Computer Applications 
~ Statistical analyses of Y-chromosomes and mtDNA data were performed using 
; Arlequin 2.000 (Schneider, Kueffer, Roessli, & Excoffier, 1996). In addition, MitDesc 
~ (F. Calafell, pers comm) was used for some mtDNA analysis. Neighbour-joining trees 
-~were constructed from distance matrices using the NEIGHBOR program included in the 
PHYLIP package (Felsenstein, 1989) and drawn with DRAWTREE and TREEVIEW 
(Page, 1996). Phylogenetic analyses of Y chromosomes and mtDNA were performed 
using Network 2.00 (Bandelt, Forster, Sykes, & Richards, 1995). 
- 3.5.4 Intrapopulation/Genetic Diversity Analyses 
Estimated allele frequencies and haplotype frequencies were calculated for each 
. population using the equation: 
x. p.=-1 
1 n 
where allele/haplotype i is observed x times in a sample containing n gene copies (Weir, 
1990; Weir, 1996). This statistic provides a value for comparisons between frequency 
estimates of discrete heritable traits in populations. 
Gene diversity was estimated by summing the squares of allele frequencies as 
follows: 
(Weir, 1996) 
where n is the sample size and j; is the frequency of allele i. This measure of variation 
is sometimes referred to as the average heterozygosity and is applicable in inbred 
populations in which there may be few heterozygotes but numerous different 
homozygous types (Weir, 1996). It is also an appropriate measure of variability in 
haploid systems such as the Y chromosome and mtDNA. 
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Haplotype diver~ity, which is equivalent to expected heterozygosity for diploid 
data or the probability that two randomly chosen haplotypes are different in a sample, 
was calculated using: 
" n ""k 2 H=-1 0- .L..Ji=lp,) n-
where n is the number of gene copies in the sample, k is the number of haplotypes and p; 
is the sample frequency ofthe i-th haplotype. The sampling variance of this statistic was 
calculated using the equation: 
(Nei, 1987). 
Nucleotide diversity, the probability that two randomly chosen homologous nucleotides 
are different, was estimated as: 
(Nei, 1987; Tajima, 1983). 
Where n is the sample size, L is the number of nucleotides in the sequence and xu is the 
frequency of the ith nucleotide at position}. 
Sequence diversity is analogous to haplotype diversity and was estimated as: 
D'- _n_""k f._ 2 ) 
- n _ 1 .L..Ji=I ~ P; 
(Calafell, Underhill, Tolun, Angelicheva, & Kalaydjieva, 1996) 
Where p; the frequency of each ofthe k unique sequences in the sample. 
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The mean pairwise difference in number of repeats across seven Y chromosome 
microsatellite loci was computed, which provides a relative value for the relatedness of 
haplotypes within a population (Perez-Lezaun et al., 1999) and within Y chromosome 
haplogroups (Bosch et al., 1999). The mean number of pairwise differences between 
mitochondrial sequences was also calculated. Mean pairwise differences were 
calculated using the equation: 
1\ 
k 
7l= I: L PtP. dlJ .. 
i=1Js1 1 
Where diJ is an estimate of the number of mutations that occurred since the divergence of 
haplotype/sequence i and}, k is the number ofhaplotypes/sequences and Pi and pj are the 
frequencies of haplotypes/sequences i and j. 
Sampling variance of this statistic was calculated using the equation: 
~ 
-v( A)= 3n(n + 1)7r+ 2(n2 + n + 3)1l' 2 
1l 11(n2 - ?n + 6) 
(Tajima, 1983). 
3.5.5 Interpopulation Analyses 
Interpopulation analyses of Y microsatellite haplotypes were performed by 
calculating genetic distances between populations. Slatkin (1995) developed a genetic 
distance that assumes single step mutation model (SMM) in microsatellites. This value, 
referred to as RsT, is analogous to FsT (Wright, 1965) which was derived under the 
assumption ofthe infinite alleles model (lAM). 
Population pairwise RsT (Slatkin, 1995) values were calculated using the equation: 
R _ (Sbar -SJ 
sr-
Sbar 
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Where, Sw is the sum over all loci of twice the weighted mean of the within-
- population variances V (A) and V (B); and Sbar is the sum over all loci of twice the 
variance V (A+B) of the combined population (Slatkin, 1995). 
Using mtDNA data, genetic distances between populations were determined 
using the intermatch-mismatch distance. This distance is calculated using the equation: 
where dij is the average number of nucleotide differences between populations i and j 
and d; and dj are the average pairwise differences within populations i and j (Di Rienzo 
et al., 1994; Mountain et al., 1995). 
The statistical significance of population pairwise distances were determined 
through 1000 iterations using the bootstrapping resampling method (Efron, 1982). 
From population pairwise genetic distance matrices, unrooted neighbour joining 
trees (Saitou & Nei, 1987) were generated using PHYLIP 3.5c (Felsenstein, 1989). This 
program was also used to test the robustness of tree branches using the statistical 
resampling process ofbootstrapping for 1000 iterations (Efron, 1982). 
To examine further population structure in the European Roma, an analysis of 
molecular variance (AMOV A) was performed (Excoffier, Smouse, & Quattro, 1992). 
This analysis estimates variance components reflecting different levels of hierarchical 
subdivisions - those due to genetic differences (i) between groups, (ii) between 
populations within groups, and (iii) between individuals within populations. Genetic 
variance of Y chromosome microsatellites was determined using the sum of size 
differences option in Arlequin 2.000. Genetic variance of mtDNA sequences was 
performed using the pairwise differences option in Arlequin 2.000. 
3.5.6 Method for Determining Coalescent Age of Y Chromosome Lineages 
The age of Y chromosome haplogroups was determined based on haplotype 
variation using the method described by Stephens et al., (1998). This method assumes 
that the probability P a haplotype does not change from its ancestor G generations ago is 
p = (1-r)G 
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In an expanded population, P is the proportion of haplotypes which are ancestral 
~(Risch et al., 1995). Therefore, an estimate of G can be determined by 
:...... G = -ln(P)/r 
Where r is the estimated rate at which variation is accumulated in the haplotype, 
~based on the recombination and mutation rate. In the case of Y chromosomes, variation 
- is only attributed to mutation. Two different values of r were determined using mutation 
rates for YSTR loci determined from a pedigree based study, 2.8 x 10-3 (95% CI 1.72-
4.27 x 10-3) [Kayser et al., 2000] and an evolutionary study, 2.6 X 10-4 (95% CI 2.33-
2.87 x 1 o-4) [Forster et al., 2000] multiplied by the number of polymorphic loci. An 
~ average of the values determined usil).g the two rates was calculated. Ninety-five 
. percent confidence intervals were calculated using the 95%CI for mutation rates. 
The number of generations, G, was converted to number of years considering a 
generation age of 20 years. 
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CHAPTER4 
RESULTS 
4.1 Genetic Composition of the Roma 
4.1.1 Identification of Male Lineages in the Roma 
For the purposes of this study, jt was assumed that identical Y chromosome 
microsatellite haplotypes are the result of a recent common ancestor and therefore must 
occur on the same ancestral Y chromosome defined by UEPs (i.e. the same haplogroup ). 
This assumption is based on the high mutation rate of Y chromosome microsatellites 
(Heyer, Puymirat, Dieltjes, Bakker, & de Knijff, 1997; Jobling, Heyer, Dieltjes, & de 
Knijff, 1999), and the near absence of homoplasmy within haplogroups (Bosch et al., 
1999). Several Y chromosomes in the sample had identical microsatellite haplotypes. 
Therefore, to minimise redundancy, UEP genotyping was performed on a subset of 94 
chromosomes from 169 unrelated males. Haplogroups were inferred for Y 
chromosomes bearing identical microsatellite haplotypes. This assumption was 
validated by genotyping some redundant Y chromosomes which, were invariably found 
to belong to the predicted haplogroup. 
4.1.1.1 Y chromosome haplogroups identified in the Roma 
Ten haplogroups were identified in the sub-sample of 94 Y chromosomes (table 
4-1 ). Fifty-nine Y chromosomes were assigned to one of these haplogroups on the basis 
of their identical haplotypes resulting in haplogroup assignments for a total of 153 Y 
chromosomes. The additional sixteen Y chromosomes bore unique haplotypes and 
could not be assigned to any known haplogroup. The haplogroup nomenclature is in 
accordance with that proposed by Underhill et al., (2000); except for haplogroup V-52 
defined by the loci M216 and M217, which was first described by Underhill et al., 
(2001). 
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Table 4-1 
Y chromosome haplogroups identified in the Roma. Number of chromosomes observed 
in a sample of94 males and inferred in a sample of 169 males. 
Haplogroup name_....:M.:.:.u;:..;;tations defining haplogroup 
Vl-68 M89, 52, 69, 82 
VT-52 M89, 170 
Vl-56 M89, 172, 67 
tx-104 M89,9,45, 173 
VI-71 M89, 168 
!II-36 M I , 145, 40, 96, PN2, 35 
V-52 M2 16,2 17 
VI-58 M89, 172 
VI-57 M89, 172,67,92 
tx-108 M89, 9, 45, 173, 17 
Unknown 
Total 
No. of observed chr. 
24 
25 
15 
12 
8 
3 
4 
I 
94 
No. of inferred chr. 
67 
35 
18 
14 
8 
4 
4 
I 
I 
16 
169 
4.1.1.2 Distribution of Y chromosome haplogroups in the Roma 
Haplogroup VI-68 is the most frequently occurring Y chromosome haplogroup 
in the Roma, representing 39.6% of the sample (figure 4-1). Other frequently occurring 
haplogroups include VI-52 (20.7%), VI-56 (10.7%) and IX-104 (8.3%). 
Unknown 
9% 
2% 
IX-108 
1% 
Figure 4-1 Proportion ofY chromosome haplogroups in Romani males 
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All the Y chromosome haplogroups identified iJ?- the Roma have been previously 
reported as occurring in other worldwide populations (table 4-2). 
Table 4-2 
Distribution and frequency in global populations of Y chromosome haplogroups 
identified in the Roma. 
Haplogroup Frequency in sample of 
169 Roma 
VI-68 39.6% 
VI-52 20.7% 
VI-56 10.7% 
IX-104 8.3% 
VI-71 4.7% 
III-36 2.4% 
V-52 2.4% 
IX-108 0.6% 
VI-57 0.6% 
VI-58 0.6% 
1Summarised from Underhill et al., (2000). 
Global populations in which haplogroup is found 1 •3 
Hunza (5.3%)1, Pakistan & India (4.5%)1, C. Asia (0.5%)1 
Europe (13.3%)1, Basque (2.2%)1 W. Europe (10%)3, E. Europe 
(20%)3, Middle East (3%)3 
Middle East (8.3%) 1, Sardinia (4.5%)1, C. Asia (1.1 %) 1 
World-wide2, W Europe (56.2%)3, E. Europe (19.8%)\ Middle 
Ea~t (8.2%)3 
W orld-wide2 
Khoisan (10.2%)1, Ethiopia (6.8%)1, S. Africa (1.9%)1 
Pakistan & India (31.8%)1, Hunza (28.9%)1, C. Asia (16.3%) 1, 
Europe (5%)1, W. Europe (1.1.%) 3, E. Europe (33.8%)3, 
Middle East (13.2%)3 
India & Pakistan (4.5%) 1, C. Asia (0.5%) 1 
Morocco (1 0.7%)1, Middle East (8.3%) 1, C. Asia (6.5%) 1, 
Pakistan & India (3.4%) 1, Europe (3.3%) 1, Hunza (2.6%)1 
2Worldwide distribution denotes its occurrence in Europe, Asia, Africa and America. 
3Summarised from Semino et al., (2000) (NB in this paper VI-52=Eu7, IX-104=Eu18, IX-108=Eul9) 
The most frequently occurring Y chromosome haplogroup in the Roma, VI-68, 
has not been reported in European populations before. Previous studies suggest it is an 
infrequently occurring haplogroup in the Indian subcontinent and Central Asia 
(Underhill et al., 2000). Haplogroup VI-56, which represents over 10% of Romani Y 
chromosomes, is found mainly in the Middle East and only in Sardinia within Europe 
(Underhill et al., 2000). In contrast to these two haplogroups, the second most 
frequently occurring hap1ogroup, VI-52, is most frequent in Eastern Europe, and 
haplogroup IX-104 is the most common haplogroup in Western Europe (Semino et al., 
2000). Haplogroup VI-52 has not been reported in India, whereas haplogroup IX-104 is 
globally dispersed and found in India. All other haplogroups identified in the Roma are 
found in either West Asian or European populations or both. The exception is 
haplogroup III-36, which is found only in African populations. 
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4.1.1.3 Results of Y chromosome microsatellite genotyping 
Haplotypes were constructed for 122 Y chromosomes using seven microsatellite 
loci. Data were collated with those of Kalaydjieva et al., (200 1 ). Four Lorn samples 
typed for UEPs were not genotyped for Y STRs by Kalaydjieva et al., (2001). Thus, 
complete haplotypes were available from 164 samples from eight populations. A single 
Lithuanian Roma sample was found to be biallelic at locus DYS19. This is probably 
due to duplication of theY chromosome segment that includes this locus (de Knijff et 
al., 1997). Duplications at this locus, as revealed by observable differences in allele 
size, occur at an estimated frequency of0.12% (Kayser et al., 2000). The possibility of 
contamination with another sample was considered; however, the unambiguous results 
from other Y chromosome loci and mitochondrial DNA suggest that this was unlikely. 
Therefore, for the purposes of analyses, this sample was resolved into two haplotypes 
that were identical at the other six Y STR loci but differed at DYS19. Thus, 21 Y 
chromosome haplotypes were obtained from the samples of 20 Lithuanian males, and 
- the total sample size was considered to be 165. 
A total of 52 unique haplotypes were identified in the sample (table 4-3). 
Haplotype names are derived from the haplogroup assignment of the Y chromosome 
plus a unique letter suffix. Twenty-two of the chromosomes occur more than once in the 
sample whilst the other 31 are singletons. Haplotype VI-68-a represents 27.3% of Y 
chromosomes in the entire Romani sample. Other frequent haplotypes are Vl-52-a 
(12.1%), VI-68-c (7.8%) and VI-56-b (7.3%). Eleven haplotypes were not assigned to a 
haplogroup and therefore given the generic prefix Ht . 
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~ Table 4-3 
~ Y chromosome haplotypes identified in the Roma 
~· Haplotype DYS19 DYS390 DYS391 DYS392 DYS393 
;-- Vl-68-a 15 22 10 11 12 
~ Vl-68-b 14 22 9 11 12 
Vl-68-c 
• Vl-68-d 
::;· Vl-68-e 
:... Vl-52-a 
Vl-52-b 
Vl-52-c 
Vl-52-d 
Vl-52-e 
Vl-52-f 
Vl-52-g 
~ Vl-52-h 
~ Vl-52·1 
Vl-52-j 
Vl-52-k 
Vl-56-a 
Vl-56-b 
Vl-56-c 
Vl-56-d 
Vl-56-e 
IX-104-a 
IX-104-b 
IX-104-c 
IX-104-d 
IX-104-e 
IX-104-f 
IX-104-g 
IX-104-h 
IX-104-1 
Vl-71-a 
Vl-71-b 
Vl-71-c 
Vl-71-d 
111-36-a 
111-36-b 
V-52-a 
V-52-b 
V-52-c 
Vl-58-a 
Vl-57-a 
IX-108-a 
Ht-a 
Ht-b 
Ht-c 
Ht-d 
Ht-e 
Ht-f 
Ht-g 
Ht-h 
Ht-j 
Ht-k 
Ht-1 
14 
15 
15 
14 
15 
17 
16 
16 
13 
14 
15 
14 
17 
16 
14 
14 
14 
15 
14 
14 
14 
14 
14 
14 
14 
14 
14 
15 
14 
14 
15 
14 
13 
13 
15 
15 
15 
14 
16 
14 
14 
16 
14 
13 
14 
15 
16 
15 
14 
15 
17 
22 
23 
21 
22 
25 
24 
22 
24 
23 
23 
23 
22 
23 
24 
23 
23 
23 
23 
23 
24 
24 
25 
24 
24 
23 
24 
24 
24 
23 
25 
23 
21 
24 
24 
24 
24 
25 
23 
22 
24 
25 
22 
25 
24 
22 
22 
23 
22 
22 
22 
24 
10 
10 
10 
10 
11 
10 
10 
11 
10 
10 
9 
10 
10 
11 
11 
10 
10 
10 
10 
11 
11 
10 
11 
11 
11 
11 
10 
11 
10 
10 
10 
10 
10 
10 
11 
10 
10 
11 
10 
11 
10 
11 
10 
10 
10 
10 
10 
10 
10 
10 
10 
11 
11 
11 
11 
11 
11 
11 
11 
12 
11 
12 
11 
11 
11 
11 
11 
11 
11 
11 
13 
13 
13 
13 
13 
13 
11 
14 
13 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
11 
12 
12 
11 
11 
11 
11 
11 
12 
12 
12 
13 
13 
13 
12 
13 
12 
13 
14 
13 
13 
13 
12 
12 
12 
12 
12 
12 
12 
13 
13 
13 
13 
13 
13 
13 
13 
13 
12 
13 
14 
13 
12 
13 
13 
12 
12 
13 
13 
12 
13 
13 
14 
14 
13 
12 
12 
13 
13 
DYS389AB DYS389CD No. of Chr. 
16 14 45 
16 14 2 
16 14 13 
16 14 2 
16 14 
16 
18 
17 
19 
17 
18 
17 
18 
16 
16 
18 
17 
17 
16 
17 
17 
16 
.17 
16 
16 
16 
16 
16 
15 
16 
16 
17 
16 
16 
19 
17 
16 
16 
16 
18 
18 
17 
16 
19 
15 
19 
16 
16 
16 
16 
17 
16 
16 
12 
13 
13 
13 
13 
14 
13 
14 
13 
14 
13 
14 
14 
14 
14 
15 
13 
13 
13 
14 
13 
13 
14 
13 
13 
12 
14 
13 
12 
14 
13 
13 
13 
13 
12 
13 
13 
14 
13 
14 
13 
14 
14 
13 
15 
14 
14 
13 
20 
3 
3 
2 
1 
1 
2 
12 
2 
2 
1 
2 
2 
3 
1 
3 
3 
1 
3 
2 
1 
1 
2 
1 
1 
4 
2 
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4.1.1.4 Analysis of Y chromosome haplogroups 
Haplogroups were assessed for internal diversity by the analysis of haplotypes 
occurring within the same haplogroup. Network analysis was used to examine the 
history of haplogroups within the population. 
4.1.1.4.1 Diversity within haplogroups. 
Diversity was determined within each haplogroup (table 4-4). Of the seven 
haplogroups that are represented more than once in the sample of Romani males, VI-68 
- and VI-56 are by far the least diverse with average haplotype diversities below 0.56, 
average pairwise differences between haplotypes that are well below 1 and average gene 
diversities less than 0.1. In contrast, haplogroups VI-52, IX-104 and VI-71 have 
haplotype diversities above 0.66, average pairwise difference values over 2 and average 
- gene diversities over 0.3. 
Table 4-4 
Summary statistics of Y chromosome haplogroup diversities 
Haplogroup N No. of Mean pairwise Haplotype diversity Average gene 
haplotypes differences diversity 
Vl-68 63 5 0.52 +/- 0.44 0.458 +/- 0.004 0.075 +/- 0.070 
VI-52 35 11 2.94 +/- 1.58 0.671 +/- 0.008 0.419 +/- 0.250 
VI-56 18 5 0.64 +/- 0.52 0.551 +/- 0.018 0.092 +/- 0.083 
IX-104 14 9 2.16 +/- 1.28 0.934 +/- 0.002 0.309 +/- 0.205 
Vl-71 8 4 2.46 +/- 1.49 0.786 +/- 0.013 0.352 +/- 0.242 
111-36 4 2 1.50 +/-1.12 0.500 +/- 0.086 0.214 +/- 0.191 
V-52 4 3 1.50 +/-1.12 0.833 +/- 0.055 0.214 +/- 0.191 
VI-58 1 1 
VI-57 1 1 
IX-108 1 1 
4.1.1.4.2 Network Analysis of Haplogroups 
Y chromosomes belonging to identical UEP defined haplogroups share a close 
evolutionary ancestry. Homoplasmy is minimised thereby, allowing a meaningful 
reconstruction of phylogenetic relationships between microsatellite haplotypes. To 
examine these relationships, median-joining networks were constructed for the four most 
frequent haplogroups (Figure 4-2). It is apparent that the five haplotypes identified in the 
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most frequently occurring haplogroup, VI-68, are closely related with all haplotypes 
related by single step mutations. Similarly, the five haplotypes contained within VI-56 
are closely related within the network. Moreover, in both these haplogroup networks no 
inferred nodes are necessary. In contrast, haplotypes within haplogroup VI-52 show a 
much more complex relationship with multiple inferred nodes representing unobserved 
haplotypes. Haplogroup IX-104 displays a network with some inferred nodes and an 
overall intermediate complexity in comparison to haplogroups VI-68, VI-56 and VI-52. 
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Figure 4-2 Networks displaying relationships between Y chromosome microsatellite haplotypes within the most frequently 
occurring haplogroups in the Roma 
4.1.1.4.3 Age of founding Y chromosome haplogroups in the Roma 
__ For a Y chromosome haplogroup that has been introduced into the population 
~- once, the determined age of the haplogroup will roughly correspond with that historical 
: event. Multiple introductions of a haplogroup by different males invalidates this 
, premise, and the coalescent age of a haplogroup will precede its introduction into the 
. population. Network analysis indicates that haplogroup VI-68 and VI-56 have been 
- introduced by a limited number of related males, whereas the diversity in haplogroups 
VI-52 and IX-104 suggests multiple admixture events. Therefore, the ages of the 
founding haplogroups VI-68 and VI-56 in the Roma were determined based on the 
frequency of the ancestral haplotype ·using coalescent theory. The rate r, at which 
:::: change accumulates within each haplogroup due to mutation at the seven loci was 
estimated as rpedigree = 0.0196 (95% CI 0.0120-0.0299) and revolutionary= 0.00182 (95% CI 
0.00163-0.00201). Using rpedigree, the coalescence ofhaplogroup VI-68 was estimated to 
be 343 years BP (95% CI 225-560), and for haplogroup VI-56 it was estimated to be 414 
- years BP (95% CI 271-676). Calculation of these values using revolutionary produced 
estimates of 3697 years (95% CI 3,347-4,128) for haplogroup VI-68 and 4,455 years 
(95%CI 4,034-4,975) for haplogroup VI-56. An average of these estimates, obtained 
using different mutation rates, suggests the diversity within haplogroup VI-68 is 2,020 
(95% CI 1,789-2,344) years old, and within VI-56 it is 2,435 (95% CI 2,153-2,826) 
years old 
4.1.2 Female Lineages in the Roma 
The mtDNA HVSl of 102 unrelated males from five Romani populations were 
sequenced. These data were collated with HVS 1 sequences from 83 Roma from three 
populations previously studied (Kalaydjieva et al., 2001). RFLP analysis was performed 
for 169 of the 185 samples (i.e. RFLP analysis was not performed on Intreni samples). 
4.1.2.1 Results of RFLP genotyping 
Mitochondrial haplogroups were designated based on RFLP motifs and the 
sequence status of nucleotide position 00073 (Passarino et al., 1996; Macaulay et al., 
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. 
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1 
l 
i 
~ 1999; Richards, Macaulay, Bandelt, & Sykes, 1998). Congruence between haplogroups 
:... 
defined by RFLPs and characteristic HVS 1 variants was examined and any 
discrepancies reanalysed (table 4-5). Haplogroup assignment for mtDNA from Intreni 
samples was based solely on HVS 1 variants. 
Table 4-5 
Definitions o[mtDNA haplogroups identified in Romani individuals 
Haplogroup HVS1 Variants 00073 Status RFLPmotif 
H A -1025Alu1, -14766Mse1 
I 16223, 16129 G -4529Hae11, +8249Avaiii-8250Hae111 
+10032Alul 
J 16126, 16069 G +4216Nlall1, +10394Dde1, -13104Bst01 
M 16223 G +10394Ddel, +10397Alu1 
Pre V/H A -14766Msel 
T 16126, 16294 G +4216Nlalll, +4914Bfal, +13366BamH1, 15606Alul,-
15925Msp1 
U(K) 16224, 16311 G + 12308Hi'!fl, -9052Haeiii-9053Hha1, + 1 0394Ddel 
U1 16189, 16249 G + 12308Hinjl, -4490Alu1, -131 03Hinjl/+ 131 04Mbol 
U3 16343 G +12308Hinjl 
us 16270 G +12308Hinjl 
w 16223, 16292 G +8249Avalli-8250Hae1I1, -8994Haeiii 
X 16223, 16278 G +14465Accl 
N1b 16145, 16176G, G 
16223 
Thirteen mtDNA haplogroups were found in the sample of 185 Romani 
individuals. Haplogroup His the most prevalent haplogroup at a frequency of 29.2% 
(figure 4-3). Haplogroup M accounts for one-quarter of all mtDNA haplogroups. Other 
common haplogroups include haplogroup U3 (13%), haplogroup J (10.1%) and 
haplogroup X (8.6%). 
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Proportional representation of mtDNA haplogroups identified in 
The frequency distribution of mtDNA haplogroups in the Roma differs markedly 
from that reported for the autochthonous European population (table 4-6). The most 
striking feature of Romani mtDNA is the high frequency of haplogroup M (defined by 
+ 10,394 Ddei and + 10,397 Alul and a HVS 1 sequence variant at position 16,223) which 
is virtually absent in other European populations. Within Europe, this mtDNA 
haplogroup has only been reported in the Saami (Delghandi , Utsi, & Krauss, 1998) and 
sporadically in Southeastern European peoples (Richards et al., 2000). Haplogroup M is 
prevalent in India, occurring at a frequency almost three times that observed in the Roma 
(Kivisild et al., 1999). Haplogroup H, the most prevalent haplogroup in Europe, is also 
the most common in the Roma. This haplogroup is geographically ubiquitous, and it is 
also the most common mtDNA haplogroup in the Near East (Richards et al., 2000). 
Within India, this haplogroup is rare, but not completely absent. The frequencies of 
haplogroups U3 and J are much higher in the Roma than observed in the European 
population. These frequencies are, however, comparable to those estimated for the non-
Romani Bulgarians. 
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t Table 4-6 
l Comparison of mtDNA haplogroup frequencies (%) in Europe, Bulgaria, Spain and f India with the Roma · 
t Pop. H I J M T U1 U3 U4 U5 U6 U(K) Pre W X N1b 
~ HV 
.. 1 
l Europe ( 0.50 0.02 0.11 
0.23 0.00 0.07 
0.52 0.01 0.01 
0.08 
0.10 
0.02 
0.01 0.01 0.07 0.01 0.07 0.04 0.01 0.02 
~ .. Bulgaria2 
:- ·Central 
0.10 0.07 0.03 0.13 0.00 0.00 0.07 
0.00 0.01 0.04 0.03 0.03 0.02 0.01 
k Spain2 
r Near 
[ Ease 
0.24 0.02 0.09 0.10 0.03 0.05 0.02 0.02 0.05 0.04 0.02 0.03 0.02 
t lndia4 0.02 0.01 0.01 0.60 0.02 0.13 0.02 0.01 0.01 
Rom a 0.29 0.02 0.11 0.25 0.02 0.01 0.13 0.03 0.02 0.02 0.02 0.09 0.01 
~ f. 1 Data from Richards et al., (1998) and summarised in Helgason eta/., 2000. 
-
2 Data from Simoni et al., 2000. 
~ 3Datafrom Richards et al., 2000. 
4Data from Kivisild eta/., 1999. 
4.1.2.2 Results of HVSl sequencing 
Sequence analysis of the mtDNA HVS 1 in the 185 samples identified 61 unique 
sequences. When combined with the RFLP results this corresponded to 62 unique 
. maternal lineages, as the Cambridge reference sequence (CRS) was found to occur in 
both haplogroup H and haplogroup Pre V /H (table 4-7). 
None of the eleven haplogroup M sequences was found to bear the characteristic 
East African HVS1 sequence of 16,129, 16,189, 16,223, 16,249, 16,311 (Quintana-
Murci et al., 1999), thereby excluding an African origin of this lineage. Thus, 
haplogroup M sequences in the Roma are most likely of Asian origin. 
Three sequences account for almost one-third of all Romani mtDNA. These 
include the haplogroup U3 sequence defined by a sequence variant at position 16,343, 
which is the most frequently occurring unique sequence in the Romani sample (12%); 
the haplogroup M sequence defined by variants at positions 16,129, 16,223, 16,291 & 
16,298 (9% ); and the hap1ogroup H sequence defined by variants at positions 16,261 & 
16,304 (9%). Conversely, thirty-seven sequences are found just once in the sample. 
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Table 4-7 
-··Female lineages identified in Romani populations 
HVS1 VARIANT(s) Haplogroup Total Turgovzi Feredjelli Montenl lntrenl Lam Kalderash Spanish Lithuanian 
N=185 N=25 N=18 N=42 N=16 N=18 N=23 Roma Roma 
N=25 N=18 
CRS* H 2 2 
93 H 1 
189 H 1 1 
223 H 2 2 
W H 1 
248 H 1 
261 H 1 
304 H 1 
354 H 3 3 
362 H 1 
186, 304 H 11 8 3 
187, 189 H 1 1 
218,278 H 6 2 3 
261, 304 H 17 3 8 2 1 1 2 
278, 293, 311 H 1 1 
51, 145, 304 H 1 1 
93,223 H 1 
93,291 H 2 
129, 172, 223, 311 I 3 
39C, 69, 126 J 1 
69, 126 J 10 3 2 4 
69,126,145,222,235,261, J 1 
271 
69,126,145,222,261,311 J 3 2 
69, 126, 193 J 1 
69, 126, 278, 366 J 1 
69, 126, 300 J 1 
69,126,311 J 1 
69, 93, 126 J 1 
129, 148,223,291, 298 M 2 2 
129, 223, 230, 233. 304 M 1 1 
129,223,230, 233,304, 344 M 8 3 3 
129, 223, 230, 233, 304, M 4 3 
344,355 
129, 223, 256, 291 M 1 
129, 223, 266, 291 M 1 1 
129, 223, 291 M 8 2 2 1 3 
129,223,291,298 M 17 3 3 2 4 4 
129, 223, 291, 298,362 M 1 1 
223, 290, 31ST M 1 
223, 291, 298 M 2 2 
192A, 320 PRE V/H 3 3 
CRS* PRE V/H 1 
126,294,296 T 1 
126, 294, 324 T 2 
126, 294, 352 T 1 
222,224, 261,311 U(K) 1 
224,311,344 U(K) 1 
224,261, 311 U(K) 1 
183C, 189, 249 U1 1 
343 U3 22 11 10 
260, 343 U3 2 2 
167, 192,270,311, 356 U5 1 1 
189, 270 U5 1 1 
192, 224, 261, 270 U5 1 1 
256, 270 U5 1 1 
28G, 192, 224,261,270 U5 1 1 
172,223,231,292 vv 3 1 2 
126,189A, 223,278 X 9 2 1 3 2 
92, 126, 189A, 223, 278 X 2 2 
92, 189A, 223, 278 X 1 1 
93, 189, 223, 241, 278 X 3 2 1 
93,96T, 189,223,241,278 X 1 . 
86, 129, 145, 176G, 223 N1b 2 2 
NB mutated sites are + 16,000 in accordance with Anderson et al., (1981) sequence of the 
mitochondrial genome. All mutations are transitions from the published sequence unless 
indicated with a letter, which indicates a transversion. ·CRS =Cambridge reference 
sequence and denotes complete identity with the Anderson et al., (1981) sequence. 
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4.1.2.3 Network analysis of mtDNA haplogroups 
4.1.2.3.1 Phylogenetic relationship between Romani mtDNA 
In order to examine the evolutionary relationship between Romani mitochondrial 
lineages, a median joining network (Bandelt, Forster, Sykes, & Richards, 1995) was 
constructed using all informative sequence variants (figure 4-4). Given the slow 
mutation rate in the coding region of mtDNA, haplogroup assignments denote 
classifications of great antiquity that predate the formation of each Romani population. 
HVS 1 variation observed within each haplogroup may represent founding lineages or be 
due to either female-mediated gene flow or the evolution of new lineages within the 
population through mutation. 
Within the Roma, haplogroup H is represented by 18 unique HVS 1 sequences; 
however, a single sequence (16,261, 16,304) accounts for almost one third of this 
haplogroup and is widely distributed among populations. This lineage has not been 
reported in a large survey ofNear Eastern and European mtDNA (Richards et al., 2000). 
Haplogroup M is represented by eleven unique HVS 1 sequences of which nine 
bear a variant at position 16,129. A transition from the reference sequence at this 
position defines a subhaplogroup M51 (Kivisild et al., 1999). Thus, in the Roma 93.5% 
of haplogroup M lineages belong to the subhaplogroup M5. The close phylogenetic 
relationship between these sequences is evident in the network. 
Haplogroup U3 occurs at a frequency of 13%, and is almost entirely represented 
by a single sequence. Previous reports indicate that this lineage is widely dispersed in 
European and near eastern populations (Richards et al., 2000). It is interesting to note 
that, within haplogroup X, a transition and transversion are observed at position 16,189. 
These may be a coincidental finding; however, evidence for sequence-context specific 
mutability has recently been suggested (Malyarchuk & Derenko, 1999). The possibility 
of a sequence context effect warrants further investigation. Haplogroup X sequences 
with a transversion at position 16,129 have not been reported in European, Near Eastern, 
or Indian populations (Kivisild et al., 1999; Richards et al., 2000) 
1 In a report by Kivisild et al. (1999), the authors denoted this subhaplogroup M4. However, in a later 
paper by the same authors it is denoted MS (Bamshad et al., 2001 ). The more recent nomenclature is 
used. 
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Figure 4-4 Median-joining network of mtDNA sequences identified in the 
Roma. All 2- and 3-digit numbers are +16,000 according to the Anderson et 
al., (1981) reference sequence. Nodes are proportional to the frequency of the 
sequence in the population. 
lll 
f. 
4.1.2.3.2 Network analysis of mtDNA haplogrop.p M 
t The variation within mtDNA haplogroup Min the Roma was compared to that 
t described for haplogroup M in Indians (Quintana-Murci et al., 1999; Kivisild et al., 
~ 
ifF 
~ 1999), through construction of a median-joining network (figure 4-5). Haplogroup M, 
!: 
~ which accounts for 60% of all Indian mtDNA, displays a great deal of internal 
& 
~· f heterogeneity. In the network of haplogroup M, the Romani sequences form a distinct 
.._ 
c subcluster of sequences of limited diversity. Nine of the eleven Romani haplogroup M 
f 
~ t sequences are characterised by a variant at position 16,129. Furthermore, six of these 
~ sequences are further defined by a s.equence variant at position 16,291. Of the 
_ sequences that do not bear the M5 diagnostic variant at position 16,129, one is closely 
related to the other sequences (16,223, 16,291, 16,298). It is interesting to note that 
position 16129 is known to be a hypermutable site in the mtDNA (Stoneking, 2000; 
Tully et al., 2000), thus its absence in this sequence might be the result of mutation. The 
other haplogroup M sequence (16,223, 16,290, 16,318T) is evidently distantly related to 
all other Romani sequences. A single haplogroup M HVS 1 sequence in the Roma, 
defined by variants at positions 16,129 and 16,291 has been identified in individuals 
belonging to the Madiga caste in Andhra Pradesh (M. Bamshad, personal 
communication). 
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Figure 4-5 Median-joining network of haplogroup M sequences in Indians 
(Quintana-Murci et al., 1999; K.ivisild et al., 1999) and Roma. Haplogroup M 
sequences identified in the Roma are in red. Subhaplogroup designations and the 
defining HVS 1 variant proposed by Bamshad et al., (200 1) are indicated. In 
addition, three frequently occurring variants that define subclades are shown. All 2-
and 3-digit numbers are + 16,000 according to the reference sequence (Anderson et 
al., 198 1 ). Branch lengths are proportional to the number of mutations except those 
that join subhaplogroups. 
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4.2 Genetic Relationships Between RQmani Populations 
4.2.1 Relatedness of Romani Populations as Inferred from Male Lineages 
4.2.1.1 Distribution of Y chromosome haplogroups in Romani populations 
The frequency of Y chromosome haplogroups within each population was 
determined (Table 4-8). Haplogroup VI-68 is the only haplogroup present in all 
populations. The proportional representation of haplogroup VI-68 varies in each 
population from a minimum value of 11.1% in the Turgovzi to a maximum of 82.4% in 
the Monteni. Haplogroup VI-68 is the most frequently occurring haplogroup in all 
Vlach populations. Haplogroup VI-52 was identified in all populations except the 
Intreni, however, the large proportion of unknown lineages in this population 
precludes an assertion that the haplogroup does not occur in this population. 
Haplogroup VI-52 is variably represented in the seven populations ranging from 4.8% in 
the Lithuanian Roma to 52.8% in the Turgovzi. 
The most common haplogroup in the Spanish Roma is VI-56 found at a 
frequency of 33.3%. This haplogroup is also well represented in the Lithuanian Roma 
(23.8%) but occurs infrequet?-tlY in other Romani populations (5.6% in the Turgovzi and 
10.3% in the Lorn). Haplogroup VI-71 is found only in populations speaking Balkan 
dialects. 
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~Table 4-8 f Distribution of Y chromosome haplogroups in Romani populations 
r"Haplogroup Turgovzi Feredjelli Intreni Monteni Lom. Kalderash 
::._ n=36 N=21 n=l7 n=17 n=19 n=ll 
: VI-68 11.1% 19.0% 58.8% 82.4% 68.4% 63.6% 
o VI-52 52.8% 23.8% 5.9% 15.8% 18.2% 
~- VI-56 5.6% 10.5% 
~iX-104 2.8% 14.3% 5.3% 9.1% 
VI-71 8.3% 23.8% 
III-36 5.6% 5.9% 9.1% 
V-52 19.0% 
IX-108 
VI-57 
VI-58 
Unknown 13.9% 41.2% 5.9% 
NB The most frequent haplogroup in each population is shaded. 
Spanish 
Rom a 
N=36 
18.5% 
14.8% 
33.3% 
22.2% 
3.7% 
3.7% 
3.7% 
Lithuanian 
Rom a 
n=21 
47.6% 
4.8% 
23.8% 
9.5% 
4.8% 
9.5% 
4.2.1.2 Distribution ofY chromosome haplotypes in Romani populations 
The frequencies of Y chromosome haplotypes in the eight populations were 
determined (table 4-9). Haplotype VI-68-a (15-22-10-11-12-16-14) is modal in the 
sample of 165 chromosomes, representing 26.6% of allY chromosomes in the Roma. 
Furthermore, haplotype VI-68-a is found in every population, whereas no other 
haplotype within the Roma is shared by more than four populations. The frequency of 
haplotype VI-68-a varies within each population, and it is modal in only the Intreni 
(0.529), Monteni (0.706) and Kalderash (0.545). However, the closely related 
haplotype, VI -68-c, is modal in the Lorn and Lithuanian Roma. Thus, in all Vlach 
populations and the Lithuanian Roma, modal haplotypes belongs to haplogroup VI-68. 
The Turgovzi and Feredjelli have a common modal haplotype, Vl-52-a, but otherwise do 
not share any haplotypes. The modal haplotype in the Spanish Roma is VI-56-b, which 
is also found at lower frequencies in the Turgovzi, Lorn and Lithuanian Roma. 
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- Table 4-9 
y chromosome haplotype frequencies in Romani populations 
Haplotype Total Turgovzi Feredjelli lntreni Monteni · Lorn 
Vl-68-a 
Vl-68-b 
Vl-68-c 
Vl-68-d 
Vl-68-e 
VI-52-a 
Vl-52-b 
Vl-52-c 
Vl-52-d 
Vl-52-e 
Vl-52-f 
Vl-52-g 
Vl-52-h 
Vl-52-1 
Vl-52-j 
Vl-52-k 
VI-56-a 
Vl-56-b 
Vl-56-c 
Vl-56-d 
Vl-56-e 
IX-104-a 
IX-104-b 
IX-104-c 
IX-104-d 
IX-104-e 
IX-104-f 
IX-104-g 
IX-104-h 
IX-104-1 
Vl-71-a 
Vl-71-b 
Vl-71-c 
Vl-71-d 
111-36-a 
111-36-b 
V-52-a 
V-52-b 
V-52-c 
IX-108-a 
VI-57-a 
VI-58-a 
Ht-a 
Ht-b 
Ht-c 
Ht-d 
N=165 N=36 N=21 N=17 N=17 N=15 
0.111 
0 
0 
0 
0 
0.389 
0.083 
0.028 
0.028 
0 
0 
0 
0 
0 
0 
0 
0.028 
0.028 
0 
0 
0 
0 
0 
0.028 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.083 
0.028 
0.028 
0 
0 
0 
0 
0 
0 
0.056 
0.028 
0.028 
0.028 
0.19 
0 
0 
0 
0 
0.238 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.095 
0.048 
0 
0 
0 
0 
0 
0 
0 
0.048 
0.143 
0.048 
0 
0 
0 
0.048 
0.095 
0.048 
0 
0 
0 
0 
0 
0 
0 
0.5.29 
0 
0.059 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.706 
0 
0 
0.059 
0.059 
0.059 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.059 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.133 
0 
0.467 
0 
0 
0 
0 
.0.067 
0 
0 
0 
0 
0 
0.067 
0 
0.067 
0 
0.133 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.067 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Ht-e 0 0 0 0 0 
Ht-f 0 0 0 0 0 
Ht-g 0 0 0 0 0 
Ht-h 0 0 0.059 0 0 
Ht-j 0 0 0.235 0 0 
Ht-k 0 0 0.118 0 0 
Ht-1 0 0 0 0.059 0 
NB Modal haplotypes within each population are highlighted. 
Kalderash 
N=11 
0.545 
0 
0 
0.091 
0 
0 
0 
0.091 
0.091 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.091 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.091 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Spanish 
Rom a 
N=27 
0.185 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.037 
0.037 
0.037 
0 
0.037 
0 
0.037 
0.222 
0.037 
0 
0.037 
0 
0 
0 
0.037 
0.074 
0.037 
0.037 
0.037 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.037 
0.037 
0 
0 
0 
0 
0 
0 
0.037 
0 
0 
0 
0 
Lithuanian 
Rom a 
N=21 
0.143 
0.095 
0.238 
0 
0 
0 
0 
0 
0 
0.048 
0 
0 
0 
0 
0 
0 
0 
0.143 
0.048 
0.048 
0 
0 
0 
0 
0.048 
0.048 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0.048 
0 
0 
0 
0 
0 
0 
0.048 
0.048 
0 
0 
0 
0 
0 
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4.2.1.3 Male-specific genetic distances between Romani populations 
Population pairwise RsT values were computed for the eight populations using Y 
STR data (table 4-1 0). In general, the genetic distances are smaller between populations 
within the same migrational grouping. It is apparent that the greatest genetic distances 
are observed between Rudari and Balkan populations. This is striking, given that 
genetic distances between each of these populations and the geographically distant 
Spanish and Lithuanian Roma are smaller. This relationship is observed in a neighbour-
joining tree depicting the distance matrix (figure 4-6). Populations cluster primarily on 
the basis of migrational/linguistic groupings. The Lithuanian and Spanish Roma are 
placed between the Vlach and Balkan Rcima. 
Table 4-10 
Matrix of population pairwise Rsr values 
Feredjelli Turgovzi Lithuanian Spanish Intreni Monteni Kalderash 
Roma Rom a 
Turgovzi 0.025 
Lithuanian Roma 0.120 0.128 
Spanish Roma 0.059 0.099 0.007 
Intreni 0.383 0.276 0.144 0.223 
Monteni 0.251 0.206 0.103 0.167 0.043 
Kalderash 0.130 0.143 0.105 0.072 0.180 0.038 
Lorn 0.106 0.100 -0.039 0,011 0.084 0.024 0.031 
NB Significant values (P<0.05 from 1000 permutations) are highlighted. 
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Figure 4-5 Unrooted neighbour-joining tree based on population pairwise Rsr distances 
determined using Y STR data 
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4.2.1.4 Genetic structure ofY chromosome diversity in the Roma 
t t To examine population structure in the Roma, an analysis of molecular variance 
,.. (AMOV A) was performed. Molecular variance was assessed under a number of 
"-
... 
~ population groupings (table 4-11). The greatest variation amongst groups was 
~·· apportioned when populations were grouped according to migrational groupings 
~ (13.28%, P<0.05). Conversely, this grouping yieldedthe smallest apportionment of 
~ 
.. 
variation to populations within groups (1.45%, P<0.05). Grouping populations by 
nationality yielded the lowest apportionment of genetic variation amongst groups, being 
.. 
~ effectively zero. Grouping populations by religion yielded a high apportionment of 
variation amongst groups (11.97% P<0.05). Grouping by metagroups did not produce 
statistically significant apportionment of variation amongst groups. 
Table 4-11 
Apportionment of molecular variance for Y STR data under different population 
groupings 
Group definition Variation amongst groups 
Whole population 
N=l 
Nationality -6.83% P=0.80645 
N=3 
Religion 11.97% P=0.01857 
N=4 
Metagroup 7.16% P=0.17693 
N=5 
Major migrations 13.28% P=O.Oll73 
N=3 
Variation among 
populations within groups 
12.07% P<0.00001 
16.07% P<O.OOOOl 
1.89% P=0.03519 
5.93% P<O.OOOOI 
1.45% P=0.01369 
NB N refers to number of defined groups in analysis 
Variation within 
populations 
87.93% P<0.00001 
90.76% P<0.00001 
86.14% P<O.OOOOl 
86.91% P<O.OOOOl 
85.27% P<O.OOOOl 
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· 4.2.2 Relationship Between Romani Populations as Inferred from Female Lineages 
4.2.2.1 Distribution of mtDNA Haplogroups in Romani populations 
- The proportional representation of mtDNA haplogroups in each Romani 
~ populations was analysed (table 4-12). Haplogroup M is the only haplogroup that is 
._ found in all Romani populations, ranging from 16.0% in the Turgovzi to 43.8% in the 
Intreni. Haplogroup His found at highest frequencies in Vlach populations. Within the 
Balkan populations, haplogroup H accounts for almost one-quarter of female lineages in 
:. the Turgovzi, but is entirely absent in the Feredjelli. Haplogroup U3 is the most 
""'·· frequent haplogroup in both the Spanish and Lithuanian Roma, but is otherwise absent 
in Romani populations aside from the Monteni in which it is rare. Conversely, 
haplogroup X is found in all Vlach and Balkan Romani populations except the Intreni, 
but is not observed in the Lithuanian or Spanish Roma. 
Table 4-12 
Distribution ofmtDNA hap_logroues in Romani f!.Of!.Ulations (values in %2 
Poeulation H I J M PreV/H T U{K} U1 U3 us w X N1b 
Turgovzi 24.0 4.0 16.0 16.0 0 4.0 0 0 0 16.0 4 16.0 0 
N=25 
Feredjelli 0 0 11.1 33.3 5.6 0 5.6 5.6 0 0 11.1 27.8 0 
N=18 
Monteni 47.6 0 7.1 21.4 7.1 4.8 0 0 2.4 0 0 9.5 0 
N=42 
lntreni 37.5 0 12.5 43.8 0 0 6.25 0 0 0 0 0 0 
N=16 
Lorn 38.9 5.6 5.6 22.2 0 0 5.6 0 0 0 0 11.1 11.1 
N=18 
Kalderash 34.8 4.3 21.7 30.4 0 4.3 0 0 0 0 0 4.3 0 
N=23 
Spanish 12.0 0 12.0 20.0 0 0 0 0 52.0 4.0 0 0 0 
Rom a 
N=25 
Lithuanian 22.2 0 0 22.2 0 0 0 0 55.6 0 0 0 0 
Rom a 
N=18 
NB Modal haplotypes within each population are highlighted. 
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4.2.2.2 Distribution of HVSl sequences in Roll_lalli populations 
The distribution ofmtDNA HVS1 sequences in the seven Romani populations is 
provided in table 4-7. No single mtDNA HVS 1 sequence was found to be common to 
:.._all populations. However, at least one of two haplogroup M sequences that differ only 
by a sequence variant at position 16,298 is found in every population. The haplogroup 
U3 sequence with a single vatiant at position 16,343 is the most frequently encountered 
sequence in the entire sample. However, the two U3 sequences bearing the 16,343, and 
the 16,343 and 16,260 variants respectively are very common in the Spanish and 
Lithuanian Roma and otherwise are fou:nd only once, in the Monteni. The haplogroup X 
_ sequence with variants at positions 16,126, 16,189A, 16,223, and 16,278 occurs in every 
Balkan and Vlach population. This sequence and other haplogroup X sequences are 
absent in the Spanish and Lithuanian Roma. The haplogroup J sequence with mutations 
at positions 16,069 and 16,126 is found in the Vlach groups but in neither of the Balkan 
populations nor in the Spanish and Lithuanian Roma. In contrast to the sequence 
lineages that adhere to population groupings, the haplogroup H sequence containing the 
16,261 and 16,304 variants appears randomly distributed - present in all populations 
except the Feredjelli and Spanish Roma. 
4.2.2.3 Female-specific genetic distances between Romani populations 
Population pairwise genetic distances between the seven populations were 
computed using intermatch-mismatch distances (table 4-13). 
Table 4-13 
Intermatch-mismatch distances between populations 
Feredjelli Turgovzi Lithuanian Spanish Intreni Monteni Kalderash 
Rom a Roma 
Turgovzi 0.050 
Lithuanian Roma 0.769 0.480 
Spanish Roma 0.644 0.360 -0.060 
lntreni 0.642 0.380 0.657 0.750 
Monteni 0.647 0.221 0.559 0.607 -0.017 
Kalderash 0.148 0.003 0.506 0.390 0.178 0.167 
Lorn 0.001 -0.020 0.419 0.356 0.264 0.257 -0.052 
NB Significant values (P<O.OS from 1000 permutations) are highlighted.· 
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Generally, the largest genetic distances are observed between the Lithuanian or 
""Spanish Roma, and Balkan or Vlach Roma. Significant distances are seen between 
Balkan and Rudari (Intreni and Monteni) populations. However, the distances between 
-the two Balkan populations and the Kalderash and Lorn are small and statistically 
-insignificant. Negative distances are observed between the Lithuanian and Spanish 
Roma, the Intreni and Monteni, the Lorn and Kalderash, and the Lorn and Turgovzi. 
An unrooted neighbour-joining tree was created from this distance matrix (figure 
4-7). As can be seen in the tree, the Lithuanian and Spanish Roma cluster closely 
together as do the Intreni and MontenL The Kalderash, Turgovzi, Lorn and Feredjelli 
are separated from these populations but, do not appear to adhere to any particular 
clustering. 
Figure 4-6 Unrooted neighbour-joining tree based on mtDNA HVS 1 intermatch-
mismatch distances between Romani populations. 
\ 
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4.2.2.4 Genetic Structure of mtDNA diversity in the Roma 
In order to examine female-specific genetic structure in the Roma, an analysis of 
molecular variation (AMOVA) was performed using mtDNA HVSl data. A variety of 
"---population groupings were created to explore different demographic and social 
- parameters and their relevance to genetic structuring (table 4-14). These different 
__ groupings did not yield dramatically different apportionments of variation amongst 
groups. The greatest apportionment of genetic variation among groups was observed 
when populations were grouped according to historical migrations (6.85%). However, 
the reciprocal apportionment of variation among populations within groups was not 
statistically significant (1.59%, P=0.05865). Statistical significance was reached for all 
three variance components when populations were grouped by metagroups. This 
grouping apportioned 6.73% (P<0.05) of genetic variation among groups, and only 
0.62% (P<O.OOOOl) of variation among populations within groups. 
Table 4-14 
Apportionment of molecular variance for mtDNA data under different population 
groupings 
Group definition Variation amongst groups 
Whole population 
N=l 
Nationality 4.87% P=0.04301 
N=3 
Religion 6.75% P=0.00978 
N=4 
Metagroup 6.73% P=0.01369 
N=5 
Major migrations 6.85% P=0.01857 
N=3 
Variation among 
populations within groups 
6.54% P<0.00001 
4.20% P<0.00001 
1.03% P=O.l4467 
0.62% P<O.OOOOl 
1.59% P=0.05865 
NB N refers to number of groups in analysis 
Variation within 
populations 
93.46% P<O.OOOOl 
89.73% P<0.00001 
92.22% P<0.00001 
92.65% P<0.00001 
91.56% P<O.OOOOl 
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4.2.2.5 Relatedness of Roma to worldwide populations as determined using 
female lineages 
The genetic relatedness of the Roma to other European and worldwide 
populations was calculated from mtDNA data by determining intermatch-mismatch 
population pairwise distances. A neighbour-joining tree was constructed that displays 
the relationship between these populations (Figure 4-7). · In this tree it is apparent that 
Romani populations form distal branches that are separated from all other populations. 
The branch distances between Romani populations are great, which reflects genetic sub-
structure and genetic divergence of these populations from each other. This contrasts 
- with the autochthonous European populations that cluster closely together, reflecting a 
low level of genetic substructure. The Roma are situated at greatest distance to Middle 
Eastern populations and lie approximately midway between European and Asian 
populations. 
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Figure 4-7 Unrooted neighbour-joining tree depicting intermatch-mismatch 
population pairwise genetic distances between Romani and worldwide populations as 
determined from mtDNA data. Bootstrap values for major branches are in percentage 
values from 1000 iterations. 
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4.3 Intrapopulation Genetic Diversity of ~omani Populations 
4.3.1 Intra population Analysis of Paternal Lineages 
Y chromosomal variation differed greatly in the eight populations, as calculated 
by the mean number of pairwise differences and the haplotype diversity index. The data 
are presented in descending order according to the average pairwise differences (Table 
4-15). 
Table 4-15 
Diversity indices for Y chromosome haplotypes in Romani populations 
Population No. Y Chrs Average Pairwise Differences Haplotype Diversity 
Spanish 27 3.72 +/- 1.94 0.926 +/- 0.001 
Rom a 
Feredjelli 21 3.35 +/- 1.79 0.900 +/- 0.002 
Turgovzi 36 3.10 +/-1.65 0.835 +/- 0.003 
Lithuanian 21 3.02 +/- 1.64 0.900 +/- 0.001 
Rom a 
Kalderash 11 2.82 +/- 1.61 0.728 +/- 0.022 
Lorn 15 2.74 +/- 1.54 0.781 +/- 0.011 
Monteni 17 1.50 +/- 0.95 0.514 +/- 0.023 
lntreni 17 1.16 +/- 0.79 0.684 +/- 0.010 
Y chromosome haplotype diversity is greatest in the Spanish Roma with 17 
haplotypes observed in the sample of 27 males. Similarly high diversity indices were 
determined for the Feredjelli, Turgovzi and Lithuanian Roma, all of whom have an 
average of more than 3 pairwise differences between haplotypes, and haplotype 
diversities greater than 0.8. In contrast, the two Rudari population, the Monteni and the 
Intreni, show a strikingly low male genetic diversity, with averages of less than 1.6 
differences between haplotypes within the population and haplotypes diversities below 
0.7. Y chromosome diversity within the Lorn and Kalderash is of an intermediate value 
relative to the other populations. 
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4.3.2 Intrapopulation Analysis of Maternal Lineages 
Three different diversity indices were calculated from mtDNA data. The data are 
presented in descending order according to the average pairwise differences (table 4-16). 
Table 4-16 
Diversity indices for mtDNA data in Romani populations 
Population N K A D 11' p 
Feredjelli 18 12 22 0.9542 0.016449 5.92 
Turgovzi 25 19 31 0.9767 0.016407 5.91 
Lorn 18 12 22 0.9542 0.013725 4.94 
Intreni 16 9 15 0.9250 0.013356 4.80 
Monteni 42 15 25 0.9129 0.013111 4.72 
Kalderash 23 15 22 0.9486 0.012330 4.44 
Spanish Roma 25 11 23 0.7933 0.010741 3.87 
Lithuanian Roma 18 5 9 0.6601 0.007298 2.63 
All 185 61 61 0.9562 0.013702 4.93 
NB N= sample size, K =no. of unique sequences, A= no. of variable positions, D =sequence diversity, 
1\'= nucleotide diversity, P= average number of pairwise differences. 
When each Romani population is analysed independently a large variation in 
mtDNA diversity is apparent. The two Balkan Romani populations, the Turgovzi and 
Feredjelli, are extremely diverse with average pairwise differences values of 5.91 and 
5.92 respectively and high sequence and nucleotide diversities. These values place them 
amongst the most heterogeneous European populations based on mtDNA (see table 4-17 
for examples of European populations). In contrast, extremely low levels of mtDNA 
diversity are indicated by the same statistics calculated for the Spanish and Lithuanian 
Roma, and the diversity values determined for these populations are very low when 
compared to other European populations. Female specific diversity in the Vlach Romani 
populations is intermediate in comparison to the other Romani populations. 
Comparisons to results from studies of other populations (table 4-17) show that 
the entire European Romani population is well within the range of genetic diversities 
observed in other populations. An average number of 4.96 pairwise differences between 
mtDNA sequences in the Roma is indicative of greater diversity than European genetic 
isolates, such as the Icelanders, Sardinians and Saami. 
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, Table 4-17 
Average number of pairwise differences of mtDNA se_quences in the Roma and other 
populations 
~ Population 
Turkish1 
Spanish1 
- European Roma 
Iceland2 
Sardinians2 
Saame 
N 
96 
89 
169 
73 
69 
115 
Average pairwise differences 
5.45 
5.02 
4.93 
4.40 
4.22 
3.99 
1Data summarised in Salas, Comas, Lareu, Bertranpetit, & Carracedo (1998). 
2Data summarised in Amason, Sigurgislason, & Benedikz (2000) 
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CHAPTERS 
DISCUSSION 
5.1 Genetic Evidence for the Origins of the Roma 
~·: --
5.1.1 The Composition and Origin of Romani Male Lineages 
~· 
t_ The determination of deep-rooted paternal lineages in the Roma revealed a single 
predominant Y chromosome haplogroup. Y chromosomes belonging to haplogroup VI-
68 account for almost two-fifths ofY chromosomes in the sample of 169 Romani males. 
Previously, this haplogroup has only been found in India and Pakistan, where it occurs 
relatively infrequently, and in Central Asia where it appears to be rare (Underhill et al., 
2000). This suggests that Y chromosome haplogroup VI-68 is restricted to populations 
of the Indian subcontinent and proximate geographical locations. Hence, its occurrence 
in the European· Rom a points to the Indian origin of Romani males. The prevalence of 
this haplogroup in the Roma (almost twice as frequent as the next most frequent 
haplogroup, VI-52), justifies the assertion that it is representative of the founding 
population. 
Y STR haplotype analysis revealed the restricted diversity within this haplogroup 
with only five unique haplotypes identified. The most frequent of these haplotypes, VI-
68-a, represents 71% of the 63 Y chromosomes belonging to this haplogroup. 
Furthermore, the four other haplotypes within this haplogroup are closely related, 
separated by single mutations at YSTR loci. This suggests that diversity within this 
haplogroup has been generated through mutation rather than male-mediated gene flow. 
The coalescent age of the VI-68 haplogroup in the Roma was dated at 2,020 years before 
present (95% CI 1,786-2,344 years). This date can be roughly equated with a profound 
bottleneck event in the proto-Roma around 2,000 years ago. It is conceivable that this 
event represented the splitting of a small population from a larger parental population. 
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Haplogroup VI-56 represents 10.7% of the Romani Y chromosomes. This 
- haplogroup has been mainly identified in Middle Eastern populations (Underhill et al., 
2000). Y STR haplotypes within this haplogroup are closely related; suggesting that 
haplogroup diversity in the Roma has arisen largely through mutation. Thus, it is likely 
_ that this lineage was introduced into the Romani population by a limited number of 
related male founders. The apparent restriction of this haplogroup to Middle Eastern 
populations suggests a possible contribution by non-Indian and non-European peoples to 
the Romani gene pool. Based on linguistic evidence, Roma are believed to have had 
extended stays in Persia and Armenia prior to their arrival in Europe (Fraser, 1992; 
Hancock, 1999a}. The presence ofhaplogroup VI-56 suggests that the Roma underwent 
__ some degree of male-mediated admixture during these sojourns. The age of the VI-56 
haplogroup was determined to be 2,435 (95%CI 2,135-2,826) years before present, 
which is older than the Indian specific haplogroup in the Roma. This is possibly due to 
the fact that the history of the Y chromosome may be confounded by population 
bottlenecks (de Knijff, 2000). However, it is possible that some diversity was already 
present within a Middle Eastern male population when it fused with Indian migrants, 
which would account for the calculated age of the haplogroup. 
In striking contrast to haplogroups VI-68 and VI-56, haplogroup VI-52 displays 
considerable internal heterogeneity. This haplogroup accounts for 21% of the Romani Y 
chromosomes, but comprises 12 relatively distantly related haplotypes. Network 
analysis of this haplogroup reveals a complex topology with different haplotypes 
separated by numerous mutations. In a survey of world-wide populations, this 
haplogroup was only found in European populations (Underhill et al., 2000). Another 
study showed it to be a common European lineage with a strong East to West clinal 
distribution (Semino et al., 2000). Thus, the most likely explanation for this haplogroup 
in the Roma is through multiple independent admixture events. The clinal distribution 
o'f this haplogroup in Europe implies that the majority of males would have come from 
Eastern European populations. The long-term Eastern European residency of most of 
the Romani populations included in this study is consistent with this claim. 
Haplogroup IX-104 accounts for 8% ofpatrilineages. This haplogroup is found 
in populations throughout the world including Africans, Europeans, Middle Easterners, 
130 
- Indians, Americans and Australians (Underhill et al., 2000). Within Europe, it accounts 
- for over half of all the male lineages in Western Europe· and almost a fifth of lineages in 
""'- Eastern Europe (Semino et al., 2000). However, the worldwide distribution of 
haplogroup IX-104 makes attempts to discern its origins in the Roma problematic. 
_ Network analysis shows that this haplogroup is composed of five hap1otypes that are 
closely related and an additional four more distantly related haplotypes. It is possible 
_ that Y chromosomes belonging to this haplogroup may have different histories of 
admixture in the Roma. The close evolutionary relatedness of some of the haplotypes 
suggests that some of these admixture events may have occurred sufficiently long ago to 
allow diversity through mutation to arise within the population. 
As well as the aforementioned four haplogroups, an additional six haplogroups 
were identified in the Roma. Each of these haplogroups represents 5% or less of the 
known Y chromosomes, but are nonetheless important as they may provide evidence of 
the initial composition of the Roma, or of subsequent admixture events. Four of these 
haplogroups, which are represented by just one chromosome in the sample, are found in 
Indian populations. These include haplogroups VI-71, IX-108, VI-57 and VI-58. Of 
these haplogroups, VI-57 is the only one that has not been found in European or Middle 
Eastern populations and thus can justifiably be considered as descended from an Indian 
male progenitor. Interestingly, a single haplogroup identified in the Roma, 111-36, has 
only previously been found in African populations from Ethiopia, southern Africa and in 
the Khoisan (Underhill et al., 2000). Although this haplogroup only represents 2.4% of 
the Romani Y chromosomes, its presence in the Roma is intriguing. Hancock (1999b; 
2000) argues that the proto-Roma comprised a military force, which may have included 
some East Africans. Further studies are required to illuminate the history of this 
haplogroup in the Roma. 
5.1.2 The Composition and Origin of Romani Female Lineages 
Nearly one-quarter of Romani matrilineages belong to the mtDNA haplogroup 
M. This haplogroup is generally considered to be very rare in Europe, where it has only 
been found in population outliers such as the Saami (Delghandi, Utsi, & Krauss, 1998). 
Haplogroup M is estimated to represent 60% of maternal lineages in India (Kivisild et 
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al., 1999). It is also occurs in East African populations, however HVS 1 sequence 
variants allow the discrimination between the Asian ·and East African subtypes of 
haplogroup M (Quintana-Murci et al., 1999). Haplogroup M sequences in the Roma can 
confidently be assigned to the Asian haplogroup M lineage. Studies of Indian mtDNA 
· demonstrated the enormous amount of variation within haplogroup M (Bamshad et al., 
2001; Kivisild et al., 1999). Network analysis makes it strikingly apparent that the 
haplogroup M sequences in the Roma comprise a small subset of the diversity observed 
within India. Moreover, Romani haplogroup M sequences are closely related and 
overwhelmingly belong to the mtDNA subhaplogroup MS. This suggests that the 
variation in haplogroup M observed in the Roma has resulted from mutation rather than 
heterogeneous origins. Furthermore, the limited diversity in extant sequences can be 
explained by a small number of related female founders. 
Determination of the Indian population that is most closely related to the Roma 
requires close analysis of this subhaplogroup. Within India, it is unclear whether 
haplogroup M5 is more prevalent in particular populations (Bamshad et al., 2001; 
Kivisild et al., 1999). A single haplogroup M sequence (16,129, 16,291) is shared by the 
Roma and Indians described by Kivisild et al., (1999). These individuals belong to the 
Madiga caste in the upper east coast of Andhra Pradesh (M. Bamshad, pers comm). 
However, conclusions cannot be drawn on the basis of a single sequence. Further 
studies of Indian populations might serve to illuminate related populations. 
The most frequently occurring maternal lineage in the Roma sample is 
haplogroup H, which accounts for 29% of all mtDNA. Haplogroup H is the most 
common haplogroup in Europe (Richards, Macaulay, Bandelt, & Sykes, 1998) and the 
Near East (Richards et al., 2000). It also occurs in India, however it is infrequent and 
represents just 2% ofmtDNA in a sample of over 500 individuals (Kivisild et al., 1999). 
Within the Roma, haplogroup H is heterogeneous. Network analysis shows that the 
eighteen haplogroup H HVS 1 sequences form a cluster of nodes of variable evolutionary 
relationships. Thirty-one percent of the haplogroup is represented by a single HVS 1 
sequence defined by mutations atpositions 16,261 and 16,304. This points to the 
antiquity of this mtDNA sequence in the Roma. The geographically widespread 
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distribution of haplogroup H makes it difficult to assign any of the sequences to 
hypothesised parental populations. 
Haplogroup U3 is the third most frequent mtDNA haplogroup in the Roma. As 
is apparent in the network analysis, this haplogroup is represented primarily by a single 
HVS 1 sequence. This points to the close biological relatedness of individuals bearing 
haplogroup U3. Haplogroup U3 is relatively uncommon in Europe (Helgason, 
Sigurethardottir, Gutcher, Ward, & Stefansson, 2000), although the frequency varies in 
different European populations (Simoni, Calafell, Pettener, Bertranpetit, & Barbujani, 
2000). Within the Near East it occurs at a frequency of 5% (Richards et al., 2000), and 
it has not been reported in Indian populations (Kivisild et al., 1999). Thus, this 
haplogroup was most likely introduced into the Roma at some stage subsequent to their 
exit from India. The almost complete absence of variation within this haplogroup 
suggests its introduction by a limited number of related individuals. 
The other mtDNA haplogroups in the Roma are all found in Indian, Near Eastern 
and European populations. Thus, determining the population origins of these female 
lineages is problematic. This might be overcome through identification of subgroups 
within these haplogroups and determination of their distribution. 
5.2 Genetic Relationships between Romani Populations 
Highly resolved paternal and maternal lineages shared amongst Romani 
populations provide evidence of genetic relatedness. This relatedness can be due to 
either common origins or gene flow. Relationships between populations can be 
quantified through genetic distance analysis. Whilst interpretations must be made 
cautiously owing to the confounding effects of genetic drift, careful consideration of the 
data permits a number of conclusions. 
5.2.1 Male Specific Genetic Structure in the Roma 
Haplogroup VI-68 is the only Y chromosome haplogroup that is found in every 
Romani population. Therefore, these separated populations are related to each other 
through a common Y chromosome haplogroup of Indian origin. The frequency of this 
haplogroup in different Romani populations varies widely. The Balkan Romani 
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populations display low frequencies of this haplogroup as do Spanish Roma. In these 
populations haplogroup VI-68 represents less than i in 5 Y chromosomes. The 
population with the highest frequency of the VI-68 haplogroup is the Monteni, in which 
it accounts for 82.4% of all Y chromosomes. The Monteni belong to the Rudari 
metagroup, as do the Intreni where VI-68 represents at least 58.8% of Y chromosomes. 
These two populations migrated to Bulgaria from Rumania after the end of slavery in the 
nineteenth century (Marushiakova & Popov, 1997). Similarly, the Kalderash and Lorn 
emigrated from Wallachia and Moldavia. In these two populations, Y chromosome VI-
68 represents over 60% of the males. Thus, it is apparent that Vlach Romani groups are 
characterised by higher frequencies of the Indian-specific Y chromosome haplogroup 
VI-68 than other Romani groups. 
Haplotype analysis reveals the close biological affinity of males with Y 
chromosomes belonging to VI-68 in these eight populations. Of the 52 YSTR 
haplotypes that were identified in the Roma, only one was common to all populations. 
This lineage, VI-68-a, accounts for 27% of Y chromosomes and thus can be referred to 
as the Romani modal male lineage. The occurrence of a common highly resolved male 
lineage in separated population has been observed previously only in the Ashkenazi and 
Sephardic Cohen priests (Thomas et al., 1998). For Jewish priests, a common Y 
chromosome is not unexpected owing to the paternal inheritance of the vocation. In the 
Roma, the presence of an identical male lineage in every population points to the 
common origin of these populations and the long-term preservation of group identity. 
The genesis of each Romani population can be understood as a process of population 
fission from a parental population. For the VI-68-a lineage to be found in every extant 
Romani population, it must have been highly represented in the parental population. 
This provides strong evidence for long-term endogamous practices in the Roma and 
proto-Roma. 
Although it is found in all populations, the Romani modal male lineage occurs at 
differing frequencies. In the Turgovzi, Feredjelli and Spanish Roma VI-68-a represents 
the only lineage belonging to haplogroup VI-68. This suggests that these populations 
were formed from a small number of founding males from the parental population of 
Indian immigrants. In contrast, in the other five populations at least two haplotypes are 
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found within the VI-68 haplogroup. The diversity within haplogroup VI-68 in these 
populations may be due to a combination of a greater number of founding males bearing 
this lineage and lesser levels of subsequent admixture, which would serve to maintain 
high frequencies ofhaplogroup VI-68. 
Genetic distances and haplotype sharing indicate a general trend in the genetic 
structure of Romani males. A neighbour-joining tree constructed from RsT population 
pairwise distances shows distinct clustering of populations according to historical 
migrations. This is reflected in AMOVA results that indicate that the largest variation 
amongst groups (and thereby, the least variation between populations within groups) is 
observed when populations are grouped a.ccording to major historical migrations. Thus, 
genetic structure of the Romani male population corresponds to historical divisions 
arising from major migrations within Europe, rather than nationality. This points to the 
maintenance of group identity following population fissions, and limited gene flow 
between historically and socially separated populations that are now geographically 
proximate. 
5.2.2 Female Specific Genetic Structure in the Roma 
The Asian-specific haplogroup M is the only mtDNA haplogroup found in all 
Romani populations. Fifty-six percent of Romani mtDNA belonging to this haplogroup 
have one of two HVS 1 sequences that differ by a single mutation. One or other of these 
sequences is found in every population, with the Feredjelli the only population in which 
both occur. Furthermore, every Romani population, with the exception of the 
Lithuanian Roma, has additional related haplogroup M sequences. The presence of 
these closely related maternal lineages attests to the common biological ancestry of 
females in Romani populations. 
The only other female lineage with a widespread distribution in the Roma is the 
haplogroup H sequence, with mutations at position 16,261 and 16,304. This lineage is 
found in five populations, but is absent in the Feredjelli and Spanish Roma. 
Nevertheless, its distribution in geographically and historically distant groups points to 
the relatedness of Romani populations. The population origins of this lineage cannot be 
discriminated; however, its widespread distribution in the Roma points to its early 
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existence, possibly in India but more likely in the Middle .East or soon after arrival in 
Europe. 
Other mtDNA lineages testify to the independent histories of the populations. 
Haplogroup X occurs in the Balkan and Vlach populations, but is absent in the 
- Lithuanian· and Spanish Roma. This haplogroup is subdivided in the Roma by a 
transition or transversion at position 16,189. A haplogroup X HVSl lineage with a 
transversion at position 16,189 is found in every Balkan and Vlach Romani population. 
Its prevalence in Balkan and Vlach Romani populations suggests that it is a female 
founding lineage. However, it is completely absent in the Spanish and Lithuanian 
Roma. Early historical records report Romani groups of 30-400 people (Fraser, 1992), 
and it is possible that very few females travelled west with these small migrating groups. 
Therefore, it is plausible that some lineages were not represented in these populations or 
else were subsequently lost through genetic drift. 
The haplogroup J sequence, defined by mutations at positions 16,069 and 16,126, 
is found only in Vlach speaking Roma. The Monteni, Lorn and Kalderash have different 
histories, but are all descended from Roma who were enslaved in Wallachia and 
Moldavia. This shared mtDNA lineage could possibly be a signature of this legacy. 
Similarly, the Spanish and Lithuanian Roma share the haplogroup U3 sequence with a 
mutation at position 16343. Haplogroup U3 represents over 50% of mtDNA in these 
populations, and is almost completely absent in all other populations. The sharing of 
this sequence at high frequency by the Spanish and Lithuanian Roma suggests that they 
have a recent common origin. Furthermore, the Lithuanian and Spanish Roma display 
the highest frequencies of theY chromosome haplogroup VI-56, which is absent or rare 
in most other Romani populations. It is interesting to observe that VI-56 and U3 are 
most frequent in Middle Eastern populations (Richards et al., 2000; Underhill et al., 
2000). Thus, these lineages provide evidence of possible admixture prior to the Roma 
entering Europe. Their over-representation in Romani populations that migrated 
westward suggests that groups splintering from the early migrant population could have 
included a larger proportion of admixed individuals of Middle Eastern origins. 
Genetic distance analysis using mtDNA HVS 1 data shows a sharp distinction 
between Spanish and Lithuanian Roma on one hand, and other populations. Within the 
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~· Balkan and Vlach groups, genetic distances between the Intreni and Monteni and the 
' 
:-.two Balkan Romani populations are large. However, genetic distances are considerably 
smaller between the two other Vlach populations, the Kalderash and Lorn, and the two 
Balkan Romani populations. This is displayed in the neighbour-joining tree in which the 
:_ .. Intreni and Monteni form a separate branch to the other Vlach and Balkan Romani 
populations. Thus, it is apparent that female genetic structuring does not conform to 
population groupings by historical migrations. · Whilst there is a clear delineation 
between the Spanish and Lithuanian Roma and all other groups, substructuring within 
populations resident in Bulgaria appears to be complex. The most statistically robust 
AMOV A results are obtained when populations are. grouped according to metagroups. 
This suggests different female histories for Romani populations resident in Bulgaria, and 
possibly reflects varying levels of female admixture in the different populations. 
When mtDNA data are used to construct a population tree comparing the 
Romani populations to world-wide populations, the contrast is illuminating. Whereas 
_ regional autochthonous populations cluster closely together, large branch distances 
separate the Romani populations. Endogamous practices and small effective population 
sizes enhance the effects of genetic drift resulting in rapid population differentiation. In 
addition to this feature of the tree, the Roma are situated midway between European and 
Asian populations which reflects their genetic heritage. 
5.3 Genetic Variation within Romani Populations 
5.3.1 Intrapopulation Diversity of Paternal Lineages 
The analysis of internal male-specific genetic diversity reveals widely varying 
degrees of genetic homogeneity within Romani populations. Populations can be 
grouped into those displaying considerable genetic heterogeneity, the Balkan and 
Western European Roma, and those showing extremely limited diversity, the Vlach 
Roma. Analysis of the male lineages in the Balkan and Western European Roma 
indicates that diversity has arisen through greater admixture with autochthonous 
Europeans. The homogeneity of Vlach male lineages points to strict adherence to male 
endogamy with very low levels of male-mediated gene flow. Until recently many Vlach 
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populations have been nomadic (Marushiakova & Popov, 1997) which could preserve 
traditional practices including endogamy. Furthermore, the enslavement of these 
populations in Moldavia and Wallachia may have served to restrict external genetic 
contributions. 
5.3.2 Intrapopulation Diversity of Female Lineages. 
lntrapopulation analysis using mtDNA data yielded contrasting results to those 
observed for male lineages. Mitochondrial DNA data indicate that the Lithuanian and 
Spanish Roma are by far the most restricted groups with diversity indices that are much 
lower than have been reported for other European populations. Whilst the two Balkan 
Romani populations show the greatest diversity, values for Vlach populations are of 
similar magnitude. Therefore, these data indicate a stricter adherence to female-specific 
endogamy in the Spanish and Lithuanian Roma than is observed in Balkan and Vlach 
groups. 
· Comparison of mtDNA diversity within the Roma to that of other populations 
points to their genetic heterogeneity. This is consistent with the Roma being composed 
of genetically differentiated population isolates. Diverse mtDNA due to admixture 
results in high pairwise differences between sequences (Amason, Sigurgislason, & 
Benedikz, 2000), and this is the probable explanation for the high value determined for 
the Roma. 
5.4 Summary of Findings 
The investigation of maternal and paternal lineages in the Roma has identified 
predominant founding lineages of Indian origins. This supports claims of an Indian 
origin of different Romani populations. The homogeneity of these lineages suggests that 
the Roma are predominantly descended from a single ethnic population in India. 
Additional possible founding female lineages suggest that there may have been greater 
female diversity amongst the founder population. These findings disprove claims that 
the Roma comprise an indigenous European population (Okely, 1983). Furthermore, 
they contradict claims that the Roma were comprised of a conglomerate of different 
ethnic groups (Hancock, 1999b; Marushiakova & Popov, 1997). The data support a 
138 
scenario in which a limited number of related emigrants left India and made their way to 
:-· Europe as a cohesive group. This implies that the population would have had a common 
~ reason and purpose for exiting India. However, these data cannot confirm nor disprove 
Hancocks (1999b, 2000) claim that the proto-Roma comprised a military force. 
~Linguistic evidence points to extended sojourns in Persia and the Middle East (Fraser, 
1992) and the genetic evidence collated in the present study provides evidence of 
possible Middle Eastern contributions to the Roma. Within Europe, the Roma have 
fractured into numerous diverse groups. The resultant social and cultural diversity is 
reflected in genetic diversity. Therefore, whilst Romani groups are related through a 
common ancestral population, they haye become genetically differentiated through the 
stochastic process of genetic drift and differing degrees and sources of admixture. The 
establishment of each new population has represented a restrictive population 
bottleneck. The number of founders in each newly formed population would also 
impact on the current genetic profile of the population. Population bottlenecks 
combined with continued adherence to endogamous practices have resulted in 
populations with restricted genetic diversities. Thus, the Roma are best described as a 
mosaic of genetically related population isolates. 
Genetic structuring in the male component of the population is related to the 
major migrations of the Roma into the Balkans, to Western Europe and out ofWallachia 
and Moldavia. However, this structuring does not appear to be the case for females. 
Social practices such as endogamy have likely shaped this structuring, and it is possible 
that some Romani populations may be more relaxed in letting unrelated females into 
their communities than males resulting in a less apparent female-specific genetic 
structure. 
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Section II 
POSITIONAL CLONING OF THE HMSNL GENE 
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CHAPTER6 
SUBJECTS AND METHODS 
6.1 Study Design and Subjects 
6.1.1 Summary of Previous Findings 
In the study by Kalaydjieva et al., (1996), a genome scan for segment sharing in 
an extended pedigree was used to localise the HMSNL gene to chromosome 8q24. All 
available polymorphic markers in the region were analysed for linkage in families from 
three Romani populations and recombination mapping reduced the critical interval to 
3cM on 8q24.3. The disease locus was defined by a conserved haplotype constructed 
from four polymorphic loci: D8S558-D8S378-D8S529-D8S256. The two internal 
markers were homozygous in all patients, and the two markers bracketing the haplotype 
showed evidence of recombinations. 
Refined genetic mapping was embarked upon by researchers at the Centre for 
Human Genetics, Edith Cowan University and the Medical School of the University of 
Sofia, Bulgaria. This was achieved by the identification of the publicly available marker 
AFM116yh8 and four novel markers; SLAP(CA)n, pJ19, pJlO and 474(CA1). 
Subsequent to the initial description of HMSNL, a number of additional Romani patients 
were identified in Bulgaria and throughout Europe. Genotyping of chromosome 8q24 
markers confirmed the identical disease haplotype in these affected individuals thus 
expanding the sample size of the study. Two positional candidate genes, sialyl 
transferase 4A (SIAT4A) and src-like adaptor (SLA), were identified. SIAT4A was 
excluded by a recombination. SLA was sequenced in affected individuals and found not 
to contain any disease-causing mutations. 
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6.1.2 Research Questions 
Kalaydjieva et al., (1996) noted the homogeneity of disease haplotypes in 
different Romani populations and postulated that HMSNL was caused by a founder 
mutation on 8q24.3. Genotyping of additional markers in the HMSNL region confirmed 
allelic homogeneity. Therefore, the search for the HMSNL gene proceeded under the 
hypothesis of a single founder mutation. This study aimed at positionally cloning the 
HMSNL gene and identifying the genetic defect in HMSNL affected individuals. To 
this end a number of research aims were developed as follows: 
1. To assemble a map of contiguous genomic clones in the HMSNL region. 
2. To determine: · 
a. which known ESTs, STSs and polymorphic loci are found in the HMSNL region. 
b. which genes are contained within the HMSNL critical region and what their 
genomic structure is as determined by complete sequencing of the genomic 
region. 
3. To perform fine-scale genetic mapping, through the use of newly identified 
polymorphic STRs and the identification of recent and historical recombinations in 
divergent Romani groups to reduce the candidate region for the HMSNL gene. 
4. To identify the disease gene and primary genetic mutation that results in the HMSNL 
phenotype 
. 5. To determine, for the purposes of future research, how the common origin and 
subsequent divergence of Romani groups impacts on the approach to refined genetic 
mapping. 
6.1.3 HMSNL Affected Individuals and Families Involved in the Study 
Refined genetic mapping was performed in 60 HMSNL affected individuals and 
114 unaffected family members from 23 families. All patients were diagnosed as having 
HMSNL, based on the clinical presentation described in Kalaydjieva et al., ( 1996, 1998). 
Bulgarian Roma came from one of three groups: the Lorn, Kalderash and Monteni. In 
addition, individuals and families were recruited through international collaboration. 
These included families from Spain (Colomer et al., 2000), Slovenia (Butinar et al., 
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1999), Italy (Merlini et al., 1998), Germany (Baethmann, Gohlich-Ratmann, Schroder, 
Kalaydjieva, & Voit, 1998), France and Rumania (Kalaydjieva et al., 2000). All 
families were of declared Romani ethnicity except for the family with an affected child 
identified in Germany. The non-consanguineous parents of this individual were of 
Bulgarian nationality, but not of declared Romani ancestry (Baethmann et al., 1998). 
Haplotype analysis confirmed that this individual was homozygous for the same disease 
allele found in the Roma. 
6.2 Methods 
6.2.1 DNA Sample Preparation 
DNA samples were extracted from blood samples collected on 3MM Whatman 
filter paper (Whatman) as described in section 3.2.1. Eluted DNA was quantified using 
spectrophotometry as described in section 3 .2.2. Stock DNA was diluted to a working 
concentration of lOng/IJ.L with dH20. 
6.2.2 Physical Characterisation of the HMSNL Region 
Physical characterisation of the HMSNL region entailed the construction of a 
map of contiguous genomic clones and STS content mapping. 
6.2.2.1 BAC library screening and BAC DNA isolation 
For the purposes of constructing a map of contiguous genomic clones spanning 
the HMSNL region, the CITB Human Bacterial Artificial Chromosome DNA Pools 
Release IV library (ResGen) was screened. Library screening involved three rounds 
using a PCR assay to probe for genomic clones. In the first round the superpools were 
screened. The results of this initial phase dictated which plate pool and row/column 
pools were screened in subsequent rounds. Probing of the genomic library in this 
manner led to a unique address, corresponding to a unique BAC clone. BAC clones 
were ordered from the commercial supplier (ResGen). The bacteria were grown for 12-
14 hours at 37°C in 100ml ofLB broth containing 251J.g/mL ofthe antibiotic kanamycin. 
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BAC DNA was isolated using the QIAfilter Plasmid Midi kit (Qiagen). For the 
purposes of subsequent experiments, the stock BAC DNA was diluted 1 000-fold. 
6.2.2.2 Chromosome walking 
Coverage of the HMSNL region with genomic clones was achieved using 
chromosome walking. For this purpose, the ends of BAC genomic inserts were 
sequenced. These newly generated STSs were used as probes for subsequent rounds of 
library screening. The genomic insert ends of the BAC clone were sequenced as 
follows: 
Four mg of purified BAC DNA was sequenced in two separate reactions using 
T7 and SP6 universal primers. These primers are complementary to the vector sequence 
at either ends of the genomic insert. Sequencing was performed using Dye Terminator 
Cycle Sequencing Ready Reaction Kits (Applied Biosystems). The thermocycling 
. program for sequencing reactions was 30 cycles of 1 min at 94°C, 1 min at 60°C and 4 
mins at 72°C. Sequencing products were precipitated and purified as described in 
section 3.4.3.3. Sequenced samples were prepared and run on the 373A DNA Analyser 
(Applied Biosystems) as described in section 3.4.3.4 and edited using Sequence 
Navigator software 1.0.1 (Applied Biosystems). 
PCR primers were designed from the two BAC insert end sequences. A PCR 
assay was used to map the end of the new BAC in the parental clone. The unmapped 
BAC insert end was used for the subsequent round ofBAC library screening. Table 7-1 
provides a list ofBAC insert end primers and PCR protocols generated during the study. 
6.2.2.3 STS content mapping 
All STSs including anonymous STSs, ESTs, microsatellite loci, and genes were 
screened in the contiguous map of genomic clones using standard PCR assays (table 6-
1 ). PCR reactions were performed in 2400 and 9600 GeneAmp PCR Systems (Applied 
Biosystems) using protocols optimised for MgCh concentration and annealing 
temperatures. Details of the PCR primers and reaction conditions are provided m 
chapter 7: tables 7-1 (STSs generated fromBAC ends) and 7-2 (microsatellite loci). 
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- Table 6-1 
Standard PCR mixture for STS mapping 
Reagent 
lOx PCR Buffer 
2.5mMdNTPs 
MgCh 
Primer A 
Primer B 
Taql DNA polymerase 
dH20 
BACDNA 
Volume 
11'-'L 
lJ~L 
0.4/0.6/0.8/1.0_p-L 
1p..L 
lp..L 
0.05 L 
4.55/4.35/4.15/3.95/J'L 
1!!!.L 
6.2.3 Refined Genetic Mapping of the HMSNL Locus 
6.2.3.1 Identification of novel microsatellite DNA in the HMSNL critical 
region 
Identification of novel microsatellite DNA was achieved by screening genomic 
clones for simple repetitive DNA. BAC DNA was subcloned to create a sublibrary. The 
sublibrary was probed with labelled repetitive oligonucleotides and positive clones were 
sequenced. 
6.2.3.1.1 Subcloning of BAC DNA 
BAC DNA was randomly digested using the restriction endonuclease, Sau3Al 
(New England Biolabs Inc.), at 37°C for 1 hour in a 1.5 mL Eppendorftube (table 6-2). 
Sau3Al digests genomic DNA to fragment sizes averaging 300bp. 
Table 6-2 
Sau3AJ restriction digest reaction mixture 
Reagent Volume 
BAC DNA 2.0j.tL 
1 Ox reaction buffer 1. 5j.tL 
DTT (5mM) 1.5j.tL 
BSA (lmg/mL) l.Sj.tL 
Sau3A1 l.Oj.tL 
dH20 7.5j.tL 
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Digest products were purified using a silica/PBS/3M Nai "glass milk" matrix as 
follows: 
To the digest mixture was added 8!J.L of glass milk and 60!J.L of Nal. The 
mixture was vortexed and left at room temperature for 10 mins with intermittent 
agitation. The mixture was centrifuged at 13,000 rpm for 1 min and the supernatant 
discarded. The pellet was resuspended in 300!J.L of New Wash (Invitrogen) by 
vortexing, and. centrifuged for 1 minute and the supernatant discarded. This washing 
process was repeated an additional two times. All traces of New Wash were removed 
following the final wash. To elute the DNA, the pellet was resuspended in 8!J.L of dH20 
and incubated at 55°C for 5 mins. The mixture was centrifuged at 13,000 rpm for 2 
mins and the eluate transferred to a dean 1. SmL Eppendorf tube. 
The phagemid, pBluescript II (KS) [Stratagene] was digested with the restriction 
endonuclease, BamH1 (New England Biolabs Inc.) at 37°C for 1 hour to create a 
complementary cloning site (table 6-3). The vector, pBluescript II (KS) contains the 
ampr gene, which confers resistance to ampicillin, allowing the use of this antibiotic as a 
selection agent. It also contains the lacZ component of ~galactosidase, which is 
interrupted by successful cloning, resulting in the absence of {3-galactosidase activity. 
Table 6-3 
BamH 1 restriction digest reaction mixture 
Reagent Volume 
pBluescript DNA 2.0!-J.L 
lOx reaction buffer l.Sf.l.L 
BamHl 1.0!-J.L 
dH20 10.5tt:L 
Ligation of BAC DNA fragments into pBluescript was performed using the 
Rapid DNA Ligation Kit (Roche). T4 DNA ligase catalyses the formation of 
phosphodiester bonds between neighbouring 3'-hydroxyl and 5'-phosphate ends of 
double stranded DNA The ligation reaction mixture was prepared (table 6-4) and 
incubated at room temperature for four hours. 
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Table 6-4 
Ligation reaction mixture 
Reagent 
Sau3Al digested BAC DNA 
BamHI digested pBluescript 
5x DNA dilution buffer 
dH20 
2x T4 DNA ligation buffer 
T4 DNA Ligase 
Volume 
4JlL 
2JlL 
2j.LL 
2JlL 
lOJ.lL 
lp.L 
Library Efficiency DH5a Competent Cells (Gibco BRL) were transformed with 
the ligated products, For this procedure, 5J..l.L of ligated products were added to 500l!L 
of DH5a cells and the mixture was gently agitated. The bacteria were heat shocked at 
42°C for 45 s and then rescued with the addition of 100l!L of LB broth followed by 
incubation at 3 7°C for 1 hour. The entire volume of bacteria was then plated on to 
MacConkey agar (Gibco BRL) plates containing lmg/mL of ampicillin as a selecting 
agent. Transformed bacteria were cultured overnight at 37°C. 
Positively transformed bacteria were identifiable as white in colour, as these 
bacteria were unable to ferment lactose due to the inactivation of {3-galactosidase 
activity. Bacteria that did were not successfully transformed were red. Approximately 
150 individual positive clones were picked and replica-plated on to a gridded Hybond 
nitrocellulose membrane (Amersham) and an agar plate. Bacteria on the two replica 
plates were grown overnight at 37°C. 
After incubation; the agar plate containing gridded subclones was stored at 4 °C. 
The gridded nitrocellulose membrane was denatured with a 1.5M NaCl/0.5M NaOH 
solution and neutralised with a 1.5M NaCl/O.SM Tris solution. The membrane was 
washed with 2x SSC and the DNA fixed to the membrane by heating at 80°C for 2 
hours. 
6.2.3.1.2 Probing gridded membranes for repetitive DNA 
Nitrocellulose membranes containing the gridded library were screened with di-, 
tri-, and tetra-nucleotide repeat probes labelled with e2P]y-ATP. To label repeat 
oligonucleotides, a reaction mixture containing T4 polynucleotide kinase (PNK) 
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[Promega] was prepared (table 6-5) and allowed to react at 37°C for 20 minutes. The 
reaction was stopped by the addition of2~L of0.5M EDT A. To remove unincorporated 
e2P]y-ATP, the reagents were run through a S-300 MicroSpin Column (Pharmacia 
Biotech). 
Table 6-5 
Reaction mixture for labelling repeat olig_onucleotides with t 2PJr·ATP 
Reagent Volume· 
Buffer 2!lL 
lOOmMDTI 2J.1L 
Oligonucleotides (lOpmol/JlL) 4JlL 
32Py-ATP 5J.1L 
dH20 5J.1L 
T4PNK 2~ 
Labelled repeat oligonucleotide probes were added to 20mL of 12x SSC and the 
mixture was added to the library membranes for overnight hybridisation at 45°C. The 
following day the membranes were washed with 12x sse at 50°C and then with 
progressively decreasing concentrations of SSC at increasing temperatures. This process 
was completed with a final wash of lx SSC at 60°C. The membrane was then exposed 
to Cronex 4 autoradiographic film (Kodak Eastman) for four hours at -80°C. The film 
was developed in a Curix 60 X-ray film developer (AGF A). Positive clones were 
identified by an increased radioactive signal, compared to that caused by background 
hybridisation. 
6.2.3.1.3 Sequencing of positive subclones 
The corresponding positive clones on the agar replica plate were picked and 
grown overnight at 37°C in 2 mL of LB containing lmg/mL of ampicillin. Plasmid 
DNA was extracted using the QIAQuick Miniprep kit (Qiagen) as per the manufacturer's 
instructions. Plasmid inserts were sequenced in both directions using the universal PCR 
primers, T3 and T7, with Dye Terminator Ready Reaction Cycle Sequencing kits 
(Applied Biosystems). Thermocycling sequencing reactions entailed 30 cycles of 30 s at 
94°C, 30 s at 50°C and 1 min at 72°C. Sequencing products were precipitated and 
purified as described in section 3.4.3.3. Samples were prepared and electrophoresed on 
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the 373A DNA Analyser (Applied Biosystems) as described in section 3.4.3.4, and 
edited using Sequence Navigator software (Applied.Biosystems). Repetitive sequences 
were identified and PCR primers designed for the amplification of micro satellites. 
6.2.3.2 Genotype analysis of microsatellites in the HMSNL region 
6. 2. 3. 2.1 PCR amplification of microsatellites with inclusion of ( 2 P]a-CTPs 
A standard PCR mixture was used to incorporate e2P]a-CTP into the amplified 
DNA fragments (table 6-6). Table 7-2 provides a list of the PCR primers and protocols 
for the newly identified microsatellites. Microsatellite loci were amplified in affected 
individuals and family members. 
Table 6-6 
Standard PCR mixture for incorporation of f 2 P] a-CTP 
into amplified microsatellite fragments 
Reagent Volwne 
Buff~ 1~ 
dNTPs (2J.l.M) 1~ 
MgCh 1~ 
Primer A 1~ 
PrimerB 1~ 
Taq1 polymerase 0.05~ 
dH20 3.75~ 
DNA 1~ 
32Pcx.-dCTP 0.2e;L 
6. 2. 3. 2. 2 Analysis of microsatellite alleles 
e2P]a-CTP labelled PCR products were electrophoresed on 6% polyacrylamide 
gels using a Pokerface II apparatus (Hoeffer). Gels were prepared using 1 OOmL of 6% 
acrylamide made from a stock solution of 40% 19: 1 bisacrylamide/acrylamide. 
Polymerisation occurred through the addition of SO!J.L of TEMED and SOO!J.L of 10% 
ammonium persulphate. Wells were formed using a plastic shark toothcomb. To 
prepare samples, 2!-ll of formamide loading buffer (98% formamide, lOmM NaOH, 
0.1% bromophenol blue and 0.1% xylene cyanol) was added to labelled PCR products, 
the DNA fragment denatured by heating at 95°C for 5 minutes, and then placed on ice. 
A 21J.L aliquot of the sample was loaded on to the gel and electrophoresed for 2.5 hours 
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at 1400V. The gels were fixed using a 10% methanol/! 0% acetic acid solution and dried 
in a Savant gel dryer. Dried gels were exposed to Cronex 4 film (Eastman Kodak) for 
12 hours at -80°C and developed using a Curix 60 X-ray film developer (AGF A). 
Allele calling was performed manually, assigning the number 1 to the largest 
observed allele. Control samples were used for each microsatellite on each gel to ensure 
compatibility of allele calling between gels. 
6.2.3.3 Haplotype analysis and fine-structure mapping of the HMSNL locus 
The physical order of microsatellite markers was determined through STS 
content mapping. Haplotypes were constructed manually using genotypic information 
from affected offspring and both parents (where available) to resolve the phase of 
alleles. Haplotypes were examined for possible parental and historical recombinations. 
6.2.4 Genomic Sequence Analysis of the HMSNL Region 
A minimal tiling path ofBAC clones spanning the HMSNL region was selected. 
These clones were forwarded to the Institute of Molecular Biotechnology in Jena, 
Germany where large-scale genomic sequencing was performed as part of the Human 
Genome Project. Genomic sequence information was submitted by Dr Karen 
Blechschmidt to the public database and is accessible through the accession numbers 
indicated in table 7-5. 
6.2.5 Candidate Gene Analysis 
The genomic structures of two positional candidate genes were determined 
through the comparison of genome sequence with the published eDNA sequence of 
Wnt 1-inducible signalling protein 1 [WISP 1] (Pennica et al., 1998) and N-myc down-
regulated gene 1 [NDRGI] (Kokame, Kato, & Miyata, 1996). This was performed using 
the homology search functions of BLAST v1.4 (Altschul et al., 1997) housed at the 
National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST/). 
Genomic structures of WISP 1 and NDRG 1 can be accessed through the Locus Link 
(http://www.ncbi.nlm.nih.gov/LocusLink/index.html) IDs provided in table 7-6. 
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6.2.5.1 Sequence analysis of WISPJ 
The five exons of WISP 1 were amplified in separate reactions (table 6-7) using 
standard 1 O!lL PCR (table 6-1 ). All coding regions and at least SObp of intronic 
sequence on each side of the exon were analysed for sequence variants. 
Table 6-7 
PCR primers and protocols for WISP I 
Primer sequence 
Exon 1-F CAT ATC TGG TGC TCC TGA TGG 
-R GTA GCA GGA CCC AGT AGAGAA G 
Exon 2-F GAC AGG AAT GCA ATG GCA G 
-R GGT GTA TCT CCT GCT GAA C 
Exon 3-F GCA TGG TCC ACA TGG AGC C 
-R GGT GGT CAG AGT TCC AGG 
Exon 4-F GTG TGG TGA AAG TGA GGG TTG 
-R GCT TGT GAA GTC TAG ACA TCC 
Exon 5-F GTA AGG TGG AAT GCT CCC AC 
-R CAG ATC AGG GTA ACT AAG GC 
Protocol 
63-55°C (A-0.5°C/cycle) 
20 cycles @ 55°C 
2.0mMMgCb 
63-55°C (A-0.5°C/cycle) 
20 cycles @ 55°C 
l.OmMMgCh 
35 cycles @ 55°C 
l.OmMMgClz 
35 cycles@ 55°C 
1.5mMMgC1z 
63-55°C (A-0.5°C/cycle) 
20 cycles@ 55°C 
2.5mMMgCh 
Size ofPCR 
fragment 
288bp 
488bp 
424bp 
304bp 
516bp 
PCR fragments were cleaned with the QIAQuick PCR Purification Kit (Qiagen). 
Sequencing of PCR products was performed with the same PCR primers using the Dye 
Terminator Ready Reaction Cycle Sequencing kit (Applied Biosystems). 
Thermocycling sequencing reactions entailed 30 cycles of 30 sat 94°C, 30 sat 50°C and 
1 min at 72°C. Sequencing products were precipitated and purified as described in 
section 3.4.3.3. Samples were prepared and electrophoresed on the 373A DNA 
Analyser (Applied Biosystems) as described in section 3.4.3.4 and edited using 
Sequence Navigator 1.0.1 software (Applied Biosystems). 
6.2.5.2 Sequence analysis of NDRGl 
The 16 exons of NDRGJ were amplified in separate reactions (table 6-8) using 
standard 1 O!lL PCR (table 6-1 ). All coding regions and at least SObp of intronic 
sequence on each side of the exon were included in the search for sequence variants. 
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Table 6-8 
PCR p_rimers and protocols for NDRG 1 
PCRPrimer Protocol Size ofPCR 
fragment 
Exon 1-F GAC TGC GAG GGT GTG GGA G 63-58°C (A-0.5°C/cycle) 313bp 
-R CTI ACT CCT GGA GTA CGC 20 cycles @ 58°C 
lmMMgCh 
Exon 2-F CTI C1T GCC ATT GGT CTI G 35 cycles@ 55°C 282bp 
-R GCATGC CCA TAA GTA CAA G 1.5mMMgCh 
Exon 3-F GAT TCA GGT CAT AGA AAG G 35 cycles @ 55°C 172bp 
-R AGAGAA GAC GGG ATG AGG lmMMgCb 
Exon 4-F CAC GCG GAT GCC ATG AAC 63-58°C (A-0.5°C/cycle) 33lbp 
-R GCA TIT CTG GCT TIT CCA G 20 cycles @ 58°C 
3mMMgC}z 
Exon 5-F CTI TGA CAC CGA GAC ACC 63-58°C (A-0.5°C/cycle) 268bp 
-R GAG CAA AGC ACC TGA ACC 20 cycles@ 58°C 
lmMMgCb 
Exon 6-F CT A ATG GCT TCT CTG TGT C 63-58°C (A-0.5°C/cycle) 178bp 
-R GTC AGT CCA GAT CAA AGC 20 cycles @ 58°C 
lmMMgCl2 
Exon 7-F AGG CTC CCG TCA CTC TG 35 cycles @ 55°C 176bp 
-R GTC TIC CTI CAT CTI AAA ATG 2mMMgCb 
Exon 8-F CCT AGT GTI TCA GAT TGC TG 63-58°C (A-0.5°C/cycle) 238bp 
-R GAG AGC TCGTAG TCT CAG 20 cycles @ 58°C 
lmMMgCl2 
Exon 9-F GGA GTC CAG CAA TGC CAC 63-58°C (A-0.5°Cicycle) 224bp 
-R CTG AGC ACC ACACAA TGC 20 cycles @ 58°C 
2mMMgCh 
ExonlO-F GAG TAG TGA CCA GCT CAG 35 cycles@ 55°C 287bp 
-R CAA ACT CAG AGC CTG CCT C lmMMgCh 
Exonll-F ACA GGG CCT CTC TCA AGT TG 35 cycles @ 55°C 346bp 
-R CTG GGT AAT GCT CAG TCT C lmMMgCh 
Exon12-F CAG GCC TGG GAG TGG GAC AAT C 35 cycles @ 55°C 20lbp 
-R GCA GGC AGG GCC ACT TCA AC 2mMMgCh 
Exon13-F CAA GCC ACA TCT GCT GAA TCC 35 cycles @ 55°C 390bp 
-R CTT TGC AGC CTC AGA TCA CC lmMMgCh 
Exon14-F GAC ACC AGC AGC CTT GCC TG 35 cycles @ 55°C 389bp 
-R CCT AGG GAA TCAGAG TCC TC lmMMgCb 
Exon15-F GGA AAC TGG CTC AGA CAG G 63-58°C (A-0.5°C/cycle) 432bp 
-R CAT GCC CTC CAC ACA CCT AAC 20 cycles @ 58°C 
2mMMgCh 
Exonl6-F GTG GAC ATG GAG AGG ACG 63-58°C (A-0.5°C/cycle) 576bp 
-R GTC TCC ACC AGA GCT CAC TC 20 cycles @ 58°C 
lmMMgCh 
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PCR fragments were cleaned with the QIAQuick PCR Purification Kit (Qiagen). 
Sequencing of PCR products was performed with the same PCR primers using the Dye 
Terminator Ready Reaction Cycle Sequencing kits (Applied Biosystems). 
Thermocycling reactions entailed 30 cycles of 30 s at 94 °C, 30 s at 50°C and 1 min at 
72°C. Sequencing products were precipitated and purified as described in section 
3.4.3.3. Samples were prepared and electrophoresed on the 373A DNA Analyser 
(Applied Biosystems) as described in section 3.4.3.4 and edited using Sequence 
Navigator 1.0.1 software (Applied Biosystems ). 
6.2.6 Analysis of the Rl48X Mutation Using Taql Restriction Endonuclease 
For the purposes of the restriction digest assay, exon 7 of NDRGJ was amplified 
using the primers and protocol described in table 6-8. A restriction digest reaction was 
performed on PCR products using the restriction endonuclease, Taql (New England 
Biolabs) for 4 hrs at 65jC (table 6-9). 
Table 6-9 
Taql digest of exon 7 of NDRGJ for R148X mutation assay 
Reagent Volume 
PCR product 7.0!lL 
lOx Reaction Buffer l.O!lL 
Taql O.l!lL 
BSA O.l!lL 
dH20 6.8!lL 
Restriction products were electrophoresed for 30 mins at 80V on a 4% agarose 
gel (3:1 standard agarose: metaphor agarose [BioWhittaker Molecular Applications]) 
stained with ethidium bromide. Separated DNA fragments were visualised with UV 
light on a transilluminator. The undigested PCR product was 176bp long and the digest 
products were 1 04bp and 72bp long. 
The PCR assay was redesigned to in order avoid a primer annealing site 
mutation. The new primers designed for amplifying ex on 7 were F-
AACTGTGGAGAA TACGGG and R·CTGTGCAGGCAGTTACGGCAGC and yielded 
a PCR product of 316bp. A lOJ.LL PCR (table 6-1) was most efficient with the use of 
HotStarTaq (Qiagen) requiring an initial denaturation and enzyme activation of 15 mins 
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at 96°C followed by 35 cycles of 30 s at 96°C followed by 30 s 55°C and extension at 
72°C for 45 s. A MgCh concentration of lmM (i.e. 0.8l1L of 25mM MgCh in a lO!J.L 
reaction) was used. The Taql restriction endonuclease assay was performed as 
described above (table 6-9) which produced digest products of 190bp and 126bp. 
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CHAPTER 7 
RESULTS 
7.1 Physical Mapping of the HMSNL Region 
7.1.1 A Map of Contiguous Genomic Clones Spanning the HMSNL Region 
The initial round of BAC library screening was performed using microsatellite 
loci that defined the core disease haplotype (Kalaydjieva et al., 1996). This included 
D8S378, D8S529, D8S256 and AFM116yh8. Chromosome walking proceeded by 
screening the BAC library in a redundant manner ensuring dense coverage of the region. 
A total of thirty-two genomic clones were identified as mapping to the region. This 
included thirty BAC clones and two PAC clones. Screening of the BAC library failed to 
identify any clones covering the region from 326J4 to 458A3. The PAC clone, 
709A24988Q2 (PAC 709), was found to extend beyond BAC 458A3. However, a gap 
remained between BAC 326J4 and PAC 709. A genomic clone that spans this gap was 
later identified through searches of genome sequence databases (218N23). Thus, a 
highly redundant map of contiguous clones, providing complete coverage of the 
HMSNL genomic region, was constructed (figure 7-1). The physical distance spanned 
by this contig was estimated to be 1Mb. 
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Figure 7-1 Map of contiguous genomic clones providing coverage of the HMSNL critical region. Blue clones represent a 
minimal tiling path, which was sequenced by the Centre for Molecular Biotechnology, Jena. Corresponding clone names are 
provided in the left column. STSs which were physically mapped to the contig are indicated. Publicly available microsatellite DNA 
are indicated in light green. Novel microsatellite DNA, identified in this study, are in dark green. Novel anonymous STSs derived 
from BAC insert ends are coloured aqua. ESTs mapped in the region are in yellow. 
7.1.2 STS Content Mapping in the HMSNL Region 
Anonymous STSs were derived from sequencing the ends of BAC inserts. 
Polymorphic markers mapped in the region included those available in public databases 
and novel microsatellites identified during the course of the study. Expression sequence 
tags (ESTs) and known genes that had been tentatively localised to chromosome 8q24 
were also screened in the contig. All STSs were systematically screened against the 
contig to aid ordering of genomic clones relative to each other (figure 7-1). In addition, 
the mapping of known and newly identified polymorphic markers facilitated refined 
genetic mapping by determining marker order for haplotype analysis. The identification 
of genes and/or ESTs mapping to the HMSNL region identified positional candidate 
genes. 
7.1.2.1 STSs localised in the map of contiguous genomic clones 
Thirty-five novel anonymous STSs generated from the sequencing ofBAC insert 
ends were used to position and order genomic clones. One of these, 543J1-SP6, 
contained a (CA)n repeat that was determined to be polymorphic and used in refined 
genetic mapping. PCRprotocols were developed for each ofthese STSs (table 7-1). 
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Table 7-1 
Primer sequences and protocols for novel STSs in the HMSNL contig map 
STS PCR primer sequence PCR protocol Product size 
132023-T? F- ctt cca aattcc ate ttg 35 cycles @ 55 13lbp 
R- tat tgg aaa gtg gtc agg 1.5mmMgCh 
210B22-SP6 F- atg ctt tga gca ctg tgg 35 cycles @ 55. 145bp 
R- egt agt tee cca tac aag 1.5mmMgCh 
132023-SP6 F- aag cca cca agg etc ag 35 cycles @ 55 119bp 
R- aag ctg gtg gac ttg gtg 1.5mmMgCh 
339K22-T7 F- atg age ttc tgg gtg tac 35 cycles @ 55 95bp 
R- tag aga gtc gaa cac cag 1.5mmMgCh 
215J20-SP6 F- tel cat gta aeg tee ttg 35@ 50' 183bp 
R- cca gac ttg aaa ttg ace 1.5mMMgCh 
247Pl4-T7 F- tta tac tea tat tct gta tg 35@ 50 204bp 
R- aga ggc atg age cac ag 1.5mM MgCI2 
423Fl4-SP6 F- get caa get cca cat ggc ac 35 @50 128bp 
R- gtg ate ate ccc tgt tee tee 1.5mMMgCh 
543Jl-SP6 F- gtc tta ctg ctg tat etc c 35@55 12lbp 
R- cca caa tac gaa tgt atg 1.5mM MgCh 
709H18-SP6 F- gtc cca gee tct ate tee tg 35@5: 130bp 
R- gag gtg gaa tit ccc ata gc 1.5mMMgCh 
522Hl9-SP6 F- cct tga tga tgc cag gtg ac 35 cycles @ 55 168bp 
R- gag gat taa aca gga gga tgc lmMMgCh 
215Cl2-SP6 F- gga tea cag tct agt ccc agg 35 cycles @ 55 235bp 
R- get gtg ggg gag aca get g 1.5mM MgCh 
PAC99-T7 F- gca gca caa gca gat cat ttt gc 35 cycles @ 55 90bp 
R- cac ccc tic ccc aac ace tc tmMMgCh 
423Fl4-T7 F- cac aac ate cac tga ttc tc 35@ 55 155bp 
R- gga tgt gca gga tat taa gg lmMMgCh 
709Hl8-T7 F- eta tgc aag aca atg ggt 35 @55 126bp 
R- gaa aac tga ata taa tit gg lmMMgCh 
137K3-T7 F- get gat aca aaa tat aeg ttg tg 35 cycles @ 55 138bp 
R- gga tgt act atg aga ate caa cg 1.5mMMgCh 
278013-SP6 F- gat ega tgc tgg teg aeg aat cc 35 cycles @ 55· · 158bp 
R- tat act gca tgg att att gtt geg 2.5mMMgCh 
PAC99-SP6 F- gag ctg act aac act att agg 35@ 55' 155bp 
R- etc aac age att tgg tat gaa cag lmMMgCh 
326J4-T7 F- gca tgc att Ita ggg caa tgg 35@58 280bp 
R- etc att aca tag gee aag ttc ac 1.5mMMgCh 
PAC709-SP6 F- caa gtc aca ceg leg ac 35 cycles @ 55 17lbp 
R- glt tgc cca gag ctg ag lmMMgCh 
534Dl-T7 F- ctt eta ate ttg caa ttt cc 35 cycles @ 55. 138bp 
R- cac ala gaa gta gaa tgc lmMMgCh 
247Bl6-SP6 F- cat gee cat aca gat cac 35@ ss· 133bp 
R- gca cag ctg atg act gg 1.5mM MgCh 
218Hl0-SP6 F- ggc ctt gga tga agt cc 35@ 55 : 256bp 
R- gat cca gac aag agg atg lmMMgCh 
17L5-T7 F- ggt etc ccc ggc tee ace 35@ 55' . l45bp 
R- ctg aaa ttl aat cca ggt cca g lmMMgCh 
458A3-SP6 F- cca caa atg tct ttc cac 35@ 50 12lbp 
R- agg atg cag aca cag agg 1.5mMMgCh 
523Kl6-T7 F- etc aca glt tta Itt cct gga c 35@ 5h 183bp 
R- gtc gat gac age cat aac tea c 1.5mMMgCh 
247Bl6-T7 F- eta tga tel eel tac ata tg 35@ 55"- 114bp 
R- caa gca ctt gca tat tta g 1.5mM MgCh 
128L20-SP6 F- ctt ctg tat ate ctt agg c 35@ 551lC 155bp 
R- gat aat tgg cca cca tta c 1.5mMMgCh 
150Hl9-T7 F- gca ttg gag gtg gca ggc tit gc 35@ 6C·•· 153bp 
R- cag gee agt gag ggt tgg tgt c 1.5mM MgCh 
259J15-SP6 F- ggt tga ctg agg ttc aaa tgt 35 cycles @ 50 198bp 
R- ace aga ccc tag gca ggt gca 2mMMgCh 
17L5-SP6 F- cct gac ttg tat aaa cag 35@ 55 148bp 
R- cat gaa ctg aaa ccc cag c lmMMgCh 
150Hl9-SP6 F- gca let cca ttg ctg ggc etc 35 @6G 150bp 
R- ctg gga atg tgt aac ctg tac c f.5mM MgCh 
534Dl-SP6 F- cat aca tgc agg tgc ttl g 35@ 5F .<; 12lbp 
R- ccc ata ggc aac age aac 1.5mMMgCh 
558H17-T7 F- gaa tgg gtc taa ace ttc 35 @Sf 224bp 
R- gee aag tgc cca gca tg 1.5mM MgCh 
259J15-T7 F- gaa tgc tgg gac ctg cct g 35@ 55 178bp 
R- get get agg gee tgg act c 1.5mMMgCh 
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7 .1.2.2 Polymorphic markers localised in the contig 
Physical mapping placed four published microsatellite loci in the contig 
(AFM116yh8, D8S378, D8S529 and D8S256). D8S558 was determined to be 
centromeric of the contig and HMSNL critical regwn. In addition to the four 
microsatellite loci, a published SNP, WIAF86, mapped to the region. Nineteen novel 
polymorphic microsatellites were identified in the course of the HMSNL study. PCR 
protocols were developed for each genetic marker (table 7-2). All microsatellites were 
CA(n) repeats except for pJl9, which is a CTG repeat. Markers were physically mapped 
in the contig, thereby determining their relative order (figure 7-1). 
Table 7-2 
PCRprimers, protocols, and approximate allele sizes ofnovel microsatellite DNA 
Locus name PCR primers PCR protocol Approximate allele size 
339CA2 F- egg ace caa ate aat ttt c 56llC-50llC (A0.5 C/cycle) 122bp 
R- cca ttt aca gtg cag atg 20 cycles@ SO C 
339CA1 
543b76 
543CA1 
423r133 
189CA17 
326CA3 
326CA1 
326CA2 
SLAP (CA) 
pJ19 
pJ10 
458b14 
458a13 
458b57 
369a89 
369CA3 
369CA2 
474CA1 
F- ttg ate tgg gag aat gat g 
R- aca tat aca ctg cca cg 
F- gtg gca gag tga gac act 
R- tat act atg ace att etc tg 
F- gtc tta ctg ctg tat etc c 
R- cca caa tac gaa tct atg 
F- cat tac agg cat ctg cca tg 
R- gtc aac atg gcg aac get g 
F- gaa aag gtc aat atg cca gg 
R- gat tga gtt gtc tat ttg tc 
F- tea tgg gat aaa aca tta gtg aa 
R- gat ttg caa ttt att caa gaa cac 
F- gaa atg ctg gca gaa gtc ttg aaa g 
R- ttg act ccc tgc att tat ace aat ctt 
F- gtg cac caa aat etc aca aat cac 
R- cca att cac cgc aag tea gac act 
F- tgc gtc aga aga ctg tgg ac 
R- tgg cca tgg ttt tea tgt gc 
F- ace aca gee cag tgc ctg att cc 
R-ttt act tgg cac cca ggc ttc tea 
F- agg gtc tta gtc cca aca 
R- aga aag aac tga cca gee 
F- etc tee etc caa agt etc c 
R-aaa gca gag gaa gcg ctg g 
F- aag tat ccc tgt tat tea gc 
R- ctt act tee agg ata aac ac 
F- aga cag tct tct tga ctg g 
R- tgt ace caa gtc cca tee 
F- etc ate tac aca etc gcg cg 
R- ggc ega tga gac ggt cg aaa 
F- gat ata att atg cag ata gg 
R- gtt att tgt ctt ate agt c 
F- etc eta cct get gtc tgc 
R- get gag aag tee atg ate 
F- tea ggc agg ctg gat tea g 
R- age aga gee atg gca cat g 
lmMMgCh 
35 cycles@ 55 C 
lmMMgCh 
35 cycles@ 50ilC 
I.SmMMgCh 
35 cycles @ 50 >C 
1.5mMMgCI2 
35 cycles@ 55 .'C 
lmMMgCh 
35 cycles@ 55 C 
lmMMgCh 
35 cycles@ 55 C 
lmMMgCh 
35 cycles@ 50. C 
1.5mMMgCh 
35 cycles@ 50.C 
I.SmMMgCh 
35 cycles @ 55 .C 
lmMMgCh 
35 cycles @ 55 IC 
lmMMgCh 
35 cycles @ 50 C 
1.5mMMgCh 
35 cycles@ 55 '.C 
lmMMgCh 
56llC-50llC (AO.S 'C/cycle) 
lmMMgCh 
35 cycles @ 55 :C 
lmMMgCh 
35 cycles @ SO C 
1.5mMMgCh 
35 cycles @ 50 'C 
1.5mMMgCh 
35 cycles @ 55 C 
lmMMgCh 
35 cycles@ 55 ~ 
lmMMgCh 
IOObp 
120bp 
lSObp 
120bp 
140bp 
160bp 
190bp 
300bp 
170bp 
l40bp 
170bp 
170bp 
llObp 
120bp 
200bp 
188bp 
199bp 
170bp 
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7.1.2.3 ESTs and known genes identified in the contig 
ESTs and genes that had been assigned to the 8q24 region and were publicly 
available in the databases were considered as potential positional candidate genes. As 
only a gross chromosomal localisation had been determined for many of these genes, a 
rational approach was taken in which plausible functional candidates were preferentially 
selected for screening. This was based on knowledge of function for genes and the 
expression patterns for ESTs. A panel of 11 genes and 15 ESTs putatively mapped to 
the region were screened against all genomic clones. Five ESTs were found in the 
contig (table 7-3). No known genes were mapped to the contig. STS content mapping 
allowed the relative positioning ofthe ESTs in the contig (figure 7-1). 
Table 7-3 
ESTs identified in the HMSNL critical region 
EST Accession number<P Unigene clusterli (#of ESTs) Corresponding Gene 
HSZ78320 Z78320 
SGC32596 H87187 Hs.300598 (4 ESTs) 
SGC32958 T32458 Hs.293696 (99 ESTs) 
L 13972 L 13972 Hs.60617 (25 ESTs) SIAT4A 
Cdaozg03 Z39096 Hs.75789 (509 ESTs} NDRG1 
'Phttp :/ /www .ncbi.nlm.nih.gov/Genbank/ 
s http://www .ncbi.nlm.nih.gov/LocusLink/ 
7.2 Genetic Mapping of the HMSNL Region 
The aim of refined genetic mapping of the HMSNL locus was to utilise historical 
and parental recombinations to narrow the critical region to a genomic segment 
amenable to mutational analysis of positional candidate genes. Accordingly, 
microsatellites were genotyped in affected individuals and parents. The genotyping of 
parents allowed the phase of alleles to be resolved. Dense marker haplotypes were 
constructed using genotypic data from 24 microsatellite loci. This enabled the 
discernment of variant alleles due to microsatellite mutations from those resulting from 
recombinations. Recombination breakpoints were physically mapped using the results 
of STS content mapping. 
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7.2.2 Haplotype Analysis and Fine-structure Mapping of.the HMSNL region 
Disease haplotypes from 60 individuals (i.e. 120 disease haplotypes) were 
constructed (table 7-4). Twenty unique disease haplotypes were observed in affected 
individuals from nine populations. These haplotypes were non-randomly distributed 
amongst populations; with only three found in more than one population. 
Within the disease haplotypes, microsatellite mutations were distinguished by the 
conservation of the common disease haplotype on both sides flanking the locus. A 
conservative _approach was taken to designating the breakpoints of recombinant 
haplotypes. Microsatellite mutations were observed at four of the loci: 339CA2, 
189CA17, D8S378 and 458bl4. Within these, locus D8S378 displays the greatest 
mutability with four different alleles arising due to mutations observed on HMSNL 
haplotypes. 
161 
0\ 
N 
Table 7-4 
HMSNL disease haplotypes constructed using 24 polymorphic microsatellite loci over a 3cM region. Affected individuals were 
from eight Romani populations. Microsatellite mutations are indicated in yellow. Recombinant haplotypes are in orange. The 
conserved minimum region of complete homozygosity is shaded in blue. 
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Thirteen unique recombinant haplotypes were observed. These are the result of 
ten recombination events, with subsequent mutations differentiating recombinant 
haplotypes. A single maternal recombination was observed in a Kalderash individual, 
the breakpoint of which mapped between markers pJlO and 458b14 (haplotype L). The 
other 12 recombinant haplotypes were the result of historical recombinations. Seven 
recombination events were observed on the centromeric side of the haplotypes, with the 
breakpoints of five of these recombinations mapping to the region between marker pJl 0 
and 458bl4 (haplotypes B, L, Q, S & T). Thus, five different recombinations define the 
centromeric boundary of the critical region. Each of these five recombinant haplotypes 
occurs in a different population. On the telomeric side, a minimum of three 
recombinational events is observed (haplotypes F and S show evidence of identical 
recombinations as do haplotypes G, Hand 0). Two historical recombinations extend to 
the region between markers D8S256 and 474CA1 (haplotype 0) and markers 474CA1 
and 369CA2 respectively (haplotype P). A single historical recombination maps to the 
region between markers 369a89 and 369CA3. Thus, the telomeric boundary of the 
HMSNL critical region is defined by a single historical recombination observed in 
individuals from the Kalderash (haplotype F) and Spanish Roma (haplotype S). 
Fine-scale haplotype mapping of the HMSNL region reduced the region of 
homozygosity to one bracketed by pJlO and 369CA3 and encompassing the loci 458bl4, 
458al3, 458b57 and 369a89. Within this haplotype, marker 458b14 displays significant 
heterogeneity with four alleles. However, none of these can confidently be considered 
as resulting from recombination. The conserved haplotype, 112/4/5-3-6-2, constructed 
from the marker order 458b14-458a13-458b57-369a89, was not found in any unaffected 
individuals. 
7.3 Sequence Analysis of the HMSNL Region 
Genomic sequencing of the HMSNL region was performed by the Centre for 
Molecular Biotechnology in Jena, Germany under the auspices of the Human Genome 
Project. 
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7.3.1 Genomic Sequencing of the Entire HMSNL Region 
A tiling path composed of ten genomic clones provides a minimally redundant 
map of contiguous clones spanning the entire HMSNL region (genomic clones in blue in 
figure 7-1). This included eight clones identified through BAC library screening and a 
single PAC clone. These entire clones were sequenced (clones and .Genbank accession 
numbers in table 7-5). With the addition of clone 218N23, identified in searches of 
public databases, complete coverage of the region was obtained. Genomic sequencing 
of the HMSNL region resulted in a total of 1,002,463 nucleotides (:=1Mb) of DNA 
sequence. 
Table 7-5 
Genomic clones sequenced in the HMSNL critical region 
Clone Accession number<ll 
543Jl AF216667 
423F14 AF257497 
215Cl2 AF228727 
137K3 AF230666 
32614 AF230667 
218N23 AF305872 
709 AF235100 
458A3 AF192304 
369M3 AF186190 
259115 AF186191 
<llhttp :/ /www .ncbi.nlm.nih.gov /Genbank/ 
. 7 .3.2 Genomic Structure of Genes in the HMSNL Region 
Sequence analysis of the 1Mb region revealed the genomic structure of five 
genes (table 7-6). The genomic structure of three of these genes had previously been 
reported: TG (Baas, van Ommen, Bikker, Amberg, & de Vijlder, 1986), SIAT4A (Chang, 
Eddy, Shows, & Lau, 1995) and SLA (Meijerink et al., 1998). In addition to the five 
genes, a pseudogene designated progesterone receptor-associated p48 protein, was 
identified in the region. 
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Table 7-6 
Genes contained within the HMSNL region 
Gene Locus ID'~' 
Thyroglobulin (TG) 7038 
Src-like adaptor (SLA) 6503 
N-myc down-regulated gene 1 (NDRG1) 10397 
Wntl-inducible signalling protein 1 (WISP 1) 8840 
Sialyl transferase 4A (SIAT4A) 6482 
'I' Available at http://www.ncbi.nlm.nih.gov/LocusLink 
7 .3.3 Integration of Genomic Sequence with Physical and Genetic Maps 
The critical region was reduced to a 202kb genomic segment flanked by the 
markers pJlO and369CA3. Sequence analysis showed that SLA and most of TG lie 
centromeric ofpJlO. SIAT4A is located telomeric of marker 369CA3. Four exons of TG 
were found in this critical region; however TG, a precursor of thyroid hormones, was 
considered to be an implausible functional candidate. Thus, two complete genes were 
contained within the critical region: NDRG 1 and WISP 1. WISP 1 spans 38kb of genomic 
sequence and comprises 5 exons oriented on the sense strand. NDRG 1 spans 60kb of 
genomic sequence and comprises 16 exons oriented on the antisense strand. 
A fine structure integrated map of the genomic structure of the two genes 
determined by sequencing, and the physical and genetic map of the HMSNL critical 
region was constructed (Figure 7-2). The three markers 369a89, 458b57 and 458al3 
that are homozygous in all affected individuals are contained within the intronic 
sequence of NDRG1 and span a region of 40kb. 
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Figure 7-2 Integrated physical and genetic map of the HMSNL critical region. The genomic structure of WISP 1 and 
NDRGI as determined by large-scale sequencing is shown. A three marker haplotype is homozygous in all 120 disease 
chromosomes. 
7.4 Mutation Analysis of HMSNL Candidate Genes 
A panel of DNA samples from three homozygous affected individuals and three 
unaffected non-carrier family members, as determined by haplotypes, was screened for 
mutations in all exons of WISP 1 and NDRG 1 using direct sequencing. 
7.4.1 Sequence Analysis of WISPJ in Affected Individuals 
The five exons of WISP 1 were sequenced in the panel of six DNA samples. No 
sequence variants were found in th~ patients. An unaffected individual was 
heterozygous for a single C~ T transition in exon five of WISP 1. This SNP would result 
in a predicted silent mutation at codon 307, retaining an asparagine codon at this 
position. 
7.4.2 Sequence Analysis of NDRGJ in Affected Individuals 
The sixteen exons of NDRG 1 were sequenced in the panel of six DNA samples. 
A cytosine to thymine transition was observed at a CpG site in codon 148 contained in 
exon 7 of the three affected individuals. This C~ T mutation results in the replacement 
of an arginine codon with a stop codon in the transcribed messenger RNA and a 
predicted truncated protein product. The Rl48X mutation was observed to be in the 
homozygous state in the DNA of all three affected individuals (figure 7-3). Sequence 
analysis of obligate carriers revealed heterozygosity at this site. The remaining 15 exons 
of NDRG1 did not display any sequence variation in affected individuals. 
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Figure 7-3 Chromatogram showing the C~T transition in DNA sequence in exon 7 
of NDRG I in affected individuals. 
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7.4.3 Segregation Analysis ofthe Rl48X Mutation in HMSNL Families 
Members of all HMSNL families were tested for the putative disease-causing 
mutation. 
7 .4.3.1 Analysis of R148X mutation using Toql restriction endonuclease 
The C-7 T transition results in the abolition of a Taq 1 restriction site. 
Segregation analysis in the HMSNL families was performed using a T aq I digest assay 
(Figure 7-4). The Rl48X mutation was found to be in the homozygous state in all 60 
affected individuals included in the study. Carriers were found to be heterozygous for 
the mutation. Unaffected family members who were predicted to be non-carriers on the 
bas1s ofbaplotype analysis did not have the Rl48X mutation. 
Unaffected Affected Carriers 
Figure 7-4 Agarose gel containing products ofTaql digests ofexon 7 of NDRGJ in 
samples of HMSNL affected, carrier, and noncarrier individuals. 
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7.4.3.2 Identification of a null allele mutation in exon 7 of NDRGJ 
Segregation analysis of the R148X disease-causing mutation revealed an 
anomalous pattern in some unaffected family members. Haplotype analysis had 
identified these individuals as carriers of the disease allele. However, in these 
individuals the PCR fa iled to amplify the wildtype allele. Thus, genotype analysis of 
samples from these individuals suggested that they were homozygous for the disease-
causing mutation. Sequence analysis identified aT -tC SNP within the annealing site of 
the original forward PCR primer (Figure 7-5). Therefore, it is likely that primer 
annealing was compromised by this SNP resulting in the non-disease allele failing to 
amplify during PCR. 
C A A l G N C T T c c 
Figure 7-5 Sequence confitmation of a primer T -tC SNP in the original PCR primer 
used for the Rl48X assay. Both alleles are observed in this sample. 
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Haplotypes from individuals in which the null allele mutation was observed were 
constructed using the genotyping results from six linked polymorphic loci (table 7-7). 
The haplotypes are evidently related, although the most recent common ancestor 
(MRCA) would be ancient as suggested by the variation observed at different loci. 
However, the null allele mutation is in complete linkage disequilibrium with allele 4 of 
the 458al3 locus. This locus is located l.Skb proximal to exon 7 of NDRGJ. Allele 4 is 
the most frequent allele at this locus in normal chromosomes, occurring at a frequency 
of 0.295 in non-disease haplotypes. However, complete linkage disequilibrium with the 
nearby locus and the dispersal of this null allele mutation in seven extended pedigrees 
from four different Romani populations suggests that it is a founder mutation. 
Table 7-7 
HaP.lOf.J!.f!.eS associated with the NDRG I exon 7 null allele mutation 
Family ~110 458b14 458al3 458b57 369a89 369CA3 
Lom2 4 1 4 4 4 1 
Monteni 1 ? 1 4 4 8 2 
Lom3 4 1 4 4 4 1 
Lom4 4 5 4 6 4 ? 
Kalderash 1 4 1 4 2 ? 4 
Italian Roma 1 1 3 4 4 7 ? 
Monteni 2 3 1 4 6 7 3 
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CHAPTERS 
DISCUSSION 
8.1 A Physical Map of the HMSNL Region 
An essential step in positional cloning is characterisation of the chromosomal 
segment to which the disease gene has been mapped. This is achieved through the 
identification of genomic clones that represent the region of interest. The construction 
of a map of contiguous clones covering the region provides a resource can that can then 
be used for the development of a physical map. In addition, these genomic clones can 
be screened to identify novel polymorphic markers and genes. 
A human BAC library was screened to obtain clones mapping to the region of 
8q24 in which the HMSNL disease gene had been localised using genetic linkage 
analysis. BACs were chosen as the cloning system as they contain genomic fragments 
of a reasonable size (an average of 120kb). Although the larger insert size of YACs 
makes them a more efficient mean of covering a genomic region, the high frequency of 
chimerism, rearrangements and deletions preclude their usefulness. On the other hand, 
cosmid clones have small genomic inserts, which makes them a less effective means of 
covering large regions of the genome. Although the genomic inserts of BACs are of a 
significant size, the construction of a contig is a laborious process. The identification of 
each unique BAC clone from the genomic library requires at least 152 individual PCRs. 
Probing of the BAC library was initiated using polymorphic markers that had 
been used to map the gene. Chromosome walking was initiated from clones identified 
using these markers. In the early rounds of assembling genomic clones there are a 
number of uncertainties, including which direction along the chromosome· one is 
walking . In this case, it was not until large-scale sequencing of the region was in 
progress that it became apparent that the centromeric subcontig was incorrectly oriented. 
In retrospect, the judicious use of methods to orient the BAC clones relative to each 
other and to determine physical distances between STSs may have reduced the amount 
of time and labour expended in constructing the BAC contig. Methods that could be 
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used include radiation hybrid mapping and fluorescent in situ hybridisation (FISH), 
however both are of limited use when examining such small regions. 
Library screening identified thirty overlapping BAC genomic clones. These 
clones provided a highly redundant representation of the genomic region. This is an 
inevitable outcome as there is no way of knowing the degree of additional coverage that 
a clone will provide prior to it identification. Fingerprint analyses of clones will allow 
an estimation of the overlap, but does not greatly ameliorate the amount of labour 
involved. Genomic representation in the Human Bacterial Artificial Chromosome DNA 
Pools Release IV library (Research Genetics) was insufficient to provide complete 
coverage of the region. Screening of a f AC library provided one redundant clone and 
one clone that extended into the unrepresented genomic region. This provided almost 
complete coverage of the region; however, the gap in the contig was only closed after 
genomic sequencing by a clone available in the public database 
(http://www.ncbi.nlm.nih.gov/). The difficulty in obtaining a clone representing this 
region suggests that some regions of the human genome may not be as readily cloneable 
as others. 
Redundant clone coverage aids in STS content mapping by generating novel 
STSs from genomic insert ends and allowing the comparative physical mapping in 
clones. This provides a means of determining the physical order of STSs. In this study, 
63 STSs were physically mapped. Of the mapped STSs, 35 were BAC insert ends. 
These sequence fragments were routinely checked for homology with genes and ESTs 
using BLAST (Altschul et al., 1997) searches, but this approach was not fruitful. 
Therefore, the STSs served only to establish the order of clones, thereby aiding in 
physically mapping ESTs, genes and polymorphic loci. In this study, the sequencing of 
the SP6 end of BAC 54311 yielded a CA(n) repeat which was polymorphic and 
subsequently used in genetic mapping. 
Screening genomic clones identified nineteen novel microsatellites. They were 
physically mapped in the contig along with the three known markers; D8S526, D8S256 
and AFM116yh8. The correct physical order of polymorphic markers is essential for 
mapping recombination breakpoints identified through refined genetic mapping. Five 
ESTs were placed on the contig. Two of these were from fully characterised cDNAs: 
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Cda0zg03, which is derived from NDRGJ, and Ll3972, which is derived from SIAT4A. 
The other three ESTs were derived from unknown geries. Physical mapping placed 
L13972 and another of the unknown ESTs telomeric of marker D8S256. This marker 
was shown to be involved in recombination by Kalaydjieva et al., (1996), therefore these 
two ESTs were excluded as positional candidates early in the study. 
Construction of a BAC contig and physical mapping provided almost complete 
coverage of a 1Mb region containing 63 ordered STSs. This contig served as the 
framework in which refined genetic mapping and positional cloning could be pursued. 
8.2 Fine-Scale Recombinant Mapping of the HMSNL Locus 
Fine structure recombination mapping of the HMSNL locus was performed using 
24 microsatellite loci. Initial localisation of the gene reported complete homozygosity in 
affected individuals at loci D8S378 and D8S529 (Kalaydjieva et al., 1996). Flanking 
markers D8S558 and D8S256 showed evidence of historical recombinations and 
therefore defined the boundaries of the critical region, estimated to be 3cM (Kalaydjieva 
et al., 1996). Of the 19 new microsatellites mapped in this interval, 18 were identified 
by probing sub-libraries of genomic clones, whilst one was fortuitously found by 
sequencing a BAC insert end. The construction of disease haplotypes using a dense 
marker map (i.e. 24 markers in a 3cM interval) allowed the discrimination of allelic 
variation at loci as a result of mutation from allelic variation due to recombination. 
Therefore, although 21 of the 24 loci (i.e. 87.5%) displayed more than one allele across 
the disease haplotypes, only 5 loci showed evidence of mutation. To reduce the 
workload, not every microsatellite locus was genotyped in every individual. New 
microsatellites were first tested for polymorphisms and those that had exhibited some 
variation were analysed in recombinant haplotypes. In some cases, it was apparent that 
a locus was bounded by the conserved haplotype and therefore inappropriate for refining 
the region. In these cases, the alleles were inferred based on the most common disease-
associated allele. Unique disease haplotypes were defined by recombination and 
mutation. Thus, it is possible that additional unique disease haplotypes would be 
identified if all possible mutations were observed; however, these are not useful in 
refining the critical region. 
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Fine structure genetic mapping aimed at identifying historical and parental 
recombination in order to reduce the critical region: Therefore, haplotypes were 
constructed for every affected individual regardless of their relationship to other persons 
in the study. From the sample of 120 disease haplotypes, thirteen unique recombinant 
haplotypes were identified. Three of these were only differentiated from each other by 
mutations at marker D8S3 78 and an additional pair of haplotypes had a common 
recombination on the telomeric side, but were differentiated by an additional 
centromeric recombination in one of the haplotypes. Therefore, the refined genetic 
mapping revealed 10 recombination events that served to reduce the size of the critical 
region. Only one recombinant haplot))Je was due to a parental recombination. This 
recombinant haplotype alone would have served to exclude the centromeric region up to 
marker pJlO. However, the exclusion of this region was buttressed by four different 
historical recombinations, all of which extended at least as far as marker pJ 1 0. On the 
telomeric side, a single historical recombination excluded the region up to marker 
369CA3. Therefore, the 3cM locus defined by Kalaydjieva et al., (1996) was reduced to 
a critical region of approximately 202kb, bracketed by markers pJIO and 369CA3. A 
four-marker conserved haplotype was found in all affected individuals in this region. 
This was defined by three homozygous loci, 458a13, 458b57 and 369a89, which are in 
complete linkage disequilibrium with the gene defect. Marker 458b14 displayed allelic 
heterogeneity, which was conservatively considered as resulting from microsatellite 
mutations. 
The refined genetic mapping of the HMSNL disease locus benefited greatly from 
the inclusion of affected individuals and families from different Romani populations. 
The five recombinations that were used to define the centromeric boundary were found 
in individuals from five different Romani populations and the telomeric boundary was 
defined by a historical recombination observed in individuals from two different 
populations. Thus, it is apparent that genetic mapping in Romani populations bears a 
number of parallels to findings in other population isolates. Initial localisation of the 
gene benefited from the preservation of relatively large IBD chromosomal segments in 
the Lorn kindred, enabling a search for shared segments in a 1 OcM genome scan 
(Kalaydjieva et al., 1996). The possibilities for refined mapping, however, were limited 
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in this population and this task was facilitated by the examination of individuals from a 
variety of Romani populations. This is analogous to the. localisation of disease genes in 
the New Finnish population, which is genetically young and homogeneous, and the 
refinement of disease loci in the Old Finnish ·population, which displays greater 
genetic heterogeneity (Jorde, Watkins, Kere, Nyman, & Eriksson, 2000). Within-
population variation of HMSNL disease haplotypes is low in comparison to the variation 
observed in the entire sample of individuals from all Romani populations. It is 
conceivable that the HMSNL locus could have been mapped by searching for large IBD 
segments within individuals from any one of the populations with a sufficiently large 
sample size. However, this would not have been feasible if shared segments were 
sought in the entire sample given the overall heterogeneity of disease haplotypes. 
Conversely, refined genetic mapping would not have been as successful if it was 
performed in affected individuals from only one of these populations. As these 
populations are descended from a common ancestral population, an IBS chromosomal 
fragment can be inferred as being IBD from a distant ancestor. Reduction of the critical 
region was dependent on the study of individuals from socially and geographically 
separated Romani groups that nevertheless share a common ancestor. Knowledge of 
endogamous practices and limited genetic diversity in Romani populations, and 
observations from this study, suggest that identical disease haplotypes may be 
represented many times over within a population; whereas, sampling from a variety of 
Romani populations increases the likelihood of observing different disease haplotypes, 
which will further refine the critical region. 
8.3 Identification of the HMSNL Disease Gene and Mutation 
Exhaustive fine-scale recombination mapping resulted in a marked reduction in 
number of positional candidates for HMSNL. The 1Mb HMSNL region, which was 
cloned in this study, contained five genes. NDRG1, SJAT4A, TG and SLA had been 
located in the contig through physical mapping of ESTs. SIAT4A, SLA and most of TG 
were excluded on the basis of historical recombinations observed in the conserved 
disease haplotype. The genomic structures of NDRG 1 and WISP 1 were determined 
through large-scale genomic sequencing. NDRG1 is transcribed as a 3,020bp mRNA, 
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which encodes a protein of 394 amino acids. WISP 1 is transcribed as a 2,830bp mRNA 
encoding a protein of 367 amino acids. On the basis of refined genetic mapping, these 
two genes and exons 46~48 of TG were the only positional candidates. Thus, prioritising 
refined genetic mapping. over sequence analysis of positional candidate gene greatly 
reduced this final stage of investigation. 
The entire genomic coding regions of NDRG 1 and WISP 1 were examined. The 
common mutation identified in all HMSNL individuals is a C-) T transition at codon 
148 in NDRGJ. The genome level mutation results in a stop codon replacing an arginine 
codon in the transcribed messenger RNA. Thus, the predicted mutant mRNA would 
produce a polypeptide of 14 7 amino acids·. This can be hypothesised to result in either a 
truncated protein of aberrant function or a degraded protein, either of which would be 
expected to result in biological malfunction at the cellular level. No other nucleotide 
variants were identified in NDRG 1 or WISP 1 in affected individuals. The disease~ 
causing. mutation segregates in all families in complete agreement with autosomal 
recessive inheritance. Therefore, the evidence that the C-) T transition in NDRG 1 is the 
disease~causing mutation fulfils the majority of criteria outlined by Cotton and Scriver 
(1998). These authors claimed that disease-causing mutations should be rare and 
therefore, population controls should be screened to demonstrate this to be the case. 
However, this is not deemed to be an appropriate criterion in the Roma where disease 
alleles can occur at frequencies well over 1% (Kalaydjieva et al., 1999; Plasilova et al., 
1999). In this study, the problems described by Bonne-Tamir et al. (1997) in proving 
that a single genome-level mutation is the disease-causing mutation in population 
isolates were overcome. This is because refined genetic mapping reduced the conserved 
disease allele to one containing just two genes, which could be completely characterised. 
NDRG 1 encodes a gene of unknown function. The eDNA for NDRG 1 was first 
reported by Kokame, Kato, & Miyata (1996) and termed reducing agents-tunicamycin-
responsive protein (RTP). It was subsequently reported by van Belzen et al., (1997) who 
called it differentiation-related gene (DRGl) and Zhou, Salnikow, & Costa, (1998) who 
called it CAP43. NDRG1 expression has been shown to be up-regulated in growth-
arrested cells (Piquemal et al., 1999; van Belzen et al., 1997) and repressed in 
transformed cells (Kurdistani et al., 1998; van Belzen et al., 1997). The protein has been 
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observed in the cytosol and found to accumulate in the mtcleus during DNA damage 
(Kurdistani et al., 1998). Database searches for a serial array of gene expression 
(SAGE) tag analysis, related ESTs and eDNA expression libraries, reveal that it is 
ubiquitously expressed in a variety of tissues and cells. 
The NDRG 1 protein is highly conserved across species. The protein shares 93% 
identity with the mouse homologue, 64% identity with the rat homologue, 29% identity 
with the Drosophila melanogastor homologue and 30% with the C. elegans homologue. 
However, these proteins show no homology to known protein motifs, apart from a 
possible phosphopantetheine-binding site (Kokame et al., 1996) and some similarity to 
the ligand-binding domain of the inositol 1 ,4,5-triphosphate receptor (Krauter-Canham 
et al., 1997). 
Taken together, previous studies of NDRGl suggest that it may act as a 
signalling molecule or a chaperone. However, elucidation of the molecular pathology of 
HMSNL requires functional studies of NDRG 1. Neuropathology studies of HMSNL 
peripheral nerve suggest that the primary defect may be in Schwann cell malfunction, 
possibly compromising axon-Schwann cell signalling (Kalaydjieva et al., 1998). A 
number of other genes involved with myelination have been identified, including protein 
myelin protein 22kd (PMP22), protein zero (PO), and connexin32 (reviewed in Scherer, 
1999). NDRG 1 may interact with these structural proteins and its aberrant expression 
may be the underlying cause of the HMSNL pathology. In addition, other genes 
involved in demyelinating neuropathies such as myotubularin-related protein-2 (Bolino 
et al., 2000), and others yet to be identified, represent possible protein partners in 
signalling pathways or structural complexes. 
8.4 A Putative Founder Null Allele Mutation 
An interesting incidental finding of this study is the observation of a null allele 
mutation that compromised the genomic assay for R148X mutation. This rogue allele is 
a normal chromosome with a SNP at the 3 end of the annealing site of the forward PCR 
primer used to amplify exon 7 of NDRGJ. The presence ofthis SNP prevented the non-
R148X allele from being amplified by the standard PCR protocol. Thus, individuals 
predicted by haplotype analysis to be heterozygous for the disease-causing mutation 
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appeared as homozygotes. SNPs are considered to be unique event mutations, which 
suggests that the chromosomes bearing this SNP in the population are related. Indeed, 
the haplotypic background on which this SNP occurs shows some evidence of 
evolutionary relatedness. However, only the most proximal marker is in complete 
linkage disequilibrium with the SNP, which suggests that the mutation is ancient. 
As PCR is commonly used for diagnostic purposes, this observation is of great 
relevance. SNPs occur at an average of once every lkb in the human genome 
(K.ruglyak, 1999). Thus, the likelihood of a primer site mutation is not insignificant. 
Previous reports of haemochromatosis screening described a similar situation of a primer 
site mutation resulting in a null allele using a common diagnostic PCR (Jeffrey, 
Chakrabarti, Hegele, & Adams, 1999). It was argued that the consequences of this 
polymorphic allele in diagnostic analyses were minimal, particularly as it was used in 
conjunction with biochemical assays (Gomez et al., 1999; Merryweather-Clarke et al., 
1999; Noll, Belloni, Stenzel, & Grady, 1999). In a population isolate, if such an allele is 
subjected to founder effect, its frequency could be greatly increased and pose a 
significant problem for predictive and diagnostic DNA testing. This is of even graver 
concern if alternative supporting diagnostic measures are not possible. This suggests 
that DNA testing should be duplicated using different primer pairs and/or in conjunction 
with haplotype analysis to ensure that this problem is minimised. 
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SECTION III 
STUDY OF THE GENETIC EPIDEMIOLOGY OF 
DISEASE ALLELES IN THE ROMA 
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CHAPTER9 
SUBJECTS AND METHODS 
9.1 Introduction 
9.1.1 Summary of Previous Findings 
Studies of genetic disorders in the Roma thus far suggest a non-random 
distribution of disease prevalence in different Romani populations. Clustering of 
disorders. in geographically and socially separated Romani groups is evident (Abicht et 
al., 1999; Kalaydjieva et al., 1996; Piccolo et al., 1996). The disease gene frequency for 
autosomal recessive disorders in the Roma has been determined in a number of studies 
(Kalaydj ieva et al., 1999; Plasilova et al., 1999; Todorova, Ashikov, Beltcheva, 
Toumev, & Kremensky, 1999). The carrier rates for these disorders in the general Roma 
population has ranged from 2-6%. However, preliminary findings suggest an increased 
carrier rate in high-risk groups. This is exemplified by the E378K founder mutation in 
CYP 1 B 1 causing primary congenital glaucoma, for which a carrier frequency in a high 
risk group is 11% (Plasilova et al., 1999) as compared to 5% estimated for the general 
Romani population (Ferak, Gen~tik, & Gen9ikova, 1982). The population structure of 
the Roma and group-specific endogamy implies that common deleterious genes may be 
found at vastly different frequencies in Romani populations. This distribution is likely 
to be affected by the time of population founding, the number of founders and differing 
population histories. 
Disease gene haplotype analysis provides a means of investigating the history of 
a gene in a population, the history of the population, and relationships between 
populations. This analysis has been applied both to continental populations (Mateu et 
al., 2001; Morral et al., 1994) and to structured populations (Varilo, Nikali, 
Suomalainen, Lonnqvist, & Peltonen, 1996). Disease haplotype analyses of private 
founder mutations in Romani populations have demonstrated conserved disease 
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haplotypes exhibiting some degree ofvariation (Kalaydjiev~ et al., 1996; Kalaydjieva et 
al., 1999; Piccolo et al., 1996). However, a systematic study of variation in disease gene 
haplotypes in different Romani populations has not been performed. Such investigations 
could provide additional insights into the histories and relationships of Romani 
population. 
The age of a disease gene can be estimated by the degree of haplotypic decay of 
the ancestral chromosome. Haplotype decay is directly correlated with the extent of 
linkage disequilibrium around rare variants. Linkage disequilibrium mapping in isolated 
populations is an alternative approach to disease gene identification, and has been 
·proposed as a means of identifying genes involved in complex traits (Jorde, Watkins, 
Kere, Nyman, & Eriksson, 2000). However, there is uncertainty about which 
populations are most appropriate for linkage disequilibrium studies (Kruglyak, 1999a, 
1999b; Terwilliger, Zollner, Laan, & Paabo, 1998). Future efforts to map the genes 
underlying both monogenic and complex traits in the Roma can be expected to benefit 
from an examination of linkage disequilibrium around known disease loci. 
9.1.2 Research Questions 
This study aimed at investigating the distribution, haplotypic diversity and 
history of two private founder mutations in Romani populations: R148X in NDRGJ on 
chromosome 8q24 and C283Y in SGCG on chromosome 13q12. 
The specific research questions were: 
1 . How do carrier and gene frequencies of the two founder mutations vary 
amongst Romani populations? 
2. What are the implications of autosomal recessive gene frequencies for gene 
mapping in the Roma? 
3. What is the history of the disease genes in these populations? 
4. What does haplotype diversity indicate about population history in the 
different populations and the historical relationship between different 
Romani population? 
5. How does linkage disequilibrium behave around rare variants in different 
Romani populations? 
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6. What are the appropriate approaches toLD mapping in the Roma? 
9.1.3 Subjects and Study Design 
Screening for the two founder mutations was performed in individuals from eight 
Romani populations (table 9-1). These Romani populations provide representation of 
the Balkan, Vlach and Western European migrational groupings. For this study, not all 
populations investigated in the population genetic study (section I) were investigated. 
This is because the Monteni and Kalderash sample used in section I included families 
selected for HMSNL, thus disallowing an unbiased sample for examining the frequency 
of the HMSNL mutation. Population samples of the Lorn, Kalaidjii and Lingurari were 
obtained by Drs Kalaydjieva and Angelicheva in Bulgaria during a field trip in June 
2000. The total sample size for ·c283Y testing was 573, because Turgovzi and 
Feredjelli data were obtained from the community genetic study (section IV). The total 
sample size for Rl48X testing was 348, as smaller samples of the Turgovzi and 
Feredjelli populations were screened. 
Table 9-1 
Populations included in the study of the R148X and C283 Y mutations 
Population Metagroup Migrational group Geographic location Sample size 
Turgovzi Xoroxane Balkan Omurtag, NE Bulgaria 50-224 
Feredjelli Xoroxane Balkan Omurtag, NE Bulgaria 19-101 
Spanish Roma Cal West European Madrid, Spain 68 
Lithuanian Roma Russian West European Vilnius, Lithuania 20 
Intreni Rudari Vlach Letnitza, N Bulgaria 28 
Lorn Jerlii Vlach Lorn, NW Bulgaria 62 
Kalaidjii Jerlii Vlach NW & SW Bulgaria 43 
Lingurari Rudari Vlach N & S Bulgaria 45 
Total 348-573 
The C283Y disease haplotypes were characterised in twenty-four unrelated 
C283Y homozygous affected individuals from the Turgovzi population. These 
individuals were from the families identified in the genetic screening program (section 
IV). Where available, both parents of affected individuals were genotyped in order to 
resolve the phase of alleles. Genotyping data from the non-C283Y chromosomes in 
these parents were used to estimate allele frequencies in the population. 
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Rl48X haplotypes were determined in the course of the HMSNL gene 
identification study (Section II). Allele frequencies at each locus in the population were 
estimated from genotyping data from non-disease chromosomes in unrelated individuals. 
9.2 Methods 
9.2.1 Mutation Assays 
The genome level C~ T mutation in ex on 7 of N DR G 1 that results in the 
HMSNL-causing R148X mutation was tested using the Taql restriction enzyme digest 
assay described in section 6.2.6. 
Testing for the C283Y mutation was performed using an assay to determine the 
G~A transition in codon 283 located in exon 8 of SGCG. The transition of a guanine to 
an adenine creates a Rsal restriction endonuclease site, enabling the use ofthis enzyme 
in discriminating between mutant and normal chromosomes. A 168 base pair fragment 
that includes the mutation site was amplified using the PCR primers 5 -CCT GTC TGT 
GGC CGG TGT GA-3 and 5 -GCG TTT ACT TCC CAT CCA CGC TGC-3 (Piccolo 
et al., 1996) in a 20 J..LL reaction mixture (table 9-2). 
Table 9-2 
PCRprotocolfor amplifying the fragment containing the SGCG C283Ymutation 
Reagent Volume 
lOx PCR Buffer 2.011L 
25mM MgC12 1.21lL 
Forward Primer (20ng) 2.011L 
Reverse Primer (20ng) 2.011L 
dNTPs (5mM) 2.011L 
Taq Polymerase 0.051!L 
dH20' 8.751!LI10.751!L 
DNA 2.011LIFTA Genecard 
The volume of dH20 was adjusted if the DNA sample was bound to a FTA Genecard 
DNA amplification was performed in a GeneAmp 2400 thermocycler (Applied 
Biosystems) using the conditions described by Piccolo. et al., (1996): an initial 
denaturation at 94°C for 5 mins was followed by 35 cycles of 1 min at 94°C, 1 min at 
59°C and 1 min at 72°C. A final extension period of 7 mins at 72°C was allowed 
followed by cooling of the sample to 4 °C. 
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A Rsa 1 restriction enzyme digest was performed subsequent to amplification of 
the 168 base pair DNA fragment (table 9-3). The reaction was incubated at 37°C for one 
hour. 
Table 9-3 
Rsal restiction digest reaction [or assessment o[C283Y genotypic status 
Reactant Volume 
lOx Buffer 1.5flL 
PCR product 7 .OflL 
dH20 5.5f.1L 
Rsal l.OflL 
To visualise the results, the digest products were electrophoresed on a 3.5% 
agarose gel at 90 volts for 30 minutes. In addition, each gel contained control samples 
of a known homozygote normal, heterozygote and homozygote mutant which were 
PCR-amplified and digested with Rsa1 for direct comparison with unknown samples. 
The gel was stained with ethidium bromide and products were visualised using an 
ultraviolet transilluminator. An image of the gel was recorded using the Kodak gel 
documentation system (Eastman Kodak). 
9.2.2 Characterisation of Disease Haplotypes 
NDRGJ R148X disease haplotypes were constructed for the purposes of refined 
genetic mapping of the HMSNL disease locus (section II). Additional genotypic data 
were used from Kalaydjieva et al., (1996) to extend disease haplotypes. 
SGCG C283Y disease haplotypes were constructed using genotyping results 
from five polymorphic microsatellites spanning a physical distance of 2.75Mb around 
SGCG (http://www .ncbi.nlm.nih. gov/ cgi -bin/Entrez/map ). 
9.2.2.1 Amplification of chromosome 13q12 microsatellites 
The five microsatellite loci were amplified using the fluorescently labelled 
primer pairs (table 9-4). The primers for microsatellites D13S232, D13S283 and 
D13S787 were labelled with HEX. Primers for D13Sl15 and Dl3S292 were labelled 
withFAM. 
185 
Table 9-4 
Primer sequences [or microsatellite loci used to define the C283Y haplotype 
Dl3S787 Forward ATC AGG ATT CCA GGA GGA AA 
Reverse ACC TGG GAG TCG GAG CTC 
Dl3S232 Forward TGC TCA CTG CTC TTG TGA IT 
Reverse GGC ACA GAA ATA AAT GTT GAT G 
D13S115 Forward TGT AAG GAG AGA GAT TTC GAC A 
Reverse TCT TAG CTG CTG GTG GTG G 
D13S283 Forward TCT CAT ATT CAA TAT TCT TAC TGC A 
Reverse GCC ATT CCA AGC GTG T 
D13S292 Forward TAA TGG CGG ACC ATG C 
Reverse TIT GAC ACT TIC CAA GTT GC 
Each microsatellite was amplified in a separate reaction (table 9-5). 
Amplification of these loci required the use of the heat activated DNA polymerase, 
TaqGold (Applied Biosystems). 
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Table 9-5 
PCR mixtures and reactions for the five microsatellite loci used to define the C283Y 
hap_lo t.lJ!.e 
Dl3S787 D13S232 D13S115 D13S283 Dl3S292 
1 Ox PCR buffer 2.0J.!L 2J.!L 2JlL 2J.!L 2J.!L 
25mMMgC12 1.2J.!L 1.2JlL 2JlL 2J.!L l.8J.!L 
Forward Primer 2.0J.!L lJlL 2JlL lJ.!L lJ.!L 
(20ng/J..LL) 
Reverse Primer 2.0J.!L lJ.!L 2JlL lflL lJ.!L 
(20ng/J.!L) 
dNTPs (5mM) 2.0J.!L 2JlL 2JlL 2J.!L 2J.!L 
TaqGold 0.05J.!L 0.05JlL 0.05JlL 0.05J.!L 0.05J.!L 
Polymerase 
dH20 8.75J.!L 8.75JlL 7.95JlL 7.95J.!L 8.15J.!L 
DNA 2.0JlL 2J.!L 2JlL 2J.!L 2J.!L 
Thermo cycling 94°C-15 mins 94 °C-15 mins 94°C-15 mins 94 °C-15 mins 94°C-15 mins 
program 35 cycles: 35 cycles: 35 cycles: 35 cycles: 35 cycles: 
50s @9 4°C 40s@ 94°C 40s@ 94°C 40s@ 94°C 40s@ 94°C 
50s@ 54°C 50s@ 55°C 50s@ 55°C 50s@ 57°C 50s@ 57°C 
50s@ 72°C 40s@ 72°C 40s@ 72°C 40s@ 72°C 40s@ 72°C 
72°C- 5 mins 72°C-5mins 72°C- 5 mins 72°C-5 mins 72°C-5mins 
4°C 4°C 4°C 4°C 4°C 
9.2.2.2 Determination of 13ql2 microsatellite DNA sizes 
Microsatellite allele sizes were determined using the 3 73A DNA Analyser 
(Applied Biosystems). Gel and sample preparation was as described in section 3.3.4 and 
section 3.3.5 respectively. Two control samples of previously determined size were 
included on each gel to ensure compatibility in sizing between the unknown samples and 
previous results. 
Polymorphic DNA fragments were assigned an allele number based on the 
designation of the smallest fragment as allele 1 and numbered sequentially (table 9-6). 
This nomenclature is not consistent with previously published allele calling, however the 
published allele numberings do not follow any logical order. 
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Table 9-6 
Allele designations for chromosome the five 13q 12 STRs used to define the C283 Y 
haeJotxee 
Dl3Sl15 D13S232 Dl3S787 D13S292 D13S283 
Size A B Size A B Size A B Size A B Size A B 
163 1 7 108 1 7 249 1 203 1 4 128 1 6 
165 2 6 110 2 6 253 2 205 2 3 129 2 3 
167 3 5 112 3 5 257 3 207 3 1 131 3 
169 4 4 114 4 261 4 209 4 133 4 
171 5 3 116 5 265 5 135 5 
173 6 2 118 6 137 6 1 
175 7 1 120 7 4 139 7 
177 8 141 8 
143 9 
145 10 2 
147 11 
149 12 4 
151 13 5 
153 14 7 
A= allele numbering used in this study, B= The Genome Database allele calling 
(http://www .gdb.org) 
9.2.2.3 Construction of C283Y haplotype 
Inheritance of alleles was determined by genotyping affected individuals and 
both parents. Haplotypes were constructed manually using the marker order Dl3S115-
Dl3S232-Dl3S787-D13S292-D13S283 as reported on the Soton genetic map 
(http:/ /cedar .genetics.soton.ac. uk/public _ html/ldb.html). 
9.2.6 Statistical Analyses 
Statistical analyses were performed using Arlequin 2.000 (Schneider, Kueffer, 
Roessli & Excoffier, 1996). Genetic diversity statistics were calculated using equations 
provided in section 3.5. Networks were drawn using Network 2.0 (Bandelt, Forster, 
Sykes & Richards, 1995). 
The age of disease alleles were determined using the method of Stephens et al., 
(1998) described in section 3.5.4. For this the rate of change, r, was estimated based on 
mutation and recombination rates. The age of disease alleles was also determined using 
the method of Risch et al. (1995). This method assesses linkage disequilibrium at a 
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linked polymorphic locus to determine a moment estimator, t, of the age of the mutation. 
If 9 is small, then log(l-9) ~ e. Therefore, 
1 P affected-P nomral og ______c:c__ _ 1-p 
normal t = _,__--;--~---<-
log(1-e) 
(Guo & Xiong, 1997; Risch et al., 1995). 
A generation age of 20 years was used for all calculations. 
Linkage disequilibrium was determined at disease linked loci using the equation 
~affected - P normal J 
P excess = r,1 _ p ) \! normal 
where Paffected is the frequency of the most common disease-associated allele and Pnormal 
is the frequency of that allele in the general population (Hastbacka et al., 1992; 
Hastbacka et al., 1994). 
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CHAPTERlO 
RESULTS 
10.1 Population Distribution and Frequencies of Founder Mutations 
The R148X and C283Y founder mutations were analysed in individuals from 8 
Romani populations. Carrier rates and gene frequencies were estimated for each 
population. 
10.1.1 Population Distribution of the R148X Mutation 
Population screening identified the R148X mutation in six Romani populations 
(table 10-1). These populations include Balkan and Vlach Roma, and the geographically 
distant Romani populations from Spain and Lithuania. The generalised carrier 
frequency of the Rl48X mutation in the Roma surveyed is 5.4%. However, a large 
variation in carrier frequencies was observed between different populations. The carrier 
frequency of the R148X mutation is highest in the Lorn population, in which the carrier 
frequency is 19.4%. In most other populations in which the disease allele is found the 
carrier frequency is below 3%. The exception is the Lithuanian Roma in which the 
carrier frequency is 5%; however, the small sample size for this population makes this 
estimate unreliable. The mutation was not identified in the Feredjelli, a Balkan Romani 
population nor in the Intreni, a Vlach population. Disease allele frequencies were over 
0.01 in the six populations in which the R148X inutation is found. The highest 
frequency of the R148X mutation was observed in the Lorn (0.097). 
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Table 10-1 
Summary of results of screening for the R148X mutation in Romani populations 
Population Number of carriers Carrier frequency Gene frequency 
Turgovzi 1 2% 0.01 
N=50 
Feredjelli 0 0 0 
N=19 
Spanish Roma 2 2.9% 0;015 
N=68 
Lithuanian Roma 1 5% 0.025 
N=20 
Intreni 0 0 0 
N=28 
Lorn 12 19.4% 0.097 
N=62 
Kalaidjii 1 2.3% 0.012 
N=43 
Lingurari 1 2.2% 0.011 
N=45 
Total 18 5.4% 0.027 
N=335 
NB sample size (N) refers to number of individuals tested 
10.1.2 Population Distribution of the C283Y Mutation 
The C283Y mutation was found in just two Romani populations (table 10-2). 
Screening of the Turgovzi and Feredjelli populations was performed as part of the pilot 
community genetics program (Section IV). The Turgovzi had been deemed to be at 
high-risk based on the prevalence of LGMD2C-affected individuals. This high-risk 
status is confirmed by a carrier frequency of 6.25%. This corresponds to a disease allele 
frequency of 0.03 in this population. The only other population in which the C283Y 
mutation was found was the Spanish Roma in which the carrier frequency is 1.6%. 
Therefore, the C283Y mutation is either absent or extremely rare in Vlach groups. A 
generalised estimate for the carrier rate of the C283Y mutation in the Roma is 2.6%. 
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Table 10-2 
Summary of results of screening for the C283 Y mutation in Romani populations 
Population Number of carriers Carrier frequency Gene frequency 
Turgovzi 14 6.25% 0.03 
N=224 
Feredjelli 0 
N=101 
Spanish Roma 1 1.6% 0.008 
N=63 
Lithuanian Roma 0 
N=20 
Intreni 0 
N=27 
Lorn 0 
N=61 
Kalaidjii 0 
N=41 
Lingurari 0 
N=36 
Total 15 2.6% 0.013 
N=573 
NB sample size (N) refers to number of individuals tested 
10.2 Analysis of the R148X and C283Y Founder Mutations 
10.2.1 The R148X Mutation in NDRGJ 
The R148X disease chromosome was characterised using a 24 marker haplotype, 
which was produced for the purposes of refined genetic mapping of the HMSNL locus. 
Three uninformative loci were discarded and data from additional seven loci, which had 
been used in the disease gene localisation study (Kalaydjieva et al., 1996), were used for 
the analysis of linkage disequilibrium. 
10.2.1.1 R148X haplotype analysis 
Twenty unique R148X haplotypes were identified in the sample (chapter, table 
7-4). As is evident in this table, there is limited sharing of haplotypes between 
populations. Haplotype M is the ancestral haplotype (36 of 120 chromosomes) and is 
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present in four of the nine populations; namely the Lom, Monteni, Rumanian and 
Spanish Roma. All other shared haplotypes are found in ·the Kalderash and one or more 
populations. Haplotype E, which differs from haplotype M by a mutation at locus 
458bl4, is prevalent in the Kalderash (14 of 37 chromosomes) and found once in the 
Monteni. Similarly, haplotype Dis common in the Kalderash (13 of 37 chromosomes) 
and is also found in the French Roma. Haplotype A is found in the Kalderash, Italian 
Roma and the German individual. 
Diversity within the disease haplotypes has been generated through microsatellite 
mutation and recombination. Network analysis of the phylogenetic history of the 
R148X haplotype visually depicts the evolution of diversity within this locus (figure 10-
1 ). In this figure, it is apparent that the ancestral haplotype M is the predominant and 
most widely dispersed haplotype. Diversity within the HMSNL haplotypes is generally 
unique to each population. Thus, diversity appears largely to have arisen within each 
subpopulation subsequent to the introduction of the disease chromosome. This is most 
apparent in the Lorn, Kalderash and Monteni in whom significant sample sizes have 
been investigated. These three populations show different haplotype profiles and the 
most frequent haplotype is different in each of these populations. The putative Romani 
ancestral haplotype M is completely absent in the Kalderash. 
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I 
o German 
o ItalianRoma 
• Kalderash 
o Lom 
• Rumanian Roma 
Sloven ian Roma 
o Spanish Roma 
• Monteni 
Figure 10-1 Network of R148X haplotypes in Romani populations. Nodes are proportional to the number of times the 
haplotype is observed in the sample. Branch lengths approximate the number of mutations at each locus and the number of 
loci in the recombinant segment. 
Average haplotype diversity was determined for the three populations with 
sample sizes over 25 (table 10-3). The greatest haplotype diversity is seen in the 
Kalderash sample (0.75) in which 10 unique haplotypes are observed. However, even 
though only four haplotypes are observed in the Lorn, haplotype diversity is virtually the 
same as in the Kalderash (i.e. 0.74). In contrast to these two populations, haplotype 
diversity in the Monteni population is very low (0.15). 
Table 10-3 
Average R148X haplotype diversity within Romani populations 
. Population No. of unique Haplotype diversity 
haplotypes 
Kalderash (n=38) 
Lorn (n=28) 
Monteni (n=26) 
10 
4 
3 
10.2.1.2 Age of the Rl48X mutation 
0.75-0.0024 
0.74-0.0017 
0.15 - 0.0089 
The estimated proportion of ancestral haplotypes in the population and rate of 
change within the haplotype was used to calculate the coalescent age of the disease 
haplotype (Stephens et al., 1998). Pancestral was estimated as the proportion of the most 
frequent haplotype for each population. The rate of change, r, calculated for the 24 
microsatellites was estimated as 24(fl)+9, where the microsatellite mutation rate, fl, is 
1.2x10-3 mutations/generation (Weber & Wong, 1993) and the recombination rate over 
the 1Mb region is estimated to be 0.01. Thus, r = 24 (1.2x10-3) + 0.01 = 0.0388. 
Table 10-4 
Coalescent age estimates of the R148X mutation. 
population is indicated 
The ancestral haplotype in each 
Population P ancestral Generations Age (20 years/gen) 
Total 0.30 (haplotype M) 
Lorn 0.39 (haplotype 0) 
Kalderash 0.37 (haplotype E) 
Monteni 0.92 (haplotype M) 
31 
24 
26 
2 
620 
480 
520 
40 
Using the method of Stephens et al., (1998), a date of 620 years was calculated 
for the HMSNL mutation in the entire Roma population. Within the Lorn and 
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Kalderash, the mutation is dated around 500 years BP, whilst the homogeneity of the 
Monteni R148X haplotypes suggests the mutation entered the population very recently. 
The ago of the R148X mutation was estimated based on linkage disequilibrium 
with proximate loci (Guo & Xiong, 1997; Risch et al., 1995). Linkage disequilibrium at 
the two loci that define the centromeric and telomeric borders of the HMSNL critical 
region was used to calculate the age of the disease allele (table 1 0-4). As the genomic 
region has been completely characterised the exact physical distance between the marker 
and the disease-causing mutation is known. To estimate the recombination fraction, e, 
the relationship lcM = 1Mb was used. Thus, for marker pJlO, e = 0.00187 and for 
marker 474CA1, 8 = 0.00114. 
Table 10-5 
Age estimates of the Rl48X mutation based on linkage disequilibrium with nearby 
polymorphic loci 
Generations 
T (20y/generation) 
TpJIO 
57.5 gen 
1,150 years 
T474CAI 
101 gen 
2,020 
Taverage 
79 gen 
1,580 years 
Using markers that flank either side of the critical region for the HMSNL locus, 
the number of generations since the R148X mutation occurred range from 57.5 to 101. 
An average of values from these two polymorphic loci places the age of the mutation 
1,580 years before present. 
10.2.1.3 Linkage disequilibrium in the HMSNL region 
The extent of linkage disequilibrium (LD) in the HMSNL locus was analysed in 
the Monteni, Lorn, Kalderash and the whole Romani population using disease 
chromosomes and population controls, namely the non-transmitted chromosomes 
observed in HMSNL families. LD was estimated using the Pexcess statistic for 27 
microsatellite loci spanning a total genetic distance of 3.3cM (figure 10-2). Paffected 
values were determined without discrimination between disease associated alleles that 
were a result of recombination from those resulting from mutation. This simulates a 
population-based case-control scenario in which parents of affected individuals are not 
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necessarily available, and therefore the phase of alleles in affected individuals is 
unknown. 
As can be seen, the P excess values increase with closer proximity to the disease-
causing mutation. P excess maxima correspond with the most likely location of the 
disease-causing variant. The P excess value for the sample of all disease chromosomes 
peaks at the three loci that are invariably homozygous in all affected individuals. In 
contrast, P excess in the Kalderash and Monteni show three independent peaks. The peak 
Pexcess value for the Lorn extends from marker 189CA17 to 369a89. The Pexcess 
maximum in the whole sample corresponds to the only location at which P excess maxima 
in all three populations overlap. 
An aberrant Pexcess value is observed at the D8S378 locus. This is a result of 
hypermutability at this locus within the Kalderash sample, which causes undetectable 
LD in the Kalderash population and a dramatic inconsistency in the LD trend over the 
HMSNL locus in the entire sample. This isolated drop in LD indicates a locus- and 
population-specific phenomenon, reminiscent of a microsatellite instability phenotype 
(Thibodeu, Bren & Schaid, 1993) 
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~ 10.2.2 The C283Y Mutation in SGCG l· 
10.2.2.1 C283Y haplotype analysis 
Eleven unique haplotypes were identified in the sample of forty-eight Turgovzi 
disease chromosomes (table 10-5). Haplotypes are closely related to each other and 
clearly derived from an ancestral chromosome, designated haplotype 1. All C283Y 
disease haplotypes were found to be associated with allele 3, an 112bp fragment, of 
marker D13S232. This was consistent with the study ofRoma from Western Europe by 
Piccolo et al., (1996) that found the C283Y mutation invariably associated with this 
allele1• Haplotype 1 is the most frequent in the Turgovzi representing 60.4% of all 
disease haplotypes. Haplotype 2 accounts for 14.6% (7 of 48 chromosomes) and 
haplotype 7 represents 8.3% (4 of 48 chromosomes). Haplotypes 2 and 7 differ from the 
ancestral haplotype at only one locus each, a mutation at D13S115 and a recombination 
between D13S292 and D13S283 respectively. The other eight C283Y haplotypes were 
found only once in the Turgovzi sample. 
C283Y haplotypes in the Turgovzi were compared to the C283Y haplotypes 
from West European Roma (M. Jeanpierre, pers comm). This sample included eighteen 
disease haplotypes from unrelated Iberian Roma, four from Roma resident in Germany 
and 2 disease haplotypes each from French and Italian Roma. A comparison of the 
frequency of these haplotypes with the Turgovzi sample shows a striking difference 
(table 1 0-6). In the Iberian Romani sample, haplotype 7 is the most frequent and 
accounts for 66.7% ( 12 of 18) of chromosomes and the Turgovzi ancestral haplotype 1 is 
found at a frequency of 5.6%. Haplotype diversity in the Turgovzi is 0.616 ± 0.0058, 
and in the Iberian Roma it is 0.569 ± 0.0201. 
1 In the initial study by Piccolo et al., (1996) the authors used the GDB allele calling which designates the 
112bp fragment as allele 5 
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Table 10-6 
C283 Y hae.lot.l.P.es in Romani e.oe.ulations 
Haplotype D13S115 D13S232 D13S787 D13S292 D13S283 Protal Turgovzi1 lberian2 Other 
1 2 3 3 3 10 0.459 29 1 4 
2 3 3 3 10 0.094 7 
3 3 2 3 0.014 1 
4 2 3 2 3 10 0.014 1 
5 
-
3 3 3 10 0.014 1 
6 2 3 3 0.040 1 2 
7 2 3 3 0.216 4 12 
8 2 3 3 0.013 1 
9 3 3 3 0.013 1 
10 
-
3 2 0.027 1 
11 2 3 3 0.013 
12 3 3 0.013 
13 3 3 0.013 
14 3 2 0.013 1 
15 3 3 0.013 1 
16 3 2 0.027 2 
Total 48 18 8 
N.B Recombinations are shown in red and microsatellite mutations are shown in yellow. 
A network relating C283Y haplotypes was constructed (figure 10-3). C283Y 
haplotypes are nonrandomly distributed in the Roma. Three haplotypes (I, 7 and 1 0) are 
shared between the Turgovzi and Iberian Roma, however they occur at different 
frequencies within the populations. Haplotypes in the Turgovzi are distributed 
throughout the network. Four unique haplotypes are observed in the Iberian Roma. 
However, haplotypes found in the Iberian Roma can be considered as a subset of those 
observed in the Turgovzi. Haplotypes in other European Roma are identi cal or closely 
related to Turgovzi haplotypes. 
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6 
Turgovzi 
0 Iberian Roma 
Other 
Figure 10-3 Median-joining network of C283Y haplotypes in Romani populations. 
Branch lengths are proportional to the number of mutations and the number of loci 
involved in recombination. 
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10.2.2.2 Age of the C283Y mutation 
The overall age of the C283Y mutation in the Roma was calculated, as was the 
age of the mutation within the Turgovzi and Iberian Roma (table 10-7) using the 
coalescent method of Stephens et al., (1998). For the C283Y haplotype defined by five 
microsatellite loci spanning 2.75Mb, the recombination rate was estimated to be 0.0275. 
Thus r = 0.0275 + 5(1.2x10-3) = 0.0335. 
Table 10-7 
Age o[the C283Ymutation based on the coalescence ofhaplotypes 
Population P ancestral · Generations 
Total 0.459 (haplotype 1) 23 
Turgovzi 0.604 (haplotype 1) 15 
Iberian 0.666 (haplotype 7) 12 
NB The ancestral haplotype in each population is indicated 
Age (20y/gen) 
460 
300 
240 
The age of the C283Y mutation in the Roma was estimated to be 460 years. The 
mutation age is younger within the Turgovzi than the Iberian Roma with an estimated 
age difference of 60 years. 
The mutation was dated in the Turgovzi based on LD observed at the flanking 
loci D13S115 and D13S283 (table 10-8). The recombination fraction between Dl3S115 
and the mutation was estimated as 0.007 and between D13S283 and the mutation as 
0.013. 
Table 10-8 
Age ofthe C283Y mutation in the Turgovzi based on LD 
Generations 
20y/gen 
Go3Sll5 Goi3S283 Gaverage 
73.6 19.3 46.45 
1,472 years 386 years 929 years 
Using linkage disequilibrium (Guo & Xiong, 1997; Risch et al., 1995), estimates 
of the number of generations since the C283Y mutation occurred differ greatly based on 
the two different loci. An average of the two estimates gives a mutation age of 929 
years before present. 
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10.2.2.3 Linkage disequilibrium around the C283Y mutation 
Thirty normal chromosomal haplotypes from the Turgovzi population were 
constructed from genotyping parents of affected individuals. None of the eleven 
Turgovzi C283Y haplotypes was found amongst the normal Turgovzi haplotypes. 
However, haplotype 16, which is homozygous in an affected Italian Roma, was found to 
occur in the sample of normal chromosomes in the Turgovzi sample. 
Allele frequencies were calculated at each locus for normal and affected 
chromosomes (table 1 0-9). Linkage disequilibrium at each locus was assessed by 
calculating the p excess statistic without discriminating between disease-associated alleles 
that have arisen through recombination from those that have arisen from mutation. The 
location of the disease causing mutation is correlated with the highest·observed value of 
linkage disequilibrium. 
Table 10-9 
Chromsome 13q 12 microsatellite allele frequencies for disease and normal 
chromosomes 
Locus Dl3S115 Dl3S232 Dl3S787 Dl3S292 Dl3S283 
Allele C283Y N C283Y N C283Y N C283Y N C283Y N 
1 0.033 0.100 0.021 
-
0.021 
2 0.771 
- -
0.062 
-
0.267 0.146 
-3 
0.167 0.200 1.00 0.233 0.938 0.367 0.979 
-4 0.067 5 0.042 0.200 
6 0.021 0.021 0.069 
7 0.100 
8 0.167 
9 
10 0.792 0.069 
11 
12 0.034 
13 0.034 
14 0.021 0.103 
P excess=O.S96 Pexcess=l P excess=0.902 P excess=0.967 P excess=O. 776 
NB The most frequent alleles for each sample are highlighted. 
203 
CHAPTERll 
DISCUSSION 
11.1 The Distribution of Private Fou~der Mutations 
HMSNL has been reported in Romani individuals from several different 
populations (Butinar et al., 1999; Colomer et al., 2000; Kalaydjieva et al., 2000; 
Kalaydjieva et al., 1996; Merlini et al., 1998). Identification of the R148X mutation in 
NDRG 1 has demonstrated the identical underlying genetic defect in affected individuals 
(section II). Similarly, LGMD2C has been diagnosed in a number of Romani 
individuals from disparate populations (Lasa et al., 1998; Merlini et al., 2000; Piccolo et 
al., 1996). These affected individuals have been shown to be homozygous for the 
C283Y mutation in SGCG. The widespread distributions of these autosomal recessive 
diseases suggests high disease allele frequencies in the Roma. Carriers of the disease 
allele are to be expected in populations in which the disease has been identified. In 
addition, the common genetic heritage of Romani populations (section I) suggests the 
disease allele may occur in populations with no reported cases of the disorders. 
Identification of the genome level mutation allows rapid population screening for 
nonsymptomatic carriers. This estimate provides an indication of the prevalence of the 
disease mutation and the expected number of affected births. 
The R148X mutation in N DR G 1 was identified in six of eight Romani 
populations. HMSNL had previously been identified in three of these populations; 
namely the Lorn, Kalderash and Spanish Roma. However, the sample of Spanish Roma 
examined in this study is of unknown relatedness to the Romani individuals included in 
the HMSNL study. In addition to these populations, the disease allele was identified in 
the Turgovzi, Kalaidjii, Lingurari and Lithuanian Roma, populations in whom HMSNL 
has not been reported. Thus, the disease allele is represented in the three major 
migrational groupings of European Roma and transcends metagroup boundaries in the 
Bulgarian Roma. The overall carrier rate in the entire Romani sample is 5.4%. 
However, within-population carrier frequencies are highly variable. The majority of 
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R148X carriers are found in the Lorn population in which a carrier frequency of 19.4% 
is observed. This carrier rate is dramatically higher than that observed in other 
populations, which range from 2-5%. The failure to identify the R148X mutation in the 
Feredjelli and Intreni possibly points to negligible carrier rates in these populations. 
However, sample sizes were small for both of these populations and should be expanded 
to confirm this suggestion. 
The frequency of the C283Y mutation in SGCG was investigated in the same 
eight Romani populations. The C283Y mutation was identified in just two populations, 
the Turgovzi and Spanish Roma. LGMD2C-affected individuals have previously been 
identified in the Spanish Roma (Lasa et al., 1998). The generalised carrier frequency of 
the C283Y mutation in the Roma is 2.6%; however, this is based on the inclusion of the 
six populations in which the mutation was not identified. Fourteen of the fifteen C283Y 
carriers are found in the Turgovzi, which corresponds with a carrier frequency of 6.25% 
within that population. In the Spanish Roma, the C283Y carrier frequency is 1.6%. The 
mutation was not identified in a sample of 101 Feredjelli, a Xoroxane Romani 
population that is co-resident with the Turgovzi. This provides evidence for limited 
gene flow between these co-resident Romani populations. The C283Y mutation was not 
identified in 165 individuals from Vlach Romani groups, thus presenting the possibility 
that the SGCG C283Y mutation is absent in the Vlach Roma. 
Mutation screening has illustrated the variability of carrier frequencies in 
Romani populations. This study has determined carrier frequencies almost as high as 
20% in one population, whilst in other populations the same disease allele is not found. 
This variation can be explained by the effect of genetic drift on recessive alleles. This 
stochastic process can result in high frequencies of a disease allele or conversely, result 
in the loss of disease alleles. With the genesis of each new Romani population it is 
possible that some disease alleles are not represented in the nascent populations, or that 
alleles occurring at very low frequencies are rapidly lost. Alternatively, it is possible 
that disease alleles are transmitted to the new populations and the same random 
processes result in inflated gene frequencies. In the French Canadian population it has 
been shown that a single carrier of a disease allele at the inception of the population 
some 250 years ago is sufficient to result in present-day carrier frequencies of 5% 
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(Heyer, 1999). Thus, it is conceivable that in Romani populations a very small number 
of founders carrying disease causing mutations can explain high carrier frequencies in 
the extant Romani populations. 
High carrier frequencies can be expected to result in a large number of affected 
births. In populations with high frequencies of particular disease alleles, the practice of 
endogamy can serve to increase the chance of two carriers forming a union and 
therefore, the chance of an affected child being born from such a union. For example, if 
marital partners in the Lorn population were selected entirely from within the 
community, in which the R148X carrier frequency is almost 20%, the expected 
frequency of HMSNL affected births would be 1 in 1 00. Similarly, a large number of 
LGMD2C-affected individuals can be expected in the Turgovzi. These findings 
represent additional examples of the phenomenon first noted in a Slovakian Romani 
population where a high incidence of congenital glaucoma (Ferak, Gencik, & 
Gencikova, 1982) is due to the high frequency of a single disease allele (Plasilova et al., 
1999). A high frequency of carriers of deleterious mutations within Romani populations 
provides justification for the implementation of targeted genetic screening. It is apparent 
that populations that are at the highest risk for increased frequencies of disease alleles · 
are those in which a large number of affected individuals are found. However, the 
common genetic heritage of Romani populations and the demonstrated widespread 
distribution of disease alleles suggest the value of offering carrier testing to Romani 
individuals from all populations. Whilst the lower frequencies of disease alleles seen in 
I 
some populations correspond with a reduced population risk, all Romani individuals can 
be considered as potential carriers of these private mutations. 
The high disease allele frequencies observed in Romani populations pose a 
potential difficulty for gene mapping studies. Gene frequencies play an important role 
in genetic linkage studies (Terwilliger & Ott, 1994). Commonly, gene frequencies are 
estimated to be between 0.01 and 0.001. In the Roma, gene frequencies have been found 
almost an order of magnitude greater than typical estimations. Such high gene 
frequencies can result in overestimated lod scores (Kruglyak, Daly, & Lander, 1995; 
Lander & Botstein, 1987). High gene frequencies are also an impediment to searches 
for large shared segments. This is due to the concomitant reduction in lengths of 
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conserved ancestral haplotypes with higher gene frequencies (Lander & Botstein, 1987). 
Therefore, the elevated gene frequencies observed in some Romani populations is an 
important consideration for the design of gene mapping studies. 
11.2 Founder Mutations and Population Histories 
The difference in· the distribution of the R148X and C283Y mutationss suggests 
two different scenarios for these disease alleles. Dating of the R148X mutation using a 
coalescent and linkage disequilibrium method produced estimates of 620 and 1,580 
years old respectively. These estimations suggest the existence of the R148X allele in 
the proto-Roma prior to their entrance into Europe and the process of population 
fracturing. The occurrence of the R148X mutation in the Vlach, Balkan and Western 
European populations points to the presence of the mutation at a reasonably high 
frequency in a common ancestral population. This claim is further supported by the 
occurrence of HMSNL in other Romani populations in which screening was not 
performed, such as the Slovenian (Butinar et al., 1999), Italian (Merlini et al., 1998) and 
Rumanian (Kalaydjieva et al., 2000) Roma. In comparison, in this study the C283Y 
mutation was only found in two populations; the Turgovzi, a Balkan Romani population 
and the Spanish Roma, a Western European Romani population. This distribution could 
be explained by a low frequency of this mutation in a parental population. Dating of the 
C283Y mutation using the coalescent method of Stephens et al., (1998) produced a 
mutation age of 460 years before present. An estimation of the allele age based on 
linkage disequilibrium was determined to be 929 years before present. These 
estimations are considerably younger than that proposed by Piccolo et al. (1996), who 
estimated that the C283Y mutation occurred at least 1,200 years BP. Their estimate was 
based on a small sample of seven disease haplotypes in unrelated consanguineous 
families from different populations. As demonstrated with the distribution of Rl48X 
haplotypes, diversity is predominantly observed between populations. Thus, mutation 
age estimates that sample a small number of chromosomes from multiple populations 
can be expected to produce older mutation age estimates than those that sample within a 
population. So far, the majority of cases of LGMD2C caused by the C283Y mutation 
have been reported in Western European Roma from Portugal, France, Italy (Piccolo et 
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al., 1996) and Spain (Lasa et al., 1998). Within Balkan and Vlach groups, the C283Y 
mutation has only been found in the Turgovzi. This distribuution suggests that the 
C283Y mutation was more highly represented in populations that migrated into Western 
Europe than in populations that remained in Eastern Europe. The relatively young age of 
the mutation and its distribution suggests the mutation may have occurred within Europe 
after the process of population fission was underway. The high carrier frequency of the 
C283Y mutation within the Turgovzi can be understood as a localised founder effect 
similar to that observed for R148X in the Lorn population. 
The R148X disease haplotype was constructed using 24 polymorphic loci. This 
provides a highly resolved haplotype in comparison to those typically used (eg. Hollox 
et al., 2001; Mateu et al., 2001; Morral et al., 1994). Therefore, differentiation between 
haplotypes will occur much more rapidly. This has clearly occurred in the Roma, as 
haplotypes appear to be largely restricted to single populations and variation has been 
generated within populations. Only four of the twenty unique haplotypes are found in 
more than one population. Shared haplotypes are of interest because they point to a 
recent common ancestor. The sharing of R148X haplotype M by the Lorn, Monteni, 
Rumanian and Spanish Roma provides evidence of the relatedness of these populations. 
The Lorn, Monteni and Rumanian Roma live in close proximity and possibly share 
similar histories which might explain identical disease haplotypes occurring in the 
populations. The presence ofR148X haplotype Min the Spanish Roma might indicate a 
more recent migration from one of these populations. The three other shared haplotypes 
are found in the Kalderash. The Kalderash practice strict endogamy and have only 
recently ceased to be nomadic (Marushiakova & Popov, 1997). Therefore, it is 
interesting to note that the Roma resident in France, which share haplotype D with the 
Kalderash resident in Bulgaria, identify themselves as Kalderash Roma (L. Kalaydjieva, 
pers comm). Haplotype sharing between the Kalderash and the Monteni, Italian Roma 
and German may be indicative of gene flow or more recent population affinities. 
The greatest haplotype diversity is observed in the Kalderash in whom ten 
haplotypes are observed. This is consistent with observations within Bulgaria that the 
prevalence of HMSNL is highest in the Kalderash (I. Tournev, pers comm). The 
coalescent age of the mutation of 520 years in the Kalderash indicates that the mutation 
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has been present within the Kalderash for a considerable time. It is interesting to 
contrast this population with the Lorn. Although only four different haplotypes are 
found in the Lorn, they are more evenly distributed and therefore, haplotype diversity 
and the age of the mutation are similar to that of the Kalderash. Furthermore, the carrier 
frequency of HMSNL is extremely high in the Lorn (19.4%). This suggests that there 
was more than one founder in the Lorn and some degree of haplotype diversity existed at 
the point of founding of the population. Therefore, the ~stimated age of the mutation in 
the Lorn is likely to be an overestimate. This highlights the fallibility of dating methods 
that do not incorporate allele frequencies into calculations. 
HMSNL disease haplotype diversity is extremely low in the Monteni. This is 
consistent with the investigation of male and female lineages which found the Monteni 
to have dramatically restricted male-specific genetic diversity and low female-specific 
genetic diversity (section 1). A single predominant disease haplotype is found in the 
Monteni with very little within-population diversity. This can be explained by the 
introduction of the mutation into the population very recently. Strict endogamous 
practices would minimise the opportunity for a different disease allele to enter the 
population, whilst genetic drift could lead to the predominance of a single disease 
haplotype. 
Population screening has revealed that the C283Y mutation is not widely 
dispersed amongst Romani populations. Haplotype diversity is greater in the Turgovzi 
than in the Iberian Roma. A network of disease haplotypes in these two populations 
illustrates that the Iberian diversity can be considered as a subset of that seen in the 
Turgovzi. This is consistent with the Iberian Roma representing a population that split 
from the Turgovzi. Dating of the C283Y allele suggests that the mutation is older in the 
Turgovzi than in the Iberian Roma, which is consistent with this scenario. It should be 
noted however, that the dates obtained within these populations appear to be 
underestimates in light of historical records. It is apparent that the population fissioning 
process represents genetic bottlenecks, with the emerging haplotype distribution in 
extant populations is largely a function of stochastic processes. The unique haplotypes 
found in each population are signatures of diversity generated after the populations have 
split. 
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11.3 Fine-Scale Linkage Disequilibrium 
Linkage disequilibrium is the nonrandom association between two loci 
(Kruglyak, 1999). Such associations are often used as evidence for a causally important 
association between genetic markers and a hypothesised disease locus or to refine the 
chromosomal location of a gene (Weiss, 1993). Linkage disequilibrium was assessed 
around the known disease locus for HMSNL. The construction of haplotypes over a 
3.3cM region using 27 polymorphic loci allowed an examination of LD variation over 
short regions of the chromosome. In addition, LD in the HMSNL locus was compared 
in three Romani populations allowing insights into population-specific phenomena. 
LD was assessed using the simple Pexcess statistic proposed by Hastbacka et al., 
(1992). This statistic essentially quantifies the difference in disease-associated allele 
frequencies to the frequency of that same allele in the unaffected population. As the aim 
of the analysis was to simulate a potential genome scan, all disease associated alleles 
were included, regardless of whether they differed from the most common allele due to 
mutation or recombination. Thus, the LD values at each locus do not exclusively reflect 
haplotype decay due to recombination. In the analysis, linkage disequilibrium was 
found to be variable across the 3.3cM region. In the whole sample, LD generally 
increased with proximity to the disease locus. Irregularities were observed in this 
general trend which can be explained by mutations at loci, and randomly occurring 
fluctuations in the frequency IBS alleles in the population controls. This deviation from 
the general trend is exemplified by the extreme reduction in LD observed at the D8S378 
locus. Hypermutability of this locus in disease chromosomes from the Kalderash 
population results in a dramatically reduced association at this proximate locus. 
Linkage disequilibrium within each of the three populations displays even 
greater variation. Within these populations, spurious false positive peaks of linkage 
disequilibrium are observed. These occur when recombinant disease haplotypes bear 
identical alleles at a polymorphic locus to the nonrecombinant disease haplotypes. 
These alleles are IBS, however this method assumes they are IBD. In the Kalderash and 
Monteni, two such false positives are observed. In the Lorn population, the region of 
maximal linkage disequilibrium extends over 14 loci spaced across approximately 
800kb. This is a result of the absence of recombinant chromosomes over this region. As 
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depicted in the network, recombinations in the Lorn are of limited extent which renders 
the Lorn population of limited use in refining the disease locus. Total linkage 
disequilibrium in all disease haplotypes is only observed over the region including 
markers 458al3-458b57-369a89. Furthermore, this segment is the only one in which 
LD maxima in the three populations are coincident. This illustrates the essential 
inclusion of Roma from disparate populations for linkage disequilibrium mapping and 
refining candidate regions. 
Linkage disequilibrium around mendelian disease alleles is evidently highly 
variable over short physical distances. However, reasonably high levels of LD are 
observed over significant portions of the genome. The Pexcess statistics remain high over 
a 3.3.cM region around the Rl48X and a 2.75cM region around the C283Y mutation. 
This presents the possibility that genome-wide scans for allelic associations with a 
particular phenotype might be possible in the Roma. Within the Rom, well defined 
phenotypes of monogenic traits can reasonably be hypothesised to result from founder 
mutations that can remain in strong linkage disequilibrium with nearby loci. The 
strongest allelic associations can be expected in populations in which genetic diversity is 
low and the mutation is young. This approach is similar to the search for shared 
genomic segments; however, in this case association is sought at a single locus rather 
than haplotypes constructed from two loci. Further studies are required to examine the 
extent and strength of allelic associations around disease loci in the Roma. However, 
these results suggest that controls could be selected from unaffected individuals in the 
same population rather than relying on pedigree samples and data exclusively. 
It is possible that the spurious drops in LD observed in the HMSNL region 
would be overcome by the use of SNPs in association mapping. Much of the irregularity 
of LD in the HMSNL region is due to microsatellite mutation. As SNPs are considered 
to be unique events, every new SNP that was encountered would provide evidence of a 
recombination. This would ameliorate the apparent absence of allelic association due to 
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locus mutation. However, the relative uninformativeness of SNPs could possibly 
undermine this benefit. 
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SECTION IV 
PILOT STUDY OF COMMUNITY BASED CARRIER 
TESTING IN THE ROMA 
213 
CHAPTER12 
SUBJECTS AND METHODS 
12.1 Introduction and Study Design 
12.1.1 Background to the Study 
Elucidation of the molecular genetic basis of disorders provides a powerful 
means for disease diagnosis and predictive testing. By disentangling the genetic defects 
that underlie disorders with similar clinical presentations, robust and definitive assays 
can be developed. Gene defects that result in inborn errors of metabolism are most 
amenable to treatment. However, for the majority of monogenic disorders, treatment 
strategies following molecular diagnosis are hindered by a lack of knowledge about gene 
function. In such situations the application of genetic medicine can only entail 
predictive testing. In nonsymptomatic prospective parents this can take the form of 
carrier testing for deleterious genes. 
Carrier testing has been widely employed for a number of genetic disorders. The 
impetus for such predictive testing is usually supplied by a disease history in the family. 
However, for some genetic disorders the population prevalence of a particular disorder is 
deemed to be high enough to warrant widespread screening. Such is the case for the 
~F508 mutation in CFTR in the Caucasian population. In population isolates, limited 
genetic diversity often results in reduced genetic heterogeneity of inherited disorders. In 
addition, founder effect can result in single mutations occurring at high frequencies. As 
a result, population-targeted carrier testing enjoys a greater efficiency in these 
populations. This scenario has been exploited in genetically isolated populations such as 
the Ashkenazi Jews and the Finns. In the Roma, a number of disease alleles have been 
found to occur at high frequencies (Kalaydjieva, Gresham & Calafell, 2001; Kalaydjieva 
et al., 1999; Plasilova et al., 1999). This suggests that targeted genetic screening may be 
fruitful in these populations. 
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In 1996, the C283Y mutation in SGCG was identified as the cause of limb girdle 
muscular dystrophy type 2C, a severe autosomal recessive form of early onset muscular 
dystrophy (Piccolo et aL, 1996). The affected individuals, resident in Spain, Italy and 
France, were all of Romani ethnicity. Analysis of the disease haplotype through 
genotyping of closely associated microsatellite markers suggested a founder mutation 
(Piccolo et al., 1996). This report was followed by the identification of additional 
affected Romain Germany (M. Jeanpierre, pers comm) and Portugal (Lasa et al., 1998). 
It was hypothesised that the same mutation might be found in Romani communities in 
the Balkans. After an extensive search of Bulgarian hospital records and fieldwork in 
Romani neighbourhoods by Dr Ivailo Toumev of the Sofia Medical School, thirty-two 
Limb Girdle Muscular Dystrophy patients were identified. The thirty-two affected 
individuals were found to belong to a total of nineteen unrelated families. All were 
Xoroxane Roma, who are Muslims and descendants of early migrants into the Balkans, 
and most resided in the northeastern part of Bulgaria. 
Given that the Roma are known to adhere to strict endogamous practices and 
exhibit reduced genetic diversity (section 1), the identification of a large number of 
individuals affected by the same genetic disorder suggested an increased frequency of 
the disease allele. Therefore, a pilot genetic screening project was initiated in the 
Northeast Bulgarian town of Omurtag during 1998. Carrier testing in the community 
was considered feasible, based on an urban population of some three to four thousand 
Romani inhabitants. Moreover, community members were deemed to be in a reasonable 
economic situation and well informed about the disease, and they demonstrated 
receptivity to the suggested study. 
12.1.2 Research Questions 
This study aimed at implementing a pilot community genetics program in a 
Romani community deemed to be at high-risk for a monogenic disorder, LGMD2C, and 
assessing factors that might affect the uptake of carrier testing. Specifically, it aimed at 
answering the following questions: 
I. What is the genetic basis of LGMD2C in Xoroxane Romani families? 
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2. What are the attitudes towards genetic disease and its prevention held by 
members of the Xoroxane community? 
3. What psychological and social factors must be addressed when implementing 
a community-based genetic program in a Romani community? 
4. Is community-wide screening a suitable approach to carrier testing for 
disease alleles in Romani populations? 
12.1.3 Subjects 
12.1.3.1 Genetic counselling and testing in affected families 
Prior to the offer of genetic testing, LGMD2C patients and members of their 
families were provided with relevant information about the disease. This included 
information on the mechanisms of inheritance of the disease, its clinical course, the 
prospects of treatment for affected individuals, the availability of carrier testing for 
unaffected relatives, and reproductive options. The consulting physicians of the field 
team provided the information in an informal setting, during a visit to the family s home. 
Thirty-two affected individuals were clinically diagnosed as having LGMD2C. 
The affected individuals came from 19 different families. These families were resident 
in northeastern Bulgaria, in the communities of Omurtag and neighbouring villages and 
in a small area south of the Balkan Mountains. Unaffected family members from 16 
families requested the carrier test. Blood samples were collected from a total of 157 
unaffected family members on FTA Genecards. Families and individuals were assigned 
an identification number to ensure anonymity. A record of the name of the individual 
referred to by the identification number was accessible only to Associate Professor 
Kalaydjieva and Dr Toumev. 
Subsequent to the mutation assay, results were provided to the Bulgarian 
physicians who were members of the field team. Individuals identified as being non-
carriers were informed of their status in writing. All identified carriers of the mutation 
were informed personally and in writing, and provided with post-test counselling. 
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12.1.3.2 Collection of samples for community genetic screening 
A field team under the leadership of Associate Professor Kalaydjieva and Dr 
Toumev collected the samples. Blood samples were obtained by a finger prick using a 
sterile lance. The blood samples were applied to individual FT A Genecards on which 
name and date of birth of the individual was recorded. All blood samples were 
forwarded to myself. 
Community members were provided with educational information regarding the 
disease, the mechanisms of inheritance and reproductive options by members ofthe field 
team. Testing for the C283Y mutation was offered to members of the community 
subsequent to and independent of the administration of a questionnaire investigating 
attitudes to genetic disease and prevention. Individuals were informed of the procedure 
for taking a blood sample, the time required for the testing to be completed and a 
tentative timetable for the return of the results and the availability of counselling for 
identified carriers. If the individual desired the test, a blood sample was requested. A 
total of 325 members of the community requested the carrier test. They included 71 
individuals who had completed the questionnaire. 
12.2 Methods 
12.2.1 Laboratory Methods 
Processing ofFTA Genecards was performed as described in section 3.2.1. The 
C283Y mutation assay was performed using the Rsal restriction endonuclease as 
described in section 9.2.1. 
12.2.2 Questionnaire Design and Analysis 
12.2.2.1 Construction of the questionnaire 
The questionnaire was designed by Associate Professor Luba Kalaydjieva of the 
Centre for Human Genetics, Edith Cowan University and Professor Assen Jablensky 
from the Department of Psychiatry and Behavioural Sciences, The University of 
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Western Australia. The questionnaire was written in Bulgarian for the purpose of 
distribution and translated into English for analysis. Throughout, a numerical coding 
system was used to facilitate recording and collation of data. The questionnaire was 
composed of four separate sections, each of which was designed to investigate different 
social and attitudinal aspects of the high-risk community, relevant to genetic disease and 
predictive testing. 
Part I was designed to collect information regarding demographic factors, 
including age and marital status of the individual, employment and household structure. 
Investigations of reproductive history included questions on number of children (living 
and deceased). This section also inqujred as to whether t)le individual wished to be 
tested for the C283Y mutation. 
Part II aimed at obtaining ethnological information regarding language, faith and 
marriage contract practices. 
Part III of the questionnaire aimed to quantify an estimate of the education level 
of the individual. This was achieved by means of a fifteen-word vocabulary test. 
Individuals were visually and orally informed of the word and asked to provide a 
definition. They were then scored as knowing the correct definition, providing a partial 
answer or clearly not knowing the meaning of the word. The interviewer recorded a 
numerically coded score. 
Part IV of the questionnaire investigated the occurrence of Limb Girdle Muscular 
Dystrophy Type 2C in the interviewees immediate and extended family, and asked 
questions designed to investigate attitudes towards prevention of the disease. In the first 
section of Part IV, the individual was asked a series of five questions that aimed at 
ascertaining whether any family members had exhibited symptoms associated with the 
disease. The second subsection of Part IV aimed at determining relevant attitudes 
towards predictive genetic testing. Three hypothetical scenarios were presented to the 
interviewee. These stories were read to the interviewee and followed by questions that 
pertained to the described scenario. These questions addressed either the reasons behind 
the actions of the characters in the scenario or the possible outcomes of these actions. 
For each question that was posed, a series of responses were provided from which the 
interviewee was asked to choose the one that best described their opinion. 
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12.2.2.2 Distribution and completion of questionnaires 
The questionnaire was presented to members of the high risk Romani community 
of Omurtag in Northeast Bulgaria during 1998. Questions were posed by means of an 
oral interview conducted by Dr lvailo Toumev and members of the field team. The 
questionnaire was presented prior to and independent of the testing for the C283Y 
mutation. A total of 102 individuals completed the questionnaire. Testing for the 
C283Y mutation was offered to all individuals, however, only 71 requested the test. 
Answers to questions were recorded on the questionnaire using the numerical 
coding system. Additional information .was recorded on the questionnaire paper by the 
interviewer in Bulgarian and translated into English by Associate Professor Kalaydjieva 
and Dr Angelicheva of the Centre for Human Genetics, Edith Cowan University. 
Subsequent to the completion of all questionnaires, the original documents were 
forwarded to myself for processing and analysis. 
12.2.2.3 Analysis of questionnaire 
Each individual who had completed a questionnaire was assigned an 
identification number. The suffix to this number indicated gender and marital status (ie. 
FM =female married, FS =female single etc.). Data and numerically coded answers 
from the questionnaires were entered into a database created using Microsoft Excel. The 
names of individuals were not included in any of the analyses. Answers to questions 
were tabulated using Microsoft Excel. Data analyses were performed using Microsoft 
Excel and SPSS v10.0. 
Nonrandom statistical relationships between answers provided in the 
questionnaire and different parameters were investigated by means of chi-squared tests, 
with P-values less than 0.05 considered significant. 
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CHAPTER13 
RESULTS 
13.1 Results of the C283Y Detection Assay 
DNA samples were investigated for the C283Y mutation using the Rsal digest. 
This assay clearly determines the genotypic state at the disease-causing mutation (figure 
13-1 ). 
Figure 13-1 Agarosc gel containing Rs-al digest products from the C283Y assay 
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13.2 C283Y Status of Affected Individuals 
LGMD2C-affected individuals came from 19 different families (Table 13-1 ). Of 
the thirty-two clinically diagnosed LGMD2C, thirty were homozygous for the C283Y 
mutation. Family 4 was found to have one affected individual homozygous for the 
C283 Y mutation and one affected individual heterozygous for the mutation. The 
affected individual from Family 17 was homozygous for the wild-type state at codon 
283 of.SGCG. 
Table 13-1 
Number of affected individuals in each family and their C283 Y status. 1 C283 YIC283 Y 
indicates homozygosity for the disease causing A ---;G mutation in codon 283 of the 
SGCG, 2 C283 YIN indicates heterozygosity for the mutation, 3 N/N indicates the wild type 
state at codon 283. 
Family 
1 
4 
6 
7 
8 
9 
10 
11 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
Total 
No. of Affected Individuals 
4 
2 
1 
1 
l 
1 
l 
2 
1 
1 
2 
1 
1 
1 
1 
2 
3 
6 
0 
32 
C283Y/C283Y 1 Patients 
4 
1 
1 
1 
1 
1 
1 
2 
1 
1 
2 
1 
0 
1 
1 
2 
3 
6 
0 
30 
C283Y/N2 Patients 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
N/N3 Patients 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
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13.3 Carrier Testing of Family Members of Affected Individuals 
Individuals from sixteen families (table 13-2) requested carrier testing. 
Table 13-2 
Family members of individuals affected by LGMD2C who requested the test for the 
C283 Y mutation 
Family Number of unaffected family Non-carriers C283Y carriers Non-obligate carriers 
members who requested test of the C283Y 
mutation 
1 44 23 21 15 
4 9 5 4 2 
8 1 0 1 1 
9 15 7 8 8 
10 3 1 2 1 
11 8 3 5 3 
13 9 3 6 4 
14 3 2 1 1 
15 4 1 3 2 
16 15 8 7 5 
17 4 4 0 0 
18 3 0 3 2 
19 2 1 1 0 
20 3 0 3 1 
21 11 5 6 2 
22 21 13 8 2 
23 2 1 1 1 
Total 157 77 80 50 
The average age of the family members was twenty-eight years and the median 
age was twenty-four years. Fifty-one percent (80/157) of family members tested were 
found to be carriers of the C283Y mutation. The other seventy-seven individuals, all of 
whom were related to affected individuals, were identified as being homozygous normal 
at codon 283. Of the eighty carriers, thirty were parents of affected individuals. 
Therefore, thirty-two percent (50/157) of family members were non-obligate carriers. 
The average age of non-obligate carriers was twenty-nine years and the median age was 
twenty-three years. Of the fifty non-obligate carriers, twenty-two were already married 
and fifteen of these reported having at least one unaffected child. Thus, a total of 
twenty-eight non-obligate family members, of an average age of nineteen years, were 
identified as carriers prior to marriage. No non-obligate high-risk couples were 
identified. 
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13.4 Pilot Public Health Genetics Program 
13.4.1 Results of Questionnaire Investigating Knowledge ofDisease and Social, 
Cultural and Attitudinal Factors Relevant to Community-based Genetic 
Screening 
13.4.1.1 Introduction 
The questionnaire was administered to a total of 102 people from the Xoroxane 
Romani population. For the large part, the questionnaire was answered by married 
individuals of childbearing age. Fifty-two of the individuals were female, of whom 
three were unmarried and forty-nine were married. Fifty males were interviewed, six 
were unmarried and forty-four were married. 
For the purposes of analyses, two questionnaires, one filled by a female and one 
by her husband, were excluded due to the incomplete and confused nature of the answers 
provided. Thus, one hundred questionnaires were analysed. The answers were coded 
and entered into a Microsoft Excel spreadsheet. 
13.4.1.2 Demographic data 
Questionnaire respondents were an average of 24 years old (table 13-3). 
Households contained an average of more than five people and almost two children. 
Table 13-3 
· Summary of demographic data for questionnaire participants 
Maximum Minimum Average 
Average age 46 years 11 years 24 years 
N=91 
No. of children in family 
N=91 
No. of people in household 
N=90 
7 
11 
0 1.9 
2 5.4 
When household composition was queried the data indicated that 21% contained 
the couple and their children, 68% contained the couple, their children and one of the 
spouses parents, and 11% contained additional members of extended family. 
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Twenty-four individuals, including males and females, reported having 
experienced a miscarriage or stillbirth. Eleven of these twenty-four reported more than 
one miscarriage or stillbirth. Two individuals stated that they had a child now deceased. 
People were asked how many members of the household had held paying jobs 
during the last year. Generally, this question was not answered. In those few cases in 
which an answer was provided, it was stated that members of the household participated 
in the buying and selling of goods as a primary source of income. 
13.4.1.3 Ethnographic information and investigation of marriage practices 
All respondents stated that Tsigane (Romany) was the preferred language of use 
in the home. In addition, 90% of people stated that Turkish was also spoken in the 
house. As the questionpaire was administered in Bulgarian, it is reasonable to state that 
at least 90% of respondents were trilingual. However, no individual reported Bulgarian 
as the preferred language of use. When asked which faith they adhered to, all 
respondents declared themselves to be Muslim. 
Four questions were posed regarding marriage norms in the community (table 
13-4). 
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Table 13-4 
Questions regarding marriage practices in the Xoroxane Roma community 
Question and Responses 
Q2.1 When a marriage is contracted, what is the role of the man s parents? (%) 
Rl. In most cases they identify the right girl 
R2. In most cases it is the man s choice and approval is sought from the parents 
R3. In most cases it is the mans choice and parental approval is not necessary 
R4. None of the above 
Q2.2 When a marriage is contracted, what is the role of the girl s parents? (%) 
Rl. In most cases they identify the right man 
R2. In most cases it is the girl s choice and approval is sought from the parents 
R3. In most cases it is the girls choice and parental approval is not necessary 
R4. None of the above 
Q2.3 When a marriage is contracted, where does the man usually come from?(%) 
Rl. From the same neighbourhood and always from the same group 
R2. Always from our group but not necessarily from the same neighbourhood 
R3. Not always from our group 
R4. None of the above 
Q2.4 When a marriage is contracted, where does the girl usually come from?(%) 
Rl. From the same neighbourhood an always from the same group 
R2. Always from our group but not necessarily from the same neighbourhood 
R3. Not always from our group 
R4. None of the above 
Percentage of responses 
48.5 
45.4 
6.2 
0.0 
3.1 
22.7 
7.2 
67.0 
70.3 
26.6 
3.1 
0.0 
67.2 
29.5 
3.3 
0.0 
Responses indicated that the role of the man s parents in marriage contracts is to 
identify the right girl for their son (48.5%), or to give their approval or disapproval of 
the mans choice of potential wife (45.4%). When the same question was asked 
regarding the role of the girl s parents, 22.7% of responses stated that the girl chooses 
the man and seeks parental approval. The majority of respondents (67%) stated that 
none of the choices provided was correct. 
In marriage contracts, 96.6% of responses indicated that the man always comes 
from the same group. Seventy per cent of interviewees stated that the man always 
comes from the same neighbourhood and group and 26.6% said that the man always 
comes from the same group but may come from a different neighbourhood. Similarly, 
96.7% responses indicated that in marriage contracts the female invariably comes from 
the same group with 67.2% stating that the female always originates from the same 
neighbourhood and group and 29.5% stating that the female always comes from the 
same group but may come from a different neighbourhood. 
13.4.1.4 Interviewee s knowledge of disease within family 
Knowledge of a family history of the disease was investigated by asking 
interviewees whether they were aware of any members of their immediate and extended 
family that has/had exhibited any of the symptoms associated with LGMD2C. Five 
questions regarding common manifestations or outcomes of the disease were asked 
(table 13-5). 
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Table 13-5 
Answers to questions investigating knowledge of the disease in individuals family 
Questions No. ofResponse 
0 1 2 
Q3. 1 Do you know a child that, at age 5-6 years, started to complain of easy 
fatigue, stopped running and playing, had difficulty in climbing stairs and 
in getting up from a kneeling position? 
Q3.2 Do you know a child who, at age 10-15 years, became unable to 
walk? 
Q3.3 Do you know young men/women who died at about 20 years of age 
and were unable to walk before that? 
Q3.4 Do you know a child with deformity of the spine who has breathing 
difficulty and frequent chest infections? 
76 7 
76 7 
95 0 
96 0 
Q3.5 Do you know a child and/or young man/woman who has heart 95 0 
problems? 
13 
13 
0 
NB. O=no affected relatives, 1 =yes, in the immediate family (siblings, own children), 
2=yes, among more distant relatives (cousins, nephews and nieces, uncles, aunts). 
Seven people (7.3%) indicated that they possibly have an immediate family 
member affected by LGMD2C by answering positively to questions 1 and 2. In addition 
to these seven people, thirteen interviewees indicated that they had a member of their 
extended family who exhibited possible symptoms of LGMD2C (indicated in question 
3-1 ). A single individual reported that they had a distant relative with known heart 
problems. However, this individual did not report that the relative showed any of the 
other symptoms of LGMD2C. Of the 21 individuals who demonstrated possible 
awareness of a family member exhibiting possible signs of the disease, 14 (67%) 
requested to have the test and, 7 (33%) declined the test. 
13.4.1.5 Attitudes towards disease and predictive testing 
Attitudes towards genetic disease and prevention-associated Issues were 
investigated using three anecdotal scenarios. These scenarios were presented to the 
interviewees and they were asked to answer questions referring to these scenarios. 
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For the purposes of analysis, the sample was divided on the basis of a number of 
criteria (table 13-6). Chi-squared 2x2 contingency tests were used to identify 
nonrandom relationships between responses and the various categorical criteria. 
Table 13-6 
Criteria used to sub-divide the respondents to the questionnaire 
Criteria Categories Sample size 
CNtotal= 1 00) 
Sex Male 49 
Female 51 
Knowledge of an affected 
family member 
Requested Carrier Test 
Children 
Age• 
Knowledge 
No Knowledge 
Requested 
Not Requested 
Have children 
No children 
Above average 
Below average 
Vocabulary test Above average 
Below average 
• Ages were not provided by all individuals. 
The first scenario was followed by Question 1: 
21 
79 
69 
31 
76 
24 
41 
52 
46 
54 
lvo and Sevda have a sick child who from age 6 has difficulty walking, 
has heart problems and chest deformity. Sevda is pregnant again and 
her doctor recommends an investigation of the unborn baby. However 
the family decided to go ahead with the pregnancy without any testing. 
Why do you think they made this choice? 
Three possible responses were provided (table 13-7). 
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Table 13-7 
Answers to scenario 1 investigating attitudes towards predictive genetic testing 
Category Response' 
1 2 3 
Male 67.4 
Female 81.6 
Knowledge of affected family member 94.7 
No knowledge of affected family member 69.7 
Requested carrier test 75.0 
Declined carrier test 74.2 
Have children 82.2 
Do not have children 50.0 
Above average age of resportdents 77.5 
Below average age of respondents 68.0 
Above average vocabulary score 76.5 
Below average vocabulary score 72.7 
Total 74.7 
2.2 
0.0 
0.0 
1.3 
0.0 
3.2 
1.4 
0.0 
2.50 
2.00 
2.0 
0.0 
1.1 
30.4 
18.4 
5.3 
28.9 
22.6 
22.6 
16.4 
50.0 
20.0 
30.0 
21.6 
27.3 
24.2 
Note. All answers are in percentage values. Significant differences are highlighted. 
1 Response 1 =Because it is Gods will and it would be sinful to interfere. Response 
2=Because one shouldn t trust medicine completely. Response 3=Because it is 
impossible to know whether an unborn child will have the disease. 
The majority of respondents (74.7%) selected answer 1, because it is Gods will 
and it would be sinful to interfere. Significantly more individuals who had already 
produced a child chose this answer (82.2%) than those who did not have a child (50%), 
x\1, N=94) = 10.131, p=O.Ol. Furthermore, significantly more people who know of an 
affected child in their family chose answer 1 (94.7%) compared to those who do not 
know of an affected child in their family (69.7%), x2 (1, N=94) = 4.752, p=0.029. 
Scenario 2 presented the individual with the following hypothetical situation: 
Ivo and Sevda are newly married and don t have children yet. Sevda 
has a cousin with the disease but there are no sick people in Ivo s 
family. Sevda wants both she and Ivo to have a test before deciding to 
have children. Sevda talks to her mother-in-law about this. The 
mother-in-law decides they do not need the test because nobody in Ivo s 
family is affected. 
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The interviewees were then asked three questions: 
• Question 2.1. Would it have been right for Ivo and Sevda to discuss the matter with 
Sevda s parents and Ivo s father and decide as a group? 
• Question 2.2. Would it have been a good idea if Ivo and Sevda did not discuss the 
matter with anyone and made their own decision? 
• Question 2.3. What would happen if the characters disobeyed the mother-in-laws 
decision? 
The answers to these questions were tabulated (table 13-8) 
Table 13-8 
Answers to q_uestions investifi.atinE£_ decision makin8_ about rep_roductive issues 
Question 2.1• Question 2.2• Question 2.3A 
Answer 1 2 3 1 2 3 1 2 3 
Male 75.0 10.8 4.2 28.6 67.3 4.1 18.4 34.7 46.9 
Female 76.5 19.6 3.9 13.7 82.4 3.9 18.0 40.0 42.0 
.. 
Knowledge of affected family member 76.2 23.8 0 9.5 90.5 0 19.0 42.9 38.1 
No knowledge of affected family member 75.6 19.2 5.1 24.1 70.9 5.1 17.9 35.9 46.2 
Requested carrier test 82.6 13.0 4.3 18.8 76.8 4.3 16.2 35.3 48.5 
Declined carrier test 60.0 36.7 3.3 25.8 71.0 3.2 22.6 41.9 35.5 
Have children 76.3 21.1 2.6 15.8 80.3 3.9 16.0 38.7 45.3 
Do not have children 73.9 17.4 8.7 37.5 58.3 4.2 25.0 33.3 41.7 
Above average age of respondents 75.6 22.0 2.4 19.5 78.0 2.4 14.6 41.5 43.9 
Below average age of respondents 76.5 19.6 3.9 23.1 71.2 5.8 19.6 31.4 49.0 
Above average performance on test 81.5 13.0 3.7 24.1 70.4 5.6 16.7 25.9 57.4 
Below average performance on test 67.4 28.3 4.3 17.4 80.4 2.2 20.0 51.1 28.9 
Total 75.8 20.2 4.0 21.0 75.0 4.0 18.2 37.4 44.4 
Note. All answers are in percentage values. Significant differences are highlighted. 
·For questions 2.1 and 2.2: Answer 1 =yes, Answer 2 =no, Answer 3 =not sure. AFor 
question 2.3: Answer I = nothing will happen, the mother-in-law will accept their 
choice, Answer 2 = They will be on bad terms after that, Answer 3 = I don t know, all 
families are different. 
Of the 99 responses provided for question 2.1, 75.8% agreed that it would have 
been right for the couple to discuss the matter with their parents. A significantly greater 
proportion of individuals who chose to have the carrier test answered that it would be 
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right to discuss the matter with the females parents and males father (82.0%) than 
those individuals who declined the carrier test (60.0%) X2 (1, N=95) = 7.155, p=0.007. 
Seventy five per cent of respondents replied that it would not be a good idea for 
the couple to make their own decision without consulting anyone. Over twice the 
proportion of males (28.6%) than females (13.7%) responded that it would be permitted 
not to consult anyone about making the decision, however, the difference was not 
significant. Significantly more people who had produced a child (80.3%) believed that 
to proceed with the test without discussing the matter with the parents would be a bad 
idea compared with those who did not have children (58.3%), X2 (1, N=96) = 5.270, 
p=0.022. 
Question 2.3 inquired about the likely outcome of disobeying the mother-in-
law s decision and going ahead with a genetic test. Thirty-seven percent said that they 
would be on bad terms with the mother-in-law if they took such a course of action. 
However, the majority of respondents (45%) said that they could not know because all 
families are different. Individuals who performed below average on the vocabulary test 
were more likely to say that they would be on bad terms after this (51.1 %) than did those 
who scored above the average (25.9%) x2 (2, N=99) =8.807 p=O.Ol2. 
A third scenario was presented to individuals on which a single question was 
asked. Four answers (A3.1, A3.2, A3.3, A3.4) were provided for this question and the 
individual was asked to respond as to whether they agreed, disagreed or were unsure 
with each answer. The scenario provided was: 
Tinka is not married yet but she often thinks of the children that she 
would like to have some day. Tinka has a girlfriend and the friend s 
brother is affected with the disease. Tinka thinks that it is a terrible 
disease and is worried by the idea of her own children being affected. 
When Tinka was offered the test, however, she declined to have it. 
Why do you think she declined? 
Table 13-9 provides the four answers and the distribution of responses to these answers. 
The majority of respondents (86%) disagreed with the answer that the character 
would decline the test because she doesn t believe a doctor could determine if she was a 
carrier for the disease. Similarly, most (718%) disagreed that she would decline the test 
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because she would think that there is nothing that could be done if she were a carrier. 
Over two-thirds of respondents agreed that if she turned out to be a carrier no-one would 
marry her and that this would be a reason to decline the test. Significantly more people 
who had a child (75.0%) than those without children (50.0%) agreed that if she turned 
out to be a carrier she will never get married and that this was a reason not to have the 
test, X2 (1, N=97) = 3.813, p=0.050. 
Of the 100 responses, 58% agreed that she would decline a test because if she 
turns out to be a carrier, the whole family would lose face and that this would be a 
reason to decline the test. Significantly more people (63.3%) who did not have a family 
member with symptoms of the disease agreed that the whole family would lose face if 
she turned out to be a carrier when compared with those who did have an affected 
family member(38.1%),X2 (1, N=97) = 5.249, p=0.022. 
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Table 13-9 
Reasons an individual miB_ht decline a B_enetic test 
No Yes Unsure 
A 1. Because she doesn t believe that doctors can find out whether she is a carrier(%) 
Male 81.6 16.3 2.0 
Female 90.2 7.8 2.0 
Knowledge of affected family member 95.2 4.8 0.0. 
- No lrnowledge of affected family member 83.5 13.9 2.5 
Requested carrier test 89.9 8.7 1.4 
Declined carrier test 77.4 19.4 3.2 
Have children 88.2 10.5 1.3 
Do not have children 79.2 16.7 4.2 
Above average age of respondents 85.4 14.6 0.0 
Below average age of respondents 84.6 11.5 3.8 
Above average performance on test 85.2 14.8 0.0 
Below average performance on test 87.0 8.7 4.3 
Total 86.0 12.0 0.0 
A2. Because there is nothing she can do even if she is found to be a carrier(%) 
Male 75.5 18.4 6.1 
Female 80.4 19.6 0 
Knowledge of an affected family member 85.7 9.5 4.8 
No knowledge of an affected family member 75.9 21.5 2.5 
Requested carrier test 81.2 15.9 2.9 
Declined carrier test 71.0 25.8 3.2 
Have children 78.9 19.7 1.3 
Do not have children 75.0 16.7 8.3 
Above average age of respondents 78.0 19.5 2.4 
Below average age of respondents 78.8 17.3 3.8 
Above average performance on test 79.6 18.5 1.9 
Below average performance on test 76.1 19.6 4.3 
Total 78.0 19.0 3.0 
A3. Because if she turns out to be carrier she will never get married (nobody would want 
to marry her)(%) 
Male 34.7 59.2 6.1 
Female 21.6 78.4 0.0 
Knowledge of an affected family member 31.6 65.8 2.5 
No knowledge of an affected family member 14.3 81.0 4.8 
Requested carrier test 24.6 71.0 4.3 
Declined carrier test 35.5 64.5 0.0 
Have children 23.7 g$}ij 1.3 
'''i\11:' Do not have children 41.7 ~ . .i9. 8.3 
Above average age of respondents 19.5 78.0 2.4 
Below average age of respondents 36.5 59.6 3.8 
Above average performance on test 29.6 66.7 3.7 
Below average performance on test 26.1 71.7 2.2 
Total 28.0 69.0 3.0 
A4. Because if she turns out to be a carrier, the whole family will lose face(%) 
Male 44.9 51.0 4.1 
Female 33.3 64.7 2.0 
Knowledge of an affected family member 32.9 
•L-· 
3.8 
No knowledge of an affected family member 61.9 0.0 
Requested carrier test 37.7 59.4 2.9 
Declined carrier test 41.9 54.8 3.2 
Have children 36.8 61.8 1.3 
Do not have children 45.8 45.8 8.3 
Above average age of respondents 43.9 56.1 0.0 
Below average age of respondents 36.5 57.7 1.9 
Above average performance on test 44.4 53.7 1.9 
Below average performance on test 32.6 63.0 4.3 
Total 39.0 58.0 1.0 
NB Significant differences are highlighted. 
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The responses to the four answers to scenario 4.3, in which respondents were 
asked to state whether they disagreed with or agreed With the answer given, can be 
grouped into two categories. Answers 1 and 2 posit mistrust in the ability of medicine to 
act in an adequate manner as a reason to decline the genetic test. Answers 3 and 4 
address the issue of fear of stigmatisation of carriers as a reason not to have the genetic 
test. Individuals were scored for each of these categories depending on their answers to 
the two questions. These answers were then considered as strongly agreed with the 
concern (a response of yes to both answers), agreed with the concern (response of 
yes to one answer and no to one answer) and did not agree with the concern (a 
response of no to both answers). An unsure response to either question was 
considered as being unsure about the issue. 
A total of 23% of responses indicated a lack of faith in medicines ability to 
detect carriers or aid them is reason to decline the test (figure 13-2). However, only 4% 
of responses strongly agree with this concern and believe that it is reason to not have the 
test. The majority of responses (69%) indicated that they disagree with the answers that 
doctors are unable to identify carriers or act if one is identified as a carrier. The 
proportion of answers provided by males and females was virtually identical and 
answers were not significantly related to any demographic factors. 
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Figure 13-2 Answers indicating that distrust of medicine would be a reason to decline 
a can-ier test. Note: 0 indicates that the individual disagrees with the answers that 
medicine is unable to act or provide adequate information, l indicates that the individual 
thinks that medicine is unable to help, 2 indicates that the individual strongly believes 
that medicine is unable to help, 8 indicates that the individual is unsure about the issue. 
A total of 47% of responses strongly agree that stigmatisation would result from 
being identified as a can-ier and that this would be a reason to decline the test (figure 13-
3). A further thirty-two percent of responses agree that the possibility of stigmatisation 
would be a reason to decline the test. Only 17% of individuals disagree that 
stigmatisation is a possible outcome and therefore not a reason to decline the test. 
Twenty percent more females (57%) than males (37%) indicated that they strongly 
agreed that the possibility of stigmatisation was suitable reason not to have the test. 
However, there were no significant relationships between demographic parameters and 
responses to these answers. 
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Figure 13-3 Responses indicating fear that positive carrier status may result in 
stigmatisation. Note: 0 indicates that the individual does not believe that being 
identified as a carrier will result in stigmatisation and therefore is not a reason to 
decline the test, 1 indicates that the individual does consider stigmatisation a 
possibility and therefore reason to decline the test, 2 indicates that the individual 
strongly believes that being identified as a carrier will result in stigmatisation and 
therefore the character should not have the test, 8 indicates that the individual is unsure 
about the issue. 
13.4.2 Screening for C283Y Carriers in a High-Risk Community 
13.4.2.1 Uptake of genetic test 
Carrier testing for the C283Y mutation was requested by 325 members of the 
high-risk community fo llowing the provision of information by the Bulgarian field team 
regarding the disease and the availability of carrier testing. All individuals originated 
from a community with LGMD2C patients. Individuals were categorised on the basis of 
sex and marital status. The participants ranged in age from 8 years to 46 years and were 
an average 19 years old at the time of the test (table 13-l 0). Children were tested only 
when parents requested testing. 
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Table 13-10 
Community members who requested test for C283 Y mutation 
Number Oldest Youngest Average Age 
Married Females 88 40 
Unmarried Females 75 25 
Married Males 78 46 
Unmarried Males 84 23 
Total 325 46 
13.4.2.2 Carrier test results 
15 
9 
16 
8 
8 
(years) 
23 
14 
23 
14 
19 . 
Carrier testing for the C283Y mutation was performed using the Rsa1 assay. 
Fourteen carriers for the C283Y mutation were identified among the 325 community 
members. Tests were replicated for these individuals to confirm results. These fourteen 
individuals comprised four married males and six married females, as well as two 
unmarried males and two unmarried females. The age of identified carriers ranged from 
12 to 30 years old with an average age of 21 years. Seven of the identified carriers had 
completed the questionnaire. Three carriers ofthe C283Y mutation had indicated in the 
questionnaire that they have a family member with possible symptoms of the disorder. 
All carriers identified in the community screening were personally contacted by 
the Bulgarian field team and provided with post-test counselling. Individuals who were 
negative for the carrier test were informed of the result in writing and in person where 
possible. There were no high-risk couples identified. The number of carriers identified 
in the sample suggested a carrier rate of 4.3% and a gene frequency of 0.022 in the 
population. 
Upon returning the results to the community members, the Bulgarian field team 
became aware that the sample of screened individuals comprised two socially and 
culturally distinct groups, the Turgovzi and Feredjelli (L. Kalaydjieva, pers. comm.). 
Members of the community informed the field team that these two groups do not 
intermarry. Individuals were then assigned to one of these two groups. A total of 233 
individuals declared themselves as Turgovzi and 101 declared themselves to be 
Feredjelli (table 13-11). 
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Table 13-11 
Group affinities of individuals who requested carrier testing 
Turgovzi Feredjelli 
Married Females 69 19 
Unmarried Females 
Married Males 
Unmarried Males 
Total 
42 
62 
51 
224 
33 
16 
33 
101 
The fourteen individuals identified as carriers in the community screening belong 
to the Turgovzi population. The C283Y mutation was absent in the 101 individuals 
belonging to the Feredjelli. Furthermore, additional investigations have revealed that all 
families with LGMD2C affected individuals are Turgovzi (L. Kalaydjieva, pers comm). 
Therefore, the detection of 14 C283Y carriers in a sample of 224 Turgovzi indicates a 
carrier frequency of 6.2%. 
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CHAPTER14 
DISCUSSION 
14.1 Private Mendelian Disorders and Mutations Among Romani 
Populations 
A number of private Mendelian disorders and/or disease-causing mutations have 
been reported in the Roma (Abicht et al., 1999; Angelicheva et al., 1999; Kalaydjieva et 
al., 1996; Kalaydjieva et al., 1999; Plasilova et al., 1999; Rogers et al., 2000). In these 
cases, complete allelic homogeneity and elevated gene frequencies have been observed 
due to founder effect. Thus, these mutations provide a rational starting point for 
molecular diagnosis when an affected individual is of known Romani ethnicity. A 
systematic survey of Romani populations has revealed high carrier rates for two founder 
mutations within populations (section III). This suggests that targeted community 
genetics programs may be justified. 
The report of Piccolo et al., (1996) in which a founder C283Y mutation in SGCG 
was identified as a cause of LGMD2C in West European Roma, provided the impetus 
for investigations of the Bulgarian Romani population for this same disease-causing 
mutation. This study of the genetic basis of LGMD2C in people of Roma ethnicity has 
aimed to confirm the occurrence of the private C283Y mutation in geographically 
separated but historically related populations. The ramifications of this phenomenon to 
public health genetics has been explored through the initiation of a pilot community-
screening program that aimed at providing genetic information to community members, 
and identifying salient social and psychological variables that may predictably affect the 
effectiveness of such an endeavour. 
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14.2 Biological Factors Impacting on Efficiency of Genetic Screening 
Program 
14.2.1 Molecular Genetic Basis of LGMD2C in the Xoroxane Roma 
The A-?G transition in codon 283 of the SGCG was confirmed to be in the 
homozygous state in thirty of thirty-two clinically diagnosed limb girdle muscular 
dystrophy type 2C patients. Thus, the founder mutation first identified as the causative 
gene defect in Roma resident in Italy, France, Spain and Portugal (Lasa et al., 1998; 
Piccolo et al., 1996) is also present in at least one Balkan Romani population. The 
common origin of this unique event mutation is validated by disease haplotype analysis, 
which reveals the same well-conserved haplotype described in Iberian Roma patients 
(section III). 
Whilst this mutation is clearly responsible for the majority of cases of LGMD2C 
it does not represent the only cause of the disease in the Romani population. 
Identification of a homozygous normal genotype in one patient and a heterozygous 
patient indicate an alternative aetiology of the muscular dystrophy in these patients. 
14.2.2 Gene Frequencies and Carrier Rates 
Genotyping of family members of affected individuals is clearly an efficient 
means of identifying carriers of the C283Y mutation. This form of carrier testing has 
been termed cascade testing by Super, Schwarz, & Malone, (1992). The fifty non-
obligate carriers identified using this approach represent a carrier identification rate of 1 
for every 2~5 family members tested. As carrier testing was offered to all family 
members regardless of age, a number of individuals were tested for whom reproductive 
issues may no longer be pertinent. However, the identification of twenty-eight carriers 
prior to marriage allows these individuals to incorporate this knowledge in future marital 
and reproductive decisions. 
In screening for the mutation in the high-risk community, the identification of 14 
carriers was initially understood to correspond with a carrier frequency of 4.3%. 
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However, further investigations revealed the restriction of these carriers to one of two 
distinct populations. The absence of any carriers in the 101 screened Feredjelli and the 
absence of any affected individuals in this group suggests that the mutation may not be 
present in this population. Thus, the carrier rate in the Turgovzi is in fact 6.2%. This 
result contrasts with a study of randomised neonatal screening samples for the C283Y 
mutation in undefined Romani groups from Northeastern Bulgarian which reported a 
heterozygote rate of 2.25% (Todorova, Ashikov, Beltcheva, Tournev, & Kremensky, 
1999). This discrepant result highlights the necessity of obtaining carrier frequencies for 
a defined population. Bulgaria is known to be home to some fifty Roma groups who 
may or may not follow strict endogamous practices (Marushiakova & Popov, 1997). 
Whilst many of these populations are descended from a common ancestral population, 
the observation that a mutant allele can occur at a high frequency in one population and 
be absent in a population living in the immediate geographical vicinity highlights the 
need for appropriately structured epidemiological studies prior to the implementation of 
targeted genetic screening in Romani populations. 
Whilst the cascade method of testing within families of affected individuals is 
the most efficient means of identifying carriers, population screening is justified when 
carrier rates are so high. A carrier frequency of 6.2% represents a significant risk for the 
members of the community and to restrict the offer of the test to family members would 
neglect addressing a significant public health concern. 
14.2.3 Laboratory Design for Founder Mutations 
Founder mutations enable very high detection rates in mutational analyses. The 
identification of a founder mutation in a homogeneous population presents the logical 
starting point for identification of carriers of heritable disorders. As such, the design of 
laboratory methods for this task is greatly simplified with only one known mutation to 
test. 
Detection of all founder alleles does not, however, mean that all carriers of the 
disorder have been detected. If we· examine the mutation detection rates in the thirty-
two affected individuals in this study, it is clear that one hundred percent of all C283Y 
chromosomes were detected. However, the ·assay failed to detect the mutational basis of 
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the disease in three disease chromosomes (4.7%) which were found to be normal 
wildtype at codon 283 of the SGCG. Nevertheless, this degree of sensitivity is markedly 
more favourable than for the majority of monogenic diseases in outbred populations 
where detection rates are only 60-90% (van Ommen, Bakker, & den Dunnen, 1999). 
Allelic heterogeneity in large regional populations will result in low detection rates in 
population based carrier screening. 
Clearly, targeted carrier testing in defined subpopulations for founder mutations 
will identify the greatest proportion of carriers for the lowest cost. Testing for a single 
mutation reduces laboratory costs and expedites large population screening. However, it 
must be borne in mind by the provider ?f genetic services and clearly communicated to 
the population that carrier detection for a known mutation does not completely correlate 
with carrier testing for a disorder. From the results obtained in genotyping LGMD2C 
affected individuals, it is reasonable to consider carrier detection rates of 95.3% for 
muscular dystrophy in this population. 
14.2.4 Expected Trends in Carrier Rates 
The social practice of endogamy, whilst fulfilling a social need, results in a 
greater incidence of autosomal recessive disorders (Bittles & Neel, 1994). Endogamous 
practices in a population increase the likelihood of two carriers of a recessive mutation 
forming a union but does not directly cause the proportion of carriers to increase. 
Factors that increase the number of carriers may be selective advantage and stochastic 
processes, such as random genetic drift. The effect of drift is more pronounced in small 
and isolated populations where it can result in the increased frequency of deleterious 
genes. 
In the Turgovzi community investigated in this study, a carrier rate of 6.2% was 
observed which corresponds with a gene frequency of 0.031. An elevated frequency of 
a deleterious allele such as the C283Y mutation poses a significant potential risk to the 
population. If we consider the marital norms identified in the questionnaire, in 
approximately 97% of cases the marital partner will come from within the group. 
Therefore, the expected affected birth rate is 1/1072 births. It is likely, however, that the 
affected birth rate would be greater than this value as calculations of carrier rates in the 
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population have excluded those carriers identified through testing within families of 
affected individuals. More correctly, this is the expected incidence of affected births to 
parents who are unaware of a familial history of the disease. 
14.3 Social Factors Relevant to Uptake of Genetic Testing and its Efficiency 
14.3.1 Family Structure and Decision Making Regarding Marriage and 
Reproductive Issues 
The majority of individuals investigated in this study live in households that 
contain at least three generations of family members. Furthermore, it is apparent from 
the questionnaire that members of the extended family are typically involved in 
decisions relating to marriage contracts and reproductive issues. In most cases, the 
parents are intimately involved in the selection and approval of their children s marriage 
partner. Similarly, decisions regarding genetic testing appear to be an issue that must be 
addressed by the family group, including the couple and both sets of parents. Therefore, 
it is clear that the provision of education and counselling for genetic issues should 
account for this dynamic through the inclusion of potential grandparents in the 
counselling process. This challenges typically held notions about the right to genetic 
privacy, which is generally asserted in the western medical setting (BMA, 1998). 
Clearly, every effort must be made to ensure that all individuals involved in the 
decision-making process are fully informed whilst meeting the criteria for respecting an 
individual s autonomy and privacy. Further investigations of culturally specific 
confidentiality systems would serve to identify the relevant level of privacy that is 
appropriate for members of this community. Close attention must also be paid to 
possible shifting family dynamics which may be evidenced by the apparent relationship 
between education (as ascertained by the vocabulary test) and greater individual control 
of reproductive decisions. 
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14.3.2 Major Social Concerns Examined in Community. 
14.3.2.1 Faith in medical investigations 
The majority of community members appear to believe that medical 
investigations are able to identify carriers and utilise that information for the benefit of 
the individual. Less than one quarter of the sampled population indicated a lack of 
confidence in the ability of medicine either to determine carrier status or to do anything 
if carrier status was found to be positive. This result would seem to indicate that 
members of this community have a reasonable level of faith in medical practices. 
However, the answers provided indicate that, for some people, concerns about the 
efficacy and reliability of medical procedures involved may prevent them accepting a 
carrier test. These concerns may be addressed through continued education and 
communal discourse. It is also possible that through first hand observation of the 
successful provision of relevant genetic information, attitudes in the community may 
change positively. 
14.3.2.2 Religious issues 
A belief that the fate of a child s health is in God s hands and that interference is 
sinful is a commonly held view by the community members. Close to three-quarters of 
the questionnaire respondents chose this as a reason not to have a prenatal test over the 
belief that it is impossible to know whether an unborn child will have the disease. This 
view was even stronger in individuals who already had a child and even more so 
amongst those who reported knowledge of an affected family member. It is interesting 
to note that seventy-five percent of individuals who indicated this attitude still requested 
the carrier test for themselves. This points to a difference in declared attitudes and 
personal choice. 
14.3.2.3 Concerns of stigmatisation 
The implications of positive carrier status of a disease-causing mutation are 
clearly a concern for members of the community. Seventy-nine percent of those 
interviewed believe that some form of stigmatisation would be an outcome of being 
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identified as a carrier of the mutation and the majority of these people strongly agree that 
it would be an outcome. Interestingly, a greater proportion of people who know of an 
affected family member believe that an individual will never get married if she is 
identified as a carrier than those who do not know an affected family member. 
However, a significantly lower proportion of people who know a possibly affected 
family member believe that the whole family will lose face if an individual is identified 
as a carrier of the disorder. 
Stigmatisation of carriers has been reported as a concern in many populations 
targeted for screening, including Greeks (Stamatoyannopoulos, 1972), Native Americans 
(Foster, Bernsten, & Carter, 1998) and .Ashkenazi Jews (Rothenberg & Rutkin, 1998). 
However, follow-up studies of detected carriers have shown that these concerns 
diminish with time (Zeesman, Clow, Cartier, & Scriver, 1984). Concerns regarding 
stigmatisation of carriers can only be addressed through effective education and dialogue 
between the genetic service provider and the community. Information must be 
transmitted that assures the community of the benign nature of being a carrier for a 
recessive disorder and serves to empower those individuals who are carriers through 
active education. 
14.3.3 Ameliorating }""actors Impacting on Attitudes Towards Genetic Testing 
Attitudes towards predictive testing were cross-tabulated with a number of 
parameters in order to identify factors that may impact on the receptivity of such a 
public health program. In general, there was a large degree of homogeneity in answers, 
which suggests well-entrenched cultural and social attitudes. However, the 
identification of factors that impact on attitudes towards testing may illuminate strategies 
for the implementation of an effective and useful program. 
14.3.3.1 Knowledge of the disease within one s family 
Knowledge of the occurrence of the disease within ones family had a strong 
impact on views held by individuals. Only 66% of people who knew the disease might 
occur in their families decided to take the test. Furthermore, of those individuals who 
knew of the disease almost all declared that the fate of a child s health was in God s 
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hands. Thus, it is apparent that knowing the disease occurs in one s family may be 
correlated with a greater degree of fatalism. However, this should not be interpreted as a 
reduced interest in knowing one s carrier status as evidenced by the large number of 
family members of affected individuals who requested the test. Clearly, a far smaller 
percentage of these people believe that identification as a carrier for the mutation would 
confer a loss of face for the whole family. However, fear of identification as a carrier 
may be increased among family members of affected individuals and impact on their 
decision to become informed about their carrier status. 
14.3.3.2 Children 
Having already produced children appears also to result in a greater degree of 
fatalism regarding the health of a newborn child. People with children also seem to 
place more emphasis on the role of the extended family in decision-making regarding 
reproductive issues. As it has been suggested that young adults prior to marriage and 
child-rearing are the most appropriate targets for carrier testing (BMA, 1998), it is 
possible that the attitudes of these people are the most important. In general, childless 
people in the community show a reduced concern with stigmatisation of carriers and are 
less inclined to believe that the fate of a child is in God s hands. Thus, members of this 
demographic group may be more receptive to counselling and testing for carrier status. 
14.4 Summary of Findings 
This study has demonstrated the implementation of a successful pilot carrier-
screening program in a Balkan Romani community at increased risk for a disease-
causing mutation. Genetic testing of patients has revealed the causative mutation as 
being identical to that found in Roma elsewhere in Europe. Cascade testing in the 
families of affected individuals has proved an efficient means of identifying a large 
number of carriers. A high gene frequency within a population justifies community 
wide screening for the mutation. 
It is apparent that population structure, as revealed by social anthropology, 
warrants careful consideration in the design of such programs. The co-habitation of 
socially distinct groups that share a common origin does not necessarily mean that the 
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deleterious gene is shared between the groups. Thus, targeted population screening must 
be preceded by epidemiological investigations that pay· close attention to the social and 
genetic structures of populations. 
In general, this Romani population appears to be receptive to carrier testing. 
Education and counselling processes must be sensitive to family structures and decision-
making processes and aim to minimise concerns about stigmatisation of carriers. This 
can only be achieved through participatory education and counselling and demonstration 
of the reproductive benefits of carrier identification. Further studies are required to 
answer the question of whether the benefits of such programs outweigh the potential 
harm. Long-term effectiveness studies should investigate the incorporation of carrier 
knowledge, a reduction in incidence of affected births and the psychological and social 
responses to knowledge of carrier status. 
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CHAPTER15 
CONCLUSION 
15.1 Summary and Recapitulation 
Historical records first mention the Roma in Europe some 800 years ago (Fraser, 
1992). Chronicles from the following centuries allow the reconstruction of their 
migration into the Balkans and, some 200 years later, into Western Europe. Subsequent 
migrations of Roma have occurred in Europe, altering the demographic topography of 
the population. The single major migration of the last 500 years occurred in the 191h 
century when Roma left Wallachia and Moldavia following the end of their enslavement 
in those lands. From an early stage, the Roma have led a nomadic existence. To ensure 
their economic viability and minimise external hostilities, it has been necessary to exist 
in small groups. Thus, the Roma have fractured into a constellation of populations. The 
differing historical legacies of these groups have resulted in a mosaic of populations 
dispersed throughout Europe. These groups have differentiated and are socially and 
culturally diverse. In many cases, adherence to strict endogamous practices has ensured 
a strong internal cohesion within each of these groups, and at the same time expedited 
their divergence from one another. 
In the absence of a recorded history, linguistics is able to clarify some of the 
opacity of the origins and historical relatedness of these groups. The languages of the 
. Roma have been studied for over 200 years, informing us that the dialects of many of 
these groups stem from a common language of Indian origins (Fraser, 1992; Hancock, 
2001). Additional shared cultural practices and traditions buttress this finding (Rishi, 
1976). However, culture is known to be a rapidly evolving phenomenon that can easily 
outpace changes in the biological composition of a population. Furthermore, cultural 
traits can be acquired, and are not necessarily indicative of biological affinities. 
Therefore, studies of the genetic composition of a population provide a unique means of 
investigating population history. 
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In this thesis, separated Romani populations have been shown to share common 
maternal and paternal lineages of Asian origin. Whereas previous genetic studies of 
Romani populations have examined the frequency distribution of common polymorphic 
variants, these lineages represent discrete variants of demonstrated restriction to Asian 
populations. Thus, the evidence provides sound support for theories of the Indian origin 
of the Roma. Limited diversity within theY chromosomal haplogroup VI-68 and the 
mitochondrial haplogroup M suggests that Romani populations are descended from a 
small number. of related founders. This points to a pre-European Romani population of a 
single ethnic identity, rather than a conglomerate of people of different Indian origins. It 
is likely that the population that exited l~dia was comprised primarily of a socially and 
ethnically distinct class of people that already had the features of a population isolate. It 
is unclear when the Roma left India, however linguistic analyses point to a departure 
after 1000 AD (Hancock, 2001). Coalescent dating ofY chromosome haplogroup VI-68 
implies that the ancestral male population existed for some 1,000 years prior to the 
emigration of the proto-Roma. 
The migration of the Roma from India into Europe can be estimated to have 
taken around 100 to 200 years. Linguistics points to a migration route through Persia 
and Armenia with possible extended stays in those regions (Fraser, 1992; Hancock, 
1999). Genetic analyses in this study show a significant population component of 
probable Middle Eastern or Central Asian origins. Haplogroup VI-56 and mitochondrial 
haplogroup U3 are both most common in Middle Eastern populations. In the Roma, 
these lineages are found in different populations and display limited diversity, which 
provides evidence for pre-European admixture by a small number of related founders. 
Disentangling the population origins of the other male and female lineages is difficult 
given their lack of regional specificity. Certainly, many of these can be attributed to 
male- and female- mediated admixture by autochthonous European populations. 
However, unique lineages in the Roma are possibly representative of pre-European 
admixture. Discerning the history of these lineages in the Roma awaits clarification of 
their distribution in worldwide populations. 
Extant Romani populations are related by common lineages but these lineages 
are nonrandomly dispersed, providing additional insights into the history of the Roma in 
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Europe. Male-specific genetic diversity is structured according to the major migrational 
groupings of Romani populations. Haplogroup VI-68 occurs at the highest frequencies 
in Vlach-speaking groups. These are groups that have at one time been resident in 
Wallachia, Moldavia and Rumania and presumably were enslaved to some degree. It is 
conceivable that slavery did much to prevent intermarriage between the Roma and the 
society that subjugated them. Similarly, the male components ofpopulations contained 
within the Balkan and West European Roma are most closely related, which reflects 
common histories within Europe. In contrast, maternal lineages do not conform to 
migration groupings. Mitochondrial DNA lineages demonstrate a clear distinction 
between the Western European Roma and all other Roma. However, there is minimal 
substructuring within the female component of geographically proximate populations. 
This is possibly indicative of greater female-mediated gene flow between geographically 
proximate populations, and greater autochthonous European female admixture in the 
Balkan and Vlach Roma. 
Long-term endogamous practices have evidently resulted in strikingly reduced 
genetic diversity in Romani populations. The genetic diversity of males is lowest in the 
Vlach populations, a reflection of the preservation of high frequencies of the founding 
haplogroup. The most restricted female genetic diversity is observed in the Lithuanian 
and Spanish Roma. These populations have relatively high male genetic diversity. 
Therefore, this suggests a stricter adherence to female endogamic practices. Further 
social anthropological investigations are required to confirm or refute this postulation. 
The unique population structure of the Roma was shown to be essential for the 
identification of the founder mutation in NDRG 1 resulting in HMSNL. Whereas the 
localisation of the disease gene by Kalaydjieva et al., (1996) was facilitated by the 
limited diversity of disease haplotypes within a single pedigree, the refinement of the 
region benefited from the heterogeneity of disease chromosomes in different Romani 
populations. Reducing the size of the critical interval to 202kb, through the use of 
multiple historical recombinations, greatly ameliorated the task of searching for a 
disease-causing mutation. This is an essential step given that positional candidate genes 
in a chromosomal segment can be numerous. The value of sampling separated Romani 
groups is highlighted by the HMSNL locus refinement based on 6 historical 
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recombinations identified in 5 populations. This illustrates the necessity of including 
individuals from different Romani populations in refined mapping efforts of disease loci. 
The homogeneity of disease haplotypes observed within endogamous Romani 
populations would impede efforts at locus refinement that are limited to a single 
population. 
Identification of the HMSNL gene defect contributes an essential step to 
understanding the cellular pathology ofthis particular disorder. The function ofNDRGl 
is poorly understood; however, published findings suggest its role as a signalling or 
chaperone molecule. Studies investigating the role of this protein in the affected tissues 
of individuals with HMSNL should elucidate the biochemical or mechanistic 
dysfunction. In addition, future studies of NDRG 1 should provide important insights 
into normal Schwann cell-axon interactions and development. This should have 
applications beyond understanding and treating HMSNL, as the same cellular 
mechanisms could underlie a number of neurological disorders, both inherited and 
acquired. 
The HMSNL mutation is widely dispersed in the Roma. Screening for R148X 
heterozygotes revealed carriers in Vlach, Balkan and West European populations. The 
disorder has been described in Italian (Merlini et al., 1998), Slovenian (Butinar et al., 
1999), Spanish (Colomer et al., 2000), French and Rumanian Roma (Chandler et al., 
2001), in addition to the initially reported occurrence in Vlach Roma (Kalaydjieva et al., 
1996). The prevalence of this disease allele can be explained by its genesis over 1000 
years ago, prior to the fracturing of Romani populations. Thus, the Rl48X disease allele 
canbe classed as a significant health risk in the Roma. A carrier frequency of 19.5% in 
the Lorn population provides the impetus for widespread community screening. In other 
populations, the frequency of carriers justifies cascade screening and possibly 
community-wide carrier testing. 
In contrast to the R148X disease allele, the C283Y allele is not widely 
distributed in Roma. This allele possibly arose after the arrival of the Roma in Europe, 
thereby restricting its distribution in separated populations. The C283Y mutation has 
been reported in a number of Western European Romani populations (Lasa et al., 1998; 
Piccolo et al., 1996). Screening of populations in this study identified a single C283Y 
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carrier in the sample of Spanish Roma. Among the Balkan and Vlach Roma it was only 
identified in the Turgovzi. In this population it occurs at high frequency, with a carrier 
rate of 6.25%. The experience of the LGMD2C screening in the Turgovzi population in 
North East Bulgaria suggests that community screening is suitable when a large number 
of affected individuals are observed. Limiting access to a carrier test to individuals 
related to affected persons is not justifiable in light of the demonstrated high carrier 
rates. Moreover, this pilot public health genetics program has shown the receptivity of a 
Romani community. However, attitudes towards predictive testing are culturally 
specific. As Romani populations are culturally heterogeneous, the findings from this 
pilot study may not be universally applicable. 
For genetic research, the high allele frequencies observed in the Roma have 
profound implications for strategies that may be employed to identify disease genes. 
Searching for IBD segments, using approaches such as homozygosity mapping and 
segment-sharing run a high risk of failure. This is because high gene frequencies 
combined with the old age of a mutation are likely to result in disease haplotypes that 
cannot be detected using conventional 1 OcM maps. Although the disease haplotype may 
not be preserved over large regions, it is possible that significant allelic associations may 
still be detected at distant marker loci. A recent study has demonstrated the success of a 
genome-wide search for linkage disequilibrium in mapping a rare form of cytochrome 
oxidase deficiency in French Canadians (Lee et al., 2001). In this study, the authors 
used untransmitted parental alleles to estimate allele frequencies in the unaffected 
population. However, in association studies, parents of affected individuals only 
provide half the information of unrelated individuals. The limited genetic diversity 
within Romani populations implies that rare genetic disorders can reasonably be 
expected to result from founder mutations. In disorders that have been examined thus 
far complete allelic homogeneity has been observed. Thus, linkage disequilibrium 
mapping for monogenic disorders need not be confined to pedigree data. True 
population-based case-control studies can be predicted to be fruitful in the Roma. This 
approach would be particularly useful for those diseases for which extended pedigrees 
are uncommon, such as late onset disorders and those that result in early mortality. 
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15.2 Future Directions 
This study has resolved some of the long-standing questions regarding the 
history and origins of the Roma. Further studies should aim at refining the origin of the 
Roma within the Indian subcontinent. Searches for the distribution of Y chromosome 
haplogroup Vl-68 and mitochondrial DNA haplogroup M5 is one possible way to seek 
for related populations within India. These lineages would also prove illuminating in 
examining other populations of hypothesised relatedness to the Roma, such as the Lorn 
and Dom of Central Asia and the Middle East, and the many non-Romani itinerant 
groups within Europe. The observed differences in sex-specific histories in the Roma 
warrant further investigation. It is possible that some of the differences are an artefact of 
the variation between Y chromosome and mtDNA mutational processes. To overcome 
this problem, use of the X chromosome should be investigated. As UEPs and 
microsatellite DNA are found on the X chromosome, this would provide more directly 
comparable data for males and females. Ideally, sample sizes for populations should be 
increased in order to provide robust results. 
Future gene mapping efforts in the Roma would benefit from the examination of 
known disease loci. It is proposed that genome-wide scans for linkage disequilibrium 
within defined Romani populations are a possible approach to mapping of monogenic 
traits. However, for this to be efficient, it is necessary to know the extent to which 
disease haplotypes are conserved in different individuals. This would dictate the 
required marker density of a genome scan for linkage disequilibrium. Knowledge of the 
' 
extent of background linkage disequilibrium would benefit this endeavour. 
Furthermore, this investigation is of relevance to the proposed role of linkage 
disequilibrium mapping for the genes underlying complex traits (Risch, 2000). 
Association between alleles can result from different demographic histories, genetic drift 
and admixture in addition to physical linkage,. Linkage disequilibrium varies 
throughout the genome, and with different population histories and structure, thus 
necessitating empirical investigations. Population modelling has suggested that linkage 
disequilibrium around common variants can be expected to only extend over 3 kb 
genomic regions in heterogeneous populations (Kruglyak, 1999). However, recent 
studies have shown that large chromosomal blocks are in linkage disequilibrium in north 
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Europeans (Reich et al., 2001). The extent of linkage disequilibrium in population 
isolates of different histories is debated. Evidence suggests that linkage disequilibrium 
is moderately higher in expanded population isolates such as the Finns and Sardinians 
(Boehnke, 2000) Others have pointed to higher levels of linkage disequilibrium in 
demographically stable population isolates such as the Saami (Laan & Paabo, 1997). 
Admixture has been shown to result in long-range linkage disequilibrium in the Lemba 
(Wilson & Goldstein, 2000) and African Americans (Pfaff et al., 2001). Thus, 
examination of linkage disequilibrium in the Roma, who have been demonstrated to be 
admixed population isolates, would be of great interest. Moreover, the study of linkage 
disequilibrium has been demonstrated. to provide additional insights into population 
history (Reich et al., 2001). 
Rare genetic disorders provide insights into gene function. In population isolates 
it is possible to find many individuals affected by the same disorder. This provides a 
useful resource for studying disease variation and modifying effects. In a study of 40 
C283Y homozygous LGMD2C affected Romani individuals, variation in the severity of 
the phenotype was observed (Merlini et al., 2000). This is a consistent finding for 
monogenic disorders that challenges the concept of simple mendelian disorders 
(Scriver & Waters, 1999). If sample size is large enough, modifying genes can be 
investigated using candidate gene association studies (Cazeneuve et al., 2000) or linkage 
studies within pedigrees for genes of strong effect (Riazuddin et al., 2000). Both of 
these approaches would be feasible in the Roma. · Disease alleles in the Roma also 
provide an important biological source material for further studies. The R148X 
mutation in NDRG 1 represents a null mutation, which is biologically equivalent to a 
gene knockout in model organisms. Expression studies of tissues expressing this gene 
would prove illuminating in revealing molecular pathways and interactions. This should 
not be limited to only the tissue believed to be involved in the disease pathology. Recent 
estimates suggest 30-40 000 genes in the human genome (Lander et al., 2001), however 
the transcriptome is believed to contain 100 000 unique transcripts. Thus, genes are 
likely to have multiple and diverse functions in different tissues. This implies that the 
same gene defect may result in different pathological pathways in different cell types. 
Therefore, tissue-specific studies of the effect of mutant alleles would prove interesting. 
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ABSTRACT 
The identification of a growing number of novel Mendelian disorders and private 
mutations in the Roma (Gypsies) points to their unique genetic heritage. Linguistic 
evidence suggests that they are of diverse Indian origins. Their social structure within 
Europe resembles that of the }a tis of India, where the endogamous group, often defined 
by profession, is the primary unit. Genetic studies have reported dramatic differences in 
the frequencies of mutations and neutral polymorphisms in different Romani 
populations. However, these studies have not resolved ambiguities regarding the origins 
and relatedness of Romani populations. In this study, we examine the genetic structure 
of 14 well-defined Romani populations. Y chromosome and mtDNA markers of 
different mutability were analysed in a total of 275 individuals. Asian Y chromosome 
haplogroup VI-68, defined by a mutation at the M82 locus was present in all14 
populations and accounted for 44.8% of Romani Y chromosomes. Asian mtDNA 
haplogroup M was also identified in all Roma populations and accounted for 26.5% of 
female lineages in the sample. Limited diversity within these two haplogroups, measured 
by the variation at eight STR loci for the Y chromosome and sequencing of the HVS 1 for 
the mtDNA, is consistent with a small group of founders splitting from a single ethnic 
population in the Indian subcontinent. Principal components analysis and AMOVA 
indicate that genetic structure in extant endogamous Romani populations has been 
shaped by genetic drift and differential admixture, and correlates with the migrational 
history of the Roma in Europe. By contrast, social organisation and professional group 
divisions appear to be the product of a more recent restitution of the caste system of 
India. 
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INTRODUCTION 
The Roma (Gypsies) became one ofthe peoples of Europe when they arrived in 
the Byzantine Empire 900-1100 years ago (Fraser 1992; Romove v Byzanci 1998). The 
formation ofthe present-day Romani populations of European countries is the 
compound product of the early migrations from the Balkans into Western Europe, 
completed by the 15th century, and three superimposed migration waves, the first in the 
end of the 19th century after the abolition of Gypsy slavery in Romania (Hancock 
1987, Fraser 1992, Li geois 1994), the second out of Yugoslavia in the 1960s and 1970s, 
and the third during the last decade, after the political and economic changes in Eastern 
Europe (Reyniers 1995). Current estimates of the total Romani population size in 
Europe range from 4 to 10 million, with the largest numbers concentrated in Central and 
Southeastern Europe (Li geois 1994; Marushiakova and Popov 200la). 
In recent years, novel single gene disorders (Kalaydjieva et al. 1996; 2000; 
Toumev et al. 1999; Angelicheva et al. 1999; Rogers et al. 2000; Thomas et al. 2001), as 
well as private mutations causing known Mendelian disorders (Piccolo et al. 1996; 
Abicht et al. 1999; Kalaydjieva et al. 1999; Plasilova et al. 1999) have been identified. 
Large Romani families with psychiatric disorders are being used in an effort to localise 
susceptibility genes (Kaneva et al. 1998), and epidemiological evidence suggests that 
there are differences in the prevalence of other complex disorders, such as Parkinson s 
disease and multiple sclerosis, between Roma and surrounding European populations 
(Milanov et al. 2000; Kalman et al. 1991). The Roma are thus emerging as an interesting 
founder population, with a potential for genetic research that is still to be explored. 
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The complex structure of Romani society, where the Romani Group is the 
primary unit, has long attracted the attention of cultural anthropologists (Petulengro 
1915-1916; Marushiakova and Popov 1997; Fraser 1992). Li geois (1994) describes the 
current social organisation of the Roma as a fluid mosaic of diversified groups . Group 
identity and the ensuing social divisions are based on a variety of criteria, such as 
customs, ethnonyms describing traditional trades, and dialects reflecting the history of 
migrations. The greatest diversity is found in the Balkans, where numerous Romani 
populations with well defined social boundaries exist (Marushiakova and Popov 1997; 
Marushiakova and Popov 2001 b). This social organisation, and its strong impact on 
rules of endogamy, has not been addressed in genetic research. Population genetic 
studies of the Roma from different European countries have been performed for nearly 
80 years and have mostly sought to compare Roma to autochthonous Europeans and 
identify genetic affinities with proposed parental populations, and with other Romani 
. populations. The low resolution of individual classical genetic markers, and the random 
sampling design have often led to contradictory results. Nonetheless, these studies have 
generally concluded that the Roma are genetically distinct from other European 
populations, while at the same time different Romani populations are separated by larger 
genetic distances than their European neighbours (reviewed in Kalaydjieva at al. 2001a). 
Recent medical genetic studies have shown that founder mutations can be shared by 
socially diverse and geographically dispersed Romani populations, while those living in 
close geographic proximity can display markedly different gene frequencies (reviewed in 
Kalaydjieva et al. 2001a). Thus social practices, as well as genetic data suggest 
significant population substructure. The relationship between traditional group divisions 
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and biological affinities however, is unclear and appears to be complex. Current patterns, 
genetic as well as social, could be the product of diverse scenarios, with different 
implications for genetic epidemiology. 
In this study, we address the issue of genetic relatedness behind the social and 
cultural diversity of Romani populations. We have used Y chromosome and mtDNA 
markers of different mutability to examine the origins and diversification of paternal and 
maternal lineages in 14 well defmed Romani populations. The findings point to common 
Asian origins and suggest that the early history of splits and migrations in Europe has 
played a major role in shaping current genetic structure. 
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SUBJECTS AND METHODS 
Study Populations 
The study included 275 unrelated males from 14 traditional Romani populations, 
selected to represent different cultural anthropological classification criteria 
(Marushiakova and Popov 1997) and allow an assessment of their genetic relevance. 
Group characteristics and numbers sampled are shown in Table 1. Most populations are 
well defined and endogamous relative to each other, except for the Lingurari, Monteni 
and Intreni, who are separated by geographic distance rather than rules of endogamy. 
The previously described Kalderash, Monteni and Lorn populations (Kalaydjieva et al. 
200 1 b) were typed for additional loci, and the Lorn sample size was expanded. 
The study also included samples from 40 males from Asia and the Middle East, 
found to carry Y chromosome haplogroups VI-68 and VI-56 defined by mutations M82 
and M67 respectively (Underhill et al. 2000). These samples were genotyped for theY 
chromosome STR markers used in this study. 
Informed consent has been obtained from all subjects involved. The study 
complies with the ethical guidelines of the participating institutions. 
Y chromosome analysis 
This part of the study included 252 Romani and 40 non-Romani males. As 
suggested by de Knijff(2000), we designate Y chromosomes defined by unique event 
polymorphisms (UEPs) as hap1ogroups , those defined by Y STRs as haplotypes , 
and those defined by both UEPs and STRs as lineages . Haplogroup designation 
follows the nomenclature proposed by Underhill et al. (2000). 
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Y chromosome haplogroups 
Comprehensive analysis ofUEPs was performed as described (Underhill et al. 
1997; 2000; 2001; Shen et al. 2000) on 94 Romani males, aiming at the identification of 
the major Y chromosome haplogroups in the Roma. 
The remaining 158 samples were typed for the M82locus, a 2bp deletion in 
derived Y chromosomes, which defines hap1ogroup VI-68 (Underhill et al. 2000). PCR 
amplification was done with fluorescently labelled primers 5 -CTGT ACTC 
CTGGGTAGCCTGT-3 and 5 -AAGAACGATTGAACACACTAACTC-3. The 
products were separated by size on a 377 DNA Analyser (Applied Biosystems). 
Among 69 Y chromosomes found to carry the ancestral M82 allele, inference of 
haplogroup affiliation was possible in 38, based on the identity of their STR haplotypes 
with the common haplotype(s) of the specific haplogroup in the fully characterised 
Romani samples. 
Y chromosome STR haplotypes 
209 Romani and 40 non-Romani individuals were genotyped for eight STR loci, 
namely DYS19, DYS388, DYS38911, DYS3891, DYS390, DYS391, DYS392, and 
DYS393. In addition, Y STR data for 43 Roma from three populations described by 
Kalaydjieva et al. (2001) were expanded by typing for DYS388. PCRprimers were as 
described (Kayser et al. 1997). The products were separated on an ABI 373A DNA 
Analyser (Applied Biosystems). Allele sizes were converted to repeat number using 
allelic ladders which were analysed in parallel. We define DYS389CD as equivalent to 
DYS3891, and DYS389AB as equivalent to DYS38911 minus DYS3891 (Rolf et al. 1998). 
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Haplotypes were constructed following the ascending numerical order of loci given 
above. 
Mitochondrial DNA 
Mitochondrial DNA was analysed in 275 Romani subjects. By analogy to theY 
chromosome, mtDNA haplogroups are defined by coding region RFLPs, haplotypes 
are defined by hypervariable segment 1 (HVS 1) sequences, and mtDNA defined by both 
RFLPs and HVS 1 sequences are referred to as lineages . 
MtDNA haplogroups 
RFLP analysis of coding regions of the mitochondrial genome was performed on 
165 samples using standard protocols (Passarino et al. 1996; Macaulay et al. 1999; 
Richards et al. 1998). This analysis provided an indication of the mtDNA haplogroups 
present in the Rorria. In 11 0 samples, where RFLP analysis was not performed, 
haplogroups were inferred from characteristic 1-iVS 1 variants (Macaulay et al. 1999; 
Simoni et al. 2000). 
MtDNA haplotypes 
HVS1 sequencing was performed on 194 samples. In addition, 81 HVS1 
sequences, previously reported in the Roma (Kalaydjieva et al. 2001b) were included in 
the statistical analyses. PCR amplification ofthe D-loop segment between positions 
15,997 and 16,400 (Anderson et al. 1981) was performed as described (Calafell et al. 
1996). The samples were sequenced in both directions and run on an ABI 373A DNA 
Analyser (Applied Biosystems ). A 360bp fragment of HVS 1, between positions 16023 
and 16384, was analysed. 
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Data Analysis 
Frequencies of male and female haplotypes, haplogroups and lineages and the 
number of shared lineages were determined by direct counting. 
Diversity indices were determined using ARLEQUIN (Schneider et al. 2000). 
Haplotype diversity, h, and its variance, V(h), were calculated according to Nei (1987). 
Pairwise differences, k, between haplotypes were calculated to provide a measure of the 
relatedness of haplotypes within haplogroups. Phylogenetic relationships between 
haplotypes within haplogroups were examined by constructing median joining networks 
using NETWORK 3.0 (Bandelt et al. 1995). 
The age of the founding Y chromosome haplogroup VI-68 lineage was calculated 
as described by Kittles et al. (1998), with a Y STR mutation rate of2.1 x w-3 (95% CI 
0.6 X w-3 to 4.9 X 10-3) (Heyer et al. 1997). The age of the mtDNA haplogroup M 
lineage in the Roma was determined considering that the mean number of mutations 
accumulated from an ancestral sequence follows a Poisson distribution (Morral et al. 
1994 ), with a mean equal to the time multiplied by mutation rate. The mutation rate and 
confidence interval estimate method were as in Saillard et al. (2000), though modified by 
weighting relative mutation rates as suggested by Meyer et al. (1999). A generation time 
of 25 years was used. 
Principal component analysis was used to examine the differences in the 
distribution of Y chromosome and mtDNA haplogroups between 12 Romani 
populations. The analysis was performed using the computer program ANT ANA 
(Harpending and Rogers 1984). 
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AMOV A (Excoffier et al. 1992) was performed on the Y STRand mtDNA 
HVS 1 data. Different groupings of populations were considered, based on the criteria 
outlined in Table 1. The apportionment of genetic variance was assessed between 
individuals within populations, between populations within groups, and between groups 
of populations. The analyses were done with ARLEQUIN (Schneider et al. 2000), using 
the sum of squared size difference setting for Y STR data, and pairwise differences 
for mtDNA HVS 1 data. Standard Bonferroni corrections were used to account for 
multiple comparisons. 
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RESULTS 
Y chromosome analysis 
The data obtained from the analysis of 252 male Roma are summarised in Table 
2. A total of seven known haplogroups were identified among the 217 Romani Y 
chromosomes where haplogroup assignment was possible. Three haplogroups, namely 
VI-68, VI-56 and VI-52, occurred at high frequencies(> 10%) and together accounted for 
about 74% of allY chromosomes. STR analysis identified 69 unique haplotypes, of 
which 47 could be assigned to known haplogroups. Four haplotypes, VI-68A and B, VI-
56A and VI-52A together accounted for 61% of allY chromosomes. 
A major paternal founding lineage 
VI-68 was by far the most common haplogroup. It was observed in a1114 
Romani populations and comprised 113 chromosomes or 44.8% ofthe overall study 
population. Haplogroup VI-68 has been found previously at low frequencies in the 
Indian subcontinent and Central Asia, but so far has not been observed in other European 
populations (Underhill et al. 2000) with the exception of one individual in the Ukraine 
(Semino et al. 2000). 
STR analysis ofhaplogroup VI-68 chromosomes identified 12 haplotypes (VI-
68A to VI-68L). In a median-joining network (Figure lA), these haplotypes clustered 
tightly together, with a single inferred node. The two high frequency haplotypes, VI-68A 
and VI-68B, are centrally located in the network, with the remaining haplotypes radiating 
from them. The high frequency of these two haplotypes is reflected in the low diversity 
along this lineage (h=0.47, k=0.56). 
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The distribution of VI -68 haplotypes in the Roma was compared to that of non-
Romani haplogroup VI-68 chromosomes from different Asian populations. The 22 non-
Romani chromosomes presented with 22 different STR haplotypes (Table 3), including a 
haplotype which was one mutational step away from the most common Romani VI-68A 
lineage. A median joining network, constructed from al134 haplogroup VI-68 
haplotypes (12 Romani and 22 Asian non-Romani) displayed a complex topology, 
where the Romani Y chromosomes represented a limited subset of closely related 
haplotypes within the overall diversity ofhaplogroup VI-68 (figure not shown). The 
non-Romani haplotypes were widely dispersed across the network with many inferred 
nodes. 
A single male lineage, VI-68A, defined by the 2-bp deletion at M82 and STR 
haplotype 15-12-16-14-22-10-11-12, was shared by 80 individuals from all Romani 
populations. This common lineage accounted for 71% ofhaplogroup VI-68 
chromosomes and for 32% of all Romani Y chromosomes examined. It was separated by 
one mutational step (at marker DYS19) from the second most common VI-68 lineage 
(VI-68B). VI-68B was not as widespread as VI-68A and occurred mostly in the Lorn 
and Lithuanian Roma (Table 2). The remaining haplogroup VI-68 lineages were rare and 
confined to individual Romani populations. When we considered the most frequent 
haplotype within haplogroup VI-68 to be the founding lineage, a coalescent date of992 
years BP (95%CI 425-3472) was estimated. 
Additional Y chromosome lineages 
Haplogroup VI-56 accounted for 10.3% (26 chromosomes) of all Romani males 
(Table 2). It was identified in 5 of the 14 Romani populations and occurred at high 
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frequency in the Lithuanian (25%) and Spanish (30%) Roma. This haplogroup has been 
found in Pakistan, Central Asia and the Middle East (Underhill et al. 2000). Within 
Europe, haplogroup VI-56 has been identified in a single male individual from Sardinia 
(Underhill et al. 2000). In the Roma, the 26 haplogroup VI-56 chromosomes fell into six 
STR haplotypes, VI-56A to VI-56F (Table 2). The pattern of the median-joining 
network for these haplotypes (Figure 1B) was similar to that described for haplogroup 
VI-68, with tight clustering ofhaplotypes and no inferred nodes. Again, the high 
frequency of a single lineage (VI-56A) was reflected in a low haplogroup diversity 
(h=0.46, k=0.59). By contrast, 18 non-Romani haplogroup VI-56 chromosomes 
displayed 11 STR haplotypes (Table 3), of which one was a single mutational step away 
from the Romani VI-56A lineage. 
Haplogroups VI-52 and IX-104, referred to as Eu7 and Eu18 by Semino et al. 
(2000), accounted for 19% and 5.6% of all Romani Y chromosomes. These two 
haplogroups are common in Europe (Underhill et al. 2000), where reverse clinal 
distributions have been reported (Semino et al. 2000), with higher frequencies ofVI-52 in 
eastern Europe and of IX -1 04 in the western part of the continent. 
Haplogroup VI-52 was identified in48 males from 9 ofthe 14 Romani 
populations (Table 2). The majority (43/48 chromosomes) were present in Roma 
resident in Bulgaria. STR analysis identified 11 haplotypes within this haplogroup. 
Two common haplotypes (VI-52A and VI-52B), contributed primarily by the Turkish-
speaking Roma from Bulgaria, accounted for 73% of the chromosomes of this 
haplogroup and for nearly 13% of all Romani Y chromosomes. Haplogroup VI-52 
diversity was moderate (h=0.70, k=3.56). The median joining network (Figure 1C) 
contained many inferred nodes, with most haplotypes differing from each other by 
multiple mutational steps. 
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Haplogroup IX-104 was found in 6 of the 14 Romani populations, with 8/14 
chromosomes coming from the Lithuanian and Spanish Roma (Table 2). STR analysis 
revealed 8 different haplotypes which connect to each other in a median joining network 
with three inferred nodes (Figure 1D). The diversity indices in haplogroup IX-104 were 
h=0.91; k=2.19. 
The remaining three characterised haplogroups, VI-71, III-36, and VI-57 were 
rare, each accounting for less than 4% of the total sample (Table 2). Whereas 
haplogroups VI-57 and III-36 show some geographic association (the Indian 
subcontinent and Central Asia for VI-57;and Ethiopia and South Africa for III-36), 
haplogroup VI-71 is widely distributed throughout the world (Underhill et al. 2000). 
Mitochondrial DNA diversity 
The results ofthe mtDNA analysis of275 Roma are shown in Table 4. A total 
of 12 mtDNA haplogroups were identified of which two, haplogroups M and H, 
accounted for 62% of the overall study population. Analysis of HVS 1 revealed 72 
sequences. Four common lineages, two ofhaplogroup Hand one each ofhaplogroups M 
and U3 accounted for 36% of all Romani individuals. 
The diversity of materna/lineages 
Haplogroup M was identified in all14 Romani populations and accounted for 73 
individuals or 26.5% of the total sample (Table 4). Haplogroup M is rare in Europe 
(Richards et al. 1998; Simoni et al. 2000), but common in Asia and Eastern Africa 
(Quintana-Murci et al. 1999). HVS 1 sequence analysis did not identify the motif 
characterising the African subhaplogroup M1 (Quintana-Murci et al. 1999; Bamshad et 
al. 2001), thereby pointing to the Asian origin ofthese Romani lineages. 
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HVS 1 analysis of haplogroup M samples revealed 14 sequences. The two most 
common haplogroup M lineages differed by a single mutation step at position 16298 
(Table 4). These two lineages were present in 13 of the 14 Romani populations and 
accounted for 14.9% of all samples. 
A transition at position 16129, which defines subhaplogroup M5 (Bamshad et al. 
2001) was present in 11 of the 14 HVS1 sequences of Romani haplogroup M. One of 
the three lineages (16223, 16291, 16298) that does not bear this variant, is closely related 
to haplogroup M5 lineages, and may represent a back mutation at position 16129, a 
known mutational hotspot (Stoneking 2000). Subhap1ogroup M5 was thus found to 
account for 97.3% ofhap1ogroup M. A modified median joining network (Figure 2) was 
used to compare haplogroup M lineages in the Roma to those observed in India 
(Quintana-Murci et al. 1999; Kivisild et al. 1999). All but two Romani lineages clustered 
together as a small subset of the overall diversity present within the Indian haplogroup 
M. The coalescence ofhaplogroup M lineages in the Roma was estimated to be 4625 
years BP (95%CI 2000-7250 years). 
Haplogroup H was the most frequent mtDNA haplogroup among the Roma 
(Table 4). It was detected in 13 of 14 Romani populations and represented 35.6% (98 
individuals) of the total sample. Haplogroup His most common in Europe (Simoni et al. 
2000) and the Near East (Richards et al. 2000), but is also found in India (Kivisild et al. 
1999). HVS1 analysis ofhaplogroup H identified 23 sequences, two ofwhich (defined 
by variants at positions 16261 and 16304, and 16218 and 16278 respectively) accounted 
for about 22% ofhaplogroup H each and together comprised 20% of the overall sample. 
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These two lineages have not been found in a large survey of Near Eastern and European 
individuals (Richards et al. 2000). 
Haplogroup U3 was identified in 28 subjects (10.2% of the entire sample), most 
of whom (23 out of 28) were Spanish and Lithuanian Roma. Only two lineages were 
identified by HVSl sequencing, with one of them accounting for 93% of all U3 samples 
(Table 4). Haplogroup U3 is distributed throughout the Middle East and Europe 
(Richards et al. 2000). 
Haplogroup X occurred in 7.6% of Romani samples and could be subdivided into 
five lineages by HVSI sequencing. Three of these, bearing a transversion at position 
16189, have not been seen in Europe and the Middle East where haplogroup X is widely 
distributed (Richards et al. 2000; Kivisild et al. 1999). 
The remaining haplogroups J, I, N1b, T, U5, U(K), U1 and W accounted for 20% 
of Romani samples. Varying numbers of Romani lineages were identified by HVS 1 
sequencing in each haplogroup. These haplogroups have been observed in Europe, the 
Middle East and India (Richards et al. 2000; Kivisild et al. 1999; Simoni et al.2000). 
Genetic structure 
As shown in Tables 2 and 4, a total of 13 paternal and 25 maternal lineages were 
found to occur in more than one Romani group. The male VI-68A lineage was shared by 
Roma from all populations, and two pairs of closely related mtDNA lineages, of 
haplogroups M and H, were common to 13 and 8 Romani populations respectively. 
At the same time, the frequency distribution of both major and rare male and 
female lineages differed dramatically between Romani populations (Figure 3). 
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Principal component analyses based on the frequencies of Y chromosome and 
mtDNA haplogroup frequencies in Romani populations revealed similar patterns for 
both comparisons (Figure 4A and Figure 4B). Three consistent clusters were observed: 
Montelli, Intreni, Lingurari, Kalderash and Lorn; Feredjelli and Turgovtzi; Spanish and 
Lithuanian Roma. The Kalaidjii North and South occupied different positions in theY 
chromosome and mtDNA comparisons. 
To examine the relevance of different cultural, historical and geographic 
classification criteria to the genetic structure of the Roma, we used AMOVA based on Y 
chromosome STR data and mtDNA HVS 1 sequences (Table 5). Country of residence, 
where all Roma from Bulgaria were compared to those from Lithuania, and from Spain 
showed no significant inter-group difference. The same result was obtained with 
comparisons based on place of residence, where three pairs of Romani populations living 
in close proximity in three small towns in Bulgaria were examined. In the analysis based 
on ethnonym reflecting traditional trade, the comparison ofbowlmakers, tinsmiths, 
traders, and livestock dealers showed no significant inter-group differences. 
Inter-group differences accounted for a significant proportion of the variance only 
when language and the history of migrations were used for classifying Romani 
populations. In the language-based classification, speakers of Balkan dialects of 
Romanes were compared to speakers ofVlax dialects (Old as well as New Vlax), of 
Romanian, and of the languages of the surrounding majority populations. The major 
difference between these two groupings was related to the Lingurari, Monteni and 
Intreni: they formed the group of Romanian speakers in the language classification, 
whereas in the classification based on migrational history they were placed together with 
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the speakers of Vlax Romanes dialects. The language division resulted in significant · 
inter-group differences for the female lineages only. Highly significant inter-group 
differences for both paternal and maternal lineages were observed only when 
classification was based on the history of migrations, comparing the old settlers in the 
Balkans, to the migrants to Wallachia and Moldavia and to those moving to northern and 
western Europe. This comparison showed that around 10% of the variance for Y 
chromosome and 5% for mtDNA (p<O.OOOOl for both) was due to differences between 
the migrational groups. 
296 
DISCUSSION 
The Roma do not have their own written history, therefore theories about their 
origins and migrations are based on legends, or on linguistics and cultural anthropology. 
Early European historical records refer to the Roma as Egyptians, and the term Gypsy is 
thought to reflect that assumption (Fraser 1992). Another popular legend is derived 
from an 11th century chronicle by a Persian historian, describing a group of 10-12 
thousand musicians and entertainers given as a gift to the ruler of Persia Shah Bahram 
Gur by an Indian Maharadja in the 5th century (Fraser 1992). The theory of the Indian 
origins ofthe Roma (reviewed in Fraser 1992) is based on the similarities between 
Romanes and languages of the Indian subcontinent. However, the lack of close 
relationship with any specific living language or dialect in India, has given rise to the 
concept of Romanes resulting from the 11mixing of linguistic subsystems in the context of 
increased interaction among speakers of these varieties11 (Hancock 2000). This linguistic 
theory has been linked to the historical period ofthe Islamic invasions of India, and 
proposes that the Roma derive from the ethnically diverse martial society of the Raj puts, 
as well as from camp-followers drawn from the lowest Varna and the out-caste or 
untouchable groups (Hancock 2000). The argument of diverse origins rooted in India is 
supported by the social organisation of the Roma, whose multiple endogamous 
populations with professional ethnonyms bear close resemblance to the jatis of India 
(Fraser 1992; Marushiakova and Popov 1997). The endogamous professional group 
organisation could thus have been an inherent social characteristic of the proto-Roma at 
the time of the exodus from India. It is also conceivable that the fragmentation into small 
populations has occurred within Europe, as a means of higher mobility and thus survival 
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in the face of repressive legislation and persecution (Hancock 1987; Fraser 1992; Li geois 
1994), and has been consolidated further by geographic dispersal and cultural and 
linguistic diversification. These scenarios could have a different impact on present 
genetic _structure, with implications for genetic research, especially into complex 
disorders. 
This study has demonstrated the sharing of identical Asian-specific paternal and 
maternal lineages between all Romani populations. Nearly 45% ofY chromosomes 
belong to haplogroup VI-68 and a single lineage within that haplogroup, found across 
Romani populations, accounts for almost one third of Romani males. A similar 
preservation of a highly resolved male lineage has been reported previously only for 
Jewish priests (Thomas et al. 1998). Similarly, Asian-specific mtDNA haplogroup M is 
found in 13 out of 14 Romani populations and accounts for 26.5% of maternal lineages in 
the Roma. The data provide strong evidence of Asian origins, in contrast to claims that 
the Roma are a socially defined population of European descent (Okely 1983; Wexler 
1997). 
Analysis of diversity within haplogroups VI-68 and M provides an insight into 
the genetic composition of the ancestral proto-Romani population. TheY chromosome 
haplogroup VI-68 STR haplotypes are closely related, suggesting recent diversification 
by mutational processes, and cluster as a subset of the overall diversity of Asian 
haplogroup VI-68. Most mtDNA haplogroup M lineages belong to subhaplogroup M5 
(Bamshad et al. 2001) and form a small subset of the diversity within Indian haplogroup 
M. Again, close genealogical relationship suggests that diversity has arisen through 
mutation rather than diverse origins or admixture. The relatively recent ages determined 
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for haplogroup Vl-68 and Min this study suggest that the ethnogenesis of the Roma can 
be understood as a profound bottleneck event. While identification of the parental 
population of the proto-Roma has to await better understanding of genetic diversity in 
the Indian subcontinent, our results point to a limited number of related founders, 
compatible with a small group of migrants splitting from a distinct caste or tribal group. 
The present findings, and the published data on global diversity do not allow a 
distinction between additional founding lineages and early admixture for Y chromosome 
haplogroup VI-56, found in the Middle East, Central Asia and Pakistan (Underhill et al. 
2000), and for mtDNA haplogroups H and X, widely distributed from Europe to India 
(Simoni et al. 2000; Richards etal. 2000; Kivisild et al. 1999). The close relationship 
between haplotypes within haplogroup VI-56, and its frequency distribution among the 
Roma, point to introduction by a small number of related males. The fact that the 
common Romani mtDNA haplogroup H and X lineages have not been found among a 
large number of Middle Eastern and European individuals (Richards et al. 2000), suggests 
that they might be founding lineages of Indian origin. Regardless of the history of these 
lineagesj the observed pattern points to greater female diversity in the early Romani 
population compared to the male component. 
While the sharing of lineages supports the common origins of the Roma, genetic 
differentiation between Romani populations is evidenced by the distribution of male and 
female lineages (Figure 3). The results ofthe AMOVA and principal component 
analysis provide an insight into the contribution of different factors to shaping the 
genetic structure of Romani populations. The irrelevance of geographic criteria for 
studying the Roma has been emphasised repeatedly by cultural anthropologists (Fraser 
299 
1992; Li geois 1994; Marushiakova and Popov 1997). In a paper on Gypsy tribes in 
Bulgaria, written by a British scholar in the early 2oth century (Petulengro 1915-1916), 
the classification of the Roma according to country of residence is likened to some 
Chinese explorer visiting London and Amsterdam [and concluding], on the strength of 
certain outward similarities, that the inhabitants of those two cities belonged to one and 
the same race . Yet country of residence has been used consistently as the descriptor in 
genetic studies ofthe Roma (reviewed in Kalaydjieva et al. 200la). Our present results 
indicate that geography has no relevance to genetic structure even when populations 
living in close proximity in the same small town are considered. This is in contrast to the 
findings for other European populations, where geographic distance rather than culture 
and language has been found to play the major role (Rosser et al. 2000). The lack of 
genetic correlation with recently acquired religions (Muslim or Christian) is hardly 
surprising. Interestingly, traditional trade reflected in the ethnonym, an important factor 
in defining self-identity of Romani populations, was found to be a poor grouping 
criterion. By far the most significant differences between groups of populations were 
observed when language and especially history of migrations were used as the 
classification criteria in the AMOV A comparisons. These two indicators are closely 
related, as the classification ofRomanes dialects is based mainly on external linguistic 
influences and borrowings. The significant difference between language groups for female 
(but not male) lineages possibly reflects the strict endogamy rules practiced by the 
Rumanian-speaking Roma towards females from other populations. Strong support for 
the migrational grouping of populations was provided also by the results of the principal 
component analysis for both male and female haplogroups. 
300 
The European migrations of the Roma have followed three major streams. While 
the majority settled within the Balkan provinces of the Ottoman Empire, some headed to 
the autonomous principalities ofWallachia and Moldavia north of the Danube (in 
present-day Romania) and others continued the journey north and west. Ottoman tax 
registries suggest that the number of Roma initially settling in the Empire would have 
been small (Marushiakova and Popov 1997), and early historical records from Western 
Europe invariably describe Gypsies arriving as a group of 50-300 individuals led by an 
elder (Colocci 1889). The early settled Romani population south of the Danube, and the 
superimposed migrations from Wallachia and Moldavia, of small groups of runaway 
slaves during the 17th_1gth century and of larger numbers after the abolition of Gypsy 
slavery in the 19th century (Marushiakova and Popov 2001 c), have spawned over 50 
socially diverse Romani populations in Bulgaria alone (Marushiakova and Popov 1997). 
Our data indicate that current genetic structure results mainly from the early splits and 
divergent routes within Europe. Two processes, genetic drift and different levels and 
sources of admixture, appear to have played a role in the subsequent differentiation of 
populations. The effects of differential admixture are illustrated by the distribution of Y 
chromosome haplogroups VI-52 and IX-104, whose occurrence among the Roma reflects 
the reported clinal distribution in Europe (Semino et al. 2000). Intra-haplogroup 
diversities in the Roma are consistent with multiple independent admixture events. 
Similar examples are provided by mtDNA haplogroups H (excluding the two common 
lineages), X, T, and U5. The effects of drift are likely to account for the different 
frequencies of the major common lineages in the diverse Romani populations (Figure 3), 
and are well illustrated by Y haplogroup VI-56 and mtDNA haplogroup U3, both 
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occurring among multiple Romani populations but over-represented in the Lithuanian 
and Spanish Roma. 
Application ofthe knowledge of the origins and diversification of the Roma 
should prove useful in the design of future medical genetic studies. These results are in 
need of further confirmation through the study of larger sample sizes, with wider 
representation of western European Roma and of populations speaking the two major 
varieties of Balkan dialects of Romanes. Nonetheless, the present data point to an 
interesting difference in the biological and cultural history of the Roma. While genetic 
differentiation appears to carry the imprint ofthe early European history of the Roma, 
social diversification seems to be the product of a recent restitution of the social 
traditions of the ancient country of origin. 
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Background: Data provided by the social sciences as well as genetic research suggest that the 8-
1 0 million Roma (Gypsies) who live in Europe today are best described as a conglomerate of 
genetically isolated founder populations. The relationship between the traditional social structure 
observed by the Roma, where the Group is the primary unit, and the boundaries, demographic 
history and biological relatedness of the diverse founder populations appears complex and has not 
been addressed by population genetic studies. 
Results: Recent medical genetic research has identified a number of novel, or previously known 
but rare conditions, caused by private founder mutations. A summary of the findings, provided in 
this review, should assist diagnosis and counselling In affected families, and promote future 
collaborative research. The available incomplete epidemiological data suggest a non-random 
distribution of disease-causing mutations among Romani groups. 
Conclusion: Although far from systematic, the published information indicates that medical 
genetics has an important role to play in improving the health of this underprivileged and forgotten 
people of Europe. Reported carrier rates for some Mendelian disorders are in the range of 5 -15%, 
sufficient to justify newborn screening and early treatment, or community-based education and 
carrier testing programs for disorders where no therapy is currendy available. To be most 
productive, future studies of the epidemiology of single gene disorders should take social 
organisation and cultural anthropology Into consideration, thus allowing the targeting of public 
health programs and contributing to the understanding of population structure and demographic 
history of the Roma. 
Introduction 
fhe Roma (Gypsies) became one ofthe peoples of Eu-
rope around one thousand years ago, when they first ar-
rived in the Balkans [1,2]. The current size of the 
European Romani population, around 8 million [2], is 
equivalent to that of an avemge European country (Fig-
lll'e 1). While human rights and socio-economic issues 
related to the Roma are increasingly becoming the focus 
of political debate and media coverage throughout Eu-
rope, their poor health status [3-6] is rarely discussed 
and still awaits the attention of the medical profession. 
This review of genetic studies of the Roma was prompted 
by two recent developments: (i) Studies conducted over 
the last decade have resulted in the identification of a 
number of novel single gene disorders and disease-caus-
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Romani population size in different European countries The collection of this type of data depends on declared ethnic 
identity which, in the case of the Roma, can be affected by a number of political and social circumstances. The estimates in the 
figure are the average of the numbers provided by different sources, such as census data, ministries of internal affairs and 
human rights organizations [2]. 
ing mutations. The accumulating data are already suffi-
cient to outline a pattern and dmw conclusions about 
public health policies and future research. (ii) The eco-
nomic and political changes in Eastern Europe and the 
wars in former Yugoslavia have led to the west-bound 
migration oflarge numbers ofRoma [7,8], changing the 
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traditional demographic profile of Gypsy minorities 
across Europe. A predictable consequence of this new di-
aspora is that medical practitioners in many countries 
will encounter Romani patients with previously un-
known or very rare disorders. A summary of the available 
information should facilitate diagnostic investigations 
and counselling in these affected families and stimulate 
international collaboration. 
Materials and Methods 
Literature searches were performed using the U.S.A Na-
tional Library of Medicine PubMed/MEDLINE databas-
es for the period 1960 to December 2000. Database 
searches using the keyword "Gypsies" identified 297 ar-
ticles whilst the keyword "Gypsy" produced 573 articles. 
The discrepancy is due mainly to the inclusion of articles 
about the "gypsy retransposable element" and the "gypsy 
moth". Searches using the tenns "Roma", "Romani" and 
"Romany" yielded results that were not relevant to the 
topic (eg. Roma, the capital of Italy) or else incomplete. 
The majority of the 297 articles dealt with issues beyond 
the focus of this review, namely social problems related 
to the health of the Roma (28.6%), or general medical 
problems (2g.6%). The remainder were reports on ge-
netic research, of which 41 studies (13.8%) were in the 
field of clinical genetics, 44 (14.8%) were molecular stud-
ies of genetic disorders, and 39 (13.1%) covered popula-
tion genetic research. In the clinical and molecular 
genetics fields, we have given preference to publications 
which were not limited to single case descriptions, and 
dealt with disorders with public health impact. Popula-
tion genetics papers were selected on the basis of the 
- compatibility of study design, specifically the analysis of 
comparable polymorphic systems. 
Complementary data on history, linguistics, cultural an-
thropology and demography were found through stand-
ard library and bibliographic searches, and included 
publications recommended by consulting experts in 
Romani studies (Drs. Elena Marushiakova and Vesselin 
Popov from the Bulgarian Academy of Sciences and Dr. 
Ian Hancock from the University of Texas at Austin). 
The "Track Record" of Genetics 
Genetic studies of the Roma have been conducted for 
over 70 years, with thousands of individuals sampled 
across Europe. During the years of the Third Reich, Gyp-
sies, together with Jews, attracted the special attention of 
German geneticists [g). A grant proposal signed by Nobel 
prize winner Ferdinand Sauerbruch and funded by the 
Deutsche Forschungsgemeinschaft designed the "genetic 
and medical research" at the death camp in Auschhwitz 
[g]. The Race Hygiene and Population Biology Research 
Centre, established in 1936, organised thorough records 
http://www .biomedcentral.com/14 71-2350/2/5 
of Jewish and Romani pedigrees and provided "the sci-
entific basis" for the "final solution", the annihilation of 
millions of Jews and Romain the concentration camps of 
Nazi-occupied Europe. 
Post-war genetic research has been preoccupied with the 
Indian origins of the Roma [10-16], pursuing the "Indi-
an connection" even in studies meant to focus on severe 
genetic disorders [17]. Most studies have remained in the 
realm of scientific exploration, away from the health 
needs of the Roma. Many publications display judge-
mental and paternalistic attitudes, that would be consid-
ered unacceptable if Used with regard to other 
populations. 
This historical "track rec0rd", the persisting practices of 
discrimination and marginalisation [3-6], and the fact 
that, unlike the Jews, the Finns and the French Canadi-
ans, the Roma are still the "object" of investigations con-
ducted by outsiders, are all likely to impact on the 
attitudes of the Roma towards genetics. Building up the 
trust and collaboration necessary for both public health 
programs and research, :should become a goal of the 
health care systems of Europe. 
Population Genetics 
Population genetic studies have used mostly "classical" 
polymorphisms to investigate Romani individuals from 
different European coun.ties and address three main 
questions: (i) similarity between Roma and Indians; (ii) 
relatedness to European populations; (iii) affinities be-
tween Romani populations from different countries [10-
24]. Single locus comparisons have resulted in contro-
versy, with some pointing to close genetic affinity be-
tween Roma and Indians., and others indicating that the 
Roma are indistinguishable from Europeans. Heteroge-
neity between countries has become apparent and has 
Jed to the conclusion that the European Roma are com-
posed of two different populations, characterised respec-
tively by a high and a low frequency of blood group B 
[23], or defmed as East and West European Roma, with 
the former closely relat~d to Indian populations [16]. 
Heterogeneity of Romani populations within the same 
country has been suggested by the very small number of 
studies addressing this i~sue [19,21,25,26]. 
In an attempt to summarise the existing data, we have 
conducted amultilocus re-analysis of several marker sys-
tems using comparable studies of the Roma in different 
European countries [11,22,23,24,26,27], Europeans 
[28-33] and north Indian populations [34-36]. The 
comparisons (Figure 2, Table 1) provide a general indica-
tion that most of the Roma are genetically closer to Indi-
ans than to European populations, hardly surprising in 
view of the linguistic theories on the Indian origins of the 
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Figure 2 
Multilocus comparison between Romani populations from different European countries, autochthonous Euro· 
pean populations and populations from north India The polymorphic systems included in the analysis comprised 
A1A2BO, MN, haptoglobin and Rh (CDE), with a total of II independent alleles. Information on these markers was available 
for the Romain Slovakia (n = 350) [26], Hungary (n = 507) [II], England (n = 109) [23], Slovenia (n = 350) [27], Sweden (n = 
115) [24] and Wales (n = 84) [22], for non-Roma Europeans (n = 5169) and for t:No north Indian populations, Rajput (n = 175) 
[34,35) and Punjabi (n = 140) [35,36). Genetic distances between pairs of populations were computed by means of Reynold's 
coancenstry coefficient [84) and displayed as a neighbour-Joining tree [85). The robustness of the branches in the tree was 
assessed with a bootstrap approach [86). The analysis was conducted using the PHYLIP 3.57c package [87]. 
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Roma proposed two centuries ago [1]. More importantly, 
the analysis highlights the internal diversity of the Roma, 
who appear to be genetically far more heterogeneous 
" than autochthonous European populations. 
Table I: Muld·locus reanalysis of previously published data on Eu· 
ropean Roma 
Populations 
All R.oma (n = 1287) versus 
· non-R.oma Europeans 
(n = 5169) 
R.oma (n = 1287) versus 
North Indians (n = 31 5) 
Between Romani 
populations (n = 1287) in 
Europe 
Proportion of the variance ex-
plained by differences 
b&tween groups within 
groups 
1.81 ± 1.45% 0.58±0.29% 
0.36 ± 0.69% 2.8 ±0.39% 
3.47±0.46% 
, Between European 0.19 ± 0.12% 
'- Populations (n = 5169) 
The populations and references included in the comparison are as in-
~ dlcated In figure 2. Genetic variance was apportioned between and 
within populations and between and within group$ of populations by 
means of the Analysis of Molecular Variance [88], as implemented in 
the Arlequin I. I package [89]. 
L 
Genetic Disorders of the Rom a 
. Diseases and mutations identified to-date 
t As a result of traditionally low socio-economic status and 
l limited access of the Roma to health care, their unique 
' genetic heritage has long escaped the attention of Euro-
pean medicine and is now being randomly "discovered". 
To date, nine Mendelian disorders caused by private 
"Romani" mutations have been described (Table 2). 
- The list includes three novel neurological disorders, 
namely hereditary motor and sensory neuropathies type 
Lorn (HMSN-L) [37-39] and type Russe (HMSN-R) 
[40], and the congenital cataracts facial dysmorphism 
neuropathy syndrome (CCFDN) [41.42]. 
In addition, a number of previously known but rare dis-
orders have been identified and shown to be caused by 
novel private mutations (Table 2). Examples include 
limb-girdle muscular dystrophy type 2C (LGMD2C) 
[43], galactokinase deficiency [44], primary congenital 
glaucoma [45], and congenital myasthenia [46]. 
In view of the lack of systematic studies, the list cannot 
be comprehensive and is likely to represent the biases 
http://www.biomedcentral.com/14 71-2350/2/5 
and interests of indiVidual medical researchers working 
in this field. Data in the li~erature, particularly from the 
Spanish Collaborative Study of Congenital Malforma-
tions [ 4 7 ], point to the existence of a number of addition-
al rare single gene disorders, whose molecular basis is 
still to be identified. These include hereditary idiopathic 
torsion dystonia (lTD) [4S], epidermolysis bullosa [49], 
albinism [49], and some rare autosomal recessive mal-
formation syndromes, suc)l as Bowen-Conradi, Jarcho-
Levin, Meckel, Smith-Le!tili-Opitz, and Fraser [47,49]. 
A third group of Mendelian disorders includes common 
conditions, where the mutation prevalent in the sur-
rounding or in global populations is likely to have been 
introduced by admixture, for example cystic fibrosis and 
delFsoB [50], phenylketonuria and the R252W and 
IVS1ont546 mutations [51,52], and medium chain acyl-
coenzyme A dehydrogenase (MCAD) deficiency and 
G9Bs [53]. · 
Molecular genetic findings. 
With the exception of phe~ylketonuria, Mendelian disor-
ders have been described. as genetically homogeneous, 
with a single mutation aqcounting for all affected indi-
viduals and related polymorphic haplotypes unambigu-
ously indicating a common origin and founder effect 
[37-40,42-46]. 
At the same time, many studies emphasise the small size 
of the conserved region of homozygosity and the diversi-
ty of disease haplotypes observed even within single af-
fected kindreds [37,40,42,44,54] (Figure 3). Haplotype 
diversification, generated:bynumerous historical recom-
binations and marker mutations [39] as a consequence 
of the old age [37.43] an~ high frequencies of disease-
causing mutations, has iip.portant implications for gene 
mapping studies: (i) Hon:).ozygosity mapping, re]ying on 
consanguinity in the affected families, is not applicable 
in studies using the standard genetic maps and can result 
in spuriously negative r~ults [54]. (ii) The diversity of 
historical recombinatioru! becomes a powerful tool in the 
subsequent refmed genetic mapping and positional clon-
ing of disease genes [55,39]. 
Epidemiological data 
Reported gene frequencies are high for both private and 
"imported" mutations, and often exceed by an order of 
magnitude those for global populations. For examp]e, 
galactokinase deficiency .whose worldwide frequency is 
1:150,000 to 1:1,ooo,ooo [56,57] affects 1 in 5,000 Rom-
ani children [ 44]; autosomal dominant polycystic kidney 
disease (ADPKD) has a global prevalence of1:1000 indi-
viduals worldwide [58] :and 1:40 among the Roma in 
some parts of Hungary [t17]; primary congenital glauco-
318 
BMC Medical Genetics (2001) 2:5 http://www .biomedcentral.com/14 71-2350/2/5 
R-IO R-:1 
10 o1nroo 6 5 6 6 01081&52 4 4 4 3 
i 01081719 1 a a 2 0105661 1 17 !7 4 
I c?mw 
'rn m~ 010S1870 11 010Sl10 4 5 I 01082480 1 1 1 010S1678 2 2 2 :!! 010SI041 1 a 7 010$1072 8 7 8 01081742 4 I 1 4 010SI005 5 4 7 7 7 0105600 2 1 6 B 4 
13 0108537 2 2 6 6 6 
DIOSIG86 g 2 I 2 I 
• R-13 R-14 rJI'-t'~ R-11 R-6 R-7 R-8 D10SI06 I 4 I 4 6 4 4 6 4 6 4 6 . msm~a 2 4 ~ ~ ·tn 4 2 2 4 t 3 t : I 2 ~~20 8 I I 8 0105601 20 10 20 10 17 20 20 17 20 17 20 11 0105681 g 2 g 2 L g 2 g g 2 g 2 g 2 
~tylepm I I I I I I I ""'SOkb ~ 
010SI742 4 1 4 1 1 I I 1 I I I 1 I 
01DSI885 5 11 5 11 11 7 11 11 7 11 7 II 7 
0105660 2 I 2 I I 6 I I 8 I 6 1 6 
0105637 2 7 2 1 7 5 7 7 5 7 5 7 5 
010SI686 g 8 g 8 2 I I I 1 7 2 7 2 
L 
Figure 3 
, Genetic mapping of hereditary motor and sensory neuropathy type Russe (HMSN-R): findings in the region of 
"-" linkage on chromosome I Oqll This affected family originates from a closed endogamous Romani group where consanguin-
~ eous marriages are common. The linkage study was conducted using the ABI Prism Linkage Mapping Sets LMS and LMS version 
2 (PE Biosystems), with an average intermarker distance of I 0 eM. The ABI panel markers flanking the HMSN-R region (shown 
In blue) presented with different alleles in the affected individuals. Haplotype heterozygosity, resulting from historical recombi-
nations and a recent cross-over event (individual R-11 ), extended into the I 0 eM interval containing the gene and could have 
resulted in exclusion of the region if homozygosity mapping had been used. In the set of affected families Included in the original 
study [40], the conserved region of homozygosity (red bars) was found to span only <500 kb. Courtesy of Dr. Tamara Rogers. 
~ rna ranges between 1:5,000 and 1:22,000 worldwide 
[59,60] and about 1:400 among the Romain Central Slo-
vakia [61,62]. 
Carrier rates for a number of disorders have been esti-
mated to be in the 5 to 20% range (Table 3). 
Although incomplete, the available data already lead to 
some practical conclusions: (i) What may appear to be a 
novel disorder confined to a single family, could in fact 
be an indication of a conunon problem affecting large 
numbers of individuals. Research should therefore ex-
tend beyond case descriptions and aim at more compre-
hensive epidemiological information. (ii) The emphasis 
on consanguinity in affected families displaces the focus 
from an obvious need for public health intervention to 
patterns of personal behaviour. In the face of the report-
ed high gene frequencies, consanguinity is no more rele-
vant than it would be as a cause of beta-thalassemia in 
Mediterranean countries. (iii) High gene frequencies 
may result in the parallel segregation of phenotypically 
similar but genetically distinct disorders within the same 
kindred [40A2]. This clustering should be borne in mind 
in diagnostic studies, where assumptions based on pedi-
gree structure should be avoided and independent clini-
cal and genetic assessment should be conducted in all 
cases. 
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Table 2: Mendelian disorders of the Roma caused by private founder mutations 
Disorder OHIM• Inheritance Map Gene Mutadon Ref. 
Location 
Primary congenital 231300 AR 2p21 CYPIBI E387K 45,54 
Glaucoma 
Galactokinase 230200 AR 17q24 GKI P28T 44 
Deficiency 
R306X .. ·· Polycystic kidney 173900 AD 4q21-q23 PKD2 90 
Disease 
Hereditary motor and 601455 AR 8q24 NDRGI RI48X 37,39 
Sensory neuropathy-L.om 
Hereditary motor and 605285 AR 10q23 40 
Sensory neuropathy-Russe 
Congenital cataracts facial 604168 AR 18qter 42 
dysmorphlsm neuropathy 
Limb girdle muscular 253700 AR 13ql2 SGCG C283Y 43,65, 
dystrophy type 2C 91 
Congenital myasthenia 254210 AR 17pll CHRNE 1267deiG 46 
Glanzmann 273800 AR 17q21 ITGA2B IVSI5DS, 64,92 
Thrombasthenia G-A+I 
• Using the OMIM numbers, detailed clinical information can be obtained at http:llwww3.ncbl.nlm.nlh.gov/Omim/ .. The R306X mutation in PKD2 
has been identified In Romani families from Bulgaria. It has not been confinned In the Hungarian ADPKD families, but appears probable because of 
a reported common migration history of all affeeted groups. 
Table 3: Reported carrier rates for single gene disorders among the Roma 
Disorder Country 
Primary congenital glaucoma Slovakia 
Galactokinase Bulgaria 
Deficiency 
Autosomal dominant polycystic Hungary 
kidney disease 
Hereditary motor and sensory Bulgaria 
neuropathy-Lam 
Limb girdle muscular dystrophy ~ulgaria 
type 2C 
MCAD defldency -spain 
Phenylketonuria Czecho 
slovakia 
Oculocutaneous albinism Spain 
Fraser syndrome Spain 
Epidermolysis bullosa Spain 
General 
Rom a 
5% 
2% 
*2% 
2% 
6% 
3.4% 
2.7% 
2.4% 
Hlgh~rlsk 
groups 
*II% 
*4%-S% 
2.4% 
*20% 
6% 
*2.5%-JO% 
Ref. 
45.54 
44 
17 
37,39 
93,66 
53 
94 
49 
47 
49 
Most estimates are based on prevalence figures. *Carrier rates detennlned through direct mutation detection are Indicated in red. **The LGMD2C 
carrier rates for the general Romani population of Bulgaria are probably an overestimate since the screening was conducted In a geographical region 
where the high risk groups are clustered. ***The screening for the G985 mutation in Spain, performed in Gypsy groups residing In different partS of 
the country, revealed substantial differences between groups. 
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Research into Mendelian disorders has provided ample 
evidence of genetic stratification, with mutations occur-
ring at high frequencies in some Romani communities 
and altogether absent in others, located in close geo-
graphic proximity. hi some cases, such as Glanzmann 
thrombasthenia [63,64], LGMD2C [65,66], galactoki-
nasedeficiency [44], CCFDN [42] and HMSN-R[40], the 
identity of the affected groups has been specified. Other 
studies, for example of congenital glaucoma [61,62] and 
ADPKD [17] provideonlyanindicationoftheareaofres-
idence of the affected communities. In the few cases 
where gene frequencies can be compared between high-
risk groups and the general Romani population of the 
same country, substantial differences become apparent 
(Table 3). 
At the same time, founder mutations have spread with 
the Romani diaspora and are shared by affected individ-
uals throughout Europe (Figure 4). International collab-
oration has already made a substantial contribution to 
_ the study of disease phenotypes in large samples of ge-
netically homogeneous patients [ 46, 67-71] as well as to 
the refined mapping of disease genes [55]. Such collabo-
ration will be essential for future research into new dis-
- orders, founder mutations and factors modifying disease 
severity, and for understanding the epidemiology of ge-
netic diseases of the Roma. The first steps to European 
collaboration have been made, with the founding of the 
Gypsy Genetic Heritage Consortium in 1997, and the 
forthcoming ENMC workshop on neuromuscular disor-
ders in Gypsies. 
Historical demographic data are limited, however tax 
registries and census data give an approximate idea of 
population size and rate of demographic growth through 
the centuries (Table 4). A small size of the original popu-
lation is suggested by the fact that although most of the 
migrants arriving in Europe in the nth-12th century re-
mained within the limits of the Ottoman Empire [1,75], 
the overall number of Roma in its Balkan provinces in 
the 15th century was estimated at only 17,000. 
During its subsequent history in Europe, this founder 
population split into numerous socially divided and geo-
graphically dispersed endogamous groups, with histori-
cal records from different parts of the continent 
consistently describing the travelling Gypsies as "a group 
of 30 to 100 people led by an elder" [1,2]. These splits, a 
possible compound product of the ancestral tradition of 
the jatis of India, and the new social pressures in Europe 
(e.g. Gypsy slavery in Romania [76] and repressive legis-
lation banning Gypsies from most western European 
countries [1,2]), can be regarded as secondary bottle-
necks, reducing further the number of unrelated found-
ers in each group. The historical formation of the 
present-day 8 million Romani population of Europe is 
http:/ lwww .biomedcentral.com/14 71-2350/2/5 
Discussion 
The pattern emerging from genetic research is that of a 
conglomerate of founder populations which extend 
across Europe but at the same time differ within individ-
ual countries, and whose demographic history, internal 
structure and relationships are poorly understood. An 
insight is provided by the social sciences. 
The 18th century theory on the Indian origins of the 
Roma [reviewed in 1], is based on the similarities be-
tween Romani and languages spoken in the Indian sub-
continent and is supported by genetic evidence. However 
the lack of close relationship to any specific language or 
dialect has left unresolved the question of the original 
ethnic composition of the proto-Roma, with both single 
[72,73] and diverse [74] origins proposed by linguists. 
Translated into the language of genetics, this is a relevant 
question related to the homogeneity or diversity of the 
fo.unding population. 
Inferred from linguistic influences retained in a11 Roma-
ni dialects, the major migration routes pass through Per-
sia, Armenia, Greece and the Slavic-speaking parts of the 
Balkans [1]. The first documents pointing to the arrival of 
the Romain the Balkans date from the 11th-12th century 
[1,75]. By the 15th century, mention of their presence can 
be found in historical records from all parts of Europe 
[1,2]. 
therefore the product of the complex initial migrations of 
numerous small groups, superimposed on which are two 
large waves of recent migrations from the Balkans into 
Western Europe, in the 19th-early 20th century, after the 
abolition ofslaveryin Rumania [1,2,76] and over the last 
decade, after the political changes in Eastern Europe 
[7,8]. 
The Group is still the primary building block of the social 
organisation of the Roma [1,2]. Group identity and the 
ensuing divisions and rules of endogamy are based on 
tradition, customs and organs of self-rule, language and 
dialects, trades, history of migrations, and religion. Indi-
vidual groups can be classified into major metagroups 
[1,2,75]: the Roma of East European extraction; the Sinti 
in Germany and Man ouches in France and Catalonia; the 
Kal6 in Spain, Ciganos in Portugal and Gitans of south-
ern France; and the Romanichals of Britain [1]. The 
greatest diversity is found in the Balkans, where numer-
ous groups with well defined social boundaries exist. The 
700-Boo,ooo Roma in Bulgaria belong to three meta-
groups, comprising a latge number of smaller groups 
[75]. 
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Figure 4 
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• Infantile cataracts due to galactokinase deficiency (GALK) 
e Hereditary motor and sensory neuropathy type Lorn (HMSNL) 
- Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome 
o Limb gridle muscular dystrophy type 2C (LGMD2C) 
• Congenital myasthenia 
• Hereditary motor and sensory neuropathy type Russe (HMSNR) 
l 
I 
Distribution of reported founder mutations In Europe The flgure is based on available information referring to the fol-
lowing disorders: • Infantile cataracts due to galactokinase deficiency in Bulgaria [44], Austria [95], Switzerland [96], Italy [97], 
Hungary and Spain [our unpublished flndings]. • Hereditary motor and sensory neuropathy- Lorn In Bulgaria [37,38], Italy [68], 
Slovenia [69], Germany [70], Spain [71], France and Romania [55] and Hungary [our unpublished findings]. • Congenital cata-
racts facial dysmorphism neuropathy syndrome in Bulgaria [41 ,42], Romania, Hungary and the United States rour unpublished 
findings]. • Umb girdle muscular dystrophy type 2C in France, Spain, Italy, Germany [43], Portugal [91] and Bulgaria [65,66,93). 
• Congenital myasthenia in Serbia, Macedonia, Greece, Bohemia and Germany [46]. • Hereditary motor and sensory neuropa-
thy- Russe in Bulgaria [40], Romania and Spain [our unpublished findings]. The existing data are the product of ad-hoc collabo-
rative studies and are not likely to represent the true spread of Romani founder mutations. The distribution of LGMD2C in . 
Western Europe and in Bulgaria leads to the prediction that the disorder occurs and awaits detection along the entire Euro-
pean migration route, spanning the Balkans and Central Europe. Filling the gaps In the map will be particularly useful in the case 
of treatable disorders which are strong candidates for newbom screening, such as galactokinase deficiency and congenital 
myasthenia. 
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Table 4: Data on the historical demography of the Roma [ref. I ,75,98] 
-
Source Period 
Ottoman Empire Tax IS"' century 
Registries 16th century 
16"' century 
Ottoman Empire 17"' century 
Army List 
Austro-Hungarian Empire 1m 
Census Data 1837 
1893 
Bulgaria 1881-1885 
Census Data 
Linguistics, history and cultural anthropology suggest 
two major, equally plausible historical scenarios that 
could lead to a "jigsaw puzzle" of founder populations: (i) 
a genetically substructured ancestral population, where 
the old social traditions of strict endogamy have been re-
tained and subsequent splits of the comprising groups 
_ have enhanced the original genetic differences; (ii) a 
small homogeneous ancestral population spawning nu-
merous subgroups where strong drift effects have result-
ed in substantial genetic divergence. Genetic research 
has indeed faced the "jigsaw puzzle" and has thus far 
been unable to resolve it. The genetic data provide evi-
dence of population stratification, however a closer ex-
amination is precluded by the random cross-section 
sampling design of most population genetic studies, 
where the traditional social organisation and self-identi-
ty of the Roma have been ignored and subjects classified 
on the basis of the political boundaries of Europe. There-
lationship between social organisation and genetic struc-
ture does not appear to be straightforward and is still to 
be addressed in population genetic research based on the 
long standing identity of Gypsy groups. The issue is of 
relevance to public health policies and the targeted pre-
vention of mendelian disorders, as well as to future stud-
ies of genetically complex disorders. 
The existing information on single gene disorders is cer-
tainly not exclusive to the Roma. The phenomenon of 
clustering of rare disorders and private founder muta-
tions has been studied in detail in well characterised 
founder populations, such as the Jews [77,78], Finns 
[79,80] and French Canadians [81]. Unlike the above ex-
amples however, genetic studies of the Roma have failed 
to take the immediate benefits of research back to the in-
dividuals and families that have been the object of re-
search; Yet by now it should be obvious that genetics has 
an important role to play in improving the quality of 
health care for the Roma. Treatable disorders such as ga-
Region Population size 
Balkan Provinces 17,000 
Balkan Provinces 65,000 
Bulgaria only 5,700 
Balkan Provinces I 1-15,000 males of 
military age 
Transylvania 39,000 
Transylvania 53,000 
Transylvania 105,000 
Bulgaria 62,324 
la~tokinase and MCAD deficiency, with an expected inci-
dence of affected births in the range of 1:1,000 to 
1:5,000, meet the standard criteria for newborn screen-
ing more than does phenylketonuria, with its average in-
cidence of 1:10,000. Adding the simple, sensitive and 
specific mutation tests to existing newborn screening 
programs would be technically simple and highly effi-
cient due to the homogeneous genetic basis of the disor-
ders. 
Carrier testing should be made available to Romani com-
munities at high risk for severe untreatable disorders. In-
formation on the identity of affected Romani 
populations is important for public health intervention 
since it would allow the planning and facilitate the imple-
mentation of targeted prevention programs, especially in 
the Eastern European countries where economic re-
sources are limited. The importance of the educational 
component of such programs has already been demon-
strated by the highly successful prevention ofTay-Sachs 
disease among Ashkenazi Jews [82] and the failure of 
sickle-cell screening among Afro-Americans [83]. This 
component would be particularly important for a popu-
lation like the Roma, which has been subject to racism 
and persecution throughout its co-existence with Euro-
pean societies. 
The attention of geneticists is increasingly attracted by 
genetically isolated populations in the third world. In 
terms of living standards and the major health indica-
tors, the Roma are much closer to the developing world 
than to their European neighbours [3]. This forgotten 
people of Europe can be regarded as a test case for theca-
pacity of genetics to provide better health. 
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N-myc Downstream-Regulated Gene 1 Is Mutated in .Hereditary 
Motor and Sensory Neuropathy-Lorn 
Luba Kalaydjieva,1' 2 David Gresham,1•• Rebecca Gooding, 1•• Lisa Heather,1 Frank Baas/ 
Rosalein de Jonge/ Karin Blechschmidt,4 Dora Angelicheva, 1 David Chandler, 1 
Penelope Worsley,1 Andre RosenthaV Rosalind H. M. King,S and P. K. Thomas5 
'Centre for Human GenetiCs, Edith Cowan University, and 'Western Australian Institute for Medical Research, Perth, Australia; 
'Neurozintuigen Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam; •Institute of Molecular Biotechnology, jena, 
Germany; and 'Institute of Neurology, University College London, London 
Hereditary motor and sensory neuropathies, to which Charcot-Marie-Tooth (CMT) disease belongs, are a common 
cause of disability in adulthood. Growing awareness that axonal loss, rather than demyelination per se, is responsible 
for the neurological deficit in demyelinating CMT disease has focused research on the mechanisms of early devel-
opment, cell differentiation, and cell-cell interactions in the peripheral nervous system. Autosomal recessive pe-
ripheral neuropathies are relatively rare but are clinically more severe than autosomal dominant forms of CMT, 
and understanding their molecular basis may provide a new perspective on these mechanisms. Here we report the 
identification of the gene responsible for hereditary motor and sensory neuropathy-Lorn (HMSNL). HMSNL shows 
features of Schwann-cell dysfunction and a concomitant early axonal involvement, suggesting that impaired axon-
glia interactions play a major role in its pathogenesis. The gene was previously mapped to 8q24.3, where conserved 
disease haplotypes suggested genetic homogeneity and a single founder mutation. We have reduced the HMSNL 
interval to 200 kb and have characterized it by means of large-scale genomic sequencing. Sequence analysis of two 
genes located in the critical region identified the founder HMSNL mutation: a premature-termination codon at 
position 148 of the N-myc downstream-regulated gene 1 (NDRG1). NDRG1 is ubiquitously expressed and has 
been proposed to play a role in growth arrest and cell differentiation, possibly as a signaling protein shuttling 
between the cytoplasm and the nucleus. We have studied expression in peripheral nerve and have detected particularly 
high levels in the Schwann cell. Taken together, these findings point to NDRG1 having a role in the peripheral 
nervous system, possibly in the Schwann-cell signaling necessary for axonal survival. 
Introduction 
Hereditary motor and sensory neuropathy-Lorn 
(HMSNL [MIM 601455]), which is an autosomal re-
cessive form of Charcot-Marie-Tooth disease, occurs 
in divergent Romani (Gypsy) groups descended from 
a small founder population-the Vlax, or Danubian 
Roma. The disorder was first described in affected 
families from Bulgaria (Kalaydjieva et al. 1996) and 
was subsequently diagnosed in families in Italy (Mer-
lini et al. 1998), Slovenia (Butinar et al. 1999), Ger-
many (Baethmann et al. 1998), Spain (Colomer et al. 
2000), France, and Rumania. HMSNL is an early-
onset peripheral neuropathy that progresses to severe 
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disability in adulthood. Clinically, it presents with 
muscle weakness and wasting, tendon areflexia, skel-
etal and foot deformities, sensory loss affecting all 
modalities, and severe reduction in nerve conduction 
velocities (Baethmann et al. 1998; Kalaydjieva et al. 
1998; Merlini et al. 1998; Butinar et al. 1999). Neural 
deafness develops during the second or third decade 
of life, with abnormalities in the brain-stem auditory-
evoked potentials suggesting involvement of the entire 
tract, including the central auditory pathways (Ka-
laydjieva et al. 1998; Butinar et al. 1999). The neu-
ropathologic observations in HMSNL (Baethmann et 
al. 1998; Kalaydjieva et al. 1998; Butinar et al. 1999; 
King et al. 1999) include Schwann-cell dysfunction, 
which is manifested by hypomyelination and demye-
lination/remyelination, failure of compaction of the 
innermost myelin lamellae, and poor hypertrophic re-
sponse (onion-bulb formation) to the demyelination 
process. At the same time, axonal involvement is doc-
umented by early, severe, and progressive axonal loss 
and by the presence of curvilinear intra-axonal inclu-
sions that are similar to those seen in the dying-back 
47 
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type of distal axonopathy in experimental vitamin E 
deficiency. 
Findings from a number of recent clinical and ex-
perimental studies (Killian et al. 1996; Garcia et al. 
1998; Robertson et al. 1999; Sahenk 1999; Sancho et 
al. 1999) of the common autosomal dominant demye-
linating forms of Charcot-Marie-Tooth (CMT) disease 
have indicated that the neurological deficit in demye-
linating neuropathies is related to axonal loss, rather 
than to demyelination per se. The neuropathologic fea-
tures of HMSNL make it impossible to attribute the 
primary defect to either Schwann cells or neurons, and 
they strongly suggest that impairment of Schwann 
cell-axonal interaction is a major component of the 
pathogenesis of this disease. The molecular basis of 
HMSNL may thus be of relevance to the general un-
derstanding of the pathogenetic mechanisms and causes 
of disability in demyelinating neuropathies. · 
The disease gene was mapped to a 3-cM interval on 
8q24.3, where closely related disease haplotypes and 
strong linkage-disequilibrium values suggested a single 
founder mutation (Kalaydjieva et al. 1996). Similar 
polymorphic haplotypes were subsequently identified in 
HMSNL chromosomes in affected families across Eu-
rope, supporting the assumption of genetic homogeneity 
and founder effect (Chandler et al. 2000). We now re-
port the identification of the HMSNL gene and the 
founder mutation causing the disease. 
Subjects and Methods 
Physical Mapping of the HMSNL Region 
A contig of genomic clones spanning the HMSNL in-
terval was assembled by screening of bacterial-artificial-
chromosome (BAC) and PAC libraries for the known 
sequence-tagged sites (STSs) in the region and for the 
end sequences of clones identified in our previous rounds 
of library screening. The screening was performed by 
means of PCR amplification (Research Genetics Human 
BAC DNA Pools, California Institute of Technology, 
B&C libraries, cell line 978K) or filter hybridization 
(PAC library #709, RPCI6, Roswell Park Cancer Insti-
tute; created by Pieter de Jonge and obtained through 
the German Human Genome Project Center, Max 
Planck Institute). Clone orientation was obtained by STS 
content mapping and by halo-FISH (Raap and Wiegant 
1994). Nonoverlapping clone ends were used as STSs in 
the next round of library walking. 
Refined Genetic Mapping 
For the identification of new polymorphic micro-
satellites, BAC and PAC contig clones were digested 
with frequent cutter restriction endonucleases and 
were shotgun cloned into pBiuescript. A replica 
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membrane of the gridded colonies was hybridized 
with a cocktail of y(3.2P]-ATP end-labeled di-/tri-/tet-
ranucleotide repeat sequences, and positive clones 
were sequenced. Markers (D8S558, D8S529, D8S378, 
and D8S256) available from public databases were 
PCR amplified with the use of fluorescently labeled 
primers (Research Genetics map pair set), were length-
separated on a 373 XL DNA analyzer (PE Biosys-
tems), and were analyzed using GENOTYPER soft-
ware (PE Biosystems). AFM116yh8 and all newly 
identified microsatellites were analyzed through in-
corporation of a(32P]-dCTP into the PCR product dur-
ing amplification. The PCR primers for the newly 
identified markers were th6se described by Chandler 
et al. (2000). Vertical-gel dectrophoresis, which was 
performed in a Hoeffer Pokerface II apparatus, was 
followed by autoradiography for 2-12 h. Allele call-
ing· was performed manually. Haplotypes were con-
structed manually and wete examined for recent and 
historical recombinations. The marker positions were 
determined by STS content mapping of the contig 
clones. 
A total of 174 individu~ls were genotyped for 24 
markers in the HMSNL reiion. Informed consent was 
obtained from all participants in the study. 
Sequencing 
BAC/PAC DNA isolation and purification with the 
QIAfilter Plasmid Midi kits: were performed according 
to the manufacturer's protocols (Qiagen). End sequenc-
ing was performed using universal primers T7 and SP6. 
Sequence analysis of the WISP1 and NDRG1 genes 
included all coding regions· and ;;.100 bp of flanking 
intronic sequences. PCR amplification was performed 
using the primers shown in table 1. The PCR products 
were purified with Qiagen QIAquick spin columns. Both 
strands were sequenced with the same primers used for 
PCR amplification. 
Sequencing of end clones and PCR products was per-
formed using Big Dye Terminator Cycle Sequencing 
Ready Reaction Kit reagents (PE Biosystems). The re-
actions were run on an ABI 377 sequencer (PE Biosys-
tems) and were analyzed using Sequence Navigator soft-
ware, version 1.0.1. 
For large-scale genomic sequencing, BAC/PAC DNA 
was isolated using the doubl.e-acetate method (Birnboim 
and Doly 1979). The close4-circle band was sonicated, 
and 1.5-2-kb fragments were size-selected by agarose 
electrophoresis and were ligated into the Smai site of 
the M13mp18 vector. M13 :templates were prepared by 
means of the Triton method (Mardis 1994). Shotgun 
sequencing was performed using ThermoSequenase 
(Amersham) and Big Dye Terminator Cycle Sequencing 
Ready Reaction Kit chemistry (PE Biosystems). Data 
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Table 1 
PCR Primers for Sequencing Analysis of NDRG1 and W/SP1 
PRIMER 
GENE AND EXON Forward Reverse 
NDRGl: 
1 GACTGCGAGGGTCTGGGAG CTTACTCCTGGAGT~CGC 
2 CTTCTTGCCATTGGTCTTG GCATGCCCATAAGTACAAG 
3 GATTCAGGTCATAGAAAGG AGAGAAGACGGGAT~AGG 
4 CACGCGGATGCCATGAAC GCATTTCTGGCTTTTCCAG 
5 CTTTGCCACCGAGACACC GAGCAAAGCACCTGAAcc 
6 CTAATGGCTTCTCTGTGTC GTCAGTCCAGATCAAAGC 
7 AGGCTCCCGTCACTCTG GTCTTCCTTCATCITAAAATG 
8 CCTAGTGTTTCAGATTGCTG GAGAGCTCGTAGCTGCAG 
9 GGAGTCCAGCAATGCCAC CTGAGCACCACACAATGC 
10 GAGTAGTGACCAGCTCAG CAAACTCAGAGCCTGCCTCTTC 
11 ACAGGGCCTCTCTCAAGTTG CTGGGTAATGCTCAQTCTC 
12 CAGGCCTGGGAGTGGGACAATC GCAGGCAGGGCCACTTCAAC 
13 CAAGCCACATCTGCTGAATCC CTTTGCAGCCTCAGATCACC 
14 GACACCAGCAGCCTTGCCTG CCTAGGGAATCAGAGTCCTC 
15 GGAAACTGGCTCAGACAGG CATGCCCTCCACACACCTAAC 
16 GTGGACATGGAGAGGACG GTCTCCACCAGAGC1CACTC 
WISP1: 
1 CATATCTGGTGCTCCTGATGG GTAGCAGGACCCAGTAGAGAAG 
2 GACAGGAATGCAATGGCAG GGTGTATCTCCTGCTGAAC 
3 GCATGGTCCACATGGAGCC GGTGGTCAGAGTTC~AGG 
4 GTGTGGTGAAAGTGAGGGTTG GCTTGTGAAGTCTAGACATCC 
5 GTAAGGTGGAATGCTCCCAC CAGATCAGGGTAAcfAAGGC 
were collected using ABI 377 automated sequencers and 
were assembled with the program PHRAP sequence-
assembly program (University of Washington Genome 
Center. 
Computational Analysis 
The genomic-sequence data were analyzed using the 
RUMMAGE-DP program (Genome Sequencing Cen-
tre, Institute of Molecular Biotechnology, Jena, Ger-
many), which combines >25 different programs (ref-
erences available at the Web site of the Genome 
Sequencing Centre, Institute of Molecular Biotech-
nology, Jena, Germany), including five programs for 
exon prediction; RepeatMasker, for tagging repetitive 
sequences; programs for prediction of CpG islands; 
and homology searches using BLAST, version 1.4, and 
FAST A, version 2.0. Recognition of promoter regions 
and transcription-start positions was performed using 
both Ghosh/Prestridge (TSSG) and Wigender (TSSW) 
motif databases. 
Screening for the R 148X Mutation 
Exon 7 of NDRGl was PCR amplified as a 176-bp 
product, by use of the following primers: 5'-AGGCTC-
CCGTCACTCTG-3' (forward) and 5'-GTCTCCTTC-
ATCTTAAAATG3' (reverse). Restriction digests were 
performed for 4 h at 65°C in a mix containing 1 x Taqi 
buffer, 10 ~I PCR product, and 10 U Taqi (Promega). 
The restriction products (lengths 104 bp and 72 bp) were 
separated in 4% agarose gel~ stained with ethidium bro-
mide and were visualized u~der UV light. 
Expression Studies 
S.A.G.E.library data were;obtained through screening 
of our own libraries constru~ted from peripheral nerve, 
glioblastoma, and fetal-brain RNA (Michiels et al. 1999) 
and through searching of S.A.G.E. public databases. The 
sequence of the NDRGl S.A.G.E. tag is GGACTITC-
CT. Expression levels are given as the number of tran-
script tags/106 transcripts in:the S.A.G.E. library. 
Northern blot analysis was conducted on RNA ex-
tracted, according to standa(d protocols, from total pe-
ripheral nerve and from • cultured nonmyelinating 
Schwann cells and hNT2 cejls (Sambrook et al. 1989). 
Reverse transcriptase-PCR (lRT-PCR) of NDRGl from 
RNA derived from the same sources mentioned above 
was performed using prim~rs 5'-AACCCACACAGT-
CACCCT-3' (forward) and 5!-GAAGTACTTGAAGGC-
CTC-3' (reverse). The 189-qp products were run on a 
1% agarose gel in 1 x Tris-~orate EDTA, were blotted, 
and were hybridized with the PCR product obtained 
with the same primers. 
Analysis of tissue-specific i transcripts was performed 
by 5' rapid amplification of eDNA ends (5'-RACE) and 
by RT-PCR of two fragment$ spanning the entire coding 
region of NDRGl. 5'-RAC:B (Boehringer Mannheim 5'/ 
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3' RACE kit) was performed on total RNA from human 
fetal brain, adult peripheral nerve, and lymphocytes, by 
use of the following NDRG1-specific primers: NDRGl-
Rl (5'-ACACAGCGTGACGTGAACAG-3'), for there-
verse-transcription step); and NDRG1-R2 (5'-CAGAG-
CCATGTAAAGTCTCG-3') and NDRG1-R3 (5'-ATGT-
CCTGCTCCTGGACATC-3'), for the 5'-RACE reac-
tions. The products were tested on agarose gels and were 
sequenced with primer NDRGl-R3. One-step RT-PCR 
was performed on the same sources of RNA as was 5'-
RACE, by use of the following two primer pairs: 
NDRG1 5' UTR-F (5'-GAAGCTCGTCAGTTCACC-3') 
and NDRGl exon 4-R (5'-GTGATCTCCTGCATGT-
CCTC3'), and NDRG1 exon 4-F (5'-GAGGACATGCA-
GGAGATCAC-3') and NDRG1 exon 15-R (5'-CCAGA-
GGCTGTGCGGGACC-3'). 
Radiation-Hybrid Mapping 
The chromosomal location of NDRG2 was deter-
mined by radiation-hybrid (RH) mapping. PCR 
screening of the GeneBridge RH panel was performed 
using primers selected from the unique 3' UTR se-
quence of KIAA1248, showing no homology to 
NDRG1 or NDRG3. The primer sequences were as fol-
lows: NDRG2RH-F2 (5'-CTGGGGCTCCA TTCACCA-
AAGC-3') and NDRG2RH-R2 (5'-AGCCCAGCCCAA-
GCTT AGCTC-3'). The results were submitted to the RH 
server of the Whitehead Institute/MIT Center for Ge-
nome Research, for calculation. 
Results 
Physical and Refined Genetic Mapping 
We have assembled a 1-Mb contig of genomic BAC, 
PAC, and cosmid clones, with a minimum tiling path 
shown in figure 1. The contig spans the entire HMSNL 
region, as defined by the recombinations identified in 
the initial study (Kalaydjieva eta!. 1996). The contig 
was anchored to the four known markers in this re-
gion on 8q24, following the order provided by pub-
lic databases (cen-D8S529/D8S378-AFM116yh8-
D8S256-tel). Our subsequent findings have shown the 
correct orientation to be as follows: cen-AFM116yh8-
D8S378-D8S529-D8S256-tel. The contig clones were 
used for physical mapping of expressed-sequence tags 
(ESTs) roughly positioned in this region and for iden-
tification of new polymorphic markers. 
Refined genetic mapping included 174 individuals (60 
patients and 114 unaffected relatives) from seven Eu-
ropean countries; the individuals were genotyped for 24 
polymorphic microsatellites, 19 of which were identified 
in our study (Chandler et al. 2000). Ten recombinant 
haplotypes, whose distribution differed between disease 
chromosomes originating from the diverse Romani 
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groups, helped to narrow the HMSNL region (fig. lb). 
In five of the seven centromeric recombinations (fig. lb, 
bottom), the breakpoints mapped to the same 90-kb 
interval between markers pjlO and 458b14, thus placing 
the centromeric boundary of the region at pJlO. Hap-
lotype analysis of the telomeric recombinants placed the 
distal boundary at marker 369CA3 (fig. lb, right). 
Within the pJ10-369CA3 interval, all HMSNL 
chromosomes shared an identical haplotype for mark-
ers 458a13-458b57-369a89. This haplotype was not 
found in any of the 88 normal chromosomes studied. 
Marker 4S8b14 presented with three different alleles 
in the disease chromosomes; however, on the basis of 
the conserved flanking haplotypes, this variation was 
assumed to result from microsatellite mutations (sim-
ilar to those observed in 339CA2, 189CA17, and, es-
pecially, D8S378; fig. lb, green boxes). 
J:'he critical HMSNL gene interval was thus defined, 
on the basis of recombination and homozygosity map-
ping, as being located between newly identified mark-
ers pJlO and 369CA3. The entire region was con-
tained in three overlapping genomic clones-PAC 
709A2498Q2 and BACs 458A3 (GenBank accession 
number AF192304) and 369M3 (GenBank accession 
number AF186190) (fig. 1). Large-scale sequencing of 
these clones identified the final exons of thyroglobulin 
in PAC 709A2498Q2 and the full length of two 
known genes: the Wntl-inducible signaling protein 1, 
WISP1 (Pennica et al. 1998), in BAC 458A3, and 
NDRG1 (aliases RTP, NDRl, DRGl, and CAP43) 
(Kokame et al. 1996; Van Belzen et a!. 1997; Kur-
distani et al. 1998; Zhou et al. 1998; Xu eta!. 1999) 
in BACs 458A3 and 369M3 (fig. la). WISP1 and 
NDRG1 are located tail to tail, in opposite orienta-
tions, and are separated by a small distance of -38 
kb. The WISPl gene spans -38 kb of genomic DNA, 
with the coding regions split into five exons. NDRG1 
is spread over 60 kb of genomic DNA and consists 
of 16 exons, including an untranslated first exon (fig. 
2). 
The HMSNL Mutation 
The search for the mutation was conducted by se-
quencing of the untranslated and promoter regions, all 
exons, and ;;;.tOO nucleotides of the flanking introns of 
WISPl and NDRG1 in a panel of DNA samples from 
patients with HMSNL and unaffected controls from the 
same population. 
This analysis revealed a total of 13 single-nucleotide 
polymorphisms (SNPs) in the two genes (table 2); only 
one of the 13 SNPs was in WISP1. The difference is due 
to the fact that sequence variation in NDRGl was in-
vestigated more extensively in individuals of diverse eth-
nic background, whereas WISPl was analyzed only in 
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Figure 1 a, Diagram of the BAC, PAC, and cosmid (HCT) clone contig of the HMSNL region. Known genes are represented by arrows pointing in the direction of their transcription. b, Positions 
of polymorphic microsatellites used to construct haplotypes on disease chromosomes. The HMSNL critical interval is flanked by markers p]lO and 369CA3 and contains the WISPl and NDRGl 
genes. 
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Figure 2 Scale diagram of the genomic and eDNA organization of NDRG1, with an illustration of the HMSNL mutation. a, Genomic 
organization. The NDRG1 gene consists of 16 exons spanning 60 kb of genomic sequence. A CpG island overlaps with the first exon and the 
5' end of intron 1. A potential promoter with a TATA box, a GC box similar to the N-myc binding region of mouse Ndrl, and a TATA-less 
enhancer were located 39 bp, 65 bp, and 81 bp upstream, respectively, of the first exon. The 5' UfR is split between the first two exons. b, 
eDNA structure. Translation starts from nucleotide position 123. c, HMSNL mutation: C--+T substitution at base 564 results in a stop signal 
(TGA) at codon 148 in exon 7 (R148X). All nucleotide positions are given relative to the published sequence (GenBank accession number 
D87953). 
the Roma. So far, our results have shown that SNPs in 
the NDRGl gene occur with a frequency of ;;;.1/423 
nucleotides. In patients with HMSNL, the WISPl gene 
sequence was identical to the published wild-type se-
quence. 
Analysis of NDRGl in individuals affected with 
HMSNL identified a C--+T transition in exon 7, at nu-
cleotide position 564 (according to the numbering of the 
reducing agents and tunicamycin-responsive protein 
(RTP) sequence [GenBank accession number D87953]). 
This substitution results in the replacement of arginine 
by a translation-termination signal at codon position 
148 (fig. 2). The R148X mutation was found in the 
homozygous state in all 60 patients with HMSNL that 
were included in the present study. 
The C--+T substitution abolished a Taqi site, and a 
restriction assay was designed as a screening test for the 
R148X mutation. In families with HMSNL, the muta-
tion segregated in 100% agreement with the carrier 
status predicted by . haplotype analysis. Analysis of 69 
additional unaffected members of the extended kindred 
(the Lorn pedigree) in which the disease was first de-
scribed resulted in the detection of 24 carriers. 
Screening for the R148X mutation also included 10 
Romani families from Rumania who had unspecified 
autosomal recessive peripheral neuropathies. The 
R148X mutation was found in six of these families, in 
whom it cosegregated with the disease phenotype and 
occurred in the homozygous state in the affected 
patients. 
We did not find the R148X mutation among 101 un-
related unaffected control individuals, including 68 non-
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Table 2 
SNPs Identified in NDRG1 and WISP1 
Gene and SNP Nucleotide Position' Ethnic Background 
NDRG1: 
T/G 
err 
err 
err 
err 
NG 
NC 
err 
err 
NG (293Pro-+Pro) 
NC 
NG 
5' urn, nt 15b 
S'urn, nt 3' 
lntronic, IVS1 +48 
Intronic, IVS2-5 
lntronic, IVS6-33 
Intronic, IVS10 + 83 
lntronic, IVS1 0-50 
lntronic, IVSll-7 
Intronic, IVS13+147 
Exon 14, 989' 
Intronic, IVS14-i24 
3' UTR, 1395' 
Afro-American 
Dutch; Roma 
Dutch; Roma 
Afro-American 
Afro-American; Dutch; Roma 
Dutch 
Afro-American; Dutch; Roma 
Roma 
Afro-American; D)ltch; Roma 
Afro-American 
Afro-American 
Afro-American 
WISPl: 
err (307Asn-+Asn) Exon 5, 1009• Rom a 
• Designated as proposed by.Antonarkis et al. (1998), with the positive IVS (intronic) 
numbers starting from the G of the donor-site invariant GT and with the negative IVS 
numbers starting from the G of the acceptor-site invariant AG. nt: nucleotide position. 
b Relative to NDRGl 5' urn novel sequence (GenBank accession number 
AF230380). 
' Relative to mRNA for RTP (GenBank accession number D87953). 
• Relative to mRNA WISPl (GenBank accession number AF100779). 
Romani Bulgarians and 33 Roma who originate from 
the same groups as do the patients with HMSNL but 
who belong to kindreds with other genetic disorders. 
The NDRG Family 
NDRGl is a known gene that has previously been 
identified in several independent in vitro studies of hu-
man cell lines (Kokame et al. 1996; Van Belzen et al. 
1997; Kurdistani et al. 1998; Zhou et al. 1998; Xu et 
al. 1999). The encoded protein is highly conserved in 
evolution (Krauter-Canham et al. 1997; Shimono et al. 
1999; Yamauchi et al. 1999). The genomic organization 
of NDRGl, as revealed in the present study (fig. 2), is 
also conserved and is closely related to that of the mouse 
gene (Shimono et al. 1999). 
The results of previous experiments (Van Belzen et al. 
1997; Piquemal et al. 1999) have suggested that 
NDRGl is a unique gene; however, a recent study {Van 
Belzen et al. 1997; Piquemal et al. 1999) has demon-
strated the existence of an Ndr gene family in the mouse. 
Since the existence of homologous genes in humans 
could affect the specificity and, hence, the reliability of 
expression studies, we have used the novel mouse se-
quences to search the human-genome databases. This 
search has confirmed the existence of related human 
genes, which we will refer to as NDRG2 and NDRG3, 
respectively, for the genes homologous to mouse Ndr2 
and Ndr3. 
NDRG2 was found to be represented by 147 ESTs 
and two eDNA sequences. To determine its chromoso-
mal localization, we have performed RH mapping with 
use of the GeneBridge panel. NDRG2 was localized to 
chromosome 14q11.2, at 6.72 cR from D14S264, with 
LOD score= 15.0. 
The NDRG3 gene was represented by 86 ESTs and a 
genomic clone from chromosome 20q11.21-qll-23. 
This provisional chromosomal localization was con-
firmed by electronic PCR. In the same genomic clone, 
this search identified four STSs (three STSs flanking 
NDRG3 and one located in its 3' UTR) that have also 
been independently localized to chromosome 20 by 
means of RH mapping. 
The BLAST comparison showed considerable ho-
mology between the three human NDR genes, with 
greater divergence in the terminal parts of the sequences. 
At the protein level, the identity (similarity) is 54% 
(70%) between NDRGl and NDRG2, 67% (81 %) be-
tween NDRGl and NDRG3, and 58% (71 %) between 
NDRG2 and NDRG3. These values are very similar to 
the percent homology reported for the members of the 
mouse Ndr family (Okuda and Kondoh 1999). Both 
mouse Ndr2 and Ndr3 (Okuda and Kondoh 1999) and 
human NDRG2 and NDRG3 lack the highly hydro-
philic amino-acid-sequence motif (GTRSRSHTSE) that 
is typical of NDRGl and that is repeated three times at 
its C-terminus. 
Expression Analysis of NDRG1 
The ubiquitous expression of NDRG1 is documented 
by 343 entries in the UniGene cluster (GenBank acces-
sion number Hs 75789) and by previous studies (Ko-
kame et a!. 1996; Van Belzen et al. 1997; Kurdistani et 
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a!. 1998; Zhou eta!. 1998; Piquemal eta!. 1999; Xu et 
a!. 1999) using various experimental systems. To date, 
no information on the peripheral nervous system has 
been published. 
To obtain a quantitative comparison of the levels of 
NDRGl expression in different tissues, we have per-
formed S.A.G.E. library screening and database 
searches. The following results, presented as the number 
of transcript tags/106 transcripts in the S.A.G.E. library, 
were obtained: peripheral nerve, 400; colorectal cancer 
(HCf116), 213; glioblastoma multiformae libraries, 
210 and 99; brain, 146; normal colon and some primary 
colon tumors, 81-105; and prostate cancer 139 and 158. 
The aforementioned values indicate that NDRGl is 
abundantly expressed in peripheral nerve, where the lev-
els of expression are significantly in excess of those in 
the other tissues examined. 
Northern blot analysis comparing total adult periph-
eral nerve RNA, cultured nonrnyelinating Schwann cells, 
and hNT2 cells, which can be induced to neuronal dif-
ferentiation, showed strong signal in total peripheral 
nerve and Schwann cells. Expression was lower in un-
differentiated hNT2 cells, and no signal was obtained 
in differentiated hNT. In view of the high sequence ho-
mology between the genes of the NDRG family and the 
possibility of cross-hybridization, these results were ver-
ified and confirmed by RT-PCR using NDRGl-specific 
primers (fig. 3). Our preliminary immunocytochemistry 
findings in peripheral nerve point to NDRGl lix:ali:i:a-
tion in the Schwann-cell cytoplasm, with no evidence of 
axonal expression (not shown). 
We have used 5'-RACE and RT-PCR to check for the 
presence of tissue-specific ND R G 1 transcripts in pe-
ripheral nerve, fetal brain, and lymphocytes. The results 
of 5'-RACE did not provide evidence of different tran-
scription-start sites: these experiments identified a short 
(15-nucleotide) novel additional sequence immediately 
upstream of the 5' UTR of the longest published NDRGl 
sequence (Kokame et a!. 1996), which, however, was 
common to all three transcripts. RT-PCR and, subse-
quently, sequencing of the entire coding region of 
NDRGl in peripheral nerve, fetal brain, and lympho-
cytes revealed a single transcript, identical to the pub-
1 2 3 
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lished eDNA sequence, with no evidence of tissue-spe-
cific alternatively spliced forms. 
Discussion 
The heterogeneous category of hereditary motor and 
sensory neuropathies consists of a large number of clin-
ically and genetically distinct conditions (recently re-
viewed in Keller and Chance [1999] and Schenone and 
Mancardi [1999]), including autosomal recessive forms, 
some of which have been placed on the human genetic 
map (Ben Othmane et al.1993; Bolino eta!. 1996; Ca-
saubon eta!. 1996; LeGuern eta!. 1996; Bouhouche et 
al. 1999). Relative to autosomal dominant CMT disease, 
these conditions are rare. However, they are clinically 
more severe (Harding and Thomas 1980) and are less 
likely to result from mutations in structural myelin pro-
teins;· therefore, understanding their genetic basis may 
provide insight into hitherto unknown molecular mech-
anisms of peripheral-nervous-system development and 
axon-glia interactions. The genetic heterogeneity of au-
tosomal recessive peripheral neuropathies and the lim-
ited number and size of families affected by any single 
disorder have presented a major obstacle to molecular 
research and gene identification. In the case of HMSNL, 
positional cloning was facilitated by the substantial 
number of patients identified over a short period of time 
after the initial description of the disease as well as by 
the history of the disease-causing mutation. HMSNL 
occurs in an ethnic group that is marginalized by most 
health-care systems; therefore, ascertainment can be pre-
dicted to be limited. The number of affected individuals 
in whom a diagnosis has already been made suggests 
that the disease is relatively common and may be the 
prevalent form of peripheral neuropathy among the 
Roma. On the other hand, the origin of the HMSNL 
mutation has been estimated to pre-date the arrival of 
the proto-Roma in Europe (Kalaydjieva et a!. 1996), 
indicating that the mutation was present in the ancestral 
population before it split into numerous small groups 
separated by geographic dispersal, social pressures, and 
rules of endogamy. The independent evolution and di-
versification of disease haplotypes in the different Ro-
4 5 
.. 
' . ' tllltf .;,., -
Figure 3 RT-PCR using specific NDRG1 primers in hNT2 cells that are not differentiated (lane 1), hNT2 cells induced to neuronal 
differentiation (lane 2), in vitro cultured nonmyelinating Schwann cells (lane 3), total adult peripheral nerve (lane 4), and fetal brain (lane 5). 
NDRG1 specificity was confirmed by transfer of the RT-PCR products to a membrane and by back-hybridization with the PCR product. 
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mani groups across Europe have provided a powerful 
tool for the refined mapping of the HMSNL gene. 
The molecular defect shared by all affected individ-
uals was found to be a truncating mutation in NDRG1. 
This gene encodes a highly conserved protein with a 
high degree of homology to the proteins in other species. 
The amino acid similarity to the Drosophila protein is 
44%; to sunflower, 48% (Krauter-Canham eta!. 1997); 
to rat Bdml, 75% (Yamauchi eta!. 1999); and to mouse 
Ndrl, 96% (Shimono eta!. 1999). These proteins show 
no homology to known motifs, except for a putative 
phosphopantetheine-binding site (Kokame eta!. 1996; 
Van Belzen et a!. 1997; Piquemal et a!. 1999) and a 
46% similarity to the ligand-binding domain of the in-
ositol 1,4,5-triphosphate receptor (Krauter-Canham et 
a!. 1997). 
The evolutionary conservation of NDRG1-related 
proteins points to an important biological role. The pre-
viously proposed functions of human NDRGl are 
based on studies of non-neural tissues. NDRG1 has 
been shown to be repressed in cell transformation (Van 
Belzen et a!. 1997; Kurdistani et a!. 1998) and up-reg-
ulated in growth-arrested differentiating cells (Van Bel-
zen eta!. 1997; Kurdistani et al. 1998; Piquemal et aL 
1999) and under conditions of cellular stress (Kokame 
eta!. 1996; Zhou eta!. 1998; Xu eta!. 1999). Inducing 
agents include p53 (Kurdistani et a!. 1998), increased 
intracellular Cal+ and forskolin (Zhou eta!. 1998), re-
tinoic acid, and vitamin D (Piquemal et a!. 1999). 
NDRG1 expression has been shown to cycle with cell 
division (Kurdistani eta!. 1998), and studies of the in-
tracellular localization of the protein suggest translo-
cation between the cytoplasm and the nucleus (Van Bel-
zen et a!. 1997; Kurdistani et a!. 1998; Piquemal eta!. 
1999). A role as a developmental gene has been doc-
umented for Ndrl, which, in the mouse embryo, is re-
pressed by N-myc and is up-regulated in cells committed 
to terminal differentiation (Shimono et a!. 1999). The 
accumulated data suggest involvement in growth arrest 
and cell differentiation during development and in the 
maintenance of the differentiated state in the adult, pos-
sibly as a signaling protein shuttling between the cy-
toplasm and the nucleus. 
In terms of patterns of expression and proposed gen-
eral functions, NDRG1 clearly resembles PMP22/gas3. 
PMP22 is also widely expressed in embryonic and adult 
tissues (Patel et a!. 1992; Baechner et a!. 1995) and is 
believed to be involved in growth arrest and cell dif-
ferentiation (Manfioletti et a!. 1990; Zoidl et a!. 1997). 
The highest levels of expression are found in the mye-
linating Schwann cell, where PMP22 is a component of 
compact myelin (Snipes et a!. 1992). PMP22 is now 
known to be responsible for CMT type 1A, hereditary 
neuropathy with liability to pressure palsies, and some 
forms of Dejerine-Sottas syndrome in humans (Patel et 
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a!. 1992; Timmerman et aL 1992; Valentijn eta!. 1992; 
Chance et al. 1993; Roa et al. 1993), and for naturally 
occurring models of peripheral neuropathy in the mouse 
(Suter et a!. 1992a, 1992b). A number of studies of 
affected humans as well as of natural and transgenic 
rodent models have pointed to the complex pathogen-
esis of these disorders where altered myelin stability and 
demyelination are only one aspect. The observed sig-
nificant phenotypic changes in both Schwann cells and 
axons (Hanemann et a!. 1997; Garcia eta!. 1998; Sa-
henk 1999; Sancho eta!. 1999; Robertson eta!. 1999) 
have suggested that, in. addition to its function as a 
myelin protein, PMP22 plays a role in early peripheral-
nervous-system development and differentiation and in 
Schwann cell-axonal interactions (reviewed in Naef and 
Suter 1998). 
Axons and glia in the peripheral nervous system are 
involved in a most complex system of communication, 
the integrity of which is essential for the differentiation, 
survival, and normal function of both types of cells 
(Snipes and Suter 1994;]essen and Mirsky 1998, 1999). 
Both the involvement of NDRG1 in these mechanisms 
and a possible functional link to PMP22 remain to be 
investigated in functional studies as well as through the 
identification of NDRG1 mutations in other peripheral 
neuropathies. The high levels of NDRG1 expression in 
peripheral nerve and, specifically, in the Schwann cell, 
together with the characteristics of the HMSNL phe-
notype, point to a possible involvement of NDRGl in 
Schwann-cell differentiation and the signaling necessary 
for axonal survival. The role of NDRG1 in growth 
arrest and cell differentiation, proposed for other tis-
sues, may thus be conserved in the peripheral nervous 
system and may be related to the complex develop-
mental transitions marking the stages of differentiation 
of the Schwann-cell lineage and Schwann cell-axonal 
interactions (Jessen and Mirsky 1998, 1999). At the 
same time, the abundant expression in adult peripheral 
nerve and the putative phosphopantetheine-binding 
domain present in the NDRG1 protein point to its pos-
sible dual role and additional involvement in the lipid 
biosynthetic pathways operating in the myelinating 
Schwann cell. 
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Hereditary motor and sensory neuropathy type Lorn, initially identified in Roma (Gypsy) families from Bulgaria, has been mapped to 
8q24. Further refined mapping of the region has been undertaken on DNA from patients diagnosed across Europe. The refined map consists 
of 25 microsatellite markers over approximately 3 eM. In this collaborative study we have identified a number of historical recombinations 
resulting from the spread of the hereditary motor and sensory neuropathy type Lom gene through Europe with the migration and isolation of 
Gypsy groups. Recombination mapping and the minimal region of homozygosity reduced the original 3 eM hereditary motor and sensory 
neuropathy type Lom region to a critical interval of about 200 kb. ©2000 Elsevier Science B.V. All rights reserved. 
Keywords: Hereditnry motor und sensory neuroputhy type Lom; Genetic mapping; Gypsy families 
1. Introduction 
Hereditary motor and sensory neuropathy type Lom 
(HMSNL) is a novel autosomal recessive demyelinating 
* Corresponding author. Centre for Human Genetics, Edith Cowan 
University, Joondalup Campus, Pcrrh. WA 6027, Australi;r. Tel.: +61-8-
9400-5808; fax: +61-8-9400-5851. 
E-mail adtlre.~s: l.kalaydjieva@cowan.edu.au (L. Kalaydjiev:r). 
neuropathy associated with deafness, which was initially 
identified in Roma (Gypsy) families from Bulgaria [1,2]. 
The HMSNL gene has been mapped to 8q24 [1). The 
conserved polymorphic haplotypes on 8q24, shared by all 
disease chromosomes in the original group of affected 
families, suggested genetic homogeneity and homozygosity 
for a single founder mutation. Since the initial description of 
the disorder, affected individuals have been diagnosed in 
0900-8966/00/$ - see front matter © 2000 Elsevier Science B. V. All rights reserved. 
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different countries across Europe, suggesting that HMSNL 
is probably the most common single autosomal recessive 
peripheral neuropathy. 
The neuropathological features include a very early and 
severe axonal loss [I ,3-7] pointing to HMSNL as a model 
disorder whose genetic and pathophysiological mechanisms 
may be relevant to understanding the general causes of 
disability in demyelinating peripheral neuropathies. Since 
neural deafness is an invariable symptom of HMSNL, the 
identification of the molecular basis of the disease will also 
contribute to disentangling the complexity of factors 
involved in hearing loss. 
The HMSNL interval defined by the initial data spanned a 
di~tance of approximately 3 eM. The Src-like adaptor 
- protein (SLAP), involved in receptor-mediated cell signal-
ling, has been subsequently placed in that interval and 
excluded as the HMSNL gene [8). Since no other candidate 
genes are known to be located in the region, the identifica-
tion of the 1-IMSNL gene has to rely on the positional clon-
ing approach whose success depends on the size of the 
critical interval. 
Here we present the results of a collaborative study of 
affected families diagnosed in Bulgaria, Spain, Italy, Slove-
nia, France, Germany and Rumania, aiming at the refined 
genetic mapping of HMSNL. 
2. Patients and methods 
2.1. HMSNL patiems and.families 
The study comprised a total of 174 subjects: 60 patients ~ and 114 unaffected relatives from 23 HMSNL families. ~ 
t 
f 
i 
~ 
~ 
! 
l 
l 
L 
The group of patients included 32 males and 28 females 
aged between 7 and 50 years. Detailed clinical examinations 
were performed in all cases. Electrophysiological investiga-
tions, including nerve conduction studies and recordings of 
brainstem auditory evoked potentials (BAEPs) were carried 
out in at least one affected individual per family. Neuro-
pathological studies were conducted on sural nerve biopsies 
obtained from seven unrelated affected subjects. 
f Informed consent for participation in the study has been 
r 
f· obtained from all subjects. The study complies with the 
> ~ eth\cal guidelines of the institutions involved. 
·2.2. Methods 
2.2.1. PolymoiJJ!zic markers used in the study 
A total of 32 markers on 8q24.3 were typed in the 
HMSNL families (Fig. 1). These included nine microsatel-
lites flanking the HMSNL region, namely 41 F08, D8S557, 
D8S 1835 and D8S558 on the centromeric side, and D8S256, 
D8S 1708, D8S 1746, D8S I 796 and D8S 1462 on the telo-
meric side. A total of23 markers were located in the interval 
between D8S558 and D8S256, defined in the initial study as 
the HMSNL gene region [I], Three of these microsatellites, 
namely D8S529, D8S378 and AFM I 16yh8 have been 
published previously and are available through the public 
genome databases. The remaining 20 polymorphic micro-
satellites have been identified as part of this study. 
2.2.2. ldent(fic:atirm r~{ new po/_)'11/0lphic microsatellites in 
the HMSNL region 
A contig of genomic BAC or PAC clones spanning the 
HMSNL region w<ts assembled and the clones were used for 
the identification of new polymorphisms. The BAC/PAC 
DNA was digested with frequent-cutter restriction endonu-
cleases. The fragments were shotgun cloned into pBiue-
script. Colonies were gridded and a replica membrane was 
hybridized with a cocktail of e2P]')'-ATP end-labelled di/tri/ 
tetranucleotide repeat sequences. Alternatively, the frag-
ments were ligated to adapter oligonucleotides RX24 
(51-AGCACTCTGCAGCCTCTAGATCTC-3 1) and RX09 
(5prime;-GAGATCTAG-3'), hybridized to a biotinylated 
anchor probe corresponding to a simple repeat sequence 
and captured using streptavidin-coated magnetic beads. 
The fragments were released by washing, PCR-amplified 
and cloned into pBiuescript. In both cases the clones were 
sequenced, using universal primers T7 and T3, to identify 
·the repeat sequence and select PCR primers for further 
analysis. Two of the new microsatellites were identified 
within BAC ends sequenced routinely as part of the physical 
mapping of the region, and three were found during the 
genomic sequencing of the HMSNL region. 
All newly identified microsatellites were tested for poly-
morphism against a panel of DNA samples of unrelated 
control individuals from the same population and subse-
quently typed in the HMSNL families. Due to their low 
polymorphism, markers 423rl33, 543b76, 4838-T3, 
369CA2 and 369CA3 were analyzed only in the families 
with evidence of recombinations, in an attempt to map the 
breakpoints. 
2.2.3. Genotyping analysis 
Markers available through the public databases were 
PCR-amplified using commercially available fluorescently 
labelled primers (Research Genetics Map Pair Set). Electro-
phoretic length separation was carried out on an ABI 373 
XL automated DNA analyzer. Allele assignment was 
performed using the ABI Genotyper software and alleles 
named by their size in base pairs. 
The newly identified microsatellite repeats were analyzed 
through the incorporation of e2P]a-dCTP in the PCR product 
during amplification. The PCR primers, the average length of 
the PCR products and the number of alleles are shown in 
Table I. The PCR products were separated by vertical aery-. 
lam ide gel electrophoresis at 1400 V for I .5-2.5 h in a Hoef-
fer Pokerface II apparatus. The gels were fixed in a 10% 
methanol/ I 0% acetic acid solution, dried in a Savant slab 
gel dryer and exposed to Cronex 4 films for 2-24 h. Allele 
calling was performed manually, numbering the alleles from 
top to bottom. Uniform allele assignment across the sample 
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Fig. I. HMSNL haplotypes. Borders of initial HMSNL region; II recombinants used in refined mapping; ·3, marker mutation; l HMSNL region defined by 
initial study; t HMSNL region defined by present study; * alleles given as size in base pairs; spaces in th¢ body of the table represent untyped markers. 
was ensured through the use of allelic ladders including 
representative samples from all gels. 
2.2.4. Haplotype analysis and recombination mapping 
The order of markers (Fig. I) was obtained by STS content 
mapping of the genomic BAC and PAC clones forming the 
contig. The haplotypes on normal and HMSNL chromo-
somes were constructed manually in each family and exam-
ined for recent and historical recombinations. 
3. Results 
3.1. The HMSNL phenotype 
The participating centres have reported consistent clinical 
findings which allow the definition of the HMSNL pheno-
type [ 1,3,4,6,7J. Onset of symptoms is in the first decade of 
life. Gait disturbances begin at age 5-10 years and difficulty 
in using the hands becomes evident at age 5-15 years. 
Muscle wasting and weakness are distally accentuated and 
particularly severe in the lower limbs. Tendon reflexes are 
absent in the lower limbs and, depending on the age of the 
patient, depressed or absent in the upper limbs. Sensory loss 
involving all modalities is also distally accentuated and 
most evident in the lower limbs. Skeletal deformities, parti-
cularly of the feet, are common. Nerve conduction studies 
show a severe reduction in motor nerve conduction velocity. 
Sensory potentials are usually unobtainable, 
Hearing loss is a characteristic feature of HMSNL and 
usually develops in the second or third decade. Abnormal 
BAEP recordings, suggesting retrocochlear involvement of 
the central auditory pathways, are present in all patients 
prior to the onset of subjective hearing loss. The deafness 
in HMSNL has been shown to be of a pure neural type, due 
to a neuropathy of the auditory nerve with function in the 
cochlear outer hair cells being preserved [6]. 
The neurophysiological findings suggestive of a demye-
linating neuropathy arc supported by the neuropathological 
observations in peripheral nerve biopsies. An excess of 
nerve fibres with inappropriately thin myelin sheaths is a. 
consistent finding [2-7J. A number of ultrastructural obser-
vations clearly distinguish HMSNL from other demyelinat-
ing neuropathies. These include (I) early and severe axonal 
loss; (2) curvilinear axonal inclusions resembling the dying-
back type of distal axonopathy seen in experimental vitamin 
E deficiency; (3) failure of compaction of the innermost 
myelin lamellae; (4) a poor hypertrophic reaction of the 
Schwann cell with the formation of atypical onion bulbs 
in young patients which regress later in the course of the 
disease; and (5) pleomorphic inclusions in the adaxonal 
Schwann cell cytoplasm. The findings point to a possible 
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Table I 
PCR primer sequences of newly identified markers in the HMSNL region 
Marker Primer sequence (5 1 - 31) Size of PCR Number of Repent 
product (bp) alleles motif 
Forward Reverse 
,~ 
48 38-T3 AAACAAGTCATCTTAGACA CACAGCAAGACTCCTTC 98 2 CCTT 
339CA2 CGGACCCAAATCAATTITC CCATTTACAGTGCAGATG 122 6 CA 
339CAI TTGATCTGGGAGAATGATG ACATATACACTGCCACG 100 5 CA 
543876 GTGGCAGAGTGAGACACT TATACTATGACCATTCTCTG 120 2 CA 
543CAI GTCTTACTGCTGTATCTCC CCACAATACGAATGTATG 150 3 CA 
423RI33 CATTACAGGCATCTGCCATG GTGAACATGGCGAACGCTG 120 3 CA 
189CA17 GAAAAGGTCAATATGCCAGG GATTGAGTTGTCTATTTGTC 140 3 CA 
326CA3 TCATGGGATAAAACATTAGTGAA GATTTGCAATTTATTCAAGAACAC 160 7 CA 
326CAI GAAATGCTGGCAGAAGTCTTGAAAG TTGACTCCCTGCATTTATACCAATCTT 190 2 CA 
32~CA2 GTGCACCAAAATCTCACAAATCAC CCAATTCACCGCAAGTCAGACACT 300 7 CA 
SLAP TGCGTCAOAAGACTGTGGAC TGGCCATGGTTTTCATGTGC 170 6 CA 
pJ 19 ACCACAGCCCAGTGCCTGATTCC TTTACTTGGCACCCAGGCTTCTCA 140 5 CTG 
pJ 10 AGGGTCTTAGTCCCAACA AGAAAGAACTGACCAGCC 170 7 CA 
458814 CTCTCCCTCCAAAGTCTCC AAAGCAGAGGAAGCGCTGG 170 5 CA 
458AI3 AAGTATCCCTGTTATTCAGC CTTACTTCCAGGATAAACAC 110 5 CA 
458857 AGACAGTCTTCTTGACTGG TGTACCCAAGTCCCATCC 120 6 CA 
369A89 CTCATCTACACACTCGCGCG GGCCGATGAGACGGTCCGAAA 200 II CA 
369CA3 GATATAATTATGCAGATAGG GTTATTTGTCTTATCAGTC 188 4 CA 
369CA2 CTCCTACCTGCTGTCTGC GCTGAGAAGTCCATGATC 199 3 CA 
474CAI TCAGGCAGGCTGGATTCAG AGCAGAGCCATGGCACATG 170 4 CA 
disruption of Schwarm cell-axonal interaction and suggest 
that the HMSNL gene product may be a growth factor, a 
growth factor receptor or a signalling molecule involved in 
the maintenance of the differentiated state of these cells. 
3.2. A dense genetic map of the HMSNL region 
The initial gene mapping study [I] placed the HMSNL 
gene between markers D8S558 and D8S256. According to 
public databases, the interval contained live known poly-
morphic microsatellites positioned in the order cen-
D8S558-D8S529/D8S378-AFM 116yh8-D8S256-tel. The 
construction of the contig and of the genetic map followed 
this order, starting from the region around D8S529 for 
which all individuals in the original study had been found 
to share the same marker allele. In the D8S529-D8S256 
interval, we have identified 20 new polymorphic microsa-
tellites. 
\Vith two exceptions, markers 4838-T3 and pJ 19, all 
newly identified microsatellites are simple CA repeats 
(Table 1 ). pJ 19 has a CTG sequence motif but our study 
has excluded an expansion of this triplet repeat as the cause 
of HMSNL and has shown pJ 19 to be a neutral variant. The 
markers were found to vary widely in terms of polymorph-
ism. Some, such as 326CA1, 543b76 and 4838-T3, 
displayed two alleles in the population studied and were 
therefore of limited value. On the other hand, a number of 
the new microsatellites of which those located within the 
critical region are of particular importance, are highly poly-
morphic and informative, e.g. 369a89 which presented with 
II alleles. These newly identified markers, together with 
those previously published, provided a dense genetic map 
of the HMSNL interval on 8q24.3 with an average inter-
marker distance of less than 0.1 eM. 
Subsequent results from the physical mapping of the 
region have reversed the original sequence of genomic 
clones and polymorphisms and placed the known markers 
in the order cen-D8S558-AFM ll6yh8-D8S378-D8S529-
D8S256-tel (Fig. 1). 
3.3. Refined mapping r!f lhe HMSNL gene 
The 32 markers spanning the entire region were gena-
typed in the group of 174 individuals, including 60 affected 
subjects. 
The analysis of polymorphic haplotypes (Fig. I) revealed 
a number of historical recombinations involving the 
markers flanking the HMSNL region, namely the centro-
meric group 4JF08, D8S557, D8SI835 and D8S558, and 
the telomeric group D8S256, D8S 1708, D8S 1746, 
D8S 1796 and D8S 1462. 
In the telomeric part of the region, haplotype diversity has 
been generated by historical recombinations occurring 
mainly around microsatellite D8S256. For the purposes of 
refining the HMSNL interval, breakpoints centromeric of 
D8S256 are of particular interest. Two such historical 
recombinations had been found in the initial study of the 
Lom family (Fig. I, haplotypes EO, El, L3 and E2, FO and 
Fl) and two more were identified in the current collection of 
affected families (Fig. 1, haplotypes 13 and S). The analysis 
of newly identified microsatellites centromeric to D8S256 
has shown that in one of these haplotypes (EO, El, L3/E2), 
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the crossover is between D8S256 and the newly identified 
marker 474CA I (Fig. I). The breakpoints in the other three 
historical recombinations are more proximal and useful for 
the relined mapping of the gene localisation. The recombi-
nation has occurred between 474CA I and the next proximal 
marker 369CA2 in one haplotype (Fo, Fl ). In the remaining 
two haplotypes (J3, S), the breakpoints map to the interval 
369a89-369CA3, thus placing the telomeric boundary of the 
HMSNL interval centromeric of marker 369CA3. 
In the centromeric group of nanking markers, a number of 
independent recombination events has generated a diversity 
of haplotypcs. In most cases, the breakpoints of these histor-
ical recombinations map between D8S 1835 and D8S558 
and are therefore of no relevance to narrowing down the 
previously defined HMSNL region. The historical recombi-
nation involving marker D8S558 (Fig. I, haplotype M), 
identified during the initial analysis ll ], was shown in this 
study to be confined to the original Lom family. 
Within the interval D8S558-369CA3, nearly identical 
haplotypes were shared by the vast majority of disease chro-
mosomes. The only variation observed was at markers 
D8S378, 189CA 17, 339CA2 and 458b 14 which presented 
with several alleles (Fig. I). The fact that these four markers 
are flanked by conserved haplotypes suggests that the 
observed differences are the product of microsatellite muta-
tions rather than historical recombinations. In most cases, 
the variant allele occurred on a specific haplotype back-
ground, suggesting secondary founder effect. With the 
exception of this variation, the markers in the interval 
formed a highly conserved haplotype observed in 90% of 
the HMSNL chromosomes (I 08 out of 120 analyzed). This 
haplotype has not been found on any of the 88 normal chro-
mosomes tested. 
Unusual haplotypes (Fig. I, haplotypes Q to V) were 
found in 12 HMSNL chromosomes from six different 
families that originate from divergent Romani groups. 
One of these was obviously the product of a maternal 
recombination. In four families, the recombinant haplotype 
was inherited by all affected members, pointing to historical 
recombinations. Tracing the recombination was not possible 
in one case, where only an affected individual and no other 
family members were available for analysis. 
In the latter case (Fig. I, haplotype V) unusual alleles 
were found for all markers centromeric to. pJ 19, suggesting 
that the recombination occurred between markers SLAP and 
pJI9. 
The only recent recombination was observed in indivi-
dual RS from an affected family from Bulgaria (Fig. 2). R5 
has inherited the normal maternal chromosome for the 
entire interval centromeric to pJ I 0. Similar to the other 
affected members of the family, he is homozygous for the 
common disease haplotype in the telomeric part of the 
region. 
In family G (Fig. 3), the paternal disease chromosome of 
affected individual G 12 carries the usual HMSNL haplotype 
(A0), whereas the maternal chromosome (haplotype T) is 
different for the entire region centromeric to pJ 10; 012 is 
also homozygous for the predominant disease haplotype in 
the tclomeric region (Figs. I and 3). In the same large 
kindred (Fig. 3), individual G 19 is closely related to the 
HMSNL branch of the extended family and has inherited 
the common disease haplotype (A11) along the entire 
HMSNL region. This haplotype has been transmitted to 
her two daughters, G21 and G22. The father in this nuclear 
family, G20, originates from the same community. His 
transmitted chromosome carries the high risk haplotype 
for the whole interval centromeric to pJ I 0 (inclusive) and 
a totally diiTcrcnl distal haplotype. The two daughters, G21 
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Fig. 2. Pedigree R. Abbreviated haplotypes for HMSNL region showing 
maternal recombination in RS, with the breakpoint mapping telomeric of 
pJ I 0. Haplotype designations as shown in Fig. I are noted at the bottom of 
haplotype bars. 
343 
D. Clrmul/er ct a/. I Neumnllt.Vcu/ar Di.vort!er.1· 10 (2000) 584-591 589 
and G22, are not affected by HMSNL. It appears probable 
that the two recombinant haplotypes segregating in this 
small endogamous Gypsy group are in fact the product of 
a single recombination event. 
In the Spanish HMSNL family (Figs. I and 4), the mater-
nal haplotype (S) inherited by the three affected children is 
different from the common disease haplotype for the entire 
region centromeric of pJ 10 and also for the telomeric part of 
the region, distal to 369CA3. All three affected individuals 
in this family are homozygous for the typical haplotype 
shared by all HMSNL chromosomes in the interval flanked 
by pJ I 0 and 369CA3. 
The recombinant haplotype (R) segregating in lhe Slove-
ni~n family [6) was found to occur on the disease chromo-
somes of two unrelated HMSNL carriers. The 
recombination in this case clearly involved pJ 10 and its 
proximal markers. The adjacent telomeric marker, 458b 14 
also presented with an unusual allele (Fig. I) which was 
conservativ'ely attributed to a microsatellite mutation, simi-
lar to those observed in the non~recombinant haplotypes of 
the B group (Fig. I). 
Haplotype Q (Fig. I), with unusual allele sizes for the 
markers centromeric of pJlO (inclusive), was identified in 
two affected siblings referred for analysis from France. 
All centromeric recombinant haplotypes observed in this 
study are shown at the bottom of Fig. J. The lack of simi-
larity between them indicates that they have been generated 
by independent crossover events. In most cases the break-
... points map to the same region between markers pJlO and 
458b 14, suggesting that it contains a recombination hot 
spot. 
The results of the recombination mapping thus place the 
HMSNL gene in the interval flanked by newly identified 
microsatellites pJlO and 369CA3. Within this interval, a 
highly conserved four-marker haplotype is shared by all 
120 HMSNL chromosomes. Our physical mapping data [ ~ indicate that the overall distance between these two 
~ f markers, contained in two overlapping BAC clones, is 
l only 206 kb. 
l 
' l 
, . 4. Discussion 
The investigation of a large number of patients from 
: . different countries has demonstrated that hereditary motor 
and sensory neuropathy type Lom presents with a consistent 
phenotype allowing the establishment of specific diagnostic 
criteria. Apart from the early onset and marked reduction of 
motor nerve conduction velocities, the manifestation that 
allows the clinical distinction of HMSNL from other auto-
somal recessive demyelinating peripheral neuropathies is 
the development of deafness in the second or third decade 
of life. Abnormal BAEP recording are invariably observed 
in all affected individuals before the onset of subjective 
hearing loss and are therefore an important diagnostic 
tool. The neuropathological features of HMSNL are also 
distinctive and point to a characteristic combination of defi-
cient Schwarm cell function and early and severe loss of 
axons. These findings do not allow any conclusions to be 
drawn concerning the localisation of the primary defect (in 
the axon or the Schwann cell) and in fact indicate that the 
genetic defect in HMSNL may affect the complex system of 
Schwa1111 cell/axon interaction and signalling. 
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possibly complementary hi~toricul recombinants in G21, G22 (unaffected) 
and G 12 (affected). Haplotype designations as shown in Fig. I are noted at 
the bottom of haplotype bars. 
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D8S558 
SP2 SP1 
6 6 6 1 4838·T3 1 1 2 1 339CA2 ? ? ? ? 339CAI 4 3 3 3 543b76 1 1 1 1 
543CAI 1 1 2 1 
423rl33 1 1 1 1 189CAI7 2 1 3 1 
AFMJI6 2 1 2 1 
326CA3 2 4 1 7 
326CAI 1 1 2 1 
326CA2 1 2 3 2 
D8S378 5 2 3 2 
SLAP 6 1 3 5 
£JI9 2 1 2 2 
DB 529 3 8 6 6 
pJIO 5 1 4 4 
458bl4 1 2 2 5 
458al3 1 3 3 3 
458b57 4 6 6 4 
369a89 6 2 2 7 
369CA3 4 2 1 1 
369CA2 2 2 3 3 
474CAI 2 2 2 2 
D8S256 3 8 2 8 
Haplotyp~ nam~ c s 
SP3 SP4 SP5 SP6 
D8S558 6 6 6 6 6 6 6 1 
4838-T3 1 2 1 2 1 2 1 1 
339CA2 ? ? ? ? ? ? ? ? 
339CAI 3 3 3 3 3 3 3 3 
543b76 1 1 1 1 1 1 1 1 
543CAI 1 2 1 2 1 2 1 1 
423rl33 1 1 1 1 1 1 1 1 
189CAI7 1 3 1 3 1 3 1 1 
AFMI16 1 2 1 2 1 2 1 1 
326CA3 4 1 4 1 4 1 4 7 
326CAI 1 2 1 2 1 2 1 1 
326CA2 2 3 2 3 2 3 2 2 
D8S378 2 3 2 3 2 3 2 2 
SLAP 1 3 1 3 1 3 1 5 
pJI9 1 2 1 2 1 2 1 2 
D8S529 8 6 8 6 8 6 8 6 
pJIO 1 4 1 4 1 4 1 4 
458bl4 2 2 2 2 2 2 2 5 
458al3 3 3 3 3 3 3 3 3 
458b57 6 6 6 6 6 6 6 4 
369a89 2 2 2 2 2 2 2 7 
369CA3 2 1 ? ? ? ? 2 1 
369CA2 2 3 ? ? ? ? 2 3 
474CAI 2 2 2 2 2 2 2 2 
D8S256 8 2 8 2 8 2 8 8 
Haplotyp~ name cs cs cs cs 
Fig. 4. Pedigree SP (Spanish). Abbrc1•iatetl haplotypcs for HMSNL region 
showing historical recombination between pJ 10 nntl 458B 14. Haplotype 
designations as shown in Fig. I are noted at the bottom of haplotype 
bars. Uninformative markers centromeric of a breakpoint are indicated by 
a thin vertical line. 
The observed clinical homogeneity is mirrored in the 
genetic findings. Both the shared region of homozygosity 
and the closely related flanking haplotypes unambiguously 
point to a single founder mutation responsible for the disor-
der in affected individuals across Europe. 
This collaborative study of affected families across 
Europe identified a number of historical recombinations 
confined to individual divergent Gypsy groups. The infor-
mation derived from these independent recombination 
events has allowed us to define precisely the HMSNL 
gene interval and reduce its size to a small physical distance 
of about 200 kb. 
Four of the microsatellites identified in this study, namely 
458b 14-458a 13-458b57-369a89, are located within the 
critical region. Despite the fact that 458b14 displays some 
variation most likely resulting from marker mutations, the 
remaining three microsatellites form the highly conserved 
haplotype 3-6-2 (respectively for 458a l3-458b57-369a89) 
shared by the.120 HMSNL chromosomes and absent in the 
88 normal chromosomes tested. While the search for the 
HMSNL mutation is in progress, these highly informative 
polymorphisms can be used for carrier testing and prenatal 
diagnosis based on linkage analysis in known high risk 
families. 
This study also leads to some general conclusions rele-
vant to future research into genetic disorders among the 
Roma. A number of reports on hereditary neurological 
disorders among the Roma have been published over the 
last few years, e.g. limb-girdle muscular dystrophy 
LGMD2C [9, I 0], the congenital cataracts facial dysmorph-
ism neuropathy (CCFDN) syndrome [ 1 I, 12] and congenital 
myasthenia [ 1 3, 14] and this population is likely to attract 
interest in the future as well. 
The emerging pattern can be summarised as follows: (a) 
Gene frequencies are often very high [I ,2, 10], therefore a 
rare or novel disorder identified in a single family should be 
considered a first indicator of a possibly common disease. 
(b) The Gypsy population of Europe consists of a large 
number of dispersed small communities which have split 
from a common ancestral population. The subsequent diver-
sification of polymorphic haplotypes around an old disease 
mutation, as shown in this study, can be a powerful tool in 
the refined genetic mapping. International collaborative 
efforts would be the most productive approach to the iden-
tification and study of affected families in this interesting 
founder population which has no geographical boundaries. 
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